Sentence,class,file
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/13/ba/main.PMC5447440.pdf
"Recently, a growing body of literature demonstrates that enhanced spinal neuroimmune and neuroinﬂammatory activities http://dx.doi.org/10.1016/j.jsps.2017.04.039 1319-0164/ /C2112017 Production and hosting by Elsevier B.V. on behalf of King Saud University.",Non-OADS,/arxiv_data1/oa_pdf/13/ba/main.PMC5447440.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).⇑Corresponding author.,Non-OADS,/arxiv_data1/oa_pdf/13/ba/main.PMC5447440.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6f/cc/main.PMC5447441.pdf
The application of ‘‘Activating http://dx.doi.org/10.1016/j.jsps.2017.04.023 1319-0164/ /C2112017 Production and hosting by Elsevier B.V. on behalf of King Saud University.,Non-OADS,/arxiv_data1/oa_pdf/6f/cc/main.PMC5447441.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).⇑Corresponding author.,Non-OADS,/arxiv_data1/oa_pdf/6f/cc/main.PMC5447441.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/14/35/main.PMC5447442.pdf
http://dx.doi.org/10.1016/j.jsps.2017.04.018 1319-0164/ /C2112017 Production and hosting by Elsevier B.V. on behalf of King Saud University.,Non-OADS,/arxiv_data1/oa_pdf/14/35/main.PMC5447442.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).⇑Corresponding authors.,Non-OADS,/arxiv_data1/oa_pdf/14/35/main.PMC5447442.pdf
5276130. http://dx.doi.org/10.1155/2016/5276130 .,Non-OADS,/arxiv_data1/oa_pdf/14/35/main.PMC5447442.pdf
http://dx.doi.org/10.3390/ijms1707099 .,Non-OADS,/arxiv_data1/oa_pdf/14/35/main.PMC5447442.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/86/6a/main.PMC5447443.pdf
http://dx.doi.org/10.1016/j.jsps.2017.05.001 1319-0164/ /C2112017 The Authors.,OADS,/arxiv_data1/oa_pdf/86/6a/main.PMC5447443.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).⇑Corresponding author.,Non-OADS,/arxiv_data1/oa_pdf/86/6a/main.PMC5447443.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ef/4b/main.PMC5447444.pdf
It is mainly used to treat the deﬁciency of kidney-yang (leading http://dx.doi.org/10.1016/j.jsps.2017.04.020 1319-0164/ /C2112017 Production and hosting by Elsevier B.V. on behalf of King Saud University.,Non-OADS,/arxiv_data1/oa_pdf/ef/4b/main.PMC5447444.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: MPS, menopausal syndrome; PGC, Polyethylene Glycosides of Cistanche; HPGC, high doses of Phenylethanoid Glycosides of Cistanche; MPGC, medium doses of Phenylethanoid Glycosides of Cistanche; LPGC, low doses of Phenylethanoid Glycosides of Cistanche; T, testosterone; E2, Estradiol; LH, luteiniz-ing hormone; FSH, follicle-stimulating hormone.",Non-OADS,/arxiv_data1/oa_pdf/ef/4b/main.PMC5447444.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b2/4d/main.PMC5447445.pdf
http://dx.doi.org/10.1016/j.jsps.2017.04.019 1319-0164/ /C2112017 Production and hosting by Elsevier B.V. on behalf of King Saud University.,Non-OADS,/arxiv_data1/oa_pdf/b2/4d/main.PMC5447445.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).⇑Corresponding authors at: School of Life Sciences, Jilin University, Changchun 130012, China (J. Xie).",Non-OADS,/arxiv_data1/oa_pdf/b2/4d/main.PMC5447445.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9d/8c/main.PMC5447446.pdf
http://dx.doi.org/10.1016/j.jsps.2017.04.030 1319-0164/ /C2112017 The Authors.,OADS,/arxiv_data1/oa_pdf/9d/8c/main.PMC5447446.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).⇑Corresponding author.,Non-OADS,/arxiv_data1/oa_pdf/9d/8c/main.PMC5447446.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d4/2a/main.PMC5447451.pdf
Notch mediates vascular endothe- http://dx.doi.org/10.1016/j.jsps.2017.04.037 1319-0164/ /C2112017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d4/2a/main.PMC5447451.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).⇑Corresponding author.,Non-OADS,/arxiv_data1/oa_pdf/d4/2a/main.PMC5447451.pdf
Published by Elsevier B.V. on behalf of King Saud University This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7f/7e/main.PMC5447452.pdf
http://dx.doi.org/10.1016/j.jsps.2017.04.024 1319-0164/ /C2112017 The Authors.,OADS,/arxiv_data1/oa_pdf/7f/7e/main.PMC5447452.pdf
Published by Elsevier B.V. on behalf of King Saud University This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).⇑Corresponding author.,Non-OADS,/arxiv_data1/oa_pdf/7f/7e/main.PMC5447452.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c4/8f/main.PMC5447453.pdf
"Recently, it has been reported that http://dx.doi.org/10.1016/j.jsps.2017.04.035 1319-0164/ /C2112017 Production and hosting by Elsevier B.V. on behalf of King Saud University.",Non-OADS,/arxiv_data1/oa_pdf/c4/8f/main.PMC5447453.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).⇑Corresponding authors at: Department of Immunology, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, China (D. Zuo).",Non-OADS,/arxiv_data1/oa_pdf/c4/8f/main.PMC5447453.pdf
"Supplementary material Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.jsps.2017.04.035 .",OADS,/arxiv_data1/oa_pdf/c4/8f/main.PMC5447453.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ca/1c/main.PMC5447454.pdf
"(2006) , which was stated as http://dx.doi.org/10.1016/j.jsps.2017.04.027 1319-0164/ /C2112017 The Authors.",OADS,/arxiv_data1/oa_pdf/ca/1c/main.PMC5447454.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).⇑Corresponding author at: School of Information Science and Technology, Yunnan Normal University, Kunming 650500, China.",Non-OADS,/arxiv_data1/oa_pdf/ca/1c/main.PMC5447454.pdf
"Chem., 10 http://dx.doi.org/10.1155/2017/6540754 6540754.",Non-OADS,/arxiv_data1/oa_pdf/ca/1c/main.PMC5447454.pdf
"Chem., 8 http://dx.doi.org/10.1155/2016/ 3216327 3216327.",Non-OADS,/arxiv_data1/oa_pdf/ca/1c/main.PMC5447454.pdf
http://dx.doi.org/10.1080/ 10236198.2016.1197214 .,Non-OADS,/arxiv_data1/oa_pdf/ca/1c/main.PMC5447454.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ab/bc/main.PMC5447457.pdf
"Drugs and reagents The Rabdosia rubescens total ﬂavonoids products were from Henan University of TCM analysis chemistry laboratory, and con- tent of total ﬂavonoids was 50.4%, batch number 20120705; nimodipine tablets, provided by Shandong Xinhua Pharmaceutical Co., Ltd. production and batch number 1105036; brain collaterals pass capsule, provided by Harbin Pharmaceutical Group Sanjing Pharmaceutical Factory Co., Ltd production, batch 201109002; sodium carboxymethyl cellulose, provided by Tianjin Hengxing chemical reagent manufacturing Co., Ltd. Production and the batch number of it is 20060728; chloral hydrate, products from Pu Shan http://dx.doi.org/10.1016/j.jsps.2017.04.032 1319-0164/ /C2112017 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/ab/bc/main.PMC5447457.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).⇑Corresponding author.,Non-OADS,/arxiv_data1/oa_pdf/ab/bc/main.PMC5447457.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f7/b3/main.PMC5447458.pdf
http://dx.doi.org/10.1016/j.jsps.2017.04.028 1319-0164/ /C2112017 Production and hosting by Elsevier B.V. on behalf of King Saud University.,Non-OADS,/arxiv_data1/oa_pdf/f7/b3/main.PMC5447458.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).⇑Corresponding author.,Non-OADS,/arxiv_data1/oa_pdf/f7/b3/main.PMC5447458.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1c/30/main.PMC5447459.pdf
(1998) as ABC 1ðGÞ¼X uv2EðGÞﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ dðuÞþdðvÞ/C02 dðuÞdðvÞs : http://dx.doi.org/10.1016/j.jsps.2017.04.021 1319-0164/ /C2112017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1c/30/main.PMC5447459.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).⇑Corresponding author.,Non-OADS,/arxiv_data1/oa_pdf/1c/30/main.PMC5447459.pdf
"Article ID 6540754, 10 pages, doi: http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/1c/30/main.PMC5447459.pdf
"Methods Med., Article ID 418106, 10 pages, doi: http://dx.doi.org/10.1155/2015/418106 .",Non-OADS,/arxiv_data1/oa_pdf/1c/30/main.PMC5447459.pdf
"Chem., Article ID 1053183, 7 pages, doi: http://dx.doi.org/10.1155/2016/1053183 .",OADS,/arxiv_data1/oa_pdf/1c/30/main.PMC5447459.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/65/6b/main.PMC5447507.pdf
http://dx.doi.org/10.1016/j.ijscr.2017.05.008 2210-2612/© 2017  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/65/6b/main.PMC5447507.pdf
"34  (Oct,  2016)  180–186,  http://dx.doi.org/10.1016/j.ijsu.2016.08.014 , Epub 2016  Sep  7.",Non-OADS,/arxiv_data1/oa_pdf/65/6b/main.PMC5447507.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bd/31/main.PMC5447508.pdf
Contents lists available at ScienceDirect International Journal for Parasitology: Parasites and Wildlife journal homepage: www.elsevier.com /locate/ijppaw http://dx.doi.org/10.1016/j.ijppaw.2017.04.006 2213-2244/Published by Elsevier Ltd on behalf of Australian Society for Parasitology.,Non-OADS,/arxiv_data1/oa_pdf/bd/31/main.PMC5447508.pdf
http://content.govdelivery.com/attachments/USDAAPHIS/2014/07/11/ ﬁle_ attachments/306647/Draft%2BNilgai%2BEA%2BComplete.pdf .,Non-OADS,/arxiv_data1/oa_pdf/bd/31/main.PMC5447508.pdf
"Texas Animal Health Commission, 2016. http://www.tahc.texas.gov/animal_health/ cattle/ .",Non-OADS,/arxiv_data1/oa_pdf/bd/31/main.PMC5447508.pdf
http://irnr.tamu.edu/pdf/cameras.pdf .,Non-OADS,/arxiv_data1/oa_pdf/bd/31/main.PMC5447508.pdf
"For instance, in a positron emissiontomography study ( Weiller et al., 1995 ), Weiller and colleagues found http://dx.doi.org/10.1016/j.nicl.2017.05.013 Received 1 January 2017; Received in revised form 4 May 2017; Accepted 20 May 2017⁎Corresponding authors.",OADS,/arxiv_data1/oa_pdf/19/ee/main.PMC5447510.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/19/ee/main.PMC5447510.pdf
"ALFF analysis The fMRI data preprocessing was performed using Data Processing Assistant for Resting-State fMRI (DPARSF) software (available at: http://rfmri.org/DPARSF ) in MATLAB (Mathworks, Inc., Natick, Massachusetts).",OADS,/arxiv_data1/oa_pdf/19/ee/main.PMC5447510.pdf
"ﬁl.ion.ucl.ac.uk/spm ) and a Resting- State fMRI Data Analysis Toolkit ( http://www.restfmri.net )(Song et al., 2011 ).",OADS,/arxiv_data1/oa_pdf/19/ee/main.PMC5447510.pdf
http://dx.doi.org/10.1038/nrn3057 .,Non-OADS,/arxiv_data1/oa_pdf/19/ee/main.PMC5447510.pdf
"Rep. 4, 6482. http://dx.doi.org/10.1038/srep06482 .",Non-OADS,/arxiv_data1/oa_pdf/19/ee/main.PMC5447510.pdf
"Pain 11, 67. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/19/ee/main.PMC5447510.pdf
http://dx.doi.org/10.1152/jn.00167.2011 .,Non-OADS,/arxiv_data1/oa_pdf/19/ee/main.PMC5447510.pdf
http://dx.doi.org/10.1016/S1474-4422(06)70382-9 .,OADS,/arxiv_data1/oa_pdf/19/ee/main.PMC5447510.pdf
"193, 63 –68.http://dx.doi.org/10.1016/j.bbr.2008.04.020 .",OADS,/arxiv_data1/oa_pdf/19/ee/main.PMC5447510.pdf
http://dx.doi.org/10.1016/j.nicl.2015.09.012 .,OADS,/arxiv_data1/oa_pdf/19/ee/main.PMC5447510.pdf
http://dx.doi.org/10.1111/j.1526-4610.2007.00916.x .,Non-OADS,/arxiv_data1/oa_pdf/19/ee/main.PMC5447510.pdf
http://dx.doi.org/10.1038/nrn1431 .,Non-OADS,/arxiv_data1/oa_pdf/19/ee/main.PMC5447510.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/19/ee/main.PMC5447510.pdf
http://dx.doi.org/10.1016/j.pain.2010.10.012 .,OADS,/arxiv_data1/oa_pdf/19/ee/main.PMC5447510.pdf
http://dx.doi.org/10.1016/j.neuroimage.2010.11.059 .,OADS,/arxiv_data1/oa_pdf/19/ee/main.PMC5447510.pdf
"117, 13 –20.http://dx.doi.org/10.1016/j.schres.2009.09.",OADS,/arxiv_data1/oa_pdf/19/ee/main.PMC5447510.pdf
http://dx.doi.org/10.1002/hbm.,Non-OADS,/arxiv_data1/oa_pdf/19/ee/main.PMC5447510.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/19/ee/main.PMC5447510.pdf
http://dx.doi.org/10.1016/j.pain.2009.11.008 .,OADS,/arxiv_data1/oa_pdf/19/ee/main.PMC5447510.pdf
http://dx.doi.org/10.1212/WNL.0000000000001610 .,Non-OADS,/arxiv_data1/oa_pdf/19/ee/main.PMC5447510.pdf
http://dx.doi.org/10.1007/ s10194-005-0252-4 .,Non-OADS,/arxiv_data1/oa_pdf/19/ee/main.PMC5447510.pdf
http://dx.doi.org/10.1111/j.,Non-OADS,/arxiv_data1/oa_pdf/19/ee/main.PMC5447510.pdf
"J. Headache Pain 16, 1 –10.http://dx.doi.org/10.1186/s10194-015-0518-4 .",Non-OADS,/arxiv_data1/oa_pdf/19/ee/main.PMC5447510.pdf
"Rep. 6, 20298. http://dx.doi.org/10.1038/srep20298 .",Non-OADS,/arxiv_data1/oa_pdf/19/ee/main.PMC5447510.pdf
JAMA.http://dx.doi.org/10.1001/jama.293.17.2118 .,OADS,/arxiv_data1/oa_pdf/19/ee/main.PMC5447510.pdf
http://dx.doi.org/10.1002/ana.22537 .,Non-OADS,/arxiv_data1/oa_pdf/19/ee/main.PMC5447510.pdf
http://dx.doi.org/10.1016/j.pain.2008.02.034 .,OADS,/arxiv_data1/oa_pdf/19/ee/main.PMC5447510.pdf
http://dx.doi.org/10.1148/radiol.12111429 .,Non-OADS,/arxiv_data1/oa_pdf/19/ee/main.PMC5447510.pdf
http://dx.doi.org/10.1007/s11682-015-9478-1 .,Non-OADS,/arxiv_data1/oa_pdf/19/ee/main.PMC5447510.pdf
"2, 25 –32.http://dx.doi.org/10.1089/brain.2012.",Non-OADS,/arxiv_data1/oa_pdf/19/ee/main.PMC5447510.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/19/ee/main.PMC5447510.pdf
"14, 81 –91.http://dx.doi.org/10.1016/S1474-4422(14) 70193-0 .",Non-OADS,/arxiv_data1/oa_pdf/19/ee/main.PMC5447510.pdf
http://dx.doi.org/10.1111/j.,Non-OADS,/arxiv_data1/oa_pdf/19/ee/main.PMC5447510.pdf
http://dx.doi.org/10.1371/journal.pone.,Non-OADS,/arxiv_data1/oa_pdf/19/ee/main.PMC5447510.pdf
http://dx.doi.org/ 10.1212/WNL.0b013e318227e4a8 .,Non-OADS,/arxiv_data1/oa_pdf/19/ee/main.PMC5447510.pdf
http://dx.doi.org/10.1523/JNEUROSCI.4496-10.2011 .,Non-OADS,/arxiv_data1/oa_pdf/19/ee/main.PMC5447510.pdf
http://dx.doi.org/10.1097/01.wco.0000227039.,Non-OADS,/arxiv_data1/oa_pdf/19/ee/main.PMC5447510.pdf
"30. http://dx.doi.org/10.1007/s10072-009- 0066-2 .Van Rossum, D., Hanisch, U.K., Quirion, R., 1997.",Non-OADS,/arxiv_data1/oa_pdf/19/ee/main.PMC5447510.pdf
http://dx.doi.org/10.1016/S0149- 7634(96)00023-1 .,OADS,/arxiv_data1/oa_pdf/19/ee/main.PMC5447510.pdf
"2015, 920353. http://dx.doi.org/ 10.1155/2015/920353 .",Non-OADS,/arxiv_data1/oa_pdf/19/ee/main.PMC5447510.pdf
http://dx.doi.org/10.1007/s40263-015-0253-z .,Non-OADS,/arxiv_data1/oa_pdf/19/ee/main.PMC5447510.pdf
http://dx.doi.org/10.1002/nbm.2917 .,Non-OADS,/arxiv_data1/oa_pdf/19/ee/main.PMC5447510.pdf
http://dx.doi.org/10.1016/j.neuroimage.2013.03.004 .,OADS,/arxiv_data1/oa_pdf/19/ee/main.PMC5447510.pdf
"12, 123. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/19/ee/main.PMC5447510.pdf
"29, 83 –91.http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/19/ee/main.PMC5447510.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/19/ee/main.PMC5447510.pdf
http://dx.doi.org/10.1371/journal.pone.0099538 .,Non-OADS,/arxiv_data1/oa_pdf/19/ee/main.PMC5447510.pdf
http://dx.doi.org/10.3988/ jcn.2014.10.3.229 .,Non-OADS,/arxiv_data1/oa_pdf/19/ee/main.PMC5447510.pdf
http://dx.doi.org/10.1001/jamainternmed.2016.,OADS,/arxiv_data1/oa_pdf/19/ee/main.PMC5447510.pdf
http://dx.doi.org/10.1016/j.neuroimage.2009.07.006 .,OADS,/arxiv_data1/oa_pdf/19/ee/main.PMC5447510.pdf
http://dx.doi.org/10.1016/j.neuroimage.2009.09.037 .Z.,OADS,/arxiv_data1/oa_pdf/19/ee/main.PMC5447510.pdf
This  is  an  open access article under the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fe/f4/main.PMC5447511.pdf
"Mobilization of  the  right  colon  was  performed,  a  4-cm  right  pararectal  incision http://dx.doi.org/10.1016/j.ijscr.2017.05.010 2210-2612/© 2017  The  Author(s).",Non-OADS,/arxiv_data1/oa_pdf/fe/f4/main.PMC5447511.pdf
"(2016),  http://dx.doi.org/10.1155/2016/5623718 (Epub  December  2015  27).",Non-OADS,/arxiv_data1/oa_pdf/fe/f4/main.PMC5447511.pdf
"22  (May  (19))  (2016)  4781–4785, http://dx.doi.org/10.3748/wjg.v22.i19.4781 .",Non-OADS,/arxiv_data1/oa_pdf/fe/f4/main.PMC5447511.pdf
"91  (November  (8))  (2009)  W7–W8,  http://dx.doi.org/10.1308/ 147870809X450601 .",Non-OADS,/arxiv_data1/oa_pdf/fe/f4/main.PMC5447511.pdf
"Case  Rep.  2  (6)  (2011)  118–121,  http://dx.doi.org/10.1016/j.ijscr.2011.03.001 (Epub  2011  April  12).",OADS,/arxiv_data1/oa_pdf/fe/f4/main.PMC5447511.pdf
"16  (May (5))  (2012)  1076–1077,  http://dx.doi.org/10.1007/s11605-012-1848-z ,  Epub 2012  Feb  28.",Non-OADS,/arxiv_data1/oa_pdf/fe/f4/main.PMC5447511.pdf
"19  (March  (9))  (2013)  1489–1493, http://dx.doi.org/10.3748/wjg.v19.",Non-OADS,/arxiv_data1/oa_pdf/fe/f4/main.PMC5447511.pdf
"Understanding how gender in ﬂuences vulnerability http://dx.doi.org/10.1016/j.nicl.2017.05.014 Received 4 February 2017; Received in revised form 27 April 2017; Accepted 21 May 2017⁎Corresponding author at: Department of Medical Imaging and Radiological Sciences, Chung Shan Medical University, No.",Non-OADS,/arxiv_data1/oa_pdf/94/b5/main.PMC5447512.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/94/b5/main.PMC5447512.pdf
http://dx.doi.org/10.1016/j.idcr.2017.05.007 Received 26 April 2017; Received in revised form 10 May 2017; Accepted 10 May 2017E-mail address: fabrice.bouscarat@aphp.fr (F. Bouscarat).IDCases 9 (2017) 28–29 2214-2509/ © 2017 The Author.,Non-OADS,/arxiv_data1/oa_pdf/43/1e/main.PMC5447513.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/43/1e/main.PMC5447513.pdf
These http://dx.doi.org/10.1016/j.redox.2017.05.009 Received 11 April 2017; Received in revised form 12 May 2017; Accepted 17 May 2017⁎Corresponding authors.,OADS,/arxiv_data1/oa_pdf/81/56/main.PMC5447514.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/81/56/main.PMC5447514.pdf
This  is  an  open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9d/18/main.PMC5447516.pdf
http://dx.doi.org/10.1016/j.ijscr.2017.04.026 2210-2612/© 2017  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/9d/18/main.PMC5447516.pdf
"Altman,  D.  Moher,  H.  Sox,  D.  Riley,  CARE  Group,  The CARE  guidelines:  consensus-based  clinical  case  reporting  guideline development,  BMJ  Case  Rep.  (2013),  http://dx.doi.org/10.1136/bcr-2013- 201554 .",Non-OADS,/arxiv_data1/oa_pdf/9d/18/main.PMC5447516.pdf
This  is  an  open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d4/72/main.PMC5447517.pdf
At  that  time  a  breast  seroma  or  capsular  contracture  was  sus- http://dx.doi.org/10.1016/j.ijscr.2017.05.023 2210-2612/© 2017  The  Author(s).,Non-OADS,/arxiv_data1/oa_pdf/d4/72/main.PMC5447517.pdf
"Guarantor Alexandre Mendonc ¸  a  Munhoz References [1]  American  Society  of  Plastic  Surgeons,  2013  Cosmetic  Plastic  Surgery  Statistics, 2013,  Available  at:  http://www.plasticsurgery.org/news/plastic-surgery- statistics/2013.html  (Accessed  8  May  2014).",Non-OADS,/arxiv_data1/oa_pdf/d4/72/main.PMC5447517.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e0/96/main.PMC5447518.pdf
Contents lists available at ScienceDirect International Journal for Parasitology: Parasites and Wildlife journal homepage: www.elsevier.com /locate/ijppaw http://dx.doi.org/10.1016/j.ijppaw.2017.04.004 2213-2244/ ©2017 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/e0/96/main.PMC5447518.pdf
Avaliable in: http://portal.cfmv.gov.br/portal/lei/index/id/326 .,OADS,/arxiv_data1/oa_pdf/e0/96/main.PMC5447518.pdf
http://repositorio.unesp.br/bitstream/handle/11449/ 110418/000786523.pdf?sequence ¼1.,Non-OADS,/arxiv_data1/oa_pdf/e0/96/main.PMC5447518.pdf
"Copyright © 2017  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7e/93/aps-44-177.PMC5447525.pdf
ORCID Kyu-Jin Chung http://orcid.org/0000-0001-6335-1818 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/7e/93/aps-44-177.PMC5447525.pdf
Available from: http://publishingresearchconsortium.com/index.php/112-  prc-projects/research-reports/peer-review-in-scholarly-jour - nals-research-report/142-peer-review-in-scholarly-journals- perspective-of-the-scholarly-community-an-international- study.,Non-OADS,/arxiv_data1/oa_pdf/7e/93/aps-44-177.PMC5447525.pdf
"Copyright © 2017  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/33/fd/aps-44-179.PMC5447526.pdf
"http://doi.org/10.1002/rcs.1754 [23],  with permission of John Wiley and  Sons via Copyright Clearance Center.",Non-OADS,/arxiv_data1/oa_pdf/33/fd/aps-44-179.PMC5447526.pdf
"http://doi.org/10.1002/rcs.1754 [23], with permission of John Wiley and Sons via Copyright Clearance Center.",Non-OADS,/arxiv_data1/oa_pdf/33/fd/aps-44-179.PMC5447526.pdf
"Adapted from http://ossovr.com [31], with permis-sion of OssoVR.",Non-OADS,/arxiv_data1/oa_pdf/33/fd/aps-44-179.PMC5447526.pdf
Available from:  http://www.geomagic.com/en/products-landing-pages/haptic.,Non-OADS,/arxiv_data1/oa_pdf/33/fd/aps-44-179.PMC5447526.pdf
Avail - able from: http://www.immersivetouch.com.,Non-OADS,/arxiv_data1/oa_pdf/33/fd/aps-44-179.PMC5447526.pdf
http://doi.org/10.1002/ rcs.1754.,Non-OADS,/arxiv_data1/oa_pdf/33/fd/aps-44-179.PMC5447526.pdf
Available from: http://www.swemac.com/simulators/trau - mavision.,Non-OADS,/arxiv_data1/oa_pdf/33/fd/aps-44-179.PMC5447526.pdf
Available from: http://ossovr.com.,Non-OADS,/arxiv_data1/oa_pdf/33/fd/aps-44-179.PMC5447526.pdf
Available from: http://caehealthcare.com/eng/interventional-simulators/ neurovr.,Non-OADS,/arxiv_data1/oa_pdf/33/fd/aps-44-179.PMC5447526.pdf
"188Copyright © 2017  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/95/0e/aps-44-188.PMC5447527.pdf
"194Copyright © 2017  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6d/a3/aps-44-194.PMC5447528.pdf
"202Copyright © 2017  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cf/e9/aps-44-202.PMC5447529.pdf
"210Copyright © 2017  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a5/a8/aps-44-210.PMC5447530.pdf
"Copyright © 2017  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/76/a0/aps-44-217.PMC5447531.pdf
"Copyright © 2017  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3f/fa/aps-44-223.PMC5447532.pdf
Available  from: http://www.acgme.org/acgmeweb/portals/0/pdfs/ milestones/plasticsurgeryassessments.pdf.,Non-OADS,/arxiv_data1/oa_pdf/3f/fa/aps-44-223.PMC5447532.pdf
"228Copyright © 2017  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8d/d7/aps-44-228.PMC5447533.pdf
3 / May 2017 233ORCID Daniel Ching http://orcid.org/0000-0003-3327-2582 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/8d/d7/aps-44-228.PMC5447533.pdf
"234Copyright © 2017  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/13/b9/aps-44-234.PMC5447534.pdf
"238Copyright © 2017  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b1/a1/aps-44-238.PMC5447535.pdf
"Copyright © 2017  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/38/77/aps-44-243.PMC5447536.pdf
ORCID Sharad Paul http://orcid.org/0000-0001-9601-9109 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/38/77/aps-44-243.PMC5447536.pdf
Available from: http://www.flir.com/uploadedFiles/Thermography/MMC/Bro - chures/T820340/T820340_EN.pdf.,Non-OADS,/arxiv_data1/oa_pdf/38/77/aps-44-243.PMC5447536.pdf
"Received: 7 Dec 2016 • Revised: 16 Feb 2017 • Accepted: 4 Mar 2017   pISSN: 2234-6163 • eISSN: 2234-6171   https://doi.org/ 10.5999/aps.2017.44.3.248   Arch Plast Surg 2017;44:248-249 Copyright  2017 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c7/f5/aps-44-248.PMC5447537.pdf
"Received: 23 Feb 2017 • Revised: 28 Mar 2017 • Accepted: 28 Mar 2017   pISSN: 2234-6163 • eISSN: 2234-6171   https://doi.org/ 10.5999/aps.2017.44.3.249   Arch Plast Surg 2017;44:249-250 Copyright  2017 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c7/f5/aps-44-248.PMC5447537.pdf
"Received: 23 Feb 2017 • Revised: 28 Mar 2017 • Accepted: 28 Mar 2017   pISSN: 2234-6163 • eISSN: 2234-6171   https://doi.org/ 10.5999/aps.2017.44.3.249   Arch Plast Surg 2017;44:249-250 Copyright  2017 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/87/1b/aps-44-249.PMC5447538.pdf
ORCID T ae Gon Kim http://orcid.org/0000-0002-6738-4630 Kyu-Jin Chung http://orcid.org/0000-0001-6335-1818 Jun Ho Lee http://orcid.org/0000-0002-0062-6420 Y ong-Ha Kim http://orcid.org/0000-0002-1804-9086Fig.,Non-OADS,/arxiv_data1/oa_pdf/87/1b/aps-44-249.PMC5447538.pdf
"Likewise, they are  not expected to be experts unless they are well-versed in male and  female pattern hair loss and have an extensive experience of treating Received: 17 Aug 2016 • Revised: 23 Dec 2016 • Accepted: 3 Feb 2017  pISSN: 2234-6163 • eISSN: 2234-6171   https://doi.org/10.5999/aps.2017.44.3.251  • Arch Plast Surg 2017;44:251-256 Copyright  2017 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution   Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits   unrestricted non-commercial use, distribution, and reproduction in any medium, provided the  original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cc/5c/aps-44-251.PMC5447539.pdf
"This is illustrated by numerous advanced care planning initiatives [ 1,2] taking a comprehensive approach enabling patients to make sure their wishes at the end of life are respected andEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ C427F0600B812386 .",Non-OADS,/arxiv_data1/oa_pdf/7a/09/40122_2016_Article_63.PMC5447540.pdf
"This article is distributed under the terms of the Creative CommonsAttribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, providea link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/7a/09/40122_2016_Article_63.PMC5447540.pdf
2014. http://www.ifd- allensbach.de/uploads/tx_reportsndocs/PD_2014_ 20.pdf .,OADS,/arxiv_data1/oa_pdf/7a/09/40122_2016_Article_63.PMC5447540.pdf
"PGA treatment success, which evaluates the method of pain control, at 24 h was consistent in the high and low BMI groups in patients treated with fentanyl ITS ( \35 kg/m2: 946/1180 [80.2%]; 35–40 kg/m2: 103/136 [75.7%]; andEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ B337F06049744C3E .",Non-OADS,/arxiv_data1/oa_pdf/46/1b/40122_2016_Article_64.PMC5447541.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/46/1b/40122_2016_Article_64.PMC5447541.pdf
Obesity and overweight fact sheet: World Health Organization; 2016. http://www.who.int/mediacentre/factsheets/ fs311/en/ .,Non-OADS,/arxiv_data1/oa_pdf/46/1b/40122_2016_Article_64.PMC5447541.pdf
Potential candidates of bariatric surgery: US Department of Health and HumanServices; 2016. https://www.niddk.nih.gov/health- information/health-topics/weight-control/bariatric- surgery/Pages/potential-candidates.aspx .,Non-OADS,/arxiv_data1/oa_pdf/46/1b/40122_2016_Article_64.PMC5447541.pdf
Keywords: Corticosteroid injection; Shoulder pain; Shoulder stiffness; Shoulder surgeryEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ 5887F0607A2E9A9C .,Non-OADS,/arxiv_data1/oa_pdf/3e/66/40122_2017_Article_65.PMC5447542.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, andindicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/3e/66/40122_2017_Article_65.PMC5447542.pdf
Keywords: Opioid-sparing; Orthopedic surgery; Parecoxib; Postoperative painEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ 6E87F06078C73AD1 .,Non-OADS,/arxiv_data1/oa_pdf/a1/bd/40122_2017_Article_66.PMC5447543.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, andindicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/a1/bd/40122_2017_Article_66.PMC5447543.pdf
2013. http://www.hcup-us.ahrq.gov/reports/ statbriefs/sb149.pdf .,OADS,/arxiv_data1/oa_pdf/a1/bd/40122_2017_Article_66.PMC5447543.pdf
2014. http://www.aaos.org/cc_ﬁles/ aaosorg/research/stats/commonprocedurestreat ments-march2014.pdf .,OADS,/arxiv_data1/oa_pdf/a1/bd/40122_2017_Article_66.PMC5447543.pdf
2016. http://www.medscape.,Non-OADS,/arxiv_data1/oa_pdf/a1/bd/40122_2017_Article_66.PMC5447543.pdf
http://www.postoppain.org/why- prospect/ .,Non-OADS,/arxiv_data1/oa_pdf/a1/bd/40122_2017_Article_66.PMC5447543.pdf
Health care decision makers are entrusted with the task of determining the value of healthEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ 5197F0602F2501B1 .,Non-OADS,/arxiv_data1/oa_pdf/c1/f6/40122_2017_Article_67.PMC5447544.pdf
"The economic burden of opioid misuse has been estimated to be over $78 billion a year in the USA [ 6], with the additional human costs of reduced quality of life, psycho- logical distress, social dysfunction, disorderedEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ 98F7F0607B10EAF6 .",Non-OADS,/arxiv_data1/oa_pdf/df/c1/40122_2017_Article_68.PMC5447545.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any non- commercial use, distribution, and reproduction in any medium, provided you give appropriatecredit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/df/c1/40122_2017_Article_68.PMC5447545.pdf
2012. http://www.samhsa.,Non-OADS,/arxiv_data1/oa_pdf/df/c1/40122_2017_Article_68.PMC5447545.pdf
"October 15, 2016: https://www.statnews.com/2016/ 10/15/trump-opioid-expanded-treatment/ .",Non-OADS,/arxiv_data1/oa_pdf/df/c1/40122_2017_Article_68.PMC5447545.pdf
1988. http://www.who.int/cancer/ palliative/painladder/en/ .,Non-OADS,/arxiv_data1/oa_pdf/df/c1/40122_2017_Article_68.PMC5447545.pdf
NCCN clinical practice guidelinesin oncology (NCCN guidelines) 2014; Version 2.2014. http://www.nccn.org/professionals/physician_gls/ PDF/pain.pdf .,Non-OADS,/arxiv_data1/oa_pdf/df/c1/40122_2017_Article_68.PMC5447545.pdf
2016. http://www.asam.,Non-OADS,/arxiv_data1/oa_pdf/df/c1/40122_2017_Article_68.PMC5447545.pdf
2013. http://www.fda.gov/downloads/ Drugs/GuidanceComplianceRegulatoryInformation/ Guidances/UCM334743.pdf .,Non-OADS,/arxiv_data1/oa_pdf/df/c1/40122_2017_Article_68.PMC5447545.pdf
"Therefore, PCPs must be increasinglyEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ 5708F0606FE96946 .",Non-OADS,/arxiv_data1/oa_pdf/53/0b/40122_2017_Article_69.PMC5447546.pdf
"This article is distributed under the terms of the Creative CommonsAttribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits anynoncommercial use, distribution, and repro- duction in any medium, provided you giveappropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes weremade.",Non-OADS,/arxiv_data1/oa_pdf/53/0b/40122_2017_Article_69.PMC5447546.pdf
Available from: https://www.ncbi.nlm.nih.gov/ books/NBK115543/ .,Non-OADS,/arxiv_data1/oa_pdf/53/0b/40122_2017_Article_69.PMC5447546.pdf
The 5-year period prevalence of opioid use disordersEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ 8818F06008E040C7 .,Non-OADS,/arxiv_data1/oa_pdf/e8/f6/40122_2017_Article_70.PMC5447547.pdf
The dataset analyzed during the current study is available from theUK Medicines and Healthcare Products Regula- tory Agency (MHRA) at: https://www.cprd.com/ dataAccess/ .Open Access.,OADS,/arxiv_data1/oa_pdf/e8/f6/40122_2017_Article_70.PMC5447547.pdf
"This article is distributed under the terms of the Creative CommonsAttribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, providea link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/e8/f6/40122_2017_Article_70.PMC5447547.pdf
Available from: https://www.cprd.com/isac/governance.asp .,Non-OADS,/arxiv_data1/oa_pdf/e8/f6/40122_2017_Article_70.PMC5447547.pdf
Available from: https://data.gov.uk/ dataset/prescription-cost-analysis-england .84 Pain Ther (2017) 6:73–84,Non-OADS,/arxiv_data1/oa_pdf/e8/f6/40122_2017_Article_70.PMC5447547.pdf
These authors found that this scale canEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ CD18F0601DE55336 .,OADS,/arxiv_data1/oa_pdf/14/3f/40122_2017_Article_71.PMC5447548.pdf
"This article is distributed under the terms of the Creative CommonsAttribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in any medium, provided you give appropriate creditto the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.Pain Ther (2017) 6:107–110 109",Non-OADS,/arxiv_data1/oa_pdf/14/3f/40122_2017_Article_71.PMC5447548.pdf
Keywords: Alzheimer’s disease; Informal caregiver; Time and costsEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ 9227F060136E97EF .,Non-OADS,/arxiv_data1/oa_pdf/6e/e5/40120_2016_Article_56.PMC5447549.pdf
"[1], caregivers in the 301 and 302 studies tended to be older on average (65 versus 52 years of age), less likely to be female (60%versus 70% female), and more likely to be t h es p o u s eo ft h es u b j e c t( 7 0 %v e r s u s 6–17%).Table 1 $US unit costs assigned to resource use components of Rud-lite Accommodation Intermediate forms of accommodation (not dementia-speciﬁc) (per day)a$116.71 Dementia-speciﬁc residential accommodation (per day)a$158.04 Long-term institutional care/nursing home -private room (per day)a$261.00 Community services Registered nurse home visits (per visit)b,h$139.08 Home health aide/orderly (per hour)a$21.00 Food delivery/Meals on wheels (per meal)c$8.00 Day care (per day)a$70.00 Transportation (publicly/insurance paid) (round trip)a$20.00 Inpatient care Geriatric (per night)d,h$7220.37 Psychiatric (per night)d,h$7220.37 Internal Medicine (per night)d,h$7220.37 Surgery (per night)d,h$7220.37 Other (per night)d,h$7220.37 ER (per visit)e,h$1401.20 Outpatient care General practitioner (per visit)f,h$148.13 Geriatrician (per visit)f,h$148.13 Neurologist (per visit)f,h$148.13 Psychiatrist (per visit)f,h$148.13 Physiotherapist (per visit)f,h$148.13 Occupational therapist (per visit)f,h$148.13 Social worker (per visit)f,h$148.13 Psychologist (per visit)f,h$148.13 Other (specialist, please specify) (per visit)f,h$148.13 Caregiving time Caregiver informal care time (per hour)g$7.06 aMetlife Mature Market Institute—Market Survey of Long-Term Care Costs (Nov 2012) bCPT code 99349, page 83 of 2008 PF&CG (inﬂated to 2012 dollars) chttp://www.sdslane.org/mow.html dHCUP All cause hospitalization discharges, 2010 (inﬂated to 2012 dollars) eHCUP Emergency Department State Statistics, 2005 (inﬂated to 2012 dollars) fCPT code 99243, page 69 of 2008 PF&CG (inﬂated to 2012 dollars) gEmployment, hours, and earnings from the current employment statistics survey (National) hMedical care inﬂation indexNeurol Ther (2017) 6:11–23 15",Non-OADS,/arxiv_data1/oa_pdf/6e/e5/40120_2016_Article_56.PMC5447549.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, providea link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/6e/e5/40120_2016_Article_56.PMC5447549.pdf
2012. http://www.alz.org/downloads/ facts_ﬁgures_2012.pdf .,Non-OADS,/arxiv_data1/oa_pdf/6e/e5/40120_2016_Article_56.PMC5447549.pdf
21. http://docs.nrdc.org/health/ﬁles/hea_08082601A.,Non-OADS,/arxiv_data1/oa_pdf/6e/e5/40120_2016_Article_56.PMC5447549.pdf
http://www.biostat.,Non-OADS,/arxiv_data1/oa_pdf/6e/e5/40120_2016_Article_56.PMC5447549.pdf
"Furthermore, in groups 1 and 2 patients, 99.0% and 94.3% received a medication for AD monotherapy, 92.3% and 59.6% were prescribed donepezil, and 40.5% and 41.5% discontinued treatment within a year,Enhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ 4327F06005B7FC2A .",Non-OADS,/arxiv_data1/oa_pdf/40/82/40120_2016_Article_57.PMC5447550.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate creditto the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.REFERENCES 1.",Non-OADS,/arxiv_data1/oa_pdf/40/82/40120_2016_Article_57.PMC5447550.pdf
2016. http://www.who.int/mediacentre/factsheets/ fs362/en/ .,Non-OADS,/arxiv_data1/oa_pdf/40/82/40120_2016_Article_57.PMC5447550.pdf
2014. https://mhlw-grants.niph.go.jp/ niph/search/NIDD00.do?resrchNum=201405037A .,Non-OADS,/arxiv_data1/oa_pdf/40/82/40120_2016_Article_57.PMC5447550.pdf
Ain Holdings Inc. http://www.ainj.co.jp/ir/ﬁnance/ summary.html [In Japanese].,OADS,/arxiv_data1/oa_pdf/40/82/40120_2016_Article_57.PMC5447550.pdf
Kraft Inc. http://www.kraft-net.co.jp/sakura/search/ [In Japanese].,Non-OADS,/arxiv_data1/oa_pdf/40/82/40120_2016_Article_57.PMC5447550.pdf
Nihon Chouzai Co. Ltd. http://www.nicho.co.jp/ faq/article/6551/ [In Japanese].,Non-OADS,/arxiv_data1/oa_pdf/40/82/40120_2016_Article_57.PMC5447550.pdf
Sogo Medical Co. Ltd. http://www.sogo-medical.co.,Non-OADS,/arxiv_data1/oa_pdf/40/82/40120_2016_Article_57.PMC5447550.pdf
http://www.mhlw.go.jp/toukei/saikin/hw/ eisei_houkoku/14/dl/kekka5.pdf [In Japanese].,Non-OADS,/arxiv_data1/oa_pdf/40/82/40120_2016_Article_57.PMC5447550.pdf
2012. https://mhlw-grants.niph.go.,Non-OADS,/arxiv_data1/oa_pdf/40/82/40120_2016_Article_57.PMC5447550.pdf
2007. http://www.fda.gov/ downloads/Drugs/GuidanceComplianceRegulatoryInformation/EnforcementActivitiesbyFDA/WarningLettersandNoticeofViolationLetterstoPharmaceutical Companies/ucm054180.pdf .,Non-OADS,/arxiv_data1/oa_pdf/40/82/40120_2016_Article_57.PMC5447550.pdf
Keywords: Alemtuzumab; Multiple Sclerosis; Natalizumab; PMLEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ 0527F0603D472800 .,Non-OADS,/arxiv_data1/oa_pdf/d0/41/40120_2016_Article_58.PMC5447551.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/d0/41/40120_2016_Article_58.PMC5447551.pdf
No deaths or progressive multifocal leukoencephalopathy cases were reported.Enhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ C527F0604BCD82AC .,Non-OADS,/arxiv_data1/oa_pdf/27/4a/40120_2016_Article_59.PMC5447552.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, andindicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/27/4a/40120_2016_Article_59.PMC5447552.pdf
Keywords: Dimethyl fumarate; Relapse-remitting multiple sclerosis; Tecﬁdera; Health related quality of life; Work productivityEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ 2D47F06060F2E04E .,Non-OADS,/arxiv_data1/oa_pdf/ab/02/40120_2016_Article_61.PMC5447554.pdf
The research was conducted in full accordance with the U.S. Health Insurance Portability and AccountabilityAct 1996 ( http://www.hhs.gov/ocr/privacy/ ).,OADS,/arxiv_data1/oa_pdf/ab/02/40120_2016_Article_61.PMC5447554.pdf
The research was conducted in full accordance with the US Health InsurancePortability and Accountability Act 1996 (HIPAA; http://www.hhs.gov/ocr/privacy/ ) All data were collected through local ﬁeldwork partners andfully de-identiﬁed prior to receipt by Adelphi.,OADS,/arxiv_data1/oa_pdf/ab/02/40120_2016_Article_61.PMC5447554.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate creditto the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/ab/02/40120_2016_Article_61.PMC5447554.pdf
"Keywords: Gadolinium-enhancing lesions; Japanese patients; Natalizumab; Relapsing- remitting multiple sclerosis; T2 lesionsEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ 8C47F060217D0440 T. Saida ( &) Kansai Multiple Sclerosis Center and Kyoto Min-iren Central Hospital, Kyoto, Japan e-mail: saida_takahiko@maia.eonet.ne.jp J.-I.",Non-OADS,/arxiv_data1/oa_pdf/2c/98/40120_2016_Article_62.PMC5447555.pdf
"This article is distributed under the terms of the Creative CommonsAttribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in anyNeurol Ther (2017) 6:153–159 157",Non-OADS,/arxiv_data1/oa_pdf/2c/98/40120_2016_Article_62.PMC5447555.pdf
This becomes 33% (0.0033/0.01) when expressed as a percentage of C.Enhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ 9D77F0601D12B409 .,Non-OADS,/arxiv_data1/oa_pdf/41/12/40120_2017_Article_63.PMC5447556.pdf
"This article is distributed under the terms of the Creative CommonsAttribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, providea link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/41/12/40120_2017_Article_63.PMC5447556.pdf
http://www.medengine.com/Redeem/ 0487F06044CFA2D4 .,Non-OADS,/arxiv_data1/oa_pdf/15/72/40120_2017_Article_64.PMC5447557.pdf
"This article is distributed under the terms of the Creative CommonsAttribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, providea link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/15/72/40120_2017_Article_64.PMC5447557.pdf
Depression screening should be included as part of the routine consultation of HIV/AIDS patients to ensure early detection and treatment.Enhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ D4F7F0600BA97D20 .,Non-OADS,/arxiv_data1/oa_pdf/67/fb/40120_2017_Article_65.PMC5447558.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, providea link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/67/fb/40120_2017_Article_65.PMC5447558.pdf
http://apps.who.int/ gb/archive/pdf_ﬁles/EB124/B124_6-en .,Non-OADS,/arxiv_data1/oa_pdf/67/fb/40120_2017_Article_65.PMC5447558.pdf
http://www.unaids.org/en/resources/fact-sheet .,Non-OADS,/arxiv_data1/oa_pdf/67/fb/40120_2017_Article_65.PMC5447558.pdf
http://www.unaids.org/en/resources/documents/2014/20140716_UNAIDS_gap_report .,Non-OADS,/arxiv_data1/oa_pdf/67/fb/40120_2017_Article_65.PMC5447558.pdf
http://www.who.int/hiv/pub/ progress_report2011/en/ .,Non-OADS,/arxiv_data1/oa_pdf/67/fb/40120_2017_Article_65.PMC5447558.pdf
http://www.unaids.org/sites/default/ﬁles/media_asset/global-AIDS-update-2016_en .,Non-OADS,/arxiv_data1/oa_pdf/67/fb/40120_2017_Article_65.PMC5447558.pdf
2002. http://www.nimh.nih.gov/publicat/ index.cfm .,OADS,/arxiv_data1/oa_pdf/67/fb/40120_2017_Article_65.PMC5447558.pdf
2016. https://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/67/fb/40120_2017_Article_65.PMC5447558.pdf
https://aims.uw.edu/ resource-library/phq-9-depression-scale .,Non-OADS,/arxiv_data1/oa_pdf/67/fb/40120_2017_Article_65.PMC5447558.pdf
http://www.who.int/ chp/knowledge/publications/adherence_report/en/ .,Non-OADS,/arxiv_data1/oa_pdf/67/fb/40120_2017_Article_65.PMC5447558.pdf
"This article is distributed under the terms of the Creative Commons Attribution- NonCommercial 4.0 International License(http://creativecommons.org/licenses/by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium,provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate ifchanges were made.",Non-OADS,/arxiv_data1/oa_pdf/34/c5/40120_2017_Article_66.PMC5447559.pdf
2016. https://www.nice.org.uk/guidance/ cg72 .,Non-OADS,/arxiv_data1/oa_pdf/34/c5/40120_2017_Article_66.PMC5447559.pdf
2010. http://apps.who.int/ classiﬁcations/icd10/browse/2010/en .,OADS,/arxiv_data1/oa_pdf/34/c5/40120_2017_Article_66.PMC5447559.pdf
2015. http://www.ema.europa.eu/docs/en_GB/ document_library/EPAR_-_Product_Information/ human/003759/WC500195130.pdf .A c c e s s e d2 8F e b 2017.,Non-OADS,/arxiv_data1/oa_pdf/34/c5/40120_2017_Article_66.PMC5447559.pdf
2015. http://www.mhra.gov.,Non-OADS,/arxiv_data1/oa_pdf/34/c5/40120_2017_Article_66.PMC5447559.pdf
2015. http://www.medicines.org.uk/ emc/medicine/14482 .,Non-OADS,/arxiv_data1/oa_pdf/34/c5/40120_2017_Article_66.PMC5447559.pdf
Lastupdate: December 2016. http://www.medicines.,Non-OADS,/arxiv_data1/oa_pdf/34/c5/40120_2017_Article_66.PMC5447559.pdf
2002. http://www.adhdeurope.eu/information/ adhd-projects/123-mapping-adhd-across-europe-en.,Non-OADS,/arxiv_data1/oa_pdf/34/c5/40120_2017_Article_66.PMC5447559.pdf
2002. http://www.adhdeurope.eu/ downloads/MappingGB.pdf .,OADS,/arxiv_data1/oa_pdf/34/c5/40120_2017_Article_66.PMC5447559.pdf
Among patients with C1 year of continuousEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ 4E18F060616328D6 .,Non-OADS,/arxiv_data1/oa_pdf/56/75/40120_2017_Article_67.PMC5447560.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in any medium, provided you give appropriate creditto the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/56/75/40120_2017_Article_67.PMC5447560.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/96/3b/main.PMC5447563.pdf
http://dx.doi.org/10.1016/j.jdcr.2017.03.006 259,OADS,/arxiv_data1/oa_pdf/96/3b/main.PMC5447563.pdf
http://dx.doi.org/10.1016/j.mmcr.2017.05.003 Received 29 April 2017; Received in revised form 11 May 2017; Accepted 22 May 2017⁎Corresponding author.,Non-OADS,/arxiv_data1/oa_pdf/ad/96/main.PMC5447564.pdf
This is an open access article under the CC BY-NC-ND license  (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ad/96/main.PMC5447564.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ec/ca/main.PMC5447565.pdf
"Case  presentation A  76  years  old  woman,  suffering  from  senile  dementia,  anxiety- depressive  syndrome, lower extremities venous insufﬁciency, biliary lithiasis,  spondylosis,  chronic  obstructive  pulmonary  dis- http://dx.doi.org/10.1016/j.ijscr.2017.05.018 2210-2612/© 2017  The  Authors.",Non-OADS,/arxiv_data1/oa_pdf/ec/ca/main.PMC5447565.pdf
"Parikh,  E.  Soto,  C.  Cameron,  R.  Mody,  Extended-spectrum beta-lactamase  infections  in  orthopedic-related  devices  and  prosthetic  joints, Orthopedics  39  (July  (4))  (2016)  e668–e673,  http://dx.doi.org/10.3928/ 01477447-20160606-07 .",Non-OADS,/arxiv_data1/oa_pdf/ec/ca/main.PMC5447565.pdf
"49  (2009)  1036–1043,  http://dx.doi.org/10.1086/605593 .",Non-OADS,/arxiv_data1/oa_pdf/ec/ca/main.PMC5447565.pdf
"Case  Rep.  8  (June)  (2014)  186, http://dx.doi.org/10.1186/1752-1947-8-186 .",Non-OADS,/arxiv_data1/oa_pdf/ec/ca/main.PMC5447565.pdf
"18  (May  (3)) (2016)  269–277,  http://dx.doi.org/10.5604/15093492.1212996 .",Non-OADS,/arxiv_data1/oa_pdf/ec/ca/main.PMC5447565.pdf
"(January)  (2017),  http://dx.doi.org/10.5301/hipint.",OADS,/arxiv_data1/oa_pdf/ec/ca/main.PMC5447565.pdf
"10 (November)  (2016)  654–661,  http://dx.doi.org/10.2174/ 1874325001610010654 .",Non-OADS,/arxiv_data1/oa_pdf/ec/ca/main.PMC5447565.pdf
"79 (April  (4))  (2014)  R442–R451,  http://dx.doi.org/10.1111/1750-3841.12397 , Epub  2014  Mar  12.",Non-OADS,/arxiv_data1/oa_pdf/ec/ca/main.PMC5447565.pdf
"Ochsner,  Management  of  infection  associated  with  prosthetic joints,  Infection  31  (2003)  99–108,  http://dx.doi.org/10.1007/s15010-002- 3079-9 .",Non-OADS,/arxiv_data1/oa_pdf/ec/ca/main.PMC5447565.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/04/e4/main.PMC5447566.pdf
http://dx.doi.org/10.1016/j.jdcr.2017.03.007 263,OADS,/arxiv_data1/oa_pdf/04/e4/main.PMC5447566.pdf
This  is  an  open  access  article under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c7/1c/main.PMC5447567.pdf
http://dx.doi.org/10.1016/j.ijscr.2017.05.022 2210-2612/© 2017  Published  by  Elsevier  Ltd  on  behalf  of  IJS  Publishing  Group  Ltd.,Non-OADS,/arxiv_data1/oa_pdf/c7/1c/main.PMC5447567.pdf
"Supplementary  data Supplementary  data  associated  with  this  article  can  be  found,  in the  online  version,  at  http://dx.doi.org/10.1016/j.ijscr.2017.05.022 .",OADS,/arxiv_data1/oa_pdf/c7/1c/main.PMC5447567.pdf
"In the outbreak on Reunion island, 53% of http://dx.doi.org/10.1016/j.idcr.2017.03.015 Received 17 March 2017; Received in revised form 29 March 2017; Accepted 29 March 2017⁎Corresponding author at: National Institute of Health Dr. Ricardo Jorge, Centre for Vectors and Infectious Diseases Research, Av.",Non-OADS,/arxiv_data1/oa_pdf/cc/80/main.PMC5447568.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/cc/80/main.PMC5447568.pdf
"DENV-3 sequences used in previous studies [18,19] and other accessible from the National Center for BiotechnologyInformation (NCBI) GenBank database ( http://www.ncbi.nlm.nih.gov ) were used as dataset.",OADS,/arxiv_data1/oa_pdf/cc/80/main.PMC5447568.pdf
Science 1988;239:476 –81.http://dx.doi.org/10.1126/science.3277268 .,Non-OADS,/arxiv_data1/oa_pdf/cc/80/main.PMC5447568.pdf
Nature 2013;496:504 –7.http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/cc/80/main.PMC5447568.pdf
http://dx.doi.org/10.1371/journal.pntd.,Non-OADS,/arxiv_data1/oa_pdf/cc/80/main.PMC5447568.pdf
Lancet Infect Dis 2007;7:319 –27.http://dx.doi.org/10.1016/S1473- 3099(07)70107-X .,OADS,/arxiv_data1/oa_pdf/cc/80/main.PMC5447568.pdf
J Gen Virol 2000;81:471 –9.http://dx.doi.org/10.1099/ 0022-1317-81-2-471 .,Non-OADS,/arxiv_data1/oa_pdf/cc/80/main.PMC5447568.pdf
Emerg Infect Dis 2006;12:1580 –3.http://dx.doi.org/10.3201/eid1210.060529 .,Non-OADS,/arxiv_data1/oa_pdf/cc/80/main.PMC5447568.pdf
Antiviral Res 2013;99:345 –70.http://dx.doi.org/10.1016/j.antiviral.,OADS,/arxiv_data1/oa_pdf/cc/80/main.PMC5447568.pdf
EmergInfect Dis 2006;12(10):1493 –9.http://dx.doi.org/10.1016/S0140-6736(16) 00320-2 .,OADS,/arxiv_data1/oa_pdf/cc/80/main.PMC5447568.pdf
J Virol Methods 2005;124:65 –71.http://dx.doi.org/10.1016/j.jviromet.2004.11.002 .,OADS,/arxiv_data1/oa_pdf/cc/80/main.PMC5447568.pdf
Virol J 2008;5:20. http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/cc/80/main.PMC5447568.pdf
Virol J 2013;10:37. http://dx.doi.org/10.1186/1743-422X-10-37 .,Non-OADS,/arxiv_data1/oa_pdf/cc/80/main.PMC5447568.pdf
Emerg Infect Dis 2017;23:272 –5.http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cc/80/main.PMC5447568.pdf
http://dx.doi.org/10.1186/s12879-016-1417-2 .,Non-OADS,/arxiv_data1/oa_pdf/cc/80/main.PMC5447568.pdf
Pediatr Infect Dis J 2012;31:459 –63.http://dx.doi.org/10.1097/INF.,OADS,/arxiv_data1/oa_pdf/cc/80/main.PMC5447568.pdf
http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/cc/80/main.PMC5447568.pdf
Science 1967;157:1307 –8.http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/cc/80/main.PMC5447568.pdf
"[27] Carey DE, Myers RM, DeRanitz CM, Jadhav M, Reuben R. The 1964 chikungunya epidemic at Vellore, South India, including observations on concurrent dengue.Trans R Soc Trop Med Hyg 1969;63:434 –5.http://dx.doi.org/10.1016/0035- 9203(69)90030-3 .",Non-OADS,/arxiv_data1/oa_pdf/cc/80/main.PMC5447568.pdf
"Dengue cases and deaths in the Countrysince 2010, http://nvbdcp.gov.in/ den-cd.html [Accessed 24 January 2017].C.O.",Non-OADS,/arxiv_data1/oa_pdf/cc/80/main.PMC5447568.pdf
"Since the irregular tissue surface or endogenous absorbers in tissues, the quantitatively measurement of http://dx.doi.org/10.1016/j.bbacli.2017.04.002 Received 10 March 2017; Accepted 22 April 2017⁎Correspondence to: G. Wang, Huashan Hospital, Shanghai, China.",Non-OADS,/arxiv_data1/oa_pdf/47/99/main.PMC5447569.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/47/99/main.PMC5447569.pdf
"Transparency document The http://dx.doi.org/10.1016/j.bbacli.2017.04.002 associated with this article can be found, in online version.References [1]B. Liu, X. Wu, B. Liu, C. Wang, Y. Liu, Q. Zhou, K. Xu, MiR-26a enhances metastasis potential of lung cancer cells via AKT pathway by targeting PTEN, BBA-Mol.",Non-OADS,/arxiv_data1/oa_pdf/47/99/main.PMC5447569.pdf
Surgery was done and the posterior thigh soft tissue mass was http://dx.doi.org/10.1016/j.jbo.2017.05.002 Received 29 April 2017; Accepted 6 May 2017E-mail address: fahad_allhedan@hotmail.com .Journal of Bone Oncology 8  (2017) 1–3 Available online 22 May 2017 2212-1374/ © 2017 The Author.,Non-OADS,/arxiv_data1/oa_pdf/79/e6/main.PMC5447570.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/79/e6/main.PMC5447570.pdf
"Pseudomonas ﬂuorescens and Pseudomonas aureofaciens were reported http://dx.doi.org/10.1016/j.btre.2017.04.002 Received 19 January 2017; Received in revised form 18 April 2017; Accepted 18 April 2017⁎Corresponding author at: School of Biotechnology, Jawaharlal Nehru University, New Delhi, 110067, India.",OADS,/arxiv_data1/oa_pdf/a1/77/main.PMC5447571.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a1/77/main.PMC5447571.pdf
"• Tel: (822) 3010-4388  • Fax: (822) 476-0090 • E-mail: hwgoo@amc.seoul.kr This is an Open Access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/4.0) which permits  unrestricted non-commercial use, distribution, and reproduction in  any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/65/23/kjr-18-555.PMC5447632.pdf
"Only a few heavy  atoms, such as calcium, iodine, barium, and xenon, having https://doi.org/10.3348/kjr.2017.18.4.555 pISSN 1229-6929  · eISSN 2005-8330Review Article  | Experiment, Engineering, and Physics",Non-OADS,/arxiv_data1/oa_pdf/65/23/kjr-18-555.PMC5447632.pdf
"The program can learn  by analyzing training data, and then make a prediction  when new data is put in.https://doi.org/10.3348/kjr.2017.18.4.570 pISSN 1229-6929  · eISSN 2005-8330Review Article  | Experiment, Engineering, and Physics",Non-OADS,/arxiv_data1/oa_pdf/12/9c/kjr-18-570.PMC5447633.pdf
Adapted from  http://scikit-learn.org/stable/tutorial/machine_learning_map/ (101).,Non-OADS,/arxiv_data1/oa_pdf/12/9c/kjr-18-570.PMC5447633.pdf
http://playground.tensorflow.org.,Non-OADS,/arxiv_data1/oa_pdf/12/9c/kjr-18-570.PMC5447633.pdf
https://arxiv.org/abs/1605.02688.,Non-OADS,/arxiv_data1/oa_pdf/12/9c/kjr-18-570.PMC5447633.pdf
https://ujjwalkarn.me/2016/08/11/ intuitive-explanation-convnets/.,Non-OADS,/arxiv_data1/oa_pdf/12/9c/kjr-18-570.PMC5447633.pdf
http://image-net.org/ challenges/LSVRC/2016/.,Non-OADS,/arxiv_data1/oa_pdf/12/9c/kjr-18-570.PMC5447633.pdf
http://arxiv.org/ abs/1411.4464.,Non-OADS,/arxiv_data1/oa_pdf/12/9c/kjr-18-570.PMC5447633.pdf
https://arxiv.org/abs/1410.1090.,Non-OADS,/arxiv_data1/oa_pdf/12/9c/kjr-18-570.PMC5447633.pdf
https://arxiv.org/abs/1411.2539.,Non-OADS,/arxiv_data1/oa_pdf/12/9c/kjr-18-570.PMC5447633.pdf
https://arxiv.org/pdf/1606.05718.pdf.,Non-OADS,/arxiv_data1/oa_pdf/12/9c/kjr-18-570.PMC5447633.pdf
https://www.2ascribe.com/transcription-services/radiology- dictation-transcription.,Non-OADS,/arxiv_data1/oa_pdf/12/9c/kjr-18-570.PMC5447633.pdf
http://scikit-learn.org/stable/tutorial/machine_learning_ map/.,Non-OADS,/arxiv_data1/oa_pdf/12/9c/kjr-18-570.PMC5447633.pdf
"Korean J Radiol 2017;18(4):585-596https://doi.org/10.3348/kjr.2017.18.4.585 pISSN 1229-6929  · eISSN 2005-8330Original Article  | Experiment, Engineering, and Physics",Non-OADS,/arxiv_data1/oa_pdf/43/24/kjr-18-585.PMC5447634.pdf
Available at: http://qibawiki.rsna.org/ images/7/7b/DCEMRIProfile_v1_6-20111213.pdf.,Non-OADS,/arxiv_data1/oa_pdf/43/24/kjr-18-585.PMC5447634.pdf
"• Tel: (3124) 361 4011  • Fax: (3124) 354 0866 • E-mail: jurgen.futterer@Radboudumc.nl This is an Open Access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/4.0) which permits  unrestricted non-commercial use, distribution, and reproduction in  any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/32/d3/kjr-18-597.PMC5447635.pdf
DWI is the most promising https://doi.org/10.3348/kjr.2017.18.4.597 pISSN 1229-6929  · eISSN 2005-8330Review Article  | Genitourinary Imaging,Non-OADS,/arxiv_data1/oa_pdf/32/d3/kjr-18-597.PMC5447635.pdf
http://dx.doi.org/10.1002/jmri.25539 45.,Non-OADS,/arxiv_data1/oa_pdf/32/d3/kjr-18-597.PMC5447635.pdf
"• Tel: (822) 870-2531  • Fax: (822) 870-3539 • E-mail: mmhoan@gmail.com This is an Open Access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/4.0) which permits  unrestricted non-commercial use, distribution, and reproduction in  any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d1/f4/kjr-18-607.PMC5447636.pdf
Although any functional https://doi.org/10.3348/kjr.2017.18.4.607 pISSN 1229-6929  · eISSN 2005-8330Original Article  | Genitourinary Imaging,Non-OADS,/arxiv_data1/oa_pdf/d1/f4/kjr-18-607.PMC5447636.pdf
"The ROC analysis with  curve fitting was performed with the JROCFIT and JLAPROC4  web-based calculators (John Eng, Johns Hopkins University;  http://www.jrocfit.org), which are direct JAVA translations  of the ROCFIT and LABROC4 programs developed by the late  Charles Metz and colleagues at the University of Chicago.",OADS,/arxiv_data1/oa_pdf/d1/f4/kjr-18-607.PMC5447636.pdf
"• Tel: (822) 3010-4348  • Fax: (822) 476-0090 • E-mail: radbaek@naver.com This is an Open Access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/4.0) which permits  unrestricted non-commercial use, distribution, and reproduction in  any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/64/62/kjr-18-615.PMC5447637.pdf
"The trans- isthmic approach refers to the insertion of a RF electrode  via the isthmus, in a midline to lateral direction, for  treatment of a nodule in either the right or left thyroid https://doi.org/10.3348/kjr.2017.18.4.615 pISSN 1229-6929  · eISSN 2005-8330Review Article  | Thyroid",Non-OADS,/arxiv_data1/oa_pdf/64/62/kjr-18-615.PMC5447637.pdf
http://dx.doi.org/10.3233/CH-16208 55.,Non-OADS,/arxiv_data1/oa_pdf/64/62/kjr-18-615.PMC5447637.pdf
http://dx.doi.org/10.1080 /02656736.2016.1274058 56.,Non-OADS,/arxiv_data1/oa_pdf/64/62/kjr-18-615.PMC5447637.pdf
Korean J Radiol 2017;18(4):624-631https://doi.org/10.3348/kjr.2017.18.4.624 pISSN 1229-6929  · eISSN 2005-8330Original Article  | Breast Imaging,Non-OADS,/arxiv_data1/oa_pdf/02/dc/kjr-18-624.PMC5447638.pdf
Supplementary Materials The online-only Data Supplement is available with this  article at https://doi.org/10.3348/kjr.2017.18.4.624.,Non-OADS,/arxiv_data1/oa_pdf/02/dc/kjr-18-624.PMC5447638.pdf
"• Tel: (82 32) 621-5851  • Fax: (82 32) 621-5874 • E-mail: acarad@naver.com This is an Open Access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/4.0) which permits  unrestricted non-commercial use, distribution, and reproduction in  any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c5/e1/kjr-18-632.PMC5447639.pdf
"Currently, the combination of the  early transmitral LV inflow velocity with annular velocity  has proven to be the best single Doppler predictor for https://doi.org/10.3348/kjr.2017.18.4.632 pISSN 1229-6929  · eISSN 2005-8330Original Article  | Cardiovascular Imaging",Non-OADS,/arxiv_data1/oa_pdf/c5/e1/kjr-18-632.PMC5447639.pdf
"• Tel: (8255) 360-1840  • Fax: (8255) 360-1848 • E-mail: kschoo0618@naver.com This is an Open Access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/4.0) which permits  unrestricted non-commercial use, distribution, and reproduction in  any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a8/84/kjr-18-643.PMC5447640.pdf
"Several parameters, including clinical symptoms  such as advanced New York Heart Association (NYHA)  functional classes, certain viruses or immunohistologic https://doi.org/10.3348/kjr.2017.18.4.643 pISSN 1229-6929  · eISSN 2005-8330Original Article  | Cardiovascular Imaging",Non-OADS,/arxiv_data1/oa_pdf/a8/84/kjr-18-643.PMC5447640.pdf
"It has  been widely accepted that functional MB linked to dynamic  compression is associated with ischemic heart disease, https://doi.org/10.3348/kjr.2017.18.4.655 pISSN 1229-6929  · eISSN 2005-8330Original Article  | Cardiovascular Imaging",Non-OADS,/arxiv_data1/oa_pdf/da/86/kjr-18-655.PMC5447641.pdf
Korean J Radiol 2017;18(4):664-673https://doi.org/10.3348/kjr.2017.18.4.664 pISSN 1229-6929  · eISSN 2005-8330Original Article  | Cardiovascular Imaging,Non-OADS,/arxiv_data1/oa_pdf/0b/b6/kjr-18-664.PMC5447642.pdf
Korean J Radiol 2017;18(4):674-681https://doi.org/10.3348/kjr.2017.18.4.674 pISSN 1229-6929  · eISSN 2005-8330Original Article  | Gastrointestinal Imaging,Non-OADS,/arxiv_data1/oa_pdf/e0/5e/kjr-18-674.PMC5447643.pdf
"• Tel: (822) 2072-3107  • Fax: (822) 743-6385 • E-mail: jmsh@snu.ac.kr This is an Open Access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/4.0) which permits  unrestricted non-commercial use, distribution, and reproduction in  any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/93/e9/kjr-18-682.PMC5447644.pdf
Assessment of  liver function is crucial to predicting the prognosis of https://doi.org/10.3348/kjr.2017.18.4.682 pISSN 1229-6929  · eISSN 2005-8330Original Article  | Gastrointestinal Imaging,Non-OADS,/arxiv_data1/oa_pdf/93/e9/kjr-18-682.PMC5447644.pdf
"• Tel: (822) 6299-3206  • Fax: (822) 6299-1577 • E-mail: netty0523@gmail.com This is an Open Access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/4.0) which permits  unrestricted non-commercial use, distribution, and reproduction in  any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/34/ae/kjr-18-691.PMC5447645.pdf
The cause of a tendon retear is thought to be https://doi.org/10.3348/kjr.2017.18.4.691 pISSN 1229-6929  · eISSN 2005-8330Original Article  | Musculoskeletal Imaging,Non-OADS,/arxiv_data1/oa_pdf/34/ae/kjr-18-691.PMC5447645.pdf
The number of  metastases is a critical prognostic factor as patients with  a large number of brain metastases have earlier disease  progression and poorer prognosis as compared to those https://doi.org/10.3348/kjr.2017.18.4.699 pISSN 1229-6929  · eISSN 2005-8330Original Article  | Neuroimaging and Head & Neck,Non-OADS,/arxiv_data1/oa_pdf/59/c0/kjr-18-699.PMC5447646.pdf
"A free software  package (JAFROC1, http://www.devchakraborty.com) was  used to perform JAFROC analysis, but other statistical  analyses were performed using SPSS software (version 17.0,  SPSS Inc., Chicago, IL, USA).",OADS,/arxiv_data1/oa_pdf/59/c0/kjr-18-699.PMC5447646.pdf
"• Tel: (82 55) 750-8211  • Fax: (82 55) 758-1568 • E-mail: choids@gnu.ac.kr This is an Open Access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/4.0) which permits  unrestricted non-commercial use, distribution, and reproduction in  any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/94/de/kjr-18-710.PMC5447647.pdf
"It develops anteriorly at the genu and  proceeds posterior to the splenium except for the rostrum,  which is the last area to show the crossed fibers (1, 5).https://doi.org/10.3348/kjr.2017.18.4.710 pISSN 1229-6929  · eISSN 2005-8330Pictorial Essay  | Neuroimaging and Head & Neck",Non-OADS,/arxiv_data1/oa_pdf/94/de/kjr-18-710.PMC5447647.pdf
"• Tel: (822) 2228-7400  • Fax: (822) 393-3035 • E-mail: djkimmd@yuhs.ac This is an Open Access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/4.0) which permits  unrestricted non-commercial use, distribution, and reproduction in  any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c8/d2/kjr-18-722.PMC5447648.pdf
"However, in real-life patient populations, the degree https://doi.org/10.3348/kjr.2017.18.4.722 pISSN 1229-6929  · eISSN 2005-8330Original Article  | Neurointervention",Non-OADS,/arxiv_data1/oa_pdf/c8/d2/kjr-18-722.PMC5447648.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c8/d2/kjr-18-722.PMC5447648.pdf
"• Tel: (822) 3410-0511  • Fax: (822) 3410-0084 • E-mail: jhkate@skku.edu This is an Open Access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/4.0) which permits  unrestricted non-commercial use, distribution, and reproduction in  any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/72/b0/kjr-18-729.PMC5447649.pdf
https://doi.org/10.3348/kjr.2017.18.4.729 pISSN 1229-6929  · eISSN 2005-8330Original Article  | Pediatric Imaging,Non-OADS,/arxiv_data1/oa_pdf/72/b0/kjr-18-729.PMC5447649.pdf
"Korean J Radiol 2017;18(4):739-748 of chronic obstructive pulmonary disease (COPD),  quantitative computed tomography (QCT) is increasingly  being used to evaluate different COPD phenotypes, such https://doi.org/10.3348/kjr.2017.18.4.739 pISSN 1229-6929  · eISSN 2005-8330Original Article  | Thoracic Imaging",Non-OADS,/arxiv_data1/oa_pdf/9d/47/kjr-18-739.PMC5447650.pdf
"At Korean J Radiol 2017;18(4):749-752https://doi.org/10.3348/kjr.2017.18.4.749 pISSN 1229-6929  · eISSN 2005-8330 Received March  5, 2017; accepted after revision March  6, 2017.",Non-OADS,/arxiv_data1/oa_pdf/31/46/kjr-18-749.PMC5447651.pdf
"• Tel: (331) 48-02-69-66  • Fax: (331) 48-02-60-53 • E-mail: olivier.seror@aphp.fr This is an Open Access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/4.0) which permits  unrestricted non-commercial use, distribution, and reproduction in  any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/31/46/kjr-18-749.PMC5447651.pdf
"Along http://dx.doi.org/10.1016/j.ymgmr.2017.05.008 Received 14 February 2017; Accepted 22 May 2017⁎Corresponding author at: Universidad Europea de Madrid, C/Tajo, s/n.",Non-OADS,/arxiv_data1/oa_pdf/7f/e9/main.PMC5447652.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/7f/e9/main.PMC5447652.pdf
"A second study examining cortical gyri ﬁcation in adolescents with PAE showed reduced cortical folding in PAE compared to matched http://dx.doi.org/10.1016/j.nicl.2017.05.015 Received 17 November 2016; Received in revised form 18 April 2017; Accepted 21 May 2017⁎Corresponding author at: Department of Psychiatry, University of Minnesota, F282/2A West, 2450 Riverside Ave., Minneapolis, MN 55454, United States.",Non-OADS,/arxiv_data1/oa_pdf/59/57/main.PMC5447653.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/59/57/main.PMC5447653.pdf
Acquisition sequences were modeled on protocols developed for multi-site imaging by the Pediatric Imaging Neurocognition and Genetics (PING) group ( Table 2)( http://ping.chd.ucsd.edu ).,OADS,/arxiv_data1/oa_pdf/59/57/main.PMC5447653.pdf
http://dx.doi.org/10.1097/ 00004703-200110000-00024 .,Non-OADS,/arxiv_data1/oa_pdf/59/57/main.PMC5447653.pdf
http://dx.doi.org/10.1111/j.1469-8749.1997.tb07493.x .,Non-OADS,/arxiv_data1/oa_pdf/59/57/main.PMC5447653.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/59/57/main.PMC5447653.pdf
http://dx.doi.org/10.1002/tera.1420370605 .,Non-OADS,/arxiv_data1/oa_pdf/59/57/main.PMC5447653.pdf
http://dx.doi.org/10.1006/nimg.1998.0395 .,OADS,/arxiv_data1/oa_pdf/59/57/main.PMC5447653.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/59/57/main.PMC5447653.pdf
http://dx.doi.org/10.1093/brain/awn137 .,Non-OADS,/arxiv_data1/oa_pdf/59/57/main.PMC5447653.pdf
http://dx.doi.org/10.1007/ s00330-005-2779-9 .,Non-OADS,/arxiv_data1/oa_pdf/59/57/main.PMC5447653.pdf
http://dx.doi.org/10.1007/s00381-003-0767-4 .,Non-OADS,/arxiv_data1/oa_pdf/59/57/main.PMC5447653.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/59/57/main.PMC5447653.pdf
http://dx.doi.org/ 10.1016/j.neuroimage.2014.07.057 .,OADS,/arxiv_data1/oa_pdf/59/57/main.PMC5447653.pdf
http://dx.doi.org/10.1016/j.neuroimage.2006.07.036 .,OADS,/arxiv_data1/oa_pdf/59/57/main.PMC5447653.pdf
http://dx.doi.org/10.1016/j.brainres.,OADS,/arxiv_data1/oa_pdf/59/57/main.PMC5447653.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/59/57/main.PMC5447653.pdf
http://dx.doi.org/10.1177/0883073810368311 .,Non-OADS,/arxiv_data1/oa_pdf/59/57/main.PMC5447653.pdf
http://dx.doi.org/10.1097/00005072- 198705000-00005 .,Non-OADS,/arxiv_data1/oa_pdf/59/57/main.PMC5447653.pdf
http://dx.doi.org/10.1007/s11065-011-9163-0 .,Non-OADS,/arxiv_data1/oa_pdf/59/57/main.PMC5447653.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/59/57/main.PMC5447653.pdf
http://dx.doi.org/ 10.1097/CHI.0b013e318185e703.Neuroimaging .,Non-OADS,/arxiv_data1/oa_pdf/59/57/main.PMC5447653.pdf
http://dx.doi.org/10.1111/j.1530- 0277.1993.tb00768.x .,Non-OADS,/arxiv_data1/oa_pdf/59/57/main.PMC5447653.pdf
http://dx.doi.org/10.1007/s40474-014-0020-8 .,Non-OADS,/arxiv_data1/oa_pdf/59/57/main.PMC5447653.pdf
"6, 1 –14.http://dx.doi.org/10.3389/fnana.2012.00003 .",Non-OADS,/arxiv_data1/oa_pdf/59/57/main.PMC5447653.pdf
http://dx.doi.org/10.1111/j.1530-0277.1992.tb01417.x .,Non-OADS,/arxiv_data1/oa_pdf/59/57/main.PMC5447653.pdf
http://dx.doi.org/10.1111/j.,Non-OADS,/arxiv_data1/oa_pdf/59/57/main.PMC5447653.pdf
http://dx.doi.org/10.1016/S0959-437X(02) 00305-2 .,OADS,/arxiv_data1/oa_pdf/59/57/main.PMC5447653.pdf
http://dx.doi.org/10.1007/BF01537962 .,Non-OADS,/arxiv_data1/oa_pdf/59/57/main.PMC5447653.pdf
http://dx.doi.org/10.1093/ cercor/3.4.313 .,Non-OADS,/arxiv_data1/oa_pdf/59/57/main.PMC5447653.pdf
http://dx.doi.org/10.1002/brb3.191 .,Non-OADS,/arxiv_data1/oa_pdf/59/57/main.PMC5447653.pdf
http://dx.doi.org/10.1126/science.3291116 .,Non-OADS,/arxiv_data1/oa_pdf/59/57/main.PMC5447653.pdf
http://dx.doi.org/10.1289/ehp.00108s3511 .,Non-OADS,/arxiv_data1/oa_pdf/59/57/main.PMC5447653.pdf
http://dx.doi.org/10.1016/0166-2236(94)90131-7 .,OADS,/arxiv_data1/oa_pdf/59/57/main.PMC5447653.pdf
http://dx.doi.org/10.1016/j.neuroimage.2010.10.072 .,OADS,/arxiv_data1/oa_pdf/59/57/main.PMC5447653.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/59/57/main.PMC5447653.pdf
http://dx.doi.org/10.1016/j.pscychresns.2011.05.004 .,OADS,/arxiv_data1/oa_pdf/59/57/main.PMC5447653.pdf
http://dx.doi.org/10.1109/TMI.2007.903576 .,Non-OADS,/arxiv_data1/oa_pdf/59/57/main.PMC5447653.pdf
http://dx.doi.org/10.1111/j.1469-8749.2009.03281.x .,Non-OADS,/arxiv_data1/oa_pdf/59/57/main.PMC5447653.pdf
1 –8.http://dx.doi.org/10.3791/3417 .,Non-OADS,/arxiv_data1/oa_pdf/59/57/main.PMC5447653.pdf
"Psychiatry 39, 28 –38.http://dx.doi.org/10.1097/00004583- 200001000-00014 .",Non-OADS,/arxiv_data1/oa_pdf/59/57/main.PMC5447653.pdf
"44, 4 –16.http://dx.doi.org/10.1017/s0012162201001591 .",Non-OADS,/arxiv_data1/oa_pdf/59/57/main.PMC5447653.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/59/57/main.PMC5447653.pdf
http://dx.doi.org/10.1542/peds.99.2.,Non-OADS,/arxiv_data1/oa_pdf/59/57/main.PMC5447653.pdf
http://dx.doi.org/10.1038/npp.2009.115 .T.J.,Non-OADS,/arxiv_data1/oa_pdf/59/57/main.PMC5447653.pdf
http://dx.doi.org/10.1523/JNEUROSCI.,OADS,/arxiv_data1/oa_pdf/59/57/main.PMC5447653.pdf
http://dx.doi.org/10.1038/ 385313a0 .,Non-OADS,/arxiv_data1/oa_pdf/59/57/main.PMC5447653.pdf
http://dx.doi.org/10.1007/978- 1-4615-3824-0_1 .,Non-OADS,/arxiv_data1/oa_pdf/59/57/main.PMC5447653.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/59/57/main.PMC5447653.pdf
http://dx.doi.org/10.3174/ ajnr.A1984 .,Non-OADS,/arxiv_data1/oa_pdf/59/57/main.PMC5447653.pdf
http://dx.doi.org/ 10.1159/000116500 .,Non-OADS,/arxiv_data1/oa_pdf/59/57/main.PMC5447653.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/59/57/main.PMC5447653.pdf
The raw sequence data are available [ https://www.ncbi.nlm.nih.gov/ Traces/study/?acc=SRP105770 ].,OADS,/arxiv_data1/oa_pdf/09/0a/main.PMC5447654.pdf
"These include lomofungin fromStreptomyces lomondensis [5]and endophenazines from Streptomyces anulatus [6,7] .C o m p a r e dt o Pseudomonas ,Streptomyces species are considered to be more promising sources for bioactive compounds from http://dx.doi.org/10.1016/j.gdata.2017.05.015 Received 5 April 2017; Received in revised form 17 May 2017; Accepted 21 May 2017⁎Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/09/0a/main.PMC5447654.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/09/0a/main.PMC5447654.pdf
"Preprocessing and genome assembly In order to evaluate read quality before and after pre-processing, FastQC assessment plots were generated for sequenced reads using Babraham Bioinformatics programme ( https://www.bioinformatics.",OADS,/arxiv_data1/oa_pdf/09/0a/main.PMC5447654.pdf
"http://dx.doi.org/10.1016/j.nicl.2017.05.016 Received 28 October 2016; Received in revised form 10 April 2017; Accepted 21 May 2017⁎Corresponding author at: Brain Dynamics Centre, The Westmead Institute for Medical Research, 176 Hawkesbury Road, Westmead, NSW 2145, Australia.",Non-OADS,/arxiv_data1/oa_pdf/c3/40/main.PMC5447655.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/c3/40/main.PMC5447655.pdf
"Pre-processing of the T1-weighted images was per- formed using the VBM8 toolbox ( http://dbm.neuro.uni-jena.de ), im- plemented within the SPM8 package ( http://www.",OADS,/arxiv_data1/oa_pdf/c3/40/main.PMC5447655.pdf
1936-5233/17http://dx.doi.org/10.1016/j.tranon.2017.03.009,OADS,/arxiv_data1/oa_pdf/e5/e8/main.PMC5447656.pdf
"C AC a n c e rJC l i n 65(2), 87 –108.http://dx.doi.org/10.3322/caac.21262 .",Non-OADS,/arxiv_data1/oa_pdf/e5/e8/main.PMC5447656.pdf
http://dx.doi.org/10.1016/j.jhep.2006.05.013 .,OADS,/arxiv_data1/oa_pdf/e5/e8/main.PMC5447656.pdf
http://dx.doi.org/10.1053/j.gastro.2011.03.006 .,OADS,/arxiv_data1/oa_pdf/e5/e8/main.PMC5447656.pdf
http://dx.doi.org/10.1158/1078-0432.ccr-08-1608 [published Online First: 2009/02/04].,Non-OADS,/arxiv_data1/oa_pdf/e5/e8/main.PMC5447656.pdf
http://dx.doi.org/10.1200/jco.2006.06.4592 .,OADS,/arxiv_data1/oa_pdf/e5/e8/main.PMC5447656.pdf
http://dx.doi.org/10.1038/nrc3239 .,Non-OADS,/arxiv_data1/oa_pdf/e5/e8/main.PMC5447656.pdf
http://dx.doi.org/10.1038/nm730 .,Non-OADS,/arxiv_data1/oa_pdf/e5/e8/main.PMC5447656.pdf
http://dx.doi.org/10.1158/2159-8290.cd-13-0310 .,Non-OADS,/arxiv_data1/oa_pdf/e5/e8/main.PMC5447656.pdf
Hepatology .http://dx.doi.org/10.1002/hep.28710 .,Non-OADS,/arxiv_data1/oa_pdf/e5/e8/main.PMC5447656.pdf
http://dx.doi.org/10.1007/s13277-015-4622-5 .,Non-OADS,/arxiv_data1/oa_pdf/e5/e8/main.PMC5447656.pdf
http://dx.doi.org/10.18632/oncotarget.5583 .,OADS,/arxiv_data1/oa_pdf/e5/e8/main.PMC5447656.pdf
http://dx.doi.org/10.1016/j.jtho.2016.06.006 .,OADS,/arxiv_data1/oa_pdf/e5/e8/main.PMC5447656.pdf
http://dx.doi.org/10.1056/NEJMoa1411087 .,OADS,/arxiv_data1/oa_pdf/e5/e8/main.PMC5447656.pdf
http://dx.doi.org/10.1056/NEJMoa1501824 .516 Peritumoral PD-L1 and prognosis in HCC Dai et al.,OADS,/arxiv_data1/oa_pdf/e5/e8/main.PMC5447656.pdf
http://dx.doi.org/10.1056/NEJMoa1510665 .,OADS,/arxiv_data1/oa_pdf/e5/e8/main.PMC5447656.pdf
http://dx.doi.org/10.1056/NEJMoa1302369 .,OADS,/arxiv_data1/oa_pdf/e5/e8/main.PMC5447656.pdf
http://dx.doi.org/10.1200/JCO.2016.67.2477 .,OADS,/arxiv_data1/oa_pdf/e5/e8/main.PMC5447656.pdf
http://dx.doi.org/10.1371/journal.pone.0130142 .,Non-OADS,/arxiv_data1/oa_pdf/e5/e8/main.PMC5447656.pdf
http://dx.doi.org/10.1158/1078-0432.ccr-13-3271 .,Non-OADS,/arxiv_data1/oa_pdf/e5/e8/main.PMC5447656.pdf
http://dx.doi.org/10.1016/s1470-2045(15)70076-8 .,OADS,/arxiv_data1/oa_pdf/e5/e8/main.PMC5447656.pdf
http://dx.doi.org/10.1200/jco.2007.15.6521 .,Non-OADS,/arxiv_data1/oa_pdf/e5/e8/main.PMC5447656.pdf
http://dx.doi.org/10.1007/s00535-014-0933-3 [published Online First: 2014/02/11].,Non-OADS,/arxiv_data1/oa_pdf/e5/e8/main.PMC5447656.pdf
http://dx.doi.org/10.1097/pap.0000000000000072 [published On- line First: 2015/08/12].,OADS,/arxiv_data1/oa_pdf/e5/e8/main.PMC5447656.pdf
http://dx.doi.org/10.1016/j.ccell.2015.03.001 [published Online First: 2015/04/11].,OADS,/arxiv_data1/oa_pdf/e5/e8/main.PMC5447656.pdf
http://dx.doi.org/10.1038/nature05115 .,Non-OADS,/arxiv_data1/oa_pdf/e5/e8/main.PMC5447656.pdf
http://dx.doi.org/10.1084/jem.20100637 .,Non-OADS,/arxiv_data1/oa_pdf/e5/e8/main.PMC5447656.pdf
http://dx.doi.org/10.1038/nm1482 .,OADS,/arxiv_data1/oa_pdf/e5/e8/main.PMC5447656.pdf
"J Exp Clin Cancer Res 34, 141. http://dx.doi.org/10.1186/s13046-015-0256-0 [published Online First: 2015/11/20].",Non-OADS,/arxiv_data1/oa_pdf/e5/e8/main.PMC5447656.pdf
http://dx.doi.org/10.1053/j.gastro.2012.02.007 .,Non-OADS,/arxiv_data1/oa_pdf/e5/e8/main.PMC5447656.pdf
http://dx.doi.org/10.1016/j.j- hep.2006.07.009 [published Online First: 2006/08/12].Translational Oncology Vol.,OADS,/arxiv_data1/oa_pdf/e5/e8/main.PMC5447656.pdf
1936-5233/17http://dx.doi.org/10.1016/j.tranon.2017.04.003,OADS,/arxiv_data1/oa_pdf/53/f7/main.PMC5447658.pdf
"MeSH Keywords:  Aortic Stenosis, Subvalvular • Coronary Artery Bypass • Coronary Artery Disease •  Electrocardiography • Myocardial Infarction • Shock, Cardiogenic  Full-text PDF: http://www.amjcaserep.com/abstract/index/idArt/902510Authors’ Contribution:  Study Design A  Data Collection B  Statistical Analysis C Data Interpretation D  Manuscript Preparation E  Literature Search F Funds Collection G1 Department of Internal Medicine, Florida State University, College of Medicine,  Tallahassee, Fl, U.S.A. 2 Department of Clinical Sciences, Florida State University, College of Medicine,  Tallahassee, Fl, U.S.A.ISSN 1941-5923 © Am J Case Rep, 2017; 18: 563-567 DOI: 10.12659/AJCR.902510 563 This work is licensed under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)",Non-OADS,/arxiv_data1/oa_pdf/1d/d6/amjcaserep-18-563.PMC5447663.pdf
"MeSH Keywords:  Angioplasty • Case Reports • Renal Artery Obstruction  Full-text PDF: http://www.amjcaserep.com/abstract/index/idArt/903876Authors’ Contribution:  Study Design A  Data Collection B  Statistical Analysis C Data Interpretation D  Manuscript Preparation E  Literature Search F Funds Collection GDepartment of Cardiovascular Medicine, Nantan General Hospital, Kyoto, JapanISSN 1941-5923 © Am J Case Rep, 2017; 18: 568-572 DOI: 10.12659/AJCR.903876 568 This work is licensed under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)",Non-OADS,/arxiv_data1/oa_pdf/04/30/amjcaserep-18-568.PMC5447664.pdf
"MeSH Keywords:  Appendiceal Neoplasms • Ovarian Neoplasms • Sequence Analysis, DNA  Full-text PDF: http://www.amjcaserep.com/abstract/index/idArt/903581Authors’ Contribution:  Study Design A  Data Collection B  Statistical Analysis C Data Interpretation D  Manuscript Preparation E  Literature Search F Funds Collection G1 Department of Pathology and Laboratory Medicine, University of Wisconsin  School of Medicine and Public Health, Madison, WI, U.S.A. 2 University of Wisconsin Hospitals and Clinics, Madison, WI, U.S.A. 3 Department of Obstetrics and Gynecology, Division of Gynecologic Oncology,  University of Wisconsin School of Medicine and Public Health, Madison, WI, U.S.A.ISSN 1941-5923 © Am J Case Rep, 2017; 18: 558-562 DOI: 10.12659/AJCR.903581 558 This work is licensed under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)",Non-OADS,/arxiv_data1/oa_pdf/49/91/amjcaserep-18-558.PMC5447665.pdf
"MeSH Keywords:  Acute Kidney Injury • Adolescent, Hospitalized • Hypernatremia • Hyponatremia • Mortality  Full-text PDF: http://www.medscimonit.com/abstract/index/idArt/902032Authors’ Contribution:  Study Design A  Data Collection B  Statistical Analysis C Data Interpretation D  Manuscript Preparation E  Literature Search F Funds Collection G1 Division of Nephrology, Zhongshan Hospital, Shanghai Medical College, Fudan  University, Shanghai, P.R.",Non-OADS,/arxiv_data1/oa_pdf/ea/18/medscimonit-23-2408.PMC5447666.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/c4/18/btt-11-065.PMC5447692.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/c4/18/btt-11-065.PMC5447692.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Biologics: Targets and Therapy 2017:11 65–69Biologics: Targets and Therapy Dovepress submit your manuscript | www.dovepress.com Dovepress  65 CASE REPORT open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/BTT .S134508Paradoxical SAPHO syndrome observed during  anti-TNFα therapy for Crohn’s disease Hitoshi Amano1 Reikei Matsuda1 T omohiko Shibata2 Daisuke Takahashi1 Shinichiro Suzuki3 1Department of Gastroenterology,   Fujisawa Shonandai Hospital,   Fujisawa, 2Division of Rheumatology,   Department of Internal Medicine,  St Marianna University School of Medicine, Y okohama City Seibu Hospital, Y okohama,  3Department of  Surgery, Fujisawa Shonandai Hospital,  Fujisawa, JapanAbstract:  Currently, anti-TNFα antibodies are used to treat Crohn’ s disease.",Non-OADS,/arxiv_data1/oa_pdf/c4/18/btt-11-065.PMC5447692.pdf
"Despite upper endoscopy and small-bowel follow-through showing no obvious abnormalities, ileocolonoscopy revealed deep discrete longitudinal ulcers accompanied by cobblestone appearance in Correspondence: Reikei Matsuda Department of Gastroenterology, Fujisawa Shonandai Hospital, 5-46 Takakura, Fujisawa, Kanagawa 252-0802, JapanTel +81 466 441 451Fax +81 466 446 771Email reikeim@hotmail.comJournal name: Biologics: Targets and Therapy Article Designation: CASE REPORTY ear: 2017V olume: 11Running head verso: Amano et alRunning head recto: SAPHO syndrome following anti-TNFα therapyDOI: http://dx.doi.org/10.2147/BTT.S134508",Non-OADS,/arxiv_data1/oa_pdf/c4/18/btt-11-065.PMC5447692.pdf
"Biologics: Targets and Therapy 2017:11submit your manuscript | www.dovepress.com Dovepress Dovepress Biologics: Targets and Therapy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/biologics-targets-and-therapy-journalBiologics: Targets and Therapy is an international, peer-reviewed journal  focusing on the patho-physiological rationale for and clinical applica-tion of Biologic agents in the management of autoimmune diseases, cancers or other pathologies where a molecular target can be identified.",Non-OADS,/arxiv_data1/oa_pdf/c4/18/btt-11-065.PMC5447692.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 69 SAPHO syndrome following anti-TNFα therapy 19.,Non-OADS,/arxiv_data1/oa_pdf/c4/18/btt-11-065.PMC5447692.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/7e/4f/ceor-9-307.PMC5447693.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/7e/4f/ceor-9-307.PMC5447693.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).ClinicoEconomics and Outcomes Research 2017:9 307–315ClinicoEconomics and Outcomes Research Dovepress submit your manuscript | www.dovepress.com Dovepress  307 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CEOR.S136577In-center hemodialysis absenteeism: prevalence  and association with outcomes Kathryn S Gray Dena E Cohen Steven M Brunelli DaVita Clinical Research, Minneapolis,   MN, USAObjective: The aim of this study was to determine the rate of missed treatments among hemodi- alysis (HD) patients, and the association between treatment nonadherence and clinical outcomes.",Non-OADS,/arxiv_data1/oa_pdf/7e/4f/ceor-9-307.PMC5447693.pdf
"1,2 For decades, the medical and public health communities have sought better under - standing of the high clinical and economic burden borne by patients treated with Correspondence: Steven M Brunelli DaVita Clinical Research, 825 South 8th Street, Minneapolis, MN 55404, USATel +1 781 292 0901Fax +1 877 683 2671Email steven.brunelli@davita.comJournal name: ClinicoEconomics and Outcomes Research Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 9Running head verso: Gray et alRunning head recto: Missed treatments and outcomesDOI: http://dx.doi.org/10.2147/CEOR.S136577",Non-OADS,/arxiv_data1/oa_pdf/7e/4f/ceor-9-307.PMC5447693.pdf
Available from: https://www.usrds.org/2015/view/.,Non-OADS,/arxiv_data1/oa_pdf/7e/4f/ceor-9-307.PMC5447693.pdf
"ClinicoEconomics and Outcomes Research 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress ClinicoEconomics and Outcomes Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinicoeconomics-and-outcomes-research-journalClinicoEconomics and Outcomes Research is an international, peer- reviewed open-access journal focusing on health technology assess-ment, pharmacoeconomics and outcomes research in the areas of   diagnosis, medical devices, and clinical, surgical and pharmacological intervention.",Non-OADS,/arxiv_data1/oa_pdf/7e/4f/ceor-9-307.PMC5447693.pdf
"Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 315 Missed treatments and outcomes Table S2  Overall comparison of short-term (30-day) and long-term (180-day) secondary outcomes by attendance status Outcome Attended, mean   (95% CI)Absence, mean   (95% CI)Difference, mean   (95% CI)P-value 30-Day outcomes Serum potassium 4.73 (4.72, 4.75) 4.73 (4.69, 4.77) 0.00 (−0.04, 0.04) 0.91 Hemoglobin 10.93 (10.90, 10.96) 10.75 (10.69, 10.81) −0.18 (−0.25, −0.12) <0.001 Ultrafiltration rate 9.76 (9.59, 9.93) 9.94 (9.12, 10.75) 0.18 (−0.65, 1.00) 0.68 Ultrafiltration volume 2.67 (2.64, 2.70) 2.61 (2.52, 2.70) −0.06 (−0.15, 0.04) 0.26 Blood pressure 147.3 (146.8, 147.8) 147.6 (146.4, 148.8) 0.3 (−1.0, 1.6) 0.68 ESA administrations 7.85 (7.74, 7.96) 7.68 (7.43, 7.93) −0.17 (−0.44, 0.10) 0.22 ESA dosea4594 (4494, 4693) 4775 (4535, 5016) 181 (−77, 439) 0.17 ESA utilizationb3953 (3859, 4047) 4060 (3835, 4284) 107 (−135, 348) 0.39 180-Day outcomes Serum potassium 4.75 (4.74, 4.76) 4.75 (4.72, 4.77) 0.00 (−0.04, 0.03) 0.78 Hemoglobin 10.93 (10.91, 10.96) 10.85 (10.8, 10.9) −0.08 (−0.14, −0.03) 0.003 Ultrafiltration rate 9.72 (9.62, 9.83) 10.03 (9.25, 10.81) 0.31 (−0.48, 1.09) 0.44 Ultrafiltration volume 2.66 (2.63, 2.69) 2.62 (2.54, 2.7) −0.04 (−0.12, 0.05) 0.39 Blood pressure 147.3 (146.8, 147.8) 147.8 (146.7, 149.0) 0.6 (−0.7, 1.8) 0.37 ESA administrations 45.25 (44.66, 45.83) 42.39 (41.12, 43.67) −2.85 (−4.25, −1.46) <0.001 ESA dosea4583 (4495, 4672) 4862 (4639, 5085) 278 (39, 518) 0.02 ESA utilizationb4160 (4074, 4246) 4429 (4212, 4646) 269 (37, 502) 0.02 Notes: aAmong patients receiving ESA.",Non-OADS,/arxiv_data1/oa_pdf/7e/4f/ceor-9-307.PMC5447693.pdf
[webpage on the  Internet] Available from https://www.hcup-us.ahrq.gov/toolssoftware/ccs/ccs.jsp.,OADS,/arxiv_data1/oa_pdf/7e/4f/ceor-9-307.PMC5447693.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/b1/42/dhps-9-025.PMC5447694.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/b1/42/dhps-9-025.PMC5447694.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Drug, Healthcare and Patient Safety 2017:9 25–37Drug, Healthcare and Patient Safety Dovepress submit your manuscript | www.dovepress.com Dovepress 25 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DHPS.S122207 Update on the renal toxicity of iodinated contrast  drugs used in clinical medicine Michele Andreucci1 T eresa Faga1 Raffaele Serra2 Giovambattista De Sarro3 Ashour Michael1 1Renal Unit, Department of  Health Sciences, 2Interuniversity  Center of Phlebolymphology  (CIFL), International Research and Educational Program in Clinical and Experimental Biotechnology,  Department of Medical and Surgical Sciences,  3Pharmacology Unit,   Department of Health Sciences,  Magna Graecia University, Catanzaro,  ItalyAbstract: An important side effect of diagnostic contrast drugs is contrast-induced acute kidney  injury (CI-AKI; a sudden decrease in renal function) occurring 48–72 hours after injection of  a contrast drug that cannot be attributed to other causes.",Non-OADS,/arxiv_data1/oa_pdf/b1/42/dhps-9-025.PMC5447694.pdf
"We are aware that all drugs used in clinical practice have some side effects in addi- tion to therapeutic efficacy; only when their efficacy prevails over the side effects are  Correspondence: Michele Andreucci Renal Unit, Department of Health Sciences, Salvatore Venuta Campus, Magna Graecia University, Viale Europa, Catanzaro 88100, ItalyTel +39 0961 364 7301Email andreucci@unicz.itJournal name: Drug, Healthcare and Patient Safety Article Designation: REVIEWY ear: 2017V olume: 9Running head verso: Andreucci et alRunning head recto: Renal toxicity of iodinated contrast drugsDOI: http://dx.doi.org/10.2147/DHPS.S122207",Non-OADS,/arxiv_data1/oa_pdf/b1/42/dhps-9-025.PMC5447694.pdf
A kidney-failure-risk equation (eight variables) is available on the website https://www.qxmd.com/calculate/calculator_125/ kidney-failure-risk-equation-8-variable.,OADS,/arxiv_data1/oa_pdf/b1/42/dhps-9-025.PMC5447694.pdf
Available from: http://www2.sas.com/proceedings/sugi29/165-29.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b1/42/dhps-9-025.PMC5447694.pdf
"Drug, Healthcare and Patient Safety 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress Drug, Healthcare and Patient Safety Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/drug-healthcare-and-patient-safety-journalDrug, Healthcare and Patient Safety is an international, peer-reviewed  open access journal exploring patient safety issues in the healthcare continuum from diagnostic and screening interventions through to treat-ment, drug therapy and surgery.",Non-OADS,/arxiv_data1/oa_pdf/b1/42/dhps-9-025.PMC5447694.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 37 Renal toxicity of iodinated contrast drugs  138.,Non-OADS,/arxiv_data1/oa_pdf/b1/42/dhps-9-025.PMC5447694.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/eb/47/copd-12-1527.PMC5447695.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2017:12 1527–1537International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1527OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/COPD.S13379 3 a cross-sectional survey of current treatment  and symptom burden of patients with COPD  consulting for routine care according to gOlD  2014 classifications Bo Ding1 Mark small2 Ulf holmgren3 1Medical evidence and Observational  research, astraZeneca gothenburg,   Mölndal, sweden; 2real World  research ( respiratory), adelphi real  World, Bollington, UK; 3global Payer  evidence and Pricing, astraZeneca  gothenburg, Mölndal, swedenBackground:  As part of the Respiratory Disease Specific Program (DSP) conducted to  provide observations of clinical practice from a physician and matched patient viewpoint,  this study aimed to establish how patients with COPD are treated according to the Global  Initiative for Chronic Obstructive Lung Disease (GOLD) classification system and to quantify  the symptom burden.",Non-OADS,/arxiv_data1/oa_pdf/eb/47/copd-12-1527.PMC5447695.pdf
"Keywords:  bronchodilators, COPD, treatment, GOLD group, symptom, routine care Introduction Many patients with COPD are not able to achieve optimal control of COPD symp - toms, despite the availability of several types of bronchodilator and anti-inflammatory  therapies.1 Relieving patients’ current symptoms in order to reduce the impact on their  daily activities, as well as lowering the risk of future exacerbations and preventing  disease progression, are key goals of the management of stable COPD.2 Patients with COPD experience several different symptoms, including dyspnea,  wheezing, and chest tightness, which can vary across 24 hours.1,3,4 Increased prevalence Correspondence: Bo Ding Medical evidence and Observational research, global Medical affairs,  astraZeneca gothenburg,  Pepparedsleden 1, se-431 83 Mölndal,  sweden Tel +46 31 776 2406 email bo.ding@astrazeneca.co m Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Ding et al Running head recto: Treatment of COPD patients by GOLD subgroups DOI: http://dx.doi.org/10.2147/COPD.S133793",Non-OADS,/arxiv_data1/oa_pdf/eb/47/copd-12-1527.PMC5447695.pdf
"Avail - able from: http://www.goldcopd.or g. Accessed November 18, 2016.",Non-OADS,/arxiv_data1/oa_pdf/eb/47/copd-12-1527.PMC5447695.pdf
"Available from: http://www.goldcopd.or g. Accessed  October 30, 2016.",Non-OADS,/arxiv_data1/oa_pdf/eb/47/copd-12-1527.PMC5447695.pdf
"Available from: http://www.goldcopd.or g. Accessed October 30, 2016.",Non-OADS,/arxiv_data1/oa_pdf/eb/47/copd-12-1527.PMC5447695.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/eb/47/copd-12-1527.PMC5447695.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/eb/47/copd-12-1527.PMC5447695.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/99/47/bctt-9-359.PMC5447696.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/99/47/bctt-9-359.PMC5447696.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Breast Cancer - Targets and Therapy 2017:9 359–364Breast Cancer - Targets and Therapy Dovepress submit your manuscript | www.dovepress.com Dovepress 359 Original researCh open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/BCTT .S132602 effect of reduced dietary fat on estradiol,  adiponectin, and igF-1 levels in postmenopausal  women with breast cancer Blanca Murillo-Ortiz1 sandra Martínez-garza1 Vanessa Cárdenas  landeros1 gerardo Cano Velázquez1 David suárez garcía2 1Clinical epidemiology research  Unit, 2Department of Oncology,   Mexican institute of social security,   leon, MexicoIntroduction: In recent years, epidemiological studies have strongly related obesity with an  increased risk of developing postmenopausal breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/99/47/bctt-9-359.PMC5447696.pdf
"insurgentes s/n, Colonia los Paraísos, 37320 leon, guanajuato, MexicoTel/fax +52 477 718 3039email bomo907@hotmail.comJournal name: Breast Cancer - Targets and Therapy Article Designation: Original ResearchY ear: 2017V olume: 9Running head verso: Murillo-Ortiz et alRunning head recto: Diet and postmenopausal breast cancerDOI: http://dx.doi.org/10.2147/BCTT.S132602",Non-OADS,/arxiv_data1/oa_pdf/99/47/bctt-9-359.PMC5447696.pdf
"Breast Cancer - Targets and Therapy 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress Breast Cancer - Targets and Therapy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/breast-cancer---targets-and-therapy-journal Breast Cancer - Targets and Therapy is an international, peer-   reviewed open access journal focusing on breast cancer research,  identification of therapeutic targets and the optimal use of preven-tative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/99/47/bctt-9-359.PMC5447696.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 364 Murillo-Ortiz et al 32.,Non-OADS,/arxiv_data1/oa_pdf/99/47/bctt-9-359.PMC5447696.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/5a/17/dddt-11-1585.PMC5447697.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2017:11 1585–1592Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1585Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S12862 3 effect of a food supplement containing berberine,  monacolin K, hydroxytyrosol and coenzyme  Q10 on lipid levels: a randomized, double-blind,  placebo controlled study sergio D’addato1 luciana scandiani2 giuliana Mombelli3 Francesca Focanti4 Federica Pelacchi4 enrica salvatori4 giorgio Di loreto4 alessandro comandini4 Pamela Maffioli5 giuseppe Derosa5 1Medical and surgical science  Department, s. Orsola Malpighi  hospital, University of Bologna,   Bologna, italy; 2Department of internal  Medicine, azienda Ospedaliera-Polo  Universitario Ospedale luigi sacco,   Milan, italy; 3Dyslipidemia center,   hospital niguarda ca’ granda, Milan,   italy; 4acra F s.p.a. angelini research  center rr&D, ancona, italy; 5center  of Diabetes and Metabolic Diseases,   Department of internal Medicine  and Therapeutics, Fondazione irccs   Policlinico san Matteo, University of  Pavia, Pavia, italyPurpose:  To evaluate the ability of the new food supplement, Body Lipid (BL), containing  red yeast rice, berberine, coenzyme Q10 and hydroxytyrosol, to lower the LDL-C in patients  with mild-to-moderate hypercholesterolemia and to assess the overall safety profile of the  product.",Non-OADS,/arxiv_data1/oa_pdf/5a/17/dddt-11-1585.PMC5447697.pdf
"There is a large body of epidemiological evidence demonstrating a strong  correlation and causal relationship between serum cholesterol level, particularly serum correspondence: giuseppe Derosa Department of internal Medicine and  Therapeutics, University of Pavia,  Fondazione irccs Policlinico san Matteo,  Piazzale golgi 2, 27100 Pavia, italy Tel +39 0382 526217 Fax +39 0382 526259 email giuseppe.derosa@unipv.i t Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: D’Addato et al Running head recto: Effect of nutraceutical combination on lipid profile DOI: http://dx.doi.org/10.2147/DDDT.S128623",Non-OADS,/arxiv_data1/oa_pdf/5a/17/dddt-11-1585.PMC5447697.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/5a/17/dddt-11-1585.PMC5447697.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/5a/17/dddt-11-1585.PMC5447697.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/14/31/bctt-9-365.PMC5447698.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/14/31/bctt-9-365.PMC5447698.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Breast Cancer - Targets and Therapy 2017:9 365–373Breast Cancer - Targets and Therapy Dovepress submit your manuscript | www.dovepress.com Dovepress 365 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/BCTT .S131334 The regulation of steroid receptors by  epigallocatechin-3-gallate in breast cancer cells Kelly Hallman* Katie Aleck* Meghan Quigley Brigitte DwyerVictoria LloydMonica Szmyd Sumi Dinda Biomedical Diagnostic and  Therapeutic Sciences, School of Health Sciences, Center for Biomedical Research, Oakland University, Rochester, MI, USA *These authors contributed equally to  this workAbstract: It has been reported that phytoestrogen epigallocatechin gallate (EGCG) suppresses  cancer cell proliferation and may have antitumor properties.",Non-OADS,/arxiv_data1/oa_pdf/14/31/bctt-9-365.PMC5447698.pdf
"Previous studies from our laboratory have shown the addition  of E 2 to breast cancer cells causes a downregulation of the ERα and an increase in cel- lular proliferation.4 Phytoestrogens have been shown to bind to ER (α  and β ) and act as Correspondence: Sumi Dinda Biomedical Diagnostic and Therapeutic Sciences, 3164 HHB, School of Health Sciences, 433 Meadow Brook Road, Oakland University, Rochester, MI 48309, USATel +1 248 364 8676Fax +1 248 364 8657Email sdinda@oakland.edu Journal name: Breast Cancer - Targets and Therapy Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 9Running head verso: Hallman et alRunning head recto: The regulation of steroid receptors by epigallocatechin-3-gallateDOI: http://dx.doi.org/10.2147/BCTT.S131334",Non-OADS,/arxiv_data1/oa_pdf/14/31/bctt-9-365.PMC5447698.pdf
"Breast Cancer - Targets and Therapy 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress Breast Cancer - Targets and Therapy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/breast-cancer---targets-and-therapy-journal Breast Cancer - Targets and Therapy is an international, peer-   reviewed open access journal focusing on breast cancer research,  identification of therapeutic targets and the optimal use of preven-tative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/14/31/bctt-9-365.PMC5447698.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 373 The regulation of steroid receptors by epigallocatechin-3-gallate  5.,Non-OADS,/arxiv_data1/oa_pdf/14/31/bctt-9-365.PMC5447698.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/22/97/dddt-11-1593.PMC5447699.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2017:11 1593–1603Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1593Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S10030 2 Profile of sarilumab and its potential in the  treatment of rheumatoid arthritis Maria Gabriella Raimondo1 Martina Biggioggero1 Chiara Crotti1 Andrea Becciolini2 ennio Giulio Favalli2 1Department of Clinical Sciences  and Health Community, Division of  Rheumatology, University of Milan,   2Department of Rheumatology,   Gaetano Pini institute, Milan, italyAbstract:  In recent years the use of biotechnological agents has drastically revolutionized  the therapeutic approach and the progression of rheumatoid arthritis (RA).",Non-OADS,/arxiv_data1/oa_pdf/22/97/dddt-11-1593.PMC5447699.pdf
"According to more recent  strategies based on a treat-to-target approach,5 the combination of methotrexate (MTX)  with a biologic disease-modifying anti-rheumatic drug (bDMARD) represents the Correspondence: ennio Giulio Favalli Department of Rheumatology, Gaetano  Pini institute, via Gaetano Pini 9, 20122  Milan, italy Tel +39 02 5829 6421 Fax +39 02 5829 6315 email ennio.favalli@gmail.co m Journal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2017 Volume: 11 Running head verso: Raimondo et al Running head recto: Sarilumab in the treatment of RA DOI: http://dx.doi.org/10.2147/DDDT.S100302",Non-OADS,/arxiv_data1/oa_pdf/22/97/dddt-11-1593.PMC5447699.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/22/97/dddt-11-1593.PMC5447699.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/22/97/dddt-11-1593.PMC5447699.pdf
"Retrieved November 15, 2014, from  http://www.aaos.",Non-OADS,/arxiv_data1/oa_pdf/6a/64/ornur-36-229.PMC5447778.pdf
Circulation Research is available at http://circres.ahajournals.org  DOI: 10.1161/CIRCRESAHA.116.310371The opinions expressed in this article are not necessarily those of the  editors or of the American Heart Association.,Non-OADS,/arxiv_data1/oa_pdf/04/a1/res-120-1718.PMC5447780.pdf
"components, if present on the section (Figure, Supple- mental Digital Content 2, http://links.lww.com/AIMM/ A102).",Non-OADS,/arxiv_data1/oa_pdf/0c/bf/pai-25-313.PMC5447781.pdf
"For each PR-stained invasive carcinoma specimen included in the method comparison study, the pathologists recorded the percentage of positive cells and the stainingintensity (Figure, Supplemental Digital Content 3, http://links.lww.com/AIMM/A103), as well as staining of DCIS components, if present on the section (Figure, Supple- mental Digital Content 4, http://links.lww.com/AIMM/A104).",Non-OADS,/arxiv_data1/oa_pdf/0c/bf/pai-25-313.PMC5447781.pdf
"Lyon, france: International agency for research on cancer; 2013. http://globocan.iarc.fr.",Non-OADS,/arxiv_data1/oa_pdf/c4/46/pai-25-320.PMC5447782.pdf
http://seer.cancer.gov/ csr/1975_2011/.,Non-OADS,/arxiv_data1/oa_pdf/c4/46/pai-25-320.PMC5447782.pdf
http://seer.cancer.gov/ csr/1975_2012/.,Non-OADS,/arxiv_data1/oa_pdf/c4/46/pai-25-320.PMC5447782.pdf
http://www.nordiqc.org/Run-33-B12-G2/Assessment/assessment-G2- HER2.htm.,Non-OADS,/arxiv_data1/oa_pdf/c4/46/pai-25-320.PMC5447782.pdf
http://www.ukneqasiccish.org/wp/wp-content/uploads/2015/07/ run_109_journal.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c4/46/pai-25-320.PMC5447782.pdf
EMEA/H/C/278/II/0047 http://www.ema.europa.eu/ docs/en_GB/document _library/EPAR_-_A ssessment_Report_-_ Variation/human/000278/WC5000749 21.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c4/46/pai-25-320.PMC5447782.pdf
"http://www.newswise.com/articles/view/596393, 2012 access 2012.11.26 11) Zoroya G: Pentagon spends $300M to study troop’ stress, trauma.",Non-OADS,/arxiv_data1/oa_pdf/53/5e/nmc-57-199.PMC5447811.pdf
"http://abcnews.go.com/h ealth/Mind- Moodnews/story?id=5517802&page=1, 2008 access 2008.8.5 12) dean PJ, o’neill d, Sterr a: Post-concussion syndrome:  prevalence after mild traumatic brain injury in comparison with a sample without head injury.",Non-OADS,/arxiv_data1/oa_pdf/53/5e/nmc-57-199.PMC5447811.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-nd/4.0/ © The Author(s) 2017 Supplementary Information accompanies this paper on the Oncogene website (http://www.nature.com/onc)Downregulation of proapoptotic MOAP-1 by UBR5 K Matsuura et al 1706 Oncogene (2017) 1698 –1706",Non-OADS,/arxiv_data1/oa_pdf/5a/54/onc2016336a.PMC5447866.pdf
"For functional annotation of differentially expressed genes, we performed over-representation analysis using gene sets from KEGG andReactome gene sets from the MSigDB website (http://software.broadinstitute.org/gsea/msigdb).",OADS,/arxiv_data1/oa_pdf/66/6c/onc2016338a.PMC5447867.pdf
AVAILABILITY OF DATA AND MATERIALS The data sets supporting the conclusions of this article are available at the National Center for Biotechnology Information ’s Gene Expression Omnibus (GEO) and are accessible through GEO Series accession numbers GSE67300 and GSE55348 (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc = GSE55348).,OADS,/arxiv_data1/oa_pdf/66/6c/onc2016338a.PMC5447867.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © The Author(s) 2017 Supplementary Information accompanies this paper on the Oncogene website (http://www.nature.com/onc)d16HER2 sustains breast tumor stemness L Castagnoli et al 1732 Oncogene (2017) 1721 –1732",Non-OADS,/arxiv_data1/oa_pdf/66/6c/onc2016338a.PMC5447867.pdf
"When we described in vitro CD19 –CD8 coupling, we performed overnight time-lapse analyses showing that T cells engaged prolonged and multiple contacts with rather static B cells (http://www.jimmunol.org/content/180/3/1362/suppl/DC1).",OADS,/arxiv_data1/oa_pdf/83/89/bmt2016294a.PMC5447868.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ © The Author(s) 2017 Supplementary Information accompanies this paper on Bone Marrow Transplantation website (http://www.nature.com/bmt)Letter to the Editor 462 Bone Marrow Transplantation (2017) 459 –462",Non-OADS,/arxiv_data1/oa_pdf/83/89/bmt2016294a.PMC5447868.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/ by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3e/26/cix212.PMC5447871.pdf
Available at: http://www.eurocoord.net/ .,Non-OADS,/arxiv_data1/oa_pdf/3e/26/cix212.PMC5447871.pdf
Available at: http://ecdc.europa.eu/en/healthtopics/ aids/Pages/hiv-modelling-tool.aspx .,Non-OADS,/arxiv_data1/oa_pdf/3e/26/cix212.PMC5447871.pdf
Available at:  http://ec.europa.eu/eurostat .,Non-OADS,/arxiv_data1/oa_pdf/3e/26/cix212.PMC5447871.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/ by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/43/f0/cix219.PMC5447873.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/ by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9d/c8/cix177.PMC5447887.pdf
Available at: https://aidsinfo.nih.gov/contentfiles/lvguidelines/adultandadoles- centgl.pdf .,Non-OADS,/arxiv_data1/oa_pdf/9d/c8/cix177.PMC5447887.pdf
Available at: http://www.wageindicator.org/ documents/publicationslist/publications-2012/AIAS_WI_countryreports_f2f_ report_Uganda_final_20121211.pdf .,Non-OADS,/arxiv_data1/oa_pdf/9d/c8/cix177.PMC5447887.pdf
Available at: http://www.clintonhealthaccess.,Non-OADS,/arxiv_data1/oa_pdf/9d/c8/cix177.PMC5447887.pdf
stortinget.no/en/In-English/) and the Swedish Riksdag (http://www.riksdagen.se/en/).,Non-OADS,/arxiv_data1/oa_pdf/70/b3/10.1177_0267323114531383.PMC5447896.pdf
Available at: http://firstmonday.org/article/view/1630/1545 Polat RK (2005) The Internet and political participation: Exploring the explanatory links.,Non-OADS,/arxiv_data1/oa_pdf/70/b3/10.1177_0267323114531383.PMC5447896.pdf
3. https://www.gov.uk/government/organisations/behavioural-insights-team 4.Spiked 1 November 2010. http://www.spiked-online.com/site/article/9840/ 5.,Non-OADS,/arxiv_data1/oa_pdf/8c/31/10.1177_0952076713509297.PMC5447898.pdf
"6.The Guardian , 6 May 2013. http://www.theguardian.com/society/2013/may/06/ jobseekers-psychometric-test-failure 7.Time , 9 August 2013, http://swampland.time.com/2013/08/09/nudge-back-in-fashion- at-white-house/ 8.",Non-OADS,/arxiv_data1/oa_pdf/8c/31/10.1177_0952076713509297.PMC5447898.pdf
See http://www.guardian.co.uk/politics/2011/feb/20/nudge-unit-oliver-letwin References Argyris C (1993) Knowledge for Action: A Guide to Overcoming Barriers to Organizational Change.,Non-OADS,/arxiv_data1/oa_pdf/8c/31/10.1177_0952076713509297.PMC5447898.pdf
Available at: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/83719/Behavioural-Insights-Team-Annual-Update-2011-12_0.pdf (accessed 12 October 2013).,OADS,/arxiv_data1/oa_pdf/8c/31/10.1177_0952076713509297.PMC5447898.pdf
Available at: https://www.gov.uk/government/publications/-fraud-error-and-debt-behavioural-insights-team-paper (accessed 12 October 2013).,Non-OADS,/arxiv_data1/oa_pdf/8c/31/10.1177_0952076713509297.PMC5447898.pdf
Available at: https://www.gov.uk/government/publications/applying-behavioural-insights-to-charitable-giving (accessed 12 October 2013).,Non-OADS,/arxiv_data1/oa_pdf/8c/31/10.1177_0952076713509297.PMC5447898.pdf
"https://doi.org/10.1177/1476127016648498Strategic Organization 2017, Vol.",Non-OADS,/arxiv_data1/oa_pdf/5a/7d/10.1177_1476127016648498.PMC5447948.pdf
Available at: http://sloanreview.mit.edu/article/how-useful-is-the- theory-of-disruptive-innovation/ King A and Tucci C (2002) Incumbent entry into new market niches: The role of experience and managerial  choice in the creation of dynamic capabilities.,Non-OADS,/arxiv_data1/oa_pdf/5a/7d/10.1177_1476127016648498.PMC5447948.pdf
Available at: http://www.palgraveconnect.com/esm/doifinder/10.1057/9781137294678.0232 Lieberman MB and Montgomery DB (1988) First-mover advantages.,Non-OADS,/arxiv_data1/oa_pdf/5a/7d/10.1177_1476127016648498.PMC5447948.pdf
"(CC-BY-NC-ND 4.0: https://creativecommons.org/licenses/by-nc-nd/4.0/) NOTE Avian Pathology Durability of alkaline agents’ bactericidal  efficacies in litter under field conditions Hakimullah HAKIM1,2), Chiharu TOYOFUKU1), Mari OTA1), Mayuko SUZUKI1),  Miyuki KOMURA1), Masashi YAMADA1), Md.",Non-OADS,/arxiv_data1/oa_pdf/8b/bd/jvms-79-815.PMC5447964.pdf
"153. http://www.fao.org /ag/ againfo/home/events/ bangkok2007/docs/part2/2_2.pdf [accessed January 21, 2017]  7.",Non-OADS,/arxiv_data1/oa_pdf/8b/bd/jvms-79-815.PMC5447964.pdf
"http://jlia.lin.gr.jp/wagyu/eng/aboutmark3.html [accessed January  21, 2017].",Non-OADS,/arxiv_data1/oa_pdf/8b/bd/jvms-79-815.PMC5447964.pdf
"(CC-BY-NC-ND 4.0: https://creativecommons.org/licenses/by-nc-nd/4.0/) NOTE Internal Medicine Acquired Fanconi syndrome in two dogs  following long-term consumption of pet jerky treats in Japan: case report Akira YABUKI1), Tomoko IWANAGA2), Urs GIGER3), Mariko SAWA1),   Moeko KOHYAMA1) and Osamu YAMATO1)* 1)Laboratory of Clinical Pathology, Joint Faculty of Veterinary Medicine, Kagoshima University, 1-21-24  Kohrimoto, Kagoshima 890-0065, Japan 2)Veterinary Teaching Hospital, Joint Faculty of Veterinary Medicine, Kagoshima University, 1-21-24 Kohrimoto,  Kagoshima 890-0065, Japan 3)Section of Medical Genetics, University of Pennsylvania, 3900 Delancey St, Philadelphia, PA 19104-6010, U.S.A. ABSTRACT.",Non-OADS,/arxiv_data1/oa_pdf/dc/47/jvms-79-818.PMC5447965.pdf
"Safety alert on jerky treats for pets https://www.avma.org/News/Issues/recalls-alerts/Pages/Safety-Alert-on-Jerky-Treats-for-Pets.aspx  [accessed 5 Apr, 2017].",Non-OADS,/arxiv_data1/oa_pdf/dc/47/jvms-79-818.PMC5447965.pdf
"Jerky pet treat investigation testing rationale and results for October 1, 2013 −December 31, 2015 http://www.fda.gov/downloads/AnimalVeterinary/SafetyHealth/ProductSafetyInformation/UCM500706.pdf [accessed 5 Apr, 2017].",Non-OADS,/arxiv_data1/oa_pdf/dc/47/jvms-79-818.PMC5447965.pdf
"(CC-BY-NC-ND 4.0: https://creativecommons.org/licenses/by-nc-nd/4.0/) NOTE Internal Medicine A novel missense mutation in the factor  XII gene in a litter of cats with factor XII deficiency Haruhiko MARUYAMA1)*, Haruki HOSOE1), Kota NAGAMATSU2), Rui KANO1) and  Hiroshi KAMATA1) 1)Laboratory of Veterinary Clinical Pathology, Department of Veterinary Medicine, Nihon University, 1866  Kameino, Fujisawa, Kanagawa 252-0880, Japan 2)Nagamatsu Animal Hospital, 2-3-10 Nishiku Sakaisunayama, Niigata 950-2044, Japan ABSTRACT.",Non-OADS,/arxiv_data1/oa_pdf/35/74/jvms-79-822.PMC5447966.pdf
"(CC-BY-NC-ND 4.0: https://creativecommons.org/licenses/by-nc-nd/4.0/) NOTE Laboratory Animal Science Noninvasive sample collection for the  genotyping of neonatal rats using adhesive tape Mariko SHIROTA1)*, Miho SUZUKI1), Hiroaki TANAKA1), Kanako SUEOKA1),   Yuri YOSHIKAWA1) and Kazuaki TANAKA2) 1)Laboratory of Comparative Toxicology, School of Veterinary Medicine, Azabu University, 1-17-71 Fuchinobe,  Chuo-ku, Sagamihara, Kanagawa 252-5201, Japan 2)Laboratory of Animal Biotechnology, School of Veterinary Medicine, Azabu University, 1-17-71 Fuchinobe,  Chuo-ku, Sagamihara, Kanagawa 252-5201, Japan ABSTRACT.",Non-OADS,/arxiv_data1/oa_pdf/66/b6/jvms-79-827.PMC5447967.pdf
"ZyGEM APPLICATION NOTE NZ107 http://www.zygem.com/images/pdf/15/Z01070_ AppNote107_TapeInhib.pdf [accessed March 10, 2017].",Non-OADS,/arxiv_data1/oa_pdf/66/b6/jvms-79-827.PMC5447967.pdf
"(CC-BY-NC-ND 4.0: https://creativecommons.org/licenses/by-nc-nd/4.0/) NOTE Pathology Jejunal fibroplasia in a rat Kazufumi KAWASAKO1)*, Takeshi KANNO1) and Masao HAMAMURA1) 1)Pathology Department, Nonclinical Research Center, Drug Development Service Segment, LSI Medience  Corporation, 1285 Kurisaki-machi, Uto, Kumamoto 869-0425, Japan ABSTRACT.",Non-OADS,/arxiv_data1/oa_pdf/6a/d2/jvms-79-830.PMC5447968.pdf
"(CC-BY-NC-ND 4.0: https://creativecommons.org/licenses/by-nc-nd/4.0/) FULL PAPER Public Health Characterization of Shiga toxin-producing  Escherichia coli from feces of sika deer (Cervus nippon) in Japan using PCR binary typing analysis to evaluate their potential human pathogenicity Hidenori KABEYA1)*, Shingo SATO1), Shinya ODA1), Megumi KAWAMURA1),  Mariko NAGASAKA1), Masanari KURANAGA1), Eiji YOKOYAMA2),   Shinichiro HIRAI2), Atsushi IGUCHI4), Tomoe ISHIHARA3), Toshiro KUROKI5),  Tomoko MORITA-ISHIHARA6), Sunao IYODA6), Jun TERAJIMA7),   Makoto OHNISHI6) and Soichi MARUYAMA1) 1)Laboratory of Veterinary Public Health, Department of Veterinary Medicine, College of Bioresource Sciences,  Nihon University, 1866 Kameino, Fujisawa-shi, Kanagawa 252-0880, Japan 2)Division of Bacteriology, Chiba Prefectural Institute of Public Health, 666-2 Nitona-cho, Chuo-ku, Chiba-shi,  Chiba 260-8715, Japan 3)Department of Microbiology, Kanagawa Prefectural Institute of Public Health, 1-3-1 Shimomachiya,   Chigasaki-shi, Kanagawa 253-0087, Japan 4)Department of Animal and Grassland Sciences, Faculty of Agriculture, University of Miyazaki, 1-1  Gakuenkibanadainishi, Miyazaki-shi, Miyazaki 889-2192, Japan 5)Department of Planning and Information, Kanagawa Prefectural Institute of Public Health, 1-3-1  Shimomachiya, Chigasaki-shi, Kanagawa 253-0087, Japan 6)Department of Bacteriology, National Institute of Infectious Diseases, Toyama 1-23-1, Shinjuku-ku,   Tokyo 162-8640, Japan 7)Division of Microbiology, National Institute of Health Sciences, 1-18-1 Kamiyoga, Setagaya-ku,   Tokyo 158-8501, Japan ABSTRACT.",Non-OADS,/arxiv_data1/oa_pdf/c3/fa/jvms-79-834.PMC5447969.pdf
"(CC-BY-NC-ND 4.0: https://creativecommons.org/licenses/by-nc-nd/4.0/) FULL PAPER Theriogenology Proteome profiling of bovine follicular   fluid-specific proteins and their effect on  in vitro embryo development Saranya SATITMANWIWAT1)*, Chinarat CHANGSANGFAH1),   Tassanee FAISAIKARM1), Kornkanok PROMTHEP1), Sujira THAMMAWUNG2),  Kulnasan SAIKHUN1) and Kampon KAEOKET3) 1)Reproductive Research Group, Institute of Molecular Biosciences, Mahidol University, Salaya, Nakhon Pathom  73170, Thailand 2)Department of Surgery and Theriogenology, Faculty of Veterinary Medicine, Khon Kaen University 40002,  Thailand 3)Semen Laboratory, Department of Clinical Sciences and Public Health, Faculty of Veterinary Science, Mahidol  University, Nakhon Pathom 73170, Thailand ABSTRACT.",Non-OADS,/arxiv_data1/oa_pdf/c1/c6/jvms-79-842.PMC5447970.pdf
"Protein identification For protein identification, the mgf files generated from the MS/MS spectra were uploaded to the MASCOT search engine v2.2  (Matrix Science, London, U.K.) (http://www.matrixscience.com).",OADS,/arxiv_data1/oa_pdf/c1/c6/jvms-79-842.PMC5447970.pdf
"(CC-BY-NC-ND 4.0: https://creativecommons.org/licenses/by-nc-nd/4.0/) NOTE Virology Influenza A virus infection in Japanese wild  boars (Sus scrofa leucomystax) Hiroshi SHIMODA1), Dung VAN NGUYEN1), Kenzo YONEMITSU1),   Shohei MINAMI1), Nao NAGATA1), Nanami HARA1), Ryusei KUWATA1),   Shin MURAKAMI2), Yuuji KODERA3), Tsutomu TAKEDA3,4), Yasuhiro YOSHIKAWA5),  Taisuke HORIMOTO2) and Ken MAEDA1)* 1)Laboratory of Veterinary Microbiology, Joint Faculty of Veterinary Medicine, Yamaguchi University, 1677-1  Yoshida, Yamaguchi 753-8515, Japan 2)Department of Veterinary Microbiology, Graduate School of Agricultural and Life Sciences, The University of  Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-8657, Japan 3)Center for Weed and Wildlife Management, Utsunomiya University, 350 Mine-machi, Utsunomioya,   Tochigi 321-8505, Japan 4)Natural Parks Foundation Nikko National Park, Yumoto, Nikko, Tochigi 321-1662, Japan 5)Department of Animal Risk Management, Chiba Institute of Science, 3 Shiomi-cho, Choshi, Chiba 288-0025,  Japan ABSTRACT.",Non-OADS,/arxiv_data1/oa_pdf/64/b7/jvms-79-848.PMC5447971.pdf
"(CC-BY-NC-ND 4.0: https://creativecommons.org/licenses/by-nc-nd/4.0/) NOTE Wildlife Science Stress assessment using hair cortisol of  kangaroos affected by the lumpy jaw disease Yukari SOTOHIRA1,2), Kazuyuki SUZUKI1), Tadashi SANO1), Chigusa ARAI1),  Mitsuhiko ASAKAWA1) and Hideaki HAYASHI1)* 1)School of Veterinary Medicine, Rakuno Gakuen University, 582 Bunkyodai-Midorimachi, Ebetsu,   Hokkaido 069-8501, Japan 2)Itozu no mori Zoological Park, 4-1-8 Kamiitozu, Kokurakita, Kitakyushu, Fukuoka 803-0845, Japan ABSTRACT.",Non-OADS,/arxiv_data1/oa_pdf/95/90/jvms-79-852.PMC5447972.pdf
"(CC-BY-NC-ND 4.0: https://creativecommons.org/licenses/by-nc-nd/4.0/) FULL PAPER Bacteriology A study on the efficacy of the recombinant  Yersinia adhesin A vaccine against yersiniosis in the early phase Kosuke TSUGO1), Shin-ichi NAKAMURA1), Hiroko YAMANAKA1) and Yumi UNE1)* 1)Laboratory of Veterinary Pathology, School of Veterinary Medicine, Azabu University, 1-17-71 Fuchinobe,  Chuo-ku, Sagamihara, Kanagawa 252–5201, Japan ABSTRACT.",Non-OADS,/arxiv_data1/oa_pdf/f9/a7/jvms-79-855.PMC5447973.pdf
"http://www.bccdc.ca/health-info/diseases-conditions/yersinia-infection (accessed Oct 12, 2016).",Non-OADS,/arxiv_data1/oa_pdf/f9/a7/jvms-79-855.PMC5447973.pdf
"(CC-BY-NC-ND 4.0: https://creativecommons.org/licenses/by-nc-nd/4.0/) FULL PAPER Bacteriology Identification of a novel Hemoplasma species  from pigs in Zhejiang province, China Yuan FU1,2), Tuanyuan SHI2), Lihua XU2), Wei WEI2,3), Fuzhuang LU2),   Xuejuan ZHANG2), Xiufang YUAN2), Junxing LI2), Jinhui LV2) and Weihuan FANG1)* 1)Institute of Preventive Veterinary Medicine, Zhejiang University, Hangzhou, Zhejiang 310058, China 2)Institute of Animal Husbandry and Veterinary Medicine, Zhejiang Academy of Agricultural Sciences,  Hangzhou, Zhejiang 310021, China 3)College of Life Science and Technology, Southwest University for Nationalities, Chengdu, Sichuan, 610041,  China ABSTRACT.",Non-OADS,/arxiv_data1/oa_pdf/94/97/jvms-79-864.PMC5447974.pdf
"(CC-BY-NC-ND 4.0: https://creativecommons.org/licenses/by-nc-nd/4.0/) NOTE Immunology Gene and protein expression of a soluble  form of CTLA-4 in a healthy dog Michihito TAGAWA1)*, Yuhei YAMAMOTO1), Genya SHIMBO1), Aiko IGUCHI2),  Xuenan XUAN3), Mizuki TOMIHARI4) and Kazuro MIYAHARA1) 1)Veterinary Medical Center, Obihiro University of Agriculture and Veterinary Medicine, Inada, Obihiro,  Hokkaido 080-8555, Japan 2)Veterinary Teaching Hospital, Faculty of Agriculture, Iwate University, 3-18-8 Ueda, Morioka, Iwate 020-8550,  Japan 3)National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine,  Inada, Obihiro, Hokkaido 080-8555, Japan 4)Department of Clinical Veterinary Science, Obihiro University of Agriculture and Veterinary Medicine, Inada,  Obihiro, Hokkaido 080-8555, Japan ABSTRACT.",Non-OADS,/arxiv_data1/oa_pdf/59/d7/jvms-79-871.PMC5447975.pdf
Nucleotide sequence results were confirmed using the BLAST search program (http://www.ncbi.nlm.nih.gov/blast/Blast.cgi) for comparison with other known sequences and aligned using CLUSTAL W software (http://www.genome.,OADS,/arxiv_data1/oa_pdf/59/d7/jvms-79-871.PMC5447975.pdf
"The sequence of the full length and alternatively spliced canine CTLA-4 genes were submitted to the DNA data bank of Japan (DDBJ; http://www.ddbj.nig.ac.jp) under accession numbers LC191194 and  LC191195, respectively.",Non-OADS,/arxiv_data1/oa_pdf/59/d7/jvms-79-871.PMC5447975.pdf
(CC-BY-NC-ND 4.0: https://creativecommons.org/licenses/by-nc-nd/4.0/) NOTE Internal Medicine Epidemiological study on feline gastric  Helicobacter spp.,Non-OADS,/arxiv_data1/oa_pdf/6e/c5/jvms-79-876.PMC5447976.pdf
"(CC-BY-NC-ND 4.0: https://creativecommons.org/licenses/by-nc-nd/4.0/) FULL PAPER Laboratory Animal Science Establishment of reference values for  complete blood count and blood gases in cynomolgus monkeys (Macaca fascicularis) Shunya NAKAYAMA1,2), Hiroshi KOIE1), Kiichi KANAYAMA1), Yuko KATAKAI3),  Yasuyo ITO-FUJISHIRO1,2), Tadashi SANKAI2), Yasuhiro YASUTOMI2,4) and  Naohide AGEYAMA2)* 1)Collage of Bioresource Science, Nihon University, Kanagawa 252-0880, Japan 2)Tsukuba Primate Research Center, National Institutes of Biomedical Innovation, Health and Nutrition,   Ibaraki 305-0843, Japan 3)The Corporation for Production and Research of Laboratory Primates, Ibaraki 305-0003, Japan 4)Department of Molecular and Experimental Medicine, Mie University Graduate School of Medicine,   Mie 514-8507, Japan ABSTRACT.",Non-OADS,/arxiv_data1/oa_pdf/c1/76/jvms-79-881.PMC5447977.pdf
"(CC-BY-NC-ND 4.0: https://creativecommons.org/licenses/by-nc-nd/4.0/) NOTE Pathology Spontaneous multicentric soft tissue  sarcoma in a captive African pygmy hedgehog (Atelerix albiventris): case report and literature review Josué DÍAZ-DELGADO1)*, Roy POOL1), Sharman HOPPES2), Argine CEREZO3),  Óscar QUESADA-CANALES 4) and George STOICA1) 1)Department of Veterinary Pathobiology, College of Veterinary Medicine and Biomedical Sciences, Texas   A&M University, College Station, TX 77843, U.S.A. 2)Department of Small Animal Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Texas  A&M University, College Station, TX 77843, U.S.A. 3)Department of Diagnostic Medicine/Pathobiology, College of Veterinary Medicine, Kansas State University,  Manhattan, KS 66506-5802, U.S.A. 4)Veterinary Histology and Pathology, Institute for Animal Health, Veterinary College, University of Las Palmas  de Gran Canaria, Trasmontaña s/n, Arucas 35413, Gran Canaria, Spain ABSTRACT.",Non-OADS,/arxiv_data1/oa_pdf/69/66/jvms-79-889.PMC5447978.pdf
"(CC-BY-NC-ND 4.0: https://creativecommons.org/licenses/by-nc-nd/4.0/) FULL PAPER Physiology Combination of vitamin E and vitamin C  alleviates renal function in hyperoxaluric rats via antioxidant activity Orapun JATURAKAN1), Thasinas DISSAYABUTRA2), Narongsak CHAIYABUTR1),  Anusak KIJTAWORNRAT1), Piyaratana TOSUKHOWONG2), Anudep RUNGSIPIPAT3),  Thumnoon NHUJAK4) and Chollada BURANAKARL1)* 1)Department of Physiology, Faculty of Veterinary Science, Chulalongkorn University, Bangkok 10330, Thailand 2)Department of Biochemistry, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand 3)Department of Pathology, Faculty of Veterinary Science, Chulalongkorn University, Bangkok 10330, Thailand 4)Department of Chemistry, Faculty of Science, Chulalongkorn University, Bangkok 10330, Thailand ABSTRACT.",Non-OADS,/arxiv_data1/oa_pdf/cc/21/jvms-79-896.PMC5447979.pdf
"(CC-BY-NC-ND 4.0: https://creativecommons.org/licenses/by-nc-nd/4.0/) FULL PAPER Virology Resurgence of bovine ephemeral fever in  mainland Japan in 2015 after a 23-year absence Yoshimasa HIRASHIMA1), Mariko NOJIRI1,2), Yasuhiro OHTSUKA3),   Tomoko KATO4), Hiroaki SHIRAFUJI4), Mitsuteru KURAZONO3),   Toyoshige IMAFUJI2) and Tohru YANASE4)* 1)Kagoshima Central Livestock Hygiene Service Center, 1678 Yuda, Higashiichiki, Hioki, Kagoshima 899-2201,  Japan 2)Nansatsu Livestock Hygiene Service Center, 4210-18 Kohri, Chiran, Minamikyushu, Kagoshima 897-0302, Japan 3)Kumage Branch, Kagoshima Central Livestock Hygiene Service Center, 6065 Noma, Nakatane,   Kagoshima 891-3604, Japan 4)Kyushu Research Station, National Institute of Animal Health, NARO, 2702 Chuzan, Kagoshima 891-0105,  Japan ABSTRACT.",Non-OADS,/arxiv_data1/oa_pdf/04/c8/jvms-79-904.PMC5447980.pdf
"(CC-BY-NC-ND 4.0: https://creativecommons.org/licenses/by-nc-nd/4.0/) NOTE Virology Phylogenetic analysis of env  gene of bovine  leukemia virus strains spread in Miyazaki  prefecture, Japan Marawan A. MARAWAN1,5), Hirohisa MEKATA2), Takumi HAYASHI1),   Satoshi SEKIGUCHI1), Yumi KIRINO3), Yoichiro HORII4),   Abdel-Moneim M. MOUSTAFA5), Faysal K. ARNAOUT5), El Sayed M. GALILA5) and  Junzo NORIMINE1,4)* 1)Laboratory of Animal Infectious Disease and Prevention, Department of Veterinary Sciences, Faculty of  Agriculture, University of Miyazaki, 1-1 Gakuen-Kibanadai-Nishi, Miyazaki 889-2192, Japan 2)Organization for Promotion of Tenure Track, University of Miyazaki, 1-1 Gakuen-Kibanadai-Nishi,   Miyazaki 889-2192, Japan 3)Project for Zoonoses Education and Research, Faculty of Agriculture, University of Miyazaki, 1-1 Gakuen- Kibanadai-Nishi, Miyazaki 889-2192, Japan 4)Division of International Cooperation and Education, Center for Animal Disease Control, University of  Miyazaki, 1-1 Gakuen-Kibanadai-Nishi, Miyazaki 889-2192, Japan 5)Infectious Diseases, Department of Animal Medicine, Faculty of Veterinary Medicine, Benha University,   Al Qalyubia Governorate 13511, Egypt ABSTRACT.",Non-OADS,/arxiv_data1/oa_pdf/f8/49/jvms-79-912.PMC5447981.pdf
"(CC-BY-NC-ND 4.0: https://creativecommons.org/licenses/by-nc-nd/4.0/) NOTE Avian Pathology An outbreak of duck hepatitis A virus type 1  infection in Japan Masahiro KAMOMAE1), Mamoru KAMEYAMA1), Jun ISHII1), Mikoto NABE1),   Yuji OGURA1), Hiroshi ISEKI2), Yu YAMAMOTO2) and Masaji MASE2,3)* 1)Himeji Livestock Hygiene Service Center, 595-15 Nakamura, Koderacho, Himeji, Hyogo 679-2166, Japan 2)National Institute of Animal Health, 3-1-5 Kannondai, Tsukuba, Ibaraki 305-0856, Japan 3)United Graduate School of Veterinary Sciences, Gifu University, 1-1 Yanagido, Gifu, Gifu 501-1193, Japan ABSTRACT.",Non-OADS,/arxiv_data1/oa_pdf/50/ec/jvms-79-917.PMC5447982.pdf
(CC-BY-NC-ND 4.0: https://creativecommons.org/licenses/by-nc-nd/4.0/) FULL PAPER Bacteriology Potential enterotoxicity and antimicrobial  resistance pattern of Aeromonas species isolated from pet turtles and their environment S. H. M. P .,Non-OADS,/arxiv_data1/oa_pdf/54/20/jvms-79-921.PMC5447983.pdf
"http://microbiolab-bg.com/wp-content/uploads/2015/05/CLSI-2014.pdf [accessed March 19, 2016]  6.",Non-OADS,/arxiv_data1/oa_pdf/54/20/jvms-79-921.PMC5447983.pdf
http://www.eucast.org/ast of bacteria/disk diffusion methodology/.,Non-OADS,/arxiv_data1/oa_pdf/54/20/jvms-79-921.PMC5447983.pdf
"2015. http://www.fda.gov/AnimalVeterinary/ResourcesforYou/ AnimalHealthLiteracy/ucm247899.htm [accessed March 25, 2016]  9.",Non-OADS,/arxiv_data1/oa_pdf/54/20/jvms-79-921.PMC5447983.pdf
"(CC-BY-NC-ND 4.0: https://creativecommons.org/licenses/by-nc-nd/4.0/) FULL PAPER Laboratory Animal Science Sequence variations in estrogen receptor 1  and 2 genes and their association with egg production traits in Chinese Dagu chickens Xiaotian NIU1)#, Thobela Louis TYASI1)#, Ning QIN1), Dehui LIU1), Hongyan ZHU1),  Xiaoxia CHEN1), Fengwei ZHANG1), Shuguo YUAN2) and Rifu XU1)* 1)Department of Animal Genetics, Breeding and Reproduction, College of Animal Science and Technology,   Jilin Agricultural University, Changchun 130118, Jilin, China 2)Jilin Grain Group Agriculture and Livestock Co., Ltd., Changchun 130062, Jilin, China ABSTRACT.",Non-OADS,/arxiv_data1/oa_pdf/d0/c7/jvms-79-927.PMC5447984.pdf
"For each sampled bird, two independent PCRs were conducted, with sequences analyzed  using BLAST (https://blast.ncbi.nlm.nih.gov/Blast.cgi?PROGRAM=blastn&PAGE_TYPE=BlastSearch&LINK_LOC=blasthome)  to confirm the amplification of the expected chicken ESR1 and ESR2 gene fragments.",OADS,/arxiv_data1/oa_pdf/d0/c7/jvms-79-927.PMC5447984.pdf
"(CC-BY-NC-ND 4.0: https://creativecommons.org/licenses/by-nc-nd/4.0/) NOTE Laboratory Animal Science Effects of expressing human T-cell leukemia  virus type 1 (HTLV-I) oncoprotein Tax on DOK1, DOK2 and DOK3 gene expression in mice Takeo OHSUGI1)* 1)Department of Laboratory Animal Science, School of Veterinary Medicine, Rakuno-Gakuen University, 582  Bunkyodai-Midorimachi, Ebetsu, Hokkaido 069-8501, Japan ABSTRACT.",Non-OADS,/arxiv_data1/oa_pdf/38/be/jvms-79-935.PMC5447985.pdf
"(CC-BY-NC-ND 4.0: https://creativecommons.org/licenses/by-nc-nd/4.0/) NOTE Virology Evaluation of calcium hydrogen carbonate  mesoscopic crystals as a disinfectant for influenza A viruses Ryuji NAKASHIMA1), Masaomi KAWAMOTO1), Shigeru MIYAZAKI1),   Rumiko ONISHI2), Koichi FURUSAKI2), Maho OSAKI3), Rikio KIRISAWA3),   Akikazu SAKUDO4) and Takashi ONODERA5)* 1)Research Institute for Animal Science in Biochemistry and Toxicology, Midori-ku, Sagamihara,   Kanagawa 252-0132, Japan 2)Mineral Activation Technical Research Center, Omuta, Fukuoka 836-0041, Japan 3)Rakuno Gakuen University, Ebetsu, Hokkaido 069-8501, Japan 4)University of the Ryukyus, Nishihara, Okinawa 903-0215, Japan 5)Research Center for Food Safety, The University of Tokyo, Yayoi, Bunkyo-ku, Tokyo 113-8657, Japan ABSTRACT.",Non-OADS,/arxiv_data1/oa_pdf/c9/b4/jvms-79-939.PMC5447986.pdf
"Washing and sterilization method, WO2014129579A1, https://www.google.com/patents/WO2014129579A1 (in Japanese) [accessed January 20, 2016].",OADS,/arxiv_data1/oa_pdf/c9/b4/jvms-79-939.PMC5447986.pdf
"Sterilizer, US5714119A, https://www.google.com/patents/US5714119 (in Japanese) [accessed January 20, 2016].",OADS,/arxiv_data1/oa_pdf/c9/b4/jvms-79-939.PMC5447986.pdf
"“Handling of the lime to use for the lines of the athletic ground”, http://www.gankaikai.or.jp/info/pdf/20080101_monbu.pdf (in Japanese) [accessed January 20, 2016].",Non-OADS,/arxiv_data1/oa_pdf/c9/b4/jvms-79-939.PMC5447986.pdf
"Interim Guidance on Environmental Management of Pandemic Influenza Virus: https://www.pandemicflu.gov/professional/hospital/influenzaguidance.html (accessed January 8, 2013).",Non-OADS,/arxiv_data1/oa_pdf/c9/b4/jvms-79-939.PMC5447986.pdf
"2006. http://www.who.int/csr/resourcse/publication/surveillance/CDS_EPR_ARO_2006_1.pdf?ud=1 [accessed April 20, 2017].",OADS,/arxiv_data1/oa_pdf/c9/b4/jvms-79-939.PMC5447986.pdf
"(CC-BY-NC-ND 4.0: https://creativecommons.org/licenses/by-nc-nd/4.0/) FULL PAPER Wildlife Science Characterizing the temporal patterns   of avian influenza virus introduction  into Japan by migratory birds Manabu ONUMA1)#*, Masayoshi KAKOGAWA2,3)#, Masae YANAGISAWA4),   Atsushi HAGA1), Tomomi OKANO5), Yasuko NEAGARI6), Tsukasa OKANO5),   Koichi GOKA1) and Mitsuhiko ASAKAWA3) 1)Ecological Risk Assessment and Control Section, Center for Environmental Biology and Ecosystem, National  Institute for Environmental Studies, 16-2, Onogawa, Tsukuba, Ibaraki 305-8506, Japan 2)Kobe Animal Kingdom, Kobe, Hyogo 650-0047, Japan 3)Department of Pathobiology, Graduate School of Veterinary Medicine, Rakuno Gakuen University, Ebetsu,  Hokkaido 069-8501, Japan 4)Pathological and Physiochemical Examination Division, Laboratory Department, Animal Quarantine Service,  11-1, Haramachi, Isogoku, Yokohama, Kanagawa 235-0008, Japan 5)Ecological Genetics Analysis Section, Center for Environmental Biology and Ecosystem, National Institute for  Environmental Studies, 16-2, Onogawa, Tsukuba, Ibaraki 305-8506, Japan 6)Biological Resource Laboratory, Laboratory for Intellectual Fundamentals for Environmental Studies, National  Institute for Environmental Studies, 16-2, Onogawa, Tuskuba, Ibaraki 305-8506, Japan ABSTRACT.",Non-OADS,/arxiv_data1/oa_pdf/be/af/jvms-79-943.PMC5447987.pdf
The sequences were analyzed by Nucleotide BLAST (https://blast.ncbi.nlm.nih.gov/Blast.cgi) for species identification.,OADS,/arxiv_data1/oa_pdf/be/af/jvms-79-943.PMC5447987.pdf
"https://www.biodic.go.jp/gankamo/seikabutu/ index.html [accessed November 22, 2016].",OADS,/arxiv_data1/oa_pdf/be/af/jvms-79-943.PMC5447987.pdf
"http://www.env.go.jp/nature/dobutsu/bird_flu/ migratory/index.html [accessed November 22, 2016].",Non-OADS,/arxiv_data1/oa_pdf/be/af/jvms-79-943.PMC5447987.pdf
"http://www.env.go.jp/nature/ dobutsu/bird_flu/attach/result20130906.pdf [accessed November 22, 2016].",Non-OADS,/arxiv_data1/oa_pdf/be/af/jvms-79-943.PMC5447987.pdf
"http://www.env.go.jp/nature/ dobutsu/bird_flu/attach/result20140924.pdf [accessed November 22, 2016].",Non-OADS,/arxiv_data1/oa_pdf/be/af/jvms-79-943.PMC5447987.pdf
"http://www.env.go.jp/nature/dobutsu/bird_flu/manual/pref_0809/full.pdf [accessed November 22, 2016].",Non-OADS,/arxiv_data1/oa_pdf/be/af/jvms-79-943.PMC5447987.pdf
"http://www.env.go.jp/nature/dobutsu/bird_flu/attach/result20150901.pdf [accessed November 22, 2016].",Non-OADS,/arxiv_data1/oa_pdf/be/af/jvms-79-943.PMC5447987.pdf
"https://www.R-project.org [accessed November 22, 2016].",Non-OADS,/arxiv_data1/oa_pdf/be/af/jvms-79-943.PMC5447987.pdf
"(CC-BY-NC-ND 4.0: https://creativecommons.org/licenses/by-nc-nd/4.0/) NOTE Wildlife Science Prenatal postcranial development in two  species of sympatric Japanese wood mice (Apodemus argenteus and A. speciosus):   a comparison of arboreal versus terrestrial congeners Daisuke KOYABU1)* 1)The University Museum, The University of Tokyo, 7-3-1 Hongo, Tokyo 113-0033, Japan ABSTRACT.",Non-OADS,/arxiv_data1/oa_pdf/3a/30/jvms-79-952.PMC5447988.pdf
"https://doi.org/10.1177/1477370816640136European Journal of Criminology 2017, Vol.",Non-OADS,/arxiv_data1/oa_pdf/c3/a7/10.1177_1477370816640136.PMC5448021.pdf
URL (accessed 21 August 2012): http://yjbpub-lications.justice.gov.uk/en-gb/Resources/Downloads/Abused%20prior%20to%20custody.pdf.,OADS,/arxiv_data1/oa_pdf/22/76/10.1177_1477370812453401.PMC5448022.pdf
URL (accessed 13  August 2012): http://www.derbyshire.gov.uk/community/about_your_county/population/   population_estimates/default.asp.,OADS,/arxiv_data1/oa_pdf/22/76/10.1177_1477370812453401.PMC5448022.pdf
"https://doi.org/10.1177/1477370816639814European Journal of Criminology 2017, Vol.",Non-OADS,/arxiv_data1/oa_pdf/e2/10/10.1177_1477370816639814.PMC5448023.pdf
URL (accessed 3 March 2016): http://www.telegraph.co.uk/news/ worldnews/europe/11846760/Without-borders-in-Europe-there-is-no-hope-of-ending-this- migrant-crisis.html.,Non-OADS,/arxiv_data1/oa_pdf/e2/10/10.1177_1477370816639814.PMC5448023.pdf
URL (accessed 3 March 2016): http://www.telegraph.co.uk/news/worldnews/ europe/eu/11846703/Migrants-great-escape-to-the-other-Europe-reveals-stark-divide.html.,Non-OADS,/arxiv_data1/oa_pdf/e2/10/10.1177_1477370816639814.PMC5448023.pdf
URL  (accessed 3 March 2016): http://www.theguardian.com/world/2015/sep/05/refugee-crisis-warm-welcome-for-people-bussed-from-budapest.,Non-OADS,/arxiv_data1/oa_pdf/e2/10/10.1177_1477370816639814.PMC5448023.pdf
URL (accessed 3 March 2016): http://www.theguardian.com/ world/2015/sep/05/migration-crisis-europe-leaders-blame-brussels-hungary-germany.,Non-OADS,/arxiv_data1/oa_pdf/e2/10/10.1177_1477370816639814.PMC5448023.pdf
"https://doi.org/10.1177/1477370816640139European Journal of Criminology 2017, Vol.",Non-OADS,/arxiv_data1/oa_pdf/60/12/10.1177_1477370816640139.PMC5448024.pdf
URL (accessed 4 March 2016): http://ssrn.com/abstract=2553535.,OADS,/arxiv_data1/oa_pdf/60/12/10.1177_1477370816640139.PMC5448024.pdf
URL (accessed 4 March 2016): http://www.vox.com/2015/3/31/8306311/ prosecutorial-discretion.,Non-OADS,/arxiv_data1/oa_pdf/60/12/10.1177_1477370816640139.PMC5448024.pdf
URL (accessed 4 March  2016): https://www.law.ox.ac.uk/research-subject-groups/centre-criminology/centreborder- criminologies/blog/2015/09/dutch-response.,Non-OADS,/arxiv_data1/oa_pdf/60/12/10.1177_1477370816640139.PMC5448024.pdf
"551 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/ 4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0a/c7/hyw194.PMC5448062.pdf
"543 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/ 4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/54/11/hyx031.PMC5448064.pdf
2014;4(2):1-3. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/6e/6f/autopsy-04-02001.PMC5448295.pdf
2014;4(2):5-7.   http://dx.doi.org/10.4322/acr.2014.015 Picture provided by Dr. Stephen A. Geller - personal archive.,Non-OADS,/arxiv_data1/oa_pdf/3e/2f/autopsy-04-02005.PMC5448296.pdf
PMid:21460491. http://dx.doi.org/ 10.1086/659156 2.,OADS,/arxiv_data1/oa_pdf/3e/2f/autopsy-04-02005.PMC5448296.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3e/2f/autopsy-04-02005.PMC5448296.pdf
http://dx.doi.org/ 10.1007/ s10151-013-1081-0 4.,Non-OADS,/arxiv_data1/oa_pdf/3e/2f/autopsy-04-02005.PMC5448296.pdf
http://dx.doi.org/ 10.1503/ cmaj.1041104 7.,Non-OADS,/arxiv_data1/oa_pdf/3e/2f/autopsy-04-02005.PMC5448296.pdf
1996 ;10(1):1-3. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3e/2f/autopsy-04-02005.PMC5448296.pdf
PMid:12471563. http://dx.doi.org/ 10.1086/342691 9.,OADS,/arxiv_data1/oa_pdf/3e/2f/autopsy-04-02005.PMC5448296.pdf
1993 ;17(1):109-13. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3e/2f/autopsy-04-02005.PMC5448296.pdf
1985 ;120(11):1321 -2. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3e/2f/autopsy-04-02005.PMC5448296.pdf
PMid:12032893. http://dx.doi.org/ 10.1086/340536 14.,OADS,/arxiv_data1/oa_pdf/3e/2f/autopsy-04-02005.PMC5448296.pdf
1996 ;22(6):932-7. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3e/2f/autopsy-04-02005.PMC5448296.pdf
1993 ;16(4):313-15.  http://dx.doi.org/ 10.1016/0732-8893(93)90081-H .,OADS,/arxiv_data1/oa_pdf/3e/2f/autopsy-04-02005.PMC5448296.pdf
PMid:11821511.  http://dx.doi.org/ 10.1056/NEJMcp011603 17.,OADS,/arxiv_data1/oa_pdf/3e/2f/autopsy-04-02005.PMC5448296.pdf
1997 ;24(3):324-33. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3e/2f/autopsy-04-02005.PMC5448296.pdf
PMid:24018052.  http://dx.doi.org/ 10.1053/j.gastro.2013.08.058 19.,Non-OADS,/arxiv_data1/oa_pdf/3e/2f/autopsy-04-02005.PMC5448296.pdf
Available from: http://journals.lww.com/jcge/pages/ articleviewer.aspx?year=9000&issue=00000&article=9 8691&type=abstract 20.,Non-OADS,/arxiv_data1/oa_pdf/3e/2f/autopsy-04-02005.PMC5448296.pdf
"PMid:24641570.  http://dx.doi.org/ 10.1111/apt.12699 Stephen  A. Geller, M.D.",OADS,/arxiv_data1/oa_pdf/3e/2f/autopsy-04-02005.PMC5448296.pdf
2014;4(2):9-20. http://dx.doi.org/10.4322/ acr.2014.012 ABSTRACT Sickle Cell Disease encompasses a group of disorders related with the hemoglobin S and other hemoglobin genotypes.,Non-OADS,/arxiv_data1/oa_pdf/e0/51/autopsy-04-02009.PMC5448297.pdf
PMid:19478026. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e0/51/autopsy-04-02009.PMC5448297.pdf
PMid:7993409.  http://dx.doi.org/ 10.1056/NEJM199406093302303 4.,OADS,/arxiv_data1/oa_pdf/e0/51/autopsy-04-02009.PMC5448297.pdf
1974 ;28(4):437-44. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e0/51/autopsy-04-02009.PMC5448297.pdf
2003 ;17(3):167-78.  http://dx.doi.org/ 10.1016/S0268-960X(03)00003-1 7.,OADS,/arxiv_data1/oa_pdf/e0/51/autopsy-04-02009.PMC5448297.pdf
http://dx.doi.org/ 10.1016/j.,OADS,/arxiv_data1/oa_pdf/e0/51/autopsy-04-02009.PMC5448297.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e0/51/autopsy-04-02009.PMC5448297.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e0/51/autopsy-04-02009.PMC5448297.pdf
PMid:21885420.  http://dx.doi.org/ 10.1183/09031936.00192910 12.,Non-OADS,/arxiv_data1/oa_pdf/e0/51/autopsy-04-02009.PMC5448297.pdf
2011 ;1(3):15-22.  http://dx.doi.org/ 10.4322/acr.2011.004 14.,Non-OADS,/arxiv_data1/oa_pdf/e0/51/autopsy-04-02009.PMC5448297.pdf
PMid:24468004.  http://dx.doi.org/ 10.1016/j.blre.2013.12.002 16.,OADS,/arxiv_data1/oa_pdf/e0/51/autopsy-04-02009.PMC5448297.pdf
PMid:15849760.  http://dx.doi.org/ 10.1002/ajh.20348 17.,Non-OADS,/arxiv_data1/oa_pdf/e0/51/autopsy-04-02009.PMC5448297.pdf
1996 ;10(6):1289 -303. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e0/51/autopsy-04-02009.PMC5448297.pdf
1927 ;14(3):621-62. http://dx.doi.org/ 10.1001/ archsurg.1927.01130150002001 19.,Non-OADS,/arxiv_data1/oa_pdf/e0/51/autopsy-04-02009.PMC5448297.pdf
PMid:8111590. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e0/51/autopsy-04-02009.PMC5448297.pdf
2014;4(2):21-6. http://dx.doi.org/10.4322/acr.2014.018 ABSTRACT Dicephalus dipus dibrachius twins are a rare form of conjoined twins.,Non-OADS,/arxiv_data1/oa_pdf/e1/b0/autopsy-04-02021.PMC5448298.pdf
2001;36(9):1435-44. http://dx.doi.org/10.1053/ jpsu.2001.26393.,Non-OADS,/arxiv_data1/oa_pdf/e1/b0/autopsy-04-02021.PMC5448298.pdf
2004;112(1):110-3. http://dx.doi.org/10.1016/ S0301-2115(03)00268-9.,OADS,/arxiv_data1/oa_pdf/e1/b0/autopsy-04-02021.PMC5448298.pdf
1980;55(8):626-30. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e1/b0/autopsy-04-02021.PMC5448298.pdf
2003;289(10):1307-10. http://dx.doi.org/10.1001/ jama.289.10.1307.,Non-OADS,/arxiv_data1/oa_pdf/e1/b0/autopsy-04-02021.PMC5448298.pdf
2002;89(9):1188-92.  http://dx.doi.org/10.1046/j.1365-2168.2002.02193.x.,Non-OADS,/arxiv_data1/oa_pdf/e1/b0/autopsy-04-02021.PMC5448298.pdf
2005;205(2):179-85.  http://dx.doi.org/10.1620/tjem.205.179.,Non-OADS,/arxiv_data1/oa_pdf/e1/b0/autopsy-04-02021.PMC5448298.pdf
1992;45(6):591-602. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e1/b0/autopsy-04-02021.PMC5448298.pdf
2009;44(4):811-20. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e1/b0/autopsy-04-02021.PMC5448298.pdf
2002;37(3):303-9. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e1/b0/autopsy-04-02021.PMC5448298.pdf
2006;92(3):382-87. http://dx.doi.org/10.1136/ hrt.2005.069682.,Non-OADS,/arxiv_data1/oa_pdf/e1/b0/autopsy-04-02021.PMC5448298.pdf
2010;44(3):406-20. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e1/b0/autopsy-04-02021.PMC5448298.pdf
"http://dx.doi.org/10.4322/acr.2014.017 ABSTRACT Although neonatal tumors are rare, neuroblastoma  is the most common neoplasia among them.",Non-OADS,/arxiv_data1/oa_pdf/68/b5/autopsy-04-02027.PMC5448299.pdf
2002;22(4):911-34. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/68/b5/autopsy-04-02027.PMC5448299.pdf
2007;369(9579):2106 -20.  http://dx.doi.org/10.1016/S0140-6736(07)60983-0 .,Non-OADS,/arxiv_data1/oa_pdf/68/b5/autopsy-04-02027.PMC5448299.pdf
2005;5(1):116-27. http://dx.doi.org/10.1102/1470- 7330.2005.0104 .,Non-OADS,/arxiv_data1/oa_pdf/68/b5/autopsy-04-02027.PMC5448299.pdf
1999;86(2):349-63. http://dx.doi.org/10.1002/ (SICI)1097-0142(19990715)86:2<349::AID- CNCR20>3.0.CO;2-Y .,Non-OADS,/arxiv_data1/oa_pdf/68/b5/autopsy-04-02027.PMC5448299.pdf
1999;86(2):364-72. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/68/b5/autopsy-04-02027.PMC5448299.pdf
2001;92(9):2451 -61. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/68/b5/autopsy-04-02027.PMC5448299.pdf
2003;98(10):2274 -81. http://dx.doi.org/10.1002/ cncr.11773 .,Non-OADS,/arxiv_data1/oa_pdf/68/b5/autopsy-04-02027.PMC5448299.pdf
2011;29(33):4358 -64. http://dx.doi.org/10.1200/ JCO.2011.35.9570 .,Non-OADS,/arxiv_data1/oa_pdf/68/b5/autopsy-04-02027.PMC5448299.pdf
2003;89(3):470-6. http://dx.doi.org/10.1038/ sj.bjc.6601154 .,Non-OADS,/arxiv_data1/oa_pdf/68/b5/autopsy-04-02027.PMC5448299.pdf
2009;27(2):298-303. http://dx.doi.org/10.1200/ JCO.2008.16.6876 .,Non-OADS,/arxiv_data1/oa_pdf/68/b5/autopsy-04-02027.PMC5448299.pdf
2009;27(2):289-97. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/68/b5/autopsy-04-02027.PMC5448299.pdf
2000;35(1):88-91. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/68/b5/autopsy-04-02027.PMC5448299.pdf
"1981;16(4, Suppl 1):636-44. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/68/b5/autopsy-04-02027.PMC5448299.pdf
2014;4(2):35-41. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d7/36/autopsy-04-02035.PMC5448300.pdf
1979 ;54(8):614-18. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d7/36/autopsy-04-02035.PMC5448300.pdf
2005 ;8(2):204-17. http://dx.doi.org/10.1007/s10024- 004-7084-0 .,Non-OADS,/arxiv_data1/oa_pdf/d7/36/autopsy-04-02035.PMC5448300.pdf
1978 ;93(4):614-6. http://dx.doi.org/10.1016/S0022- 3476(78)80897-X .,Non-OADS,/arxiv_data1/oa_pdf/d7/36/autopsy-04-02035.PMC5448300.pdf
2011 ;155A (5):943-68. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d7/36/autopsy-04-02035.PMC5448300.pdf
1989 ;26(1):37-44. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d7/36/autopsy-04-02035.PMC5448300.pdf
1993 ;22(1):107-15.  http://dx.doi.org/10.1093/ije/22.1.107 .,Non-OADS,/arxiv_data1/oa_pdf/d7/36/autopsy-04-02035.PMC5448300.pdf
1989 ;35(2):88-92.  http://dx.doi.org/10.1111/j.1399-0004.1989.tb02912.x .,Non-OADS,/arxiv_data1/oa_pdf/d7/36/autopsy-04-02035.PMC5448300.pdf
1984 ;63(3):218-28. http://dx.doi.org/10.1007/ BF00685248 .,Non-OADS,/arxiv_data1/oa_pdf/d7/36/autopsy-04-02035.PMC5448300.pdf
2010 ;152A (1):245-55. http://dx.doi.org/10.1002/ ajmg.a.33188 .,Non-OADS,/arxiv_data1/oa_pdf/d7/36/autopsy-04-02035.PMC5448300.pdf
1998 ;78(3):274-81. http://dx.doi.org/10.1002/(SICI)1096- 8628(19980707)78:3<274::AID-AJMG14>3.0.CO;2-C .,OADS,/arxiv_data1/oa_pdf/d7/36/autopsy-04-02035.PMC5448300.pdf
2005 ;110(3):208- 21. http://dx.doi.org/10.1007/s00401-005-1059-8 .,Non-OADS,/arxiv_data1/oa_pdf/d7/36/autopsy-04-02035.PMC5448300.pdf
2013 ;16(3):160-7. http://dx.doi.org/10.2350/12-09- 1253-OA.1 .,Non-OADS,/arxiv_data1/oa_pdf/d7/36/autopsy-04-02035.PMC5448300.pdf
2003 ;12(21):2863 -71. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d7/36/autopsy-04-02035.PMC5448300.pdf
2010 ;12(5):15-222. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d7/36/autopsy-04-02035.PMC5448300.pdf
200;28(7):493-503.  http://dx.doi.org/10.1046/j.1440-1681.2001.03477.x .,Non-OADS,/arxiv_data1/oa_pdf/d7/36/autopsy-04-02035.PMC5448300.pdf
1988 ;9(1):53-61. http://dx.doi.org/10.1016/8756- 3282(88)90027-0 .,Non-OADS,/arxiv_data1/oa_pdf/d7/36/autopsy-04-02035.PMC5448300.pdf
1998 ;273(21):13007 -14. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d7/36/autopsy-04-02035.PMC5448300.pdf
"2014;4(2):43-8. http://dx.doi.org/10.4322/acr.2014.016 ABSTRACT Although infectious diseases are the most prevalent cause of fevers of unknown origin (FUO), this diagnosis remains  challenging in some pediatric patients.",Non-OADS,/arxiv_data1/oa_pdf/ac/af/autopsy-04-02043.PMC5448301.pdf
http://dx.doi.org/10.5433/1679-0367.2008v29n2p121 4.,Non-OADS,/arxiv_data1/oa_pdf/ac/af/autopsy-04-02043.PMC5448301.pdf
1998;26(1):80-4. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ac/af/autopsy-04-02043.PMC5448301.pdf
2001;3(4):247- 62. http://dx.doi.org/10.2165/00128072-200103040- 00002,Non-OADS,/arxiv_data1/oa_pdf/ac/af/autopsy-04-02043.PMC5448301.pdf
PMid:17041206. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ac/af/autopsy-04-02043.PMC5448301.pdf
PMid:10400104. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ac/af/autopsy-04-02043.PMC5448301.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ac/af/autopsy-04-02043.PMC5448301.pdf
PMid:8553962.  http://dx.doi.org/10.2214/ajr.166.2.8553962 15.,Non-OADS,/arxiv_data1/oa_pdf/ac/af/autopsy-04-02043.PMC5448301.pdf
PMid:22541698. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ac/af/autopsy-04-02043.PMC5448301.pdf
PMid:20706820. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ac/af/autopsy-04-02043.PMC5448301.pdf
PMid:19217231. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ac/af/autopsy-04-02043.PMC5448301.pdf
PMid:21055685.  http://dx.doi.org/10.1016/j.cld.2010.07.005 19.,OADS,/arxiv_data1/oa_pdf/ac/af/autopsy-04-02043.PMC5448301.pdf
PMid:15256619. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ac/af/autopsy-04-02043.PMC5448301.pdf
PMid:11176245. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ac/af/autopsy-04-02043.PMC5448301.pdf
"http://dx.doi.org/10.1128/ AAC.39.11.2387 Conflict of interest:  None Submitted on:  April 8, 2014 Accepted on:  June 10, 2014 Correspondence   Divisão de Clínica Pediátrica   Hospital Universitário da Universidade de São Paulo   Av.",Non-OADS,/arxiv_data1/oa_pdf/ac/af/autopsy-04-02043.PMC5448301.pdf
2014;4(2):49-54. http://dx.doi.org/10.4322/acr.2014.014 ABSTRACT HIV infection is known to be associated with the development of a wide range of neoplasia.,Non-OADS,/arxiv_data1/oa_pdf/53/42/autopsy-04-02049.PMC5448302.pdf
1994 ;6(5):489-91.http://dx.doi.org/10.1097/00001622- 199409000-00007 .,Non-OADS,/arxiv_data1/oa_pdf/53/42/autopsy-04-02049.PMC5448302.pdf
2005 ;104(7):1505 -11.http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/53/42/autopsy-04-02049.PMC5448302.pdf
2000 ;133(6):401-10.http://dx.doi.org/10.7326/0003- 4819-133-6-200009190-00007 .,Non-OADS,/arxiv_data1/oa_pdf/53/42/autopsy-04-02049.PMC5448302.pdf
2010 ;24(1):57-69.http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/53/42/autopsy-04-02049.PMC5448302.pdf
2002 ;33(4):392-404.http://dx.doi.org/10.1053/ hupa.2002.124723 .,Non-OADS,/arxiv_data1/oa_pdf/53/42/autopsy-04-02049.PMC5448302.pdf
1961 ;49(213):80-9.http://dx.doi.org/10.1002/ bjs.18004921319 .,Non-OADS,/arxiv_data1/oa_pdf/53/42/autopsy-04-02049.PMC5448302.pdf
1978 ;42(2):693-707.http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/53/42/autopsy-04-02049.PMC5448302.pdf
1998 ;77(3):511-4. http://dx.doi.org/10.1038/bjc.1998.82 .,Non-OADS,/arxiv_data1/oa_pdf/53/42/autopsy-04-02049.PMC5448302.pdf
2006 ;47(10):2140 -6.http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/53/42/autopsy-04-02049.PMC5448302.pdf
1969 ;170(2):232-8. http://dx.doi.org/10.1097/00000658-196908000-00011 .,Non-OADS,/arxiv_data1/oa_pdf/53/42/autopsy-04-02049.PMC5448302.pdf
2002 ;56(5):696-700.http://dx.doi.org/10.1016/ S0016-5107(02)70119-3 .,OADS,/arxiv_data1/oa_pdf/53/42/autopsy-04-02049.PMC5448302.pdf
http://dx.doi.org/10.1016/S0016- 5107(97)80026-0 .,OADS,/arxiv_data1/oa_pdf/53/42/autopsy-04-02049.PMC5448302.pdf
2003 ;22(42):6639 - 45.http://dx.doi.org/10.1038/sj.onc.1206815 .,Non-OADS,/arxiv_data1/oa_pdf/53/42/autopsy-04-02049.PMC5448302.pdf
2007 ;14(6):431-43.http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/53/42/autopsy-04-02049.PMC5448302.pdf
2005 ;23(28):7060 -8.http://dx.doi.org/10.1200/ JCO.2005.15.503 .,Non-OADS,/arxiv_data1/oa_pdf/53/42/autopsy-04-02049.PMC5448302.pdf
2000 ;156(3):751-60. http://dx.doi.org/10.1016/S0002-9440(10)64941-3 .,Non-OADS,/arxiv_data1/oa_pdf/53/42/autopsy-04-02049.PMC5448302.pdf
2002 ;99(7):2285 -90.http://dx.doi.org/10.1182/ blood.V99.7.2285 .,Non-OADS,/arxiv_data1/oa_pdf/53/42/autopsy-04-02049.PMC5448302.pdf
2000 ;52(2):290-1.http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/53/42/autopsy-04-02049.PMC5448302.pdf
2013 ;92(6):861-2.http://dx.doi.org/10.1007/s00277- 012-1646-4 .,Non-OADS,/arxiv_data1/oa_pdf/53/42/autopsy-04-02049.PMC5448302.pdf
2009 ;13(1):2-4.http://dx.doi.org/10.1590/S1413- 86702009000100002 .,Non-OADS,/arxiv_data1/oa_pdf/53/42/autopsy-04-02049.PMC5448302.pdf
"2014;4(2):55-60. http://dx.doi.org/10.4322/acr.2014.011 ABSTRACT Müllerian adenosarcoma is a rare, mixed tumor that can occur throughout the female genital tract, but is most commonly  found in the uterus.",Non-OADS,/arxiv_data1/oa_pdf/64/e3/autopsy-04-02055.PMC5448303.pdf
1974 ;34(4):1138 -49.http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/64/e3/autopsy-04-02055.PMC5448303.pdf
1978 ;6(3):261-74.http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/64/e3/autopsy-04-02055.PMC5448303.pdf
1995 ;59(3):412-22.http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/64/e3/autopsy-04-02055.PMC5448303.pdf
2002 ;26(10):1243 -58. http://dx.doi.org/10.1097/00000478-200210000-00001 .,Non-OADS,/arxiv_data1/oa_pdf/64/e3/autopsy-04-02055.PMC5448303.pdf
1979 ;3(3):167-80.http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/64/e3/autopsy-04-02055.PMC5448303.pdf
2011 ;25(6):705- 18.http://dx.doi.org/10.1016/j.bpobgyn.2011.05.010 .,OADS,/arxiv_data1/oa_pdf/64/e3/autopsy-04-02055.PMC5448303.pdf
1993 ;17(3):204-6. http://dx.doi.org/10.1016/0899-7071(93)90111-Y .,OADS,/arxiv_data1/oa_pdf/64/e3/autopsy-04-02055.PMC5448303.pdf
1995 ;48(3):299-306.http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/64/e3/autopsy-04-02055.PMC5448303.pdf
2010 ;17(2):122-9. http://dx.doi.org/10.1097/PAP .0b013e3181cfe732 .,Non-OADS,/arxiv_data1/oa_pdf/64/e3/autopsy-04-02055.PMC5448303.pdf
2004 ;93(2):336-339.http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/64/e3/autopsy-04-02055.PMC5448303.pdf
1988 ;37(2):128-32.http://dx.doi.org/10.1002/ jso.2930370213 .,Non-OADS,/arxiv_data1/oa_pdf/64/e3/autopsy-04-02055.PMC5448303.pdf
1997 ;65(2):237-40.http://dx.doi.org/10.1006/ gyno.1997.4625 .,Non-OADS,/arxiv_data1/oa_pdf/64/e3/autopsy-04-02055.PMC5448303.pdf
2009;113(1):11-7. http://dx.doi.org/10.1097/ AOG.0b013e3181917a0c 24- McCluggage WG.,Non-OADS,/arxiv_data1/oa_pdf/64/e3/autopsy-04-02055.PMC5448303.pdf
2010;17(2):122- 9. http://dx.doi.org/10.1097/PAP .0b013e3181cfe732,Non-OADS,/arxiv_data1/oa_pdf/64/e3/autopsy-04-02055.PMC5448303.pdf
"2014;4(2):61-7. http://dx.doi.org/10.4322/acr.2014.013 ABSTRACT Takotsubo cardiomyopathy (TTC), also known as apical ballooning syndrome, broken heart syndrome, or stress- induced cardiomyopathy, is defined as a transient disturbance of the left ventricle, which is quite often associated with  electrocardiographic abnormalities that may mimic acute myocardial infarction.",Non-OADS,/arxiv_data1/oa_pdf/73/6c/autopsy-04-02061.PMC5448304.pdf
PMid:17527002. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/73/6c/autopsy-04-02061.PMC5448304.pdf
PMid:16720686. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/73/6c/autopsy-04-02061.PMC5448304.pdf
PMid:23683950. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/73/6c/autopsy-04-02061.PMC5448304.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/73/6c/autopsy-04-02061.PMC5448304.pdf
PMid:20117439. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/73/6c/autopsy-04-02061.PMC5448304.pdf
PMid:22192296. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/73/6c/autopsy-04-02061.PMC5448304.pdf
PMid:16810474.  http://dx.doi.org/10.1007/s00059-006-2822-x 8.,OADS,/arxiv_data1/oa_pdf/73/6c/autopsy-04-02061.PMC5448304.pdf
PMid:19106400. http://dx.doi.org/10.1161/ CIRCULATIONAHA.108.767012 9.,Non-OADS,/arxiv_data1/oa_pdf/73/6c/autopsy-04-02061.PMC5448304.pdf
2014:0:1-9. http://dx.doi.org/ 10.1136/ heartjnl-2013-304691.,Non-OADS,/arxiv_data1/oa_pdf/73/6c/autopsy-04-02061.PMC5448304.pdf
PMid:22133904. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/73/6c/autopsy-04-02061.PMC5448304.pdf
PMid:15703419.  http://dx.doi.org/10.1056/NEJMoa043046 13.,OADS,/arxiv_data1/oa_pdf/73/6c/autopsy-04-02061.PMC5448304.pdf
PMid:21871590. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/73/6c/autopsy-04-02061.PMC5448304.pdf
http://dx.doi.org/10.1136/ heart.89.9.1027,Non-OADS,/arxiv_data1/oa_pdf/73/6c/autopsy-04-02061.PMC5448304.pdf
PMid:21169615. http://dx.doi.,OADS,/arxiv_data1/oa_pdf/73/6c/autopsy-04-02061.PMC5448304.pdf
http://dx.doi.org/10.1177/2048872613505231 20.,Non-OADS,/arxiv_data1/oa_pdf/73/6c/autopsy-04-02061.PMC5448304.pdf
PMid:23328559. http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/73/6c/autopsy-04-02061.PMC5448304.pdf
PMid:19365274. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/73/6c/autopsy-04-02061.PMC5448304.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/05/1e/omx016.PMC5448454.pdf
[Available from: http://www.nccn.org/ professionals/physician_gls/pdf/colon.pdf .,Non-OADS,/arxiv_data1/oa_pdf/05/1e/omx016.PMC5448454.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/ licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/63/5f/omx020.PMC5448456.pdf
"847 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/11/2f/czx024.PMC5448457.pdf
https://www.ids.ac.uk/ﬁles/dmﬁle/IETAAnnex1ServicedeliveryJoshiFinal28Oct2010.pdf Joshi A.,Non-OADS,/arxiv_data1/oa_pdf/11/2f/czx024.PMC5448457.pdf
"Harare, Zimbabwe: EQUINET, UCT HEU, 200. http://www.equinetafrica.org/sites/default/ﬁles/uploads/documents/ Dis57FINchitah.pdf Manzano-Santaella A.",Non-OADS,/arxiv_data1/oa_pdf/11/2f/czx024.PMC5448457.pdf
"http://www.unicef.org/infobycountry/zam bia_statistics.html Westhorp G, Walker B, Rogers P, Overbeeke N, Ball D and Brice G et al.",Non-OADS,/arxiv_data1/oa_pdf/11/2f/czx024.PMC5448457.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8f/48/omx014.PMC5448458.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/03/1f/omx017.PMC5448459.pdf
"825 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6f/16/czx023.PMC5448494.pdf
"Retrieved from http://bora.uib.no/handle/1956/1813 Accessed 20 Feb 2016 Lugtenberg M, Burgers JS, Westert GP.",Non-OADS,/arxiv_data1/oa_pdf/6f/16/czx023.PMC5448494.pdf
"Retrieved 11/02, 2016, from http://www.tacaids.go.tz/index.php?option ¼com_content&view ¼cat egory&layout ¼blog&id ¼46&Itemid ¼230.",Non-OADS,/arxiv_data1/oa_pdf/6f/16/czx023.PMC5448494.pdf
"Retrieved 11/02, 2016, from http://www.unaids.org/sites/default/ﬁles/ media_asset/UNAIDS_Global_Report_2013_en_1.pdf.",OADS,/arxiv_data1/oa_pdf/6f/16/czx023.PMC5448494.pdf
"Retrieved 21/12/2015, 2015, from https://www.usaid.gov/what-we-do/global-health/hiv-and-aids/technical-areas/ strengthening-health-systems-support-hiv-and.",Non-OADS,/arxiv_data1/oa_pdf/6f/16/czx023.PMC5448494.pdf
Supplemental Material All supplemental material is available is available at http://journals.sagepub.com/doi/suppl/10.1086/690206 References 1.,Non-OADS,/arxiv_data1/oa_pdf/d5/3a/10.1086_690206.PMC5448524.pdf
Available at: http://truvenhealth.com/Portals/0/Assets/HealthInsights/TRU_15667_0415_HSI_ESI_ WP.pdf (accessed 15 September 2015).,Non-OADS,/arxiv_data1/oa_pdf/45/ef/10.1086_690007.PMC5448526.pdf
Available at: http://www.census.gov/prod/cen2010/briefs/ c2010br-03.pdf (accessed 1 December 2015).,OADS,/arxiv_data1/oa_pdf/45/ef/10.1086_690007.PMC5448526.pdf
"Ourstudies were not designed to determine if E2 directly orindirectly regulates gremlin 1 expression, but given thepresence of a putative estrogen response element in theGrem1 promoter (as reported by SABiosciences’ proprietary DECODE database (http://www.sabiosciences.",OADS,/arxiv_data1/oa_pdf/d3/7c/10.1177_2045893217702055.PMC5448529.pdf
Available at: http://www.fda.gove/ Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm455125.htm.,Non-OADS,/arxiv_data1/oa_pdf/71/f6/10.1177_2045893216686930.PMC5448531.pdf
Please visit the Submissions Guidelines page toﬁnd out more details: https://us.sagepub.com/en-us/nam/pulmonary-circulation/journal202599#submission-guidelines.,Non-OADS,/arxiv_data1/oa_pdf/b6/f0/10.1177_2045893217703544.PMC5448532.pdf
Available at: http://www.who.int/whr/2002/en/ (last accessed 6 Dec 2015).,OADS,/arxiv_data1/oa_pdf/98/78/10.1086_690687.PMC5448541.pdf
"http://dx.doi.org/10.1016/j.ymgmr.2017.05.003 Received 10 February 2017; Received in revised form 4 May 2017; Accepted 5 May 2017⁎Corresponding author at: Center of Diabetes, Endocrine and Metabolism, Toho University Sakura Medical Center, 564-1 Shimoshizu, Sakura City, Chiba 285-8741, Japan.",Non-OADS,/arxiv_data1/oa_pdf/46/49/main.PMC5448575.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/46/49/main.PMC5448575.pdf
"Ribeiro, E ﬀects of yerba maté, a plant extract formulation ( “YGD ”) and resveratrol in 3T3-L1 adipogenesis, Molecules 19 (10) (2014) 16909 –16924, http://dx.doi.org/10.3390/ molecules191016909.E .",Non-OADS,/arxiv_data1/oa_pdf/46/49/main.PMC5448575.pdf
"6 (4) (2012) 286 –293, http://dx.doi.org/10.4162/nrp.2012.6.4.286 .",Non-OADS,/arxiv_data1/oa_pdf/46/49/main.PMC5448575.pdf
"9 (4) (2016) 183–190, http://dx.doi.org/10.1016/j.jams.2016.02.002 .",OADS,/arxiv_data1/oa_pdf/46/49/main.PMC5448575.pdf
"19 (2) (2016) 441 –446, http://dx.doi.org/10.1515/pjvs-2016-0056 .",Non-OADS,/arxiv_data1/oa_pdf/46/49/main.PMC5448575.pdf
"Shieh, Role of adiponectin gene variants, adipokines and hydrometry-based percent body fat in metabolically healthy and abnormal obesity, Obes Res Clin Pract (May 25, 2016), http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/46/49/main.PMC5448575.pdf
Available from URL: http://ganjoho.jp/data/reg_stat/statis tics/brochure/2015/cancer_statistics_2015.pdf [Online; cited 13 July 2016.],OADS,/arxiv_data1/oa_pdf/53/12/CAS-108-853.PMC5448596.pdf
"Availablefrom: http://globocan.iarc.fr, last accessed on 17 April 2017.",Non-OADS,/arxiv_data1/oa_pdf/2d/0b/CAS-108-1065.PMC5448603.pdf
"MeSH Keywords:  Carcinoma, Non-Small-Cell Lung • Computational Biology • MicroRNAs  Full-text PDF: http://www.medscimonit.com/abstract/index/idArt/901460Authors’ Contribution:  Study Design A  Data Collection B  Statistical Analysis C Data Interpretation D  Manuscript Preparation E  Literature Search F Funds Collection G1 Department of Medical Oncology, First Affiliated Hospital of Guangxi Medical  University, Nanning, Guangxi, P.R.",Non-OADS,/arxiv_data1/oa_pdf/1d/f8/medscimonit-23-2453.PMC5448611.pdf
"Selection of GEO dataset Next, we obtained the microarray profiles of LUAD from the  GEO database (Gene Expression Omnibus, http://www.ncbi.",OADS,/arxiv_data1/oa_pdf/1d/f8/medscimonit-23-2453.PMC5448611.pdf
"Gene ontology enrichment and target prediction analysis The targets of miR-375 were predicted through 12 programs,  including miRWALK2.0 ( http://zmf.umm.uni-heidelberg.de/apps/ zmf/mirwalk2/miRretsys-self.html ).",OADS,/arxiv_data1/oa_pdf/1d/f8/medscimonit-23-2453.PMC5448611.pdf
The Kyoto Encyclopedia of  Genes and Genomes (KEGG) database ( http://www.genome.,OADS,/arxiv_data1/oa_pdf/1d/f8/medscimonit-23-2453.PMC5448611.pdf
"MeSH Keywords:  Drug Delivery Systems • Etoposide • Folate Receptor 1  Full-text PDF: http://www.medscimonit.com/abstract/index/idArt/904683Authors’ Contribution:  Study Design A  Data Collection B  Statistical Analysis C Data Interpretation D  Manuscript Preparation E  Literature Search F Funds Collection G1 School of Pharmacy, Bengbu Medical College, Bengbu, Anhui, P.R.",Non-OADS,/arxiv_data1/oa_pdf/87/8d/medscimonit-23-2426.PMC5448612.pdf
"In this study, we referred to the latest RBP catalog, which includes 1542 genes,(21)approximately 7.5% of all human cod- ing genes (http://www.gencodegenes.org).",OADS,/arxiv_data1/oa_pdf/70/b5/CAS-108-877.PMC5448617.pdf
RNA sequencing V2 read counts and patient clinical parametersbased on 310 patients from the TCGA LIHC cohort weredownloaded from the TCGA data portal (https://tcga-data.nci.,OADS,/arxiv_data1/oa_pdf/70/b5/CAS-108-877.PMC5448617.pdf
Gene-level somatic mutation data of theTCGA LIHC cohort were downloaded from the TCGA dataportal (https://tcga-data.nci.nih.gov/tcga/).,OADS,/arxiv_data1/oa_pdf/70/b5/CAS-108-877.PMC5448617.pdf
"The expression data of overexpression and control cells wereanalyzed using the GSEA tool (version 2.2.1; Broad Institute,http://www.broadinstitute.org/gsea/index.jsp).",OADS,/arxiv_data1/oa_pdf/70/b5/CAS-108-877.PMC5448617.pdf
Differences in colony formation assay results between groupswere analyzed using an unpaired Student’s t-test in GraphPad Prism 5 (http://www.graphpad.com/).,OADS,/arxiv_data1/oa_pdf/70/b5/CAS-108-877.PMC5448617.pdf
Biomed Res Int 2015; 2015 : http://dx.doi.org/10.1155/2015/528954.,OADS,/arxiv_data1/oa_pdf/70/b5/CAS-108-877.PMC5448617.pdf
"The miR-1207-5p sequence was obtained from the miRBase webpage (http://www.mirbase.org/), and the3 0-UTR sequence of the target mRNA was downloaded from TargetScan.",OADS,/arxiv_data1/oa_pdf/e8/91/CAS-108-868.PMC5448618.pdf
"Clinical responses wereassessed according to RECIST version 1.1 (RECIST 1.1) andimmune-related RECIST, and the severities of adverse events were graded according to the National Cancer Institute Com- mon Terminology Criteria for Adverse Events, version 4.0(CTCAE 4.0, http://ctep.cancer.gov/protocolDevelopment/eTable 1.",Non-OADS,/arxiv_data1/oa_pdf/d9/6a/CAS-108-1022.PMC5448619.pdf
Nat Commun 2016; 7: 11406. https://doi.org/10.1038/ncomms11406.,Non-OADS,/arxiv_data1/oa_pdf/d9/6a/CAS-108-1022.PMC5448619.pdf
"CDB0466K, http://www.clst.riken.jp/arg/mutant%20mice%20list.html) on aC57BL/6 background were used along with wild-type litter-mates.",Non-OADS,/arxiv_data1/oa_pdf/bb/6f/CAS-108-910.PMC5448622.pdf
"[Cited 1 Mar 2017] Available from URL: http://www.fda.- gov/downloads/BiologicsBloodVaccines/GuidanceComplianceRegula- toryInformation/Guidances/Vaccines/UCM278673.pdf 24 Grothey A, Van Cutsem E, Sobrero A et al.",OADS,/arxiv_data1/oa_pdf/7a/98/CAS-108-1013.PMC5448625.pdf
"MeSH Keywords:  Urinary Bladder Calculi • Urinary Bladder Diseases • Urinary Diversion  Full-text PDF: http://www.medscimonit.com/abstract/index/idArt/904406Authors’ Contribution:  Study Design A  Data Collection B  Statistical Analysis C Data Interpretation D  Manuscript Preparation E  Literature Search F Funds Collection GDepartment of Urology, Sir Run Run Shaw Hospital, College of Medicine, Zhejiang  University, Hangzhou, Zhejiang, P.R.",Non-OADS,/arxiv_data1/oa_pdf/2e/be/medscimonit-23-2400.PMC5448627.pdf
"MeSH Keywords:  Imaging, Three-Dimensional • Ligaments • Penis • Visible Human Projects  Full-text PDF: http://www.medscimonit.com/abstract/index/idArt/901926Authors’ Contribution:  Study Design A  Data Collection B  Statistical Analysis C Data Interpretation D  Manuscript Preparation E  Literature Search F Funds Collection G1 Department of Plastic and Reconstructive Surgery, Southwest Hospital, Third  Military Medical University, Chongqing, P.R.",Non-OADS,/arxiv_data1/oa_pdf/86/82/medscimonit-23-2436.PMC5448629.pdf
"MeSH Keywords:  Abortion, Induced • Chorionic Villi • Decidua  Full-text PDF: http://www.medscimonit.com/abstract/index/idArt/904645Authors’ Contribution:  Study Design A  Data Collection B  Statistical Analysis C Data Interpretation D  Manuscript Preparation E  Literature Search F Funds Collection G1 Shandong University, Jinan, Shandong, P.R.",Non-OADS,/arxiv_data1/oa_pdf/89/65/medscimonit-23-2445.PMC5448630.pdf
Available from URL: http://packageinserts.bms.com/pi/ pi_opdivo.pdf.,OADS,/arxiv_data1/oa_pdf/c6/61/CAS-108-1000.PMC5448646.pdf
Available from URL: http://ec.europa.eu/hea lth/documents/community-register/2015/20150720132394/anx_132394_en.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c6/61/CAS-108-1000.PMC5448646.pdf
"Target prediction for miR-135a-3p was also undertaken using the algorithms TargetScan (http://www.targetscan.org/ve rt_71/), miRDB (http://mirdb.org/miRDB/), and miRanda(http://www.microrna.org/microrna/home.do) in terms of basesequence.",OADS,/arxiv_data1/oa_pdf/e7/55/CAS-108-886.PMC5448652.pdf
Available from URL: http://ganjoho.jp/en/public/statistics/short_pred.,OADS,/arxiv_data1/oa_pdf/1f/48/CAS-108-987.PMC5448660.pdf
J Drug Deliv 2013; 905091 https://doi.org/10.1155/2013/905091.,Non-OADS,/arxiv_data1/oa_pdf/1f/48/CAS-108-987.PMC5448660.pdf
Available from URL: https://clinicaltrials.gov/ct2/show/NCT02752685?,Non-OADS,/arxiv_data1/oa_pdf/1f/48/CAS-108-987.PMC5448660.pdf
Available from URL: https://clinicaltrials.gov/ct2/show/NCT02425891?term=NCT02425891&rank=1.,Non-OADS,/arxiv_data1/oa_pdf/1f/48/CAS-108-987.PMC5448660.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/b9/2c/itt-6-031.PMC5448691.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/b9/2c/itt-6-031.PMC5448691.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).ImmunoTargets and Therapy  2017:6 31–38ImmunoTargets and Therapy Dovepress submit your manuscript | www.dovepress.com Dovepress 31 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/ITT .S117264Targeting innate immunity to downmodulate  adaptive immunity and reverse type 1 diabetes Arata Itoh   William M Ridgway Division of Immunology, Allergy  and Rheumatology, University of Cincinnati College of Medicine,  Cincinnati, OH, USAAbstract:  Type 1 diabetes (T1D) is characterized by specific destruction of pancreatic insulin- producing beta cells accompanied by evidence of beta-cell-directed autoimmunity such as  autoreactive T cells and islet autoantibodies (IAAs).",Non-OADS,/arxiv_data1/oa_pdf/b9/2c/itt-6-031.PMC5448691.pdf
"In contrast to cure, in most clinical autoimmune diseases (such as rheumatoid arthritis), current approaches do Correspondence: William M Ridgway   Division of Immunology, Allergy and  Rheumatology, University of Cincinnati College of Medicine, Medical Science Building, 231 Albert Sabin Way, Room 7505, Mail Location #0563 Cincinnati, OH 45267, USA Tel +1 513 558 5551   Email ridgwawm@ucmail.uc.eduJournal name: ImmunoTargets and Therapy  Article Designation: REVIEWY ear: 2017V olume: 6Running head verso: Itoh and RidgwayRunning head recto: Targeting innate immunity and re-educating adaptive immunity to reverse T1DDOI: http://dx.doi.org/10.2147/ITT.S117264",Non-OADS,/arxiv_data1/oa_pdf/b9/2c/itt-6-031.PMC5448691.pdf
"ImmunoTargets and Therapy  2017:6submit your manuscript | www.dovepress.com Dovepress Dovepress ImmunoTargets and Therapy  Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/immunotargets-and-therapy-journalImmunoTargets and Therapy is an international, peer-reviewed open access  journal focusing on the immunological basis of diseases, potential targets for  immune based therapy and treatment protocols employed to improve patient  management.",Non-OADS,/arxiv_data1/oa_pdf/b9/2c/itt-6-031.PMC5448691.pdf
Visit http://www.dovepress.com/ testimonials.php to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b9/2c/itt-6-031.PMC5448691.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/ac/05/ccid-10-205.PMC5448692.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/ac/05/ccid-10-205.PMC5448692.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Clinical, Cosmetic and Investigational Dermatology 2017:10 205–210Clinical, Cosmetic and Investigational Dermatology Dovepress submit your manuscript | www.dovepress.com Dovepress 205 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CCID.S135716 Tattoo removal with ingenol mebutate Sarah-Jane Cozzi1 Thuy T Le1 Steven M Ogbourne2 Cini James1 Andreas Suhrbier1 1Inflammation Biology Laboratory,   QIMR Berghofer Medical Research  Institute, Brisbane, 2Genecology  Research Center, Faculty of Science,  Health, Engineering and Education,  University of the Sunshine Coast,  Maroochydore DC, QLD, AustraliaAbstract:  An increasing number of people are getting tattoos; however, many regret the deci- sion and seek their removal.",Non-OADS,/arxiv_data1/oa_pdf/ac/05/ccid-10-205.PMC5448692.pdf
"2 Tattoo removal can also be incomplete, with tattoos containing Correspondence: Andreas Suhrbier  Inflammation Biology Laboratory, QIMR Berghofer Medical Research Institute, Locked Bag 2000, Royal Brisbane Hospital, QLD 4029, AustraliaTel +61 7 3362 0415Fax +61 7 3362 0111Email Andreas.Suhrbier@qimrberghofer.edu.auJournal name: Clinical, Cosmetic and Investigational Dermatology Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Cozzi et alRunning head recto: Tattoo removal with ingenol mebutateDOI: http://dx.doi.org/10.2147/CCID.S135716",Non-OADS,/arxiv_data1/oa_pdf/ac/05/ccid-10-205.PMC5448692.pdf
"Clinical, Cosmetic and Investigational Dermatology 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Clinical, Cosmetic and Investigational Dermatology Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/clinical-cosmetic-and-investigational-dermatology-journal Clinical, Cosmetic and Investigational Dermatology is an interna- tional, peer-reviewed, open access, online journal that focuses on   the latest clinical and experimental research in all aspects of skin   disease and cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/ac/05/ccid-10-205.PMC5448692.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authorsDovepress 210 Cozzi et al,Non-OADS,/arxiv_data1/oa_pdf/ac/05/ccid-10-205.PMC5448692.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ac/04/copd-12-1539.PMC5448693.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2017:12 1539–1547International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1539OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S13624 1 Delayed but successful response to noninvasive  ventilation in COPD patients with acute  hypercapnic respiratory failure Malcolm lemyze1,2 Quentin Bury3 aurélie guiot4 Marie Jonard1,2 Usman Mohammad2 nicolas Van grunderbeeck5 gaelle gasan1 Didier Thevenin2 Jihad Mallat2 1Department of respiratory and  Critical Care Medicine, schaffner  hospital, lens, 2Intensive Care Unit,   arras hospital, arras, 3respiratory  Intermediate Care Unit, Béthune  Beuvry hospital, Béthune,   4Department of Cardiology, Bois  Bernard hospital, Bois Bernard,   5respiratory step Down Unit,   schaffner hospital, lens, FranceBackground:  We evaluated a new noninvasive ventilation (NIV) protocol that allows the  pursuit of NIV in the case of persistent severe respiratory acidosis despite a first NIV challenge  in COPD patients with acute hypercapnic respiratory failure (AHRF).",Non-OADS,/arxiv_data1/oa_pdf/ac/04/copd-12-1539.PMC5448693.pdf
"Keywords:  noninvasive ventilation, acute respiratory failure, COPD, hypercapnia, intubation Introduction Since the first randomized clinical trial targeting COPD patients in the early 1990s, a  considerable amount of evidence has strongly supported the use of noninvasive venti - lation (NIV) to reduce mortality, intubation rates, and the length of stay in hospital in  COPD patients with acute hypercapnic respiratory failure (AHRF).1–4 Subsequently,  international guidelines rightly recommended NIV as the first-line therapy for patients  with AHRF.3,4 Several authors have carefully advised an escalation to endotracheal  intubation in the case of persistent respiratory acidosis after a first NIV challenge.5–7  Others have recently tested extracorporeal CO2 removal membrane after a first NIV  trial that had failed to reverse hypercapnic acidosis.8,9 However, on the one hand,  overcautious recommendations may lead to abusive endotracheal intubation which  can increase the risk of ventilator-associated pneumonia, ventilator-associated muscle Correspondence: Malcolm lemyze Department of respiratory and Critical  Care Medicine, schaffner hospital, 99  route de la Bassée, 62300 lens, France email malcolmlemyze@yahoo.f r Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Lemyze et al Running head recto: Delayed but successful response to NIV in COPD patients DOI: http://dx.doi.org/10.2147/COPD.S136241",Non-OADS,/arxiv_data1/oa_pdf/ac/04/copd-12-1539.PMC5448693.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/ac/04/copd-12-1539.PMC5448693.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ac/04/copd-12-1539.PMC5448693.pdf
Available from:  https://www.legifrance.gouv.fr/affichTexte.do?cidTexte=JORFTEXT0 00000446240&dateTexte.,Non-OADS,/arxiv_data1/oa_pdf/ac/04/copd-12-1539.PMC5448693.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/67/84/cia-12-903.PMC5448694.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2017:12 903–910Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  903RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S13296 3 Cognitive decline in normal aging and its  prevention: a review on non-pharmacological  lifestyle strategies Blanka Klimova1,2 Martin valis2 Kamil Kuca3,4 1Department of Applied Linguistics,   Faculty of Informatics and  Management, University of Hradec  Kralove, 2Department of Neurology,   3Biomedical Research Centre,   University Hospital Hradec Kralove,   4Department of Chemistry, Faculty of  Science, University of Hradec Kralove,   Hradec Kralove, Czech RepublicAbstract:  The purpose of this study is to examine the effects of the selected non-pharmacological  lifestyle activities on the delay of cognitive decline in normal aging.",Non-OADS,/arxiv_data1/oa_pdf/67/84/cia-12-903.PMC5448694.pdf
"Since there are findings13–16 that cer - tain non-pharmacological lifestyle activities such as physical activities or adherence Correspondence: Kamil Kuca University Hospital Hradec Kralove,  Sokolska 581, Hradec Kralove 500 05,  Czech Republic Tel +420 60 328 9166 Fax +420 49 583 5200 email kamil.kuca@fnhk.c z Journal name: Clinical Interventions in Aging Article Designation: Review Y ear: 2017 Volume: 12 Running head verso: Klimova et al Running head recto: Cognitive decline in normal aging and its prevention DOI: http://dx.doi.org/10.2147/CIA.S132963",Non-OADS,/arxiv_data1/oa_pdf/67/84/cia-12-903.PMC5448694.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/67/84/cia-12-903.PMC5448694.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/67/84/cia-12-903.PMC5448694.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/fc/b7/cia-12-873.PMC5448695.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2017:12 873–896Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  873RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S13079 4 effects of multi-domain interventions in (pre)frail  elderly on frailty, functional, and cognitive status:  a systematic review Lenore Dedeyne1 Mieke Deschodt2–4 Sabine verschueren5 Jos T ournoy1,3 evelien Gielen1,3 1Department of Clinical and  experimental Medicine, 2Department  of Public Health and Primary Care,   KU Leuven – University of Leuven,   Leuven, Belgium; 3Department of  Geriatric Medicine, University  Hospitals Leuven, Leuven, Belgium;   4Department of Public Health,   Institute of Nursing Science,   University of Basel, Basel, Switzerland;   5Department of Rehabilitation  Sciences, KU Leuven – University  of Leuven, Heverlee, BelgiumBackground:  Frailty is an aging syndrome caused by exceeding a threshold of decline across  multiple organ systems leading to a decreased resistance to stressors.",Non-OADS,/arxiv_data1/oa_pdf/fc/b7/cia-12-873.PMC5448695.pdf
"Keywords:  nutrition, supplement, exercise, cognition, hormone, social, vulnerable, older adults Introduction Frailty is a late-life syndrome that results from reaching a threshold of decline across  multiple organ systems.1 Because frailty leads to excess vulnerability and reduced  ability to maintain homeostasis, frail elderly are predisposed to functional deficits,  comorbidity, and mortality.1,2 Despite a lack of international consensus on the definition of frailty, two conceptual  definitions are commonly used.3,4 First, Fried et al introduced the frailty phenotype and  described frailty based on the presence of five physical characteristics: unintentional Correspondence: evelien Gielen Department of Geriatric Medicine,  University Hospitals Leuven, Herestraat  49/7003 35, Leuven, Belgium Tel +32 16 34 09 31 email evelien.gielen@uzleuven.b e Journal name: Clinical Interventions in Aging Article Designation: Review Y ear: 2017 Volume: 12 Running head verso: Dedeyne et al Running head recto: Multi-domain interventions for frail elderly DOI: http://dx.doi.org/10.2147/CIA.S130794",Non-OADS,/arxiv_data1/oa_pdf/fc/b7/cia-12-873.PMC5448695.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/fc/b7/cia-12-873.PMC5448695.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/fc/b7/cia-12-873.PMC5448695.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/20/7c/hp-5-033.PMC5448696.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/20/7c/hp-5-033.PMC5448696.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Hypoxia 2017:5 33–43Hypoxia Dovepress submit your manuscript | www.dovepress.com Dovepress 33 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/HP .S132462Neuroprotection via RNA-binding protein RBM3  expression is regulated by hypothermia but not  by hypoxia in human SK-N-SH neurons Lisa-Maria Rosenthal1 Giang T ong1 Christoph Walker1 Sylvia J Wowro1 Jana Krech1 Constanze Pfitzer1,2 Georgia Justus1 Felix Berger1,3 Katharina Rose Luise  Schmitt1 1Department of Congenital Heart  Disease/Pediatric Cardiology, German  Heart Institute Berlin, 2Berlin Institute  of Health (BIH), 3Department of  Pediatric Cardiology, Charité – University Medical Center, Berlin,  GermanyObjective: Therapeutic hypothermia is an established treatment for perinatal asphyxia.",Non-OADS,/arxiv_data1/oa_pdf/20/7c/hp-5-033.PMC5448696.pdf
"3–5 Moderate therapeutic hypothermia (32.0°C–33.9°C) is also recommended Correspondence: Lisa-Maria Rosenthal Department of Congenital Heart Disease/Pediatric Cardiology, Deutsches Herzzentrum Berlin, Augustenburger Platz 1, 13353 Berlin, GermanyTel +49 30 4593 2806Fax +49 30 450 559947Email rosenthal@dhzb.deJournal name: Hypoxia Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 5Running head verso: Rosenthal et alRunning head recto: Neuroprotection via RNA-binding protein RBM3 expressionDOI: http://dx.doi.org/10.2147/HP .S132462",Non-OADS,/arxiv_data1/oa_pdf/20/7c/hp-5-033.PMC5448696.pdf
"Hypoxia 2017:5submit your manuscript | www.dovepress.com Dovepress Dovepress Hypoxia Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/hypoxia-journalHypoxia is an international, peer-reviewed, open access journal that aims  to improve understanding of the biological response to hypoxia.",Non-OADS,/arxiv_data1/oa_pdf/20/7c/hp-5-033.PMC5448696.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 43 Neuroprotection via RNA-binding protein RBM3 expression,Non-OADS,/arxiv_data1/oa_pdf/20/7c/hp-5-033.PMC5448696.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/54/07/dddt-11-1605.PMC5448697.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2017:11 1605–1621Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1605Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/DDDT .S12900 8 Development of antiproliferative long-circulating  liposomes co-encapsulating doxorubicin and  curcumin, through the use of a quality-by-design  approach lucia ruxandra T efas1 Bianca sylvester1 ioan T omuta1 alina sesarman2,3 emilia licarete2,3 Manuela Banciu2,3 alina Porfire1 1Department of Pharmaceutical  T echnology and Biopharmaceutics,   Faculty of Pharmacy, University  of Medicine and Pharmacy “ iuliu  Haţieganu”, 2Department of  Molecular Biology and Biotechnology,   Faculty of Biology and geology,   3Molecular Biology centre, institute  for interdisciplinary research in  Bio-Nano-Sciences, Babeş-Bolyai  University, cluj-n apoca, romaniaAbstract:  The aim of this work was to use the quality-by-design (QbD) approach in the devel - opment of long-circulating liposomes co-loaded with curcumin (CUR) and doxorubicin (DOX)  and to evaluate the cytotoxic potential of these liposomes in vitro using C26 murine colon  carcinoma cell line.",Non-OADS,/arxiv_data1/oa_pdf/54/07/dddt-11-1605.PMC5448697.pdf
"Therefore, combination therapy has emerged as a new correspondence: ioan Tomuta Department of Pharmaceutical  Technology and Biopharmaceutics,  Faculty of Pharmacy, University of  Medicine and Pharmacy “Iuliu Haţieganu”,  41 Victor Babeş Street, 400012 Cluj- napoca, romania Tel/fax +40 264 59 5770 email tomutaioan@umfcluj.r o Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Tefas et al Running head recto: Antiproliferative liposomes co-encapsulating DOX and CUR DOI: http://dx.doi.org/10.2147/DDDT.S129008",Non-OADS,/arxiv_data1/oa_pdf/54/07/dddt-11-1605.PMC5448697.pdf
Available from: http://www.ich.org/fileadmin/Public_Web_Site/ ICH_Products/Guidelines/Quality/Q8_R1/Step4/Q8_R2_Guideline.,Non-OADS,/arxiv_data1/oa_pdf/54/07/dddt-11-1605.PMC5448697.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/54/07/dddt-11-1605.PMC5448697.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/54/07/dddt-11-1605.PMC5448697.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/5b/36/clep-9-297.PMC5448698.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/5b/36/clep-9-297.PMC5448698.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Clinical Epidemiology 2017:9 297–310Clinical Epidemiology Dovepress submit your manuscript | www.dovepress.com Dovepress 297 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CLEP .S124382 Transmission of health care-associated infections  from roommates and prior room occupants:   a systematic review Bevin Cohen1 Catherine Crawford Cohen1 Borghild Løyland2 Elaine L Larson1 1Columbia University School of  Nursing, New Y ork, NY, USA; 2Oslo  and Akershus University College,   Oslo, NorwayAbstract:  Pathogens that cause health care-associated infections (HAIs) are known to survive  on surfaces and equipment in health care environments despite routine cleaning.",Non-OADS,/arxiv_data1/oa_pdf/5b/36/clep-9-297.PMC5448698.pdf
"15–18 Pathogens that survive on Correspondence: Bevin Cohen Columbia University School of Nursing, 630 West 168th Street, New York,   NY 10032, USATel +1 212 342 4111Fax +1 212 305 0722Email bac2116@columbia.eduJournal name: Clinical Epidemiology Article Designation: REVIEWY ear: 2017V olume: 9Running head verso: Cohen et alRunning head recto: Infection transmission from roommates and prior room occupantsDOI: http://dx.doi.org/10.2147/CLEP .S124382",Non-OADS,/arxiv_data1/oa_pdf/5b/36/clep-9-297.PMC5448698.pdf
Available from: http://www.cdc.gov/hai/pdfs/hai/scott_costpaper.pdf.,OADS,/arxiv_data1/oa_pdf/5b/36/clep-9-297.PMC5448698.pdf
Available from http://www.cdc.gov/hicpac/pdf/MDRO/MDROGuideline2006.pdf.,OADS,/arxiv_data1/oa_pdf/5b/36/clep-9-297.PMC5448698.pdf
Available from: http://www.cdc.gov/hicpac/pdf/isolation/Isolation2007.pdf.,OADS,/arxiv_data1/oa_pdf/5b/36/clep-9-297.PMC5448698.pdf
"Clinical Epidemiology 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress Clinical Epidemiology Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinical-epidemiology-journalClinical Epidemiology is an international, peer-reviewed, open access,  online journal focusing on disease and drug epidemiology, identifica-tion of risk factors and screening procedures to develop optimal pre-ventative initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/5b/36/clep-9-297.PMC5448698.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/66/13/ahmt-8-057.PMC5448699.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/66/13/ahmt-8-057.PMC5448699.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Adolescent Health, Medicine and Therapeutics 2017:8 57–67Adolescent Health, Medicine and Therapeutics Dovepress submit your manuscript | www.dovepress.com Dovepress  57 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AHMT .S110859Gender nonconforming youth: current  perspectives Diane Ehrensaft Department of Pediatrics, University  of California, San Francisco, CA, USAAbstract: Beginning with a case vignette, a discussion follows of the reformulation of theories  of gender development taking into consideration the recent upsurge of gender nonconforming  and transgender youth presenting for gender services and also in the culture at large.",Non-OADS,/arxiv_data1/oa_pdf/66/13/ahmt-8-057.PMC5448699.pdf
"Up until second grade, he, then she with the name Daisy, truly believed that when she reached puberty she would simply switch gears, grow a penis, get a beard,  Correspondence: Diane Ehrensaft Department of Pediatrics, University of California, 445 Bellevue Avenue Suite 302 Oakland, CA 94610, USAEmail dehrensaft@earthlink.netJournal name: Adolescent Health, Medicine and Therapeutics Article Designation: REVIEWY ear: 2017V olume: 8Running head verso: EhrensaftRunning head recto: Gender nonconforming youthDOI: http://dx.doi.org/10.2147/AHMT.S110859",Non-OADS,/arxiv_data1/oa_pdf/66/13/ahmt-8-057.PMC5448699.pdf
Available from: http://metronews.ca/news/toronto/1315743/outcry-prompts-camh-to-review-its-controversial-treatment-of-trans-youth 18.,Non-OADS,/arxiv_data1/oa_pdf/66/13/ahmt-8-057.PMC5448699.pdf
"Adolescent Health, Medicine and Therapeutics 2017:8submit your manuscript | www.dovepress.com Dovepress Dovepress Adolescent Health, Medicine and Therapeutics Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/adolescent-health-medicine-and-therapeutics-journalAdolescent Health, Medicine and Therapeutics is an international,   peer-reviewed, open access journal focusing on health, pathology, and  treatment issues specific to the adolescent age group.",Non-OADS,/arxiv_data1/oa_pdf/66/13/ahmt-8-057.PMC5448699.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/66/13/ahmt-8-057.PMC5448699.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/c4/bb/clep-9-291.PMC5448700.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/c4/bb/clep-9-291.PMC5448700.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Clinical Epidemiology 2017:9 291–296Clinical Epidemiology Dovepress submit your manuscript | www.dovepress.com Dovepress 291 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CLEP .S129268 Hypoglycemia: a review of definitions used  in clinical trials evaluating antihyperglycemic  drugs for diabetes Chakrapani Balijepalli1,2 Eric Druyts2 Gaye Siliman2 Michel Joffres1 Kristian Thorlund2,3 Edward J Mills3 1Faculty of Health Sciences, Simon  Fraser University, Burnaby, 2Precision  Health Economics, Vancouver, BC,   3Department of Health Research  Methods, Evidence, and Impact,   Faculty of Health Sciences, McMaster University, Hamilton, ON, CanadaObjective: To understand the severity and potential impact of heterogeneity in definitions  of hypoglycemia used in diabetes research, we aimed to review the hypoglycemia definitions  adopted in randomized controlled trials (RCTs).",Non-OADS,/arxiv_data1/oa_pdf/c4/bb/clep-9-291.PMC5448700.pdf
"Hypoglycemia is a common side effect of diabetes therapy, resulting in a lack of  adequate cerebral glucose supply, leading to a range of neurogenic and neuroglycopenic Correspondence: Chakrapani Balijepalli Faculty of Health Sciences, Simon Fraser University, 8888 University Drive, Burnaby, BC, Canada   Tel +1 604 336 3050 ext 111   Email chakrapani_balijepalli@sfu.caJournal name: Clinical Epidemiology Article Designation: REVIEWY ear: 2017V olume: 9Running head verso: Balijepalli et alRunning head recto: Hypoglycemia: a review of definitionsDOI: http://dx.doi.org/10.2147/CLEP .S129268",Non-OADS,/arxiv_data1/oa_pdf/c4/bb/clep-9-291.PMC5448700.pdf
"Clinical Epidemiology 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress Clinical Epidemiology Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinical-epidemiology-journalClinical Epidemiology is an international, peer-reviewed, open access,  online journal focusing on disease and drug epidemiology, identifica-tion of risk factors and screening procedures to develop optimal pre-ventative initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/c4/bb/clep-9-291.PMC5448700.pdf
Available from: https://www.idf.org/sites/default/files/EN_6E_Atlas_Full_0.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c4/bb/clep-9-291.PMC5448700.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/06/2c/hp-5-045.PMC5448701.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/06/2c/hp-5-045.PMC5448701.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Hypoxia 2017:5 45–59Hypoxia Dovepress submit your manuscript | www.dovepress.com Dovepress 45 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/HP .S132832KEMTUB012-NI2, a novel potent tubulysin analog  that selectively targets hypoxic cancer cells and  is potentiated by cytochrome p450 reductase  downregulation Paolo Lazzari1  Marco Spiga1  Monica Sani1,2  Matteo Zanda2,3  Ian N Fleming4 1KemoT ech s.r.l., Parco Scientifico  della Sardegna, Pula, Cagliari, 2C.N.R.",Non-OADS,/arxiv_data1/oa_pdf/06/2c/hp-5-045.PMC5448701.pdf
"1,4 The efficacy of standard chemotherapies in  hypoxic tumors is affected by multiple factors as follows: 1) poor tumor vasculature can limit drug delivery to hypoxic cells; 2) the low pH of the extracellular environment can alter the ionic charge of the drug; 3) limited cell proliferation can significantly reduce the efficacy of agents that target cycling cells; 4) hypoxic cells have decreased Correspondence: Ian N Fleming Aberdeen Biomedical Imaging Centre, Institute of Medical Sciences, Foresterhill, Aberdeen AB25 2ZD, Scotland, UK   Tel +44 1224 438 357   Fax +44 1224 438 364   Email i.n.fleming@abdn.ac.ukJournal name: Hypoxia Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 5Running head verso: Lazzari et alRunning head recto: Hypoxia-targeted tubulysinDOI: http://dx.doi.org/10.2147/HP .S132832 Video abstract Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/06/2c/hp-5-045.PMC5448701.pdf
Or use: http://youtu.be/57A_ECtVEzo,Non-OADS,/arxiv_data1/oa_pdf/06/2c/hp-5-045.PMC5448701.pdf
"Hypoxia 2017:5submit your manuscript | www.dovepress.com Dovepress Dovepress Hypoxia Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/hypoxia-journalHypoxia is an international, peer-reviewed, open access journal that aims  to improve understanding of the biological response to hypoxia.",Non-OADS,/arxiv_data1/oa_pdf/06/2c/hp-5-045.PMC5448701.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 59 Hypoxia-targeted tubulysin Rf: 0.23 (dichloromethane/methanol 90:10).,Non-OADS,/arxiv_data1/oa_pdf/06/2c/hp-5-045.PMC5448701.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/a6/e2/copd-12-1549.PMC5448702.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2017:12 1549–1564International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1549OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S13780 6 Identification of thyroxine-binding globulin as a  candidate plasma marker of chronic obstructive  pulmonary disease Wenqi Diao1 Ning Shen1 Yipeng Du1 Xiaoyan Sun1 Beibei Liu1 Ming Xu2,3 Bei he1 1Department of Respiratory  Medicine, 2Department of Cardiology,   Institute of Vascular Medicine,   Peking University Third Hospital,   3Key Laboratory of Molecular  Cardiovascular Sciences, Ministry  of Education, Beijing, People’s  Republic of ChinaAbstract:  Biomarkers for the management of chronic obstructive pulmonary disease (COPD)  are limited.",Non-OADS,/arxiv_data1/oa_pdf/a6/e2/copd-12-1549.PMC5448702.pdf
"Recently, proteomics has been widely applied in the identification of biomarkers  in various diseases due to the high-throughput and unbiased characteristics of the  technique.13–17 Likewise, the technique has also been used in biomarker studies of  COPD.18–20 Several markers identified by proteomic studies have provided new insights Correspondence: Bei he Department of Respiratory Medicine,  Peking University Third Hospital,  49 North Garden Road, Haidian District,  Beijing, 100191, People’s Republic of  China Tel +86 10 8226 5210 Fax +86 10 8208 6810 email puh3_hb@bjmu.edu.c n Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Diao et al Running head recto: THBG: a plasma marker of COPD DOI: http://dx.doi.org/10.2147/COPD.S137806",Non-OADS,/arxiv_data1/oa_pdf/a6/e2/copd-12-1549.PMC5448702.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/a6/e2/copd-12-1549.PMC5448702.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a6/e2/copd-12-1549.PMC5448702.pdf
"https://doi.org/10.1177/1087057117696795SLAS Discovery 2017, Vol.",Non-OADS,/arxiv_data1/oa_pdf/28/31/10.1177_1087057117696795.PMC5448717.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bb/7f/main.PMC5448720.pdf
"Contents lists available at ScienceDirect Prostate International journal homepage: https://www.journals.elsevie r.com/prostate-international http://dx.doi.org/10.1016/j.prnil.2017.01.008 p2287-8882 e2287-903X/ ©2017 Asian Paci ﬁc Prostate Society, Published by Elsevier Korea LLC.",Non-OADS,/arxiv_data1/oa_pdf/bb/7f/main.PMC5448720.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/62/83/main.PMC5448721.pdf
"Contents lists available at ScienceDirect Prostate International journal homepage: https://www.journals.elsevier.c om/prostate-international http://dx.doi.org/10.1016/j.prnil.2017.03.003 p2287-8882 e2287-903X/ ©2017 Asian Paci ﬁc Prostate Society, Published by Elsevier Korea LLC.",Non-OADS,/arxiv_data1/oa_pdf/62/83/main.PMC5448721.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/79/5f/main.PMC5448724.pdf
"Contents lists available at ScienceDirect Prostate International journal homepage: https://www.journals.elsevier.c om/prostate-international http://dx.doi.org/10.1016/j.prnil.2017.01.006 p2287-8882 e2287-903X/ ©2017 Asian Paci ﬁc Prostate Society, Published by Elsevier Korea LLC.",Non-OADS,/arxiv_data1/oa_pdf/79/5f/main.PMC5448724.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4b/7b/main.PMC5448727.pdf
"Contents lists available at ScienceDirect Prostate International journal homepage: https://www.journals.elsevier.c om/prostate-international http://dx.doi.org/10.1016/j.prnil.2017.02.002 p2287-8882 e2287-903X/ ©2017 Asian Paci ﬁc Prostate Society, Published by Elsevier Korea LLC.",Non-OADS,/arxiv_data1/oa_pdf/4b/7b/main.PMC5448727.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/cf/9a/main.PMC5448728.pdf
"Contents lists available at ScienceDirect Prostate International journal homepage: https://www.journals.elsevier.c om/prostate-international http://dx.doi.org/10.1016/j.prnil.2017.01.007 p2287-8882 e2287-903X/ ©2017 Asian Paci ﬁc Prostate Society, Published by Elsevier Korea LLC.",Non-OADS,/arxiv_data1/oa_pdf/cf/9a/main.PMC5448728.pdf
ANZ JSurg 2017. http://dx.doi.org/10.1111/ans.13904.,OADS,/arxiv_data1/oa_pdf/cf/9a/main.PMC5448728.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fa/b9/main.PMC5448729.pdf
"Contents lists available at ScienceDirect Prostate International journal homepage: https://www.journals.elsevier.c om/prostate-international http://dx.doi.org/10.1016/j.prnil.2017.01.005 p2287-8882 e2287-903X/ ©2017 Asian Paci ﬁc Prostate Society, Published by Elsevier Korea LLC.",Non-OADS,/arxiv_data1/oa_pdf/fa/b9/main.PMC5448729.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/43/01/main.PMC5448731.pdf
"Contents lists available at ScienceDirect Prostate International journal homepage: https://www.journals.elsevier.c om/prostate-international http://dx.doi.org/10.1016/j.prnil.2017.03.002 p2287-8882 e2287-903X/ ©2017 Asian Paci ﬁc Prostate Society, Published by Elsevier Korea LLC.",Non-OADS,/arxiv_data1/oa_pdf/43/01/main.PMC5448731.pdf
"For reprints and permission queries, plea se visit SAGE’s website at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/d7/fa/10.1177_2325967117707737.PMC5448732.pdf
"For reprints and permission queries, plea se visit SAGE’s website at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/96/bb/10.1177_2325967117703726.PMC5448737.pdf
"For reprints and permission queries, plea se visit SAGE’s website at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/c7/05/10.1177_2325967117707498.PMC5448789.pdf
http://www.sportsmed.org/apps/aossm_2013/ scientific_posters.html.,Non-OADS,/arxiv_data1/oa_pdf/c7/05/10.1177_2325967117707498.PMC5448789.pdf
"https://doi.org/10.1177/2050313X17704530 SAGE Open Medical Case Reports Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution- NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction  and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages  (https://us.sagepub.com/en-us/nam/open-access-at-sage).SAGE Open Medical Case Reports Volume 5: 1 –2 © The Author(s) 2017 Reprints and permissions:  sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/2050313X17704530 journals.sagepub.com/home/sco Abdou, Asmaa Gaber Acmaz, G.Aissaoui, AbirAlexopoulos, DAmbrosini, AAmorim, Robson LuisAnagnostou, EvangelosAroen, AsbjornArora, AnilAsai, KazuhisaBannier, MABarili, FabioBar-Sela, GilBas, Veysel NijatBatagini, NayaraBaumeister, R. G. H.Belyavskaya, T.Bender, AndreasBezgin, TahirBishop, BryanBlackford, MarthaBland, J.D.Bonn-Miller, Marcel O.Bortolotti, UbertoBorzio, MBoucher, LMBozgeyik, ZBrand, SergeBrorsson, ALBuc, EmmanuelBurrell, JamesCalvagna, GMCavalcante, Leonardo PessoaCesaro, SimoneCevik, YunsurChabowski, MariuszChan, TYChang, Chung-HsingChen, Chih-HaoChen, Lu-AnChen, S.Cheng, Chen-ChuanChikamoto, A.Choi, John K.Citrome, LeslieClarke, CharlotteColeman, DMCurtis, BrianDane, CemDanson, EdwardDarbari, ADas, S.Davidson, Jane W.De Azevêdo Silva, J.de Carvalho, MDehghani, NimaDemiraslan, HayatiDeschler, DanielDoddamani, ParveenDriesenga, Scott A.Duchalais, EmilieDulović, ODurmaz, B.Dymond, SimonEl Demellawy, DinaEngels, YvonneEscapa Garrachón, J.M.Espigol-Frigolé, GeorginaEsposito, A.Exline, Julie J.Faverani, LPFeldner, Matthew T.Fineschi, VittorioFlom, RossFoley, PJFranz, Randall W.Fujishiro, JunFukumoto, YoshihiroGalvin, SeanGaudino, RossellaGentimi, FGeorges, Jean-LouisGifford, G.Giurazza, FrancescoGokhale, SankalpGoldman, JeremyGómez-Oliva, C.González-Abraldes, I.Gosau, MGoumenos, D. S.Graber, Mark L.Guber, Helena A.Harizanov, Rumen N.Hassan, K. M.Hirche, ChristophHiroshige, TasukuHomma, TakahiroIida, YImamura, MasayukiInagaki, K.Inui, AtsuyukiJi, J.H.Jiang, YawenJomha, NadrKanagotagi, SachinKaratas, YasarKarlsson, StaffanKasznicki, JacekKaul, PKeser, GokhanKiely, E.M.Kilic, LeventKim, YHKlammt, JuergenKorczynski, PiotrKostopoulou, AGKoury, JosephKulkarni, Adwait UdayKullar, RajKurien, Anil M. Thanks to Reviewers The Editorial Team of SAGE Open Medical Case Reports would like to thank the following people for reviewing articles for the Journal during 2015 and 2016.",Non-OADS,/arxiv_data1/oa_pdf/6c/0f/10.1177_2050313X17704530.PMC5448864.pdf
"https://doi.org/10.1177/2050313X17709190 SAGE Open Medical Case Reports Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution- NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction  and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages  (https://us.sagepub.com/en-us/nam/open-access-at-sage).SAGE Open Medical Case Reports Volume 5: 1 –8 © The Author(s) 2017 Reprints and permissions:  sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/2050313X17709190 journals.sagepub.com/home/sco Introduction Primary hepatic lymphoma (PHL) is confined to the liver  without evidence of lymphomatous involvement in any other lymphoid structures, such as lymph nodes, the spleen, or bone marrow.",Non-OADS,/arxiv_data1/oa_pdf/d1/71/10.1177_2050313X17709190.PMC5448865.pdf
"https://doi.org/10.1177/2050313X17710594 SAGE Open Medical Case Reports Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution- NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction  and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages  (https://us.sagepub.com/en-us/nam/open-access-at-sage).SAGE Open Medical Case Reports Volume 5: 1 –3 © The Author(s) 2017 Reprints and permissions:  sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/2050313X17710594 journals.sagepub.com/home/sco Introduction Schizophrenia is a chronic disease that requires long-term  management with antipsychotics; however, an important barrier to the success of long-term treatment is drug non-compliance, which increases the risk of recurrence and hos-pitalization.",Non-OADS,/arxiv_data1/oa_pdf/e4/f2/10.1177_2050313X17710594.PMC5448866.pdf
"5, 544 –552 http://dx.doi.org/10.1080/15476286.2016.1191735",Non-OADS,/arxiv_data1/oa_pdf/77/d8/krnb-14-05-1191735.PMC5449078.pdf
"30,45,59Mutations in PRPF31 were ﬁrst described 15 year ago by Vithana et al..60To date, »60 mutations have been reported according to http://www.hgmd.cf.ac.uk60-65Most mutations in PRPF31 are deletions, frameshifts or mutations that inhibit splicing and thus include introns that contain many prematurestop codons.",Non-OADS,/arxiv_data1/oa_pdf/77/d8/krnb-14-05-1191735.PMC5449078.pdf
Nat Rev Mol Cell Biol 2014; 15:108-21; PMID:24452469; http://dx.doi.org/ 10.1038/nrm3742 2.,OADS,/arxiv_data1/oa_pdf/77/d8/krnb-14-05-1191735.PMC5449078.pdf
Cell 2009; 136:701-18; PMID:19239890; http://dx.doi.org/10.1016/j.cell.2009.02.009 3.,OADS,/arxiv_data1/oa_pdf/77/d8/krnb-14-05-1191735.PMC5449078.pdf
J Cell Biol 2016; 212:13-27; PMID:26728853;http://dx.doi.org/10.1083/jcb.201510032 4.,OADS,/arxiv_data1/oa_pdf/77/d8/krnb-14-05-1191735.PMC5449078.pdf
FEBS Lett 2015; 589:1598-606; PMID:25957814; http://dx.doi.org/10.1016/j.febslet.2015.04.052 5.,OADS,/arxiv_data1/oa_pdf/77/d8/krnb-14-05-1191735.PMC5449078.pdf
Clin Genetics 2013; 84:132-41; PMID:23701314;http://dx.doi.org/10.1111/cge.12203 6.,OADS,/arxiv_data1/oa_pdf/77/d8/krnb-14-05-1191735.PMC5449078.pdf
Lancet 2006; 368:1795-809; PMID:17113430; http://dx.doi.org/10.1016/ S0140-6736(06)69740-7 7.,Non-OADS,/arxiv_data1/oa_pdf/77/d8/krnb-14-05-1191735.PMC5449078.pdf
J Cell Biol 2010; 191:75-86; PMID:20921136; http://dx.doi.org/10.1083/jcb.201004030 8.,OADS,/arxiv_data1/oa_pdf/77/d8/krnb-14-05-1191735.PMC5449078.pdf
Mol Cell 2005; 19:53-63;PMID:15989964; http://dx.doi.org/10.1016/j.molcel.2005.05.007 9.,OADS,/arxiv_data1/oa_pdf/77/d8/krnb-14-05-1191735.PMC5449078.pdf
Mol Cell 2006; 23:49-59; PMID:16818232; http://dx.doi.org/10.1016/j.molcel.2006.05.025 11.,OADS,/arxiv_data1/oa_pdf/77/d8/krnb-14-05-1191735.PMC5449078.pdf
Trends Biochem Sci 2016; 41:33-45;PMID:26682498; http://dx.doi.org/10.1016/j.tibs.2015.11.003 12.,OADS,/arxiv_data1/oa_pdf/77/d8/krnb-14-05-1191735.PMC5449078.pdf
RNA1999; 5:959-71; PMID:10411139; http://dx.doi.org/10.1017/S135583829999012X 14.,Non-OADS,/arxiv_data1/oa_pdf/77/d8/krnb-14-05-1191735.PMC5449078.pdf
A structural analysis of the group II intron active site and implications for the spliceosome.RNA 2010; 16:1-9; PMID:19948765; http://dx.doi.org/10.1261/ rna.1791310 16.,OADS,/arxiv_data1/oa_pdf/77/d8/krnb-14-05-1191735.PMC5449078.pdf
EMBO J 2013; 32:2804-18; PMID:24002212; http://dx.doi.org/10.1038/ emboj.2013.198 17.,Non-OADS,/arxiv_data1/oa_pdf/77/d8/krnb-14-05-1191735.PMC5449078.pdf
RNA Biol 2011; 8:372-7; PMID:21445000; http://dx.doi.org/10.4161/rna.8.3.15386 18.,OADS,/arxiv_data1/oa_pdf/77/d8/krnb-14-05-1191735.PMC5449078.pdf
RNA Biol 2010; 7:345-53; PMID:20458185; http://dx.doi.org/10.4161/ rna.7.3.12089 19.,OADS,/arxiv_data1/oa_pdf/77/d8/krnb-14-05-1191735.PMC5449078.pdf
Science 2015; 349:1182-91; PMID:26292707; http://dx.doi.org/10.1126/science.aac7629RNA BIOLOGY 549,Non-OADS,/arxiv_data1/oa_pdf/77/d8/krnb-14-05-1191735.PMC5449078.pdf
Science 2015; 349:1191-8; PMID:26292705; http://dx.doi.org/10.1126/science.aac8159 21.,Non-OADS,/arxiv_data1/oa_pdf/77/d8/krnb-14-05-1191735.PMC5449078.pdf
RNA Biol 2013; 10:133-48; PMID:23353571; http://dx.doi.org/10.4161/rna.23507 22.,OADS,/arxiv_data1/oa_pdf/77/d8/krnb-14-05-1191735.PMC5449078.pdf
Genes Dev 2013; 27:413- 28; PMID:23431055; http://dx.doi.org/10.1101/gad.207779.112 23.,OADS,/arxiv_data1/oa_pdf/77/d8/krnb-14-05-1191735.PMC5449078.pdf
"Spiluttini B, Gu B, Belagal P, Smirnova AS, Nguyen VT, Hebert C, Schmidt U, Bertrand E, Darzacq X, Bensaude O. Splicing-indepen-dent recruitment of U1 snRNP to a transcription unit in living cells.J Cell Sci 2010; 123:2085-93; PMID:20519584; http://dx.doi.org/ 10.1242/jcs.061358 24.",OADS,/arxiv_data1/oa_pdf/77/d8/krnb-14-05-1191735.PMC5449078.pdf
Science 2009; 323:1205-8; PMID:19251627; http://dx.doi.org/10.1126/science 26.,Non-OADS,/arxiv_data1/oa_pdf/77/d8/krnb-14-05-1191735.PMC5449078.pdf
Nucleic Acids Res 2015; 43:3208-18; PMID:25735748; http://dx.doi.org/10.1093/nar/gkv157 27.,Non-OADS,/arxiv_data1/oa_pdf/77/d8/krnb-14-05-1191735.PMC5449078.pdf
J CellSci 2014; 127:3909-15; PMID:25052091; http://dx.doi.org/10.1242/ jcs.15538 28.,OADS,/arxiv_data1/oa_pdf/77/d8/krnb-14-05-1191735.PMC5449078.pdf
Embo J 2002; 21:5527-38; PMID:12374753; http://dx.doi.org/ 10.1093/emboj/cdf544 29.,OADS,/arxiv_data1/oa_pdf/77/d8/krnb-14-05-1191735.PMC5449078.pdf
ELife 2015; 4: e07320; PMID:26161500; http://dx.doi.org/10.7554/eLife.07320 30.,Non-OADS,/arxiv_data1/oa_pdf/77/d8/krnb-14-05-1191735.PMC5449078.pdf
Exp Cell Res 2005; 302:61-8;PMID:15541726; http://dx.doi.org/10.1016/j.yexcr.2004.08.022 32.,OADS,/arxiv_data1/oa_pdf/77/d8/krnb-14-05-1191735.PMC5449078.pdf
Hum MolGenet 2002; 11:87-92; PMID:11773002; http://dx.doi.org/10.1093/ hmg/11.1.87 33.,OADS,/arxiv_data1/oa_pdf/77/d8/krnb-14-05-1191735.PMC5449078.pdf
Human mutation 2008;29:869-78; PMID:18412284; http://dx.doi.org/10.1002/humu.20747 34.,Non-OADS,/arxiv_data1/oa_pdf/77/d8/krnb-14-05-1191735.PMC5449078.pdf
"Comitato A, Spampanato C, Chakarova C, Sanges D, Bhattacharya SS, Marigo V. Mutations in splicing factor PRPF3, causing retinal degeneration, form detrimental aggregates in photoreceptor cells.Hum Mol Genet 2007; 16:1699-707; PMID:17517693; http://dx.doi.org/10.1093/hmg/ddm118 35.",Non-OADS,/arxiv_data1/oa_pdf/77/d8/krnb-14-05-1191735.PMC5449078.pdf
Hum Mol Genet 2008; 17:225- 39; PMID:17932117; http://dx.doi.org/10.1093/hmg/ddm300 36.,OADS,/arxiv_data1/oa_pdf/77/d8/krnb-14-05-1191735.PMC5449078.pdf
Hum Mol Genet 2011;20:2116-30; PMID:21378395; http://dx.doi.org/10.1093/hmg/ddr094 37.,OADS,/arxiv_data1/oa_pdf/77/d8/krnb-14-05-1191735.PMC5449078.pdf
Invest Ophthalmol Visual Sci 2008; 49:3830-8;PMID:18552388; http://dx.doi.org/10.1167/iovs.07-1483 38.,Non-OADS,/arxiv_data1/oa_pdf/77/d8/krnb-14-05-1191735.PMC5449078.pdf
Invest Ophthalmol Visual Sci 2011; 52:190-8; PMID:20811066; http://dx.doi.org/10.1167/iovs.10-5194 39.,Non-OADS,/arxiv_data1/oa_pdf/77/d8/krnb-14-05-1191735.PMC5449078.pdf
Am J Pathol 2014; 184:2641-52; PMID:25111227; http://dx.doi.org/10.1016/j.apath.2014.06.026 40.,OADS,/arxiv_data1/oa_pdf/77/d8/krnb-14-05-1191735.PMC5449078.pdf
Hum Mol Genet 2011; 20:368-77; PMID:21051334;http://dx.doi.org/10.1093/hmg/ddq473 41.,OADS,/arxiv_data1/oa_pdf/77/d8/krnb-14-05-1191735.PMC5449078.pdf
Hum Mol Genet 2014; 23(11):2926-39;PMID:24419317; http://dx.doi.org/10.1093/hmg/ddu005 4 2 .,OADS,/arxiv_data1/oa_pdf/77/d8/krnb-14-05-1191735.PMC5449078.pdf
PLoS One 2014; 9:e111754; PMID:25383878; http://dx.doi.org/ 10.1371/journal.pone.0111754 43.,Non-OADS,/arxiv_data1/oa_pdf/77/d8/krnb-14-05-1191735.PMC5449078.pdf
J Mol Biol 2000; 298:567-75; PMID:10788320;http://dx.doi.org/101006/jmbi.2000.3685 45.,OADS,/arxiv_data1/oa_pdf/77/d8/krnb-14-05-1191735.PMC5449078.pdf
Embo J 2002; 21:1148- 57; PMID:11867543; http://dx.doi.org/10.1093/emboj/21.5.1148 46.,OADS,/arxiv_data1/oa_pdf/77/d8/krnb-14-05-1191735.PMC5449078.pdf
Am J Hum Genet 2011; 88:643-9; PMID:21549338; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/77/d8/krnb-14-05-1191735.PMC5449078.pdf
Cell Reports 2015; 10:429-40; PMID:25600876; http://dx.doi.org/10.1016/j.celrep.2014.12.030 48.,OADS,/arxiv_data1/oa_pdf/77/d8/krnb-14-05-1191735.PMC5449078.pdf
PLoS One 2012; 7:e29729; PMID:22235333; http://dx.doi.org/ 10.1371/journal.pone.0029729 49.,Non-OADS,/arxiv_data1/oa_pdf/77/d8/krnb-14-05-1191735.PMC5449078.pdf
Curr Opin Struct Biol 2014; 25:57-66; PMID:24480332; http://dx.doi.org/ 10.1016/j.sbi.2013.12.002550 /C20SR U/C14/C20ZI/C20CKOV /C19A AND D. STAN /C20EK,OADS,/arxiv_data1/oa_pdf/77/d8/krnb-14-05-1191735.PMC5449078.pdf
Mol Cell 2007; 25:615-24;PMID:17317632; http://dx.doi.org/10.1016/j.molcel.2007.01.023 5 1 .,OADS,/arxiv_data1/oa_pdf/77/d8/krnb-14-05-1191735.PMC5449078.pdf
Structure 2013; 21:910-19; PMID:23727230; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/77/d8/krnb-14-05-1191735.PMC5449078.pdf
Nat Struct Mol Biol 2009; 16:42-8; PMID:19098916; http://dx.doi.org/ 10.1038/nsmb 55.,OADS,/arxiv_data1/oa_pdf/77/d8/krnb-14-05-1191735.PMC5449078.pdf
Genome Biol 2015; 16:201; PMID:26392272; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/77/d8/krnb-14-05-1191735.PMC5449078.pdf
Leu-kemia 2015; 29:126-36; PMID:24781015; http://dx.doi.org/10.1038/leu.2014.144 59.,Non-OADS,/arxiv_data1/oa_pdf/77/d8/krnb-14-05-1191735.PMC5449078.pdf
Mol Cell 2001; 8:375-81; PMID:11545739; http://dx.doi.org/10.1016/S1097-2765(01)00305-7 61.,OADS,/arxiv_data1/oa_pdf/77/d8/krnb-14-05-1191735.PMC5449078.pdf
Hum Mutation 2006; 27:644-53;PMID:16708387; http://dx.doi.org/10.1002/humu.,OADS,/arxiv_data1/oa_pdf/77/d8/krnb-14-05-1191735.PMC5449078.pdf
Am J Ophthal- mol 2005; 140:537-40; PMID:16139010; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/77/d8/krnb-14-05-1191735.PMC5449078.pdf
Am J Med Genetics Part A 2003; 121A:235-9; PMID:12923864;http://dx.doi.org/10.1002/ajmg.a.20224 64.,Non-OADS,/arxiv_data1/oa_pdf/77/d8/krnb-14-05-1191735.PMC5449078.pdf
Invest Ophthalmol Visual Sci 2006; 47:4579-88; PMID:17003455; http://dx.doi.org/10.1167/iovs.06-0440 65.,Non-OADS,/arxiv_data1/oa_pdf/77/d8/krnb-14-05-1191735.PMC5449078.pdf
J Clin Invest 2008; 118:1519-31; PMID:18317597; http://dx.doi.org/10.1172/JCI34211 67.,Non-OADS,/arxiv_data1/oa_pdf/77/d8/krnb-14-05-1191735.PMC5449078.pdf
Hum Mol Genet 2002; 11:3209-19; PMID:12444105; http://dx.doi.org/ 10.1093/hmg/11.25.3209 71.,OADS,/arxiv_data1/oa_pdf/77/d8/krnb-14-05-1191735.PMC5449078.pdf
Biochim Biophys Acta 2006; 1762:304-11; PMID:16427773; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/77/d8/krnb-14-05-1191735.PMC5449078.pdf
Hum Mol Genet 2009; 18:2014-23; PMID:19293337; http://dx.doi.org/10.1093/hmg/ddp125.,OADS,/arxiv_data1/oa_pdf/77/d8/krnb-14-05-1191735.PMC5449078.pdf
Nat Struct Mol Biol 2009; 16:731- 9; PMID:19525970; http://dx.doi.org/10.1038/nsmb.1625 76.,OADS,/arxiv_data1/oa_pdf/77/d8/krnb-14-05-1191735.PMC5449078.pdf
Mol Cell 2006; 23:389-99; PMID:16885028;http://dx.doi.org/10.1016/j.molcel.2006.05.043 78.,OADS,/arxiv_data1/oa_pdf/77/d8/krnb-14-05-1191735.PMC5449078.pdf
Mutation 2014; 35:308-17; PMID:24302620; http://dx.doi.org/ 10.1002/humu.22481 80.,Non-OADS,/arxiv_data1/oa_pdf/77/d8/krnb-14-05-1191735.PMC5449078.pdf
PLoS One 2012; 7:e45464; PMID:23029027; http://dx.doi.org/10.1371/journal.pone.0045464 81.,Non-OADS,/arxiv_data1/oa_pdf/77/d8/krnb-14-05-1191735.PMC5449078.pdf
HumMutation 2011; 32:E2246-58; PMID:21618346; http://dx.doi.org/ 10.1002/humu.21485 82.,Non-OADS,/arxiv_data1/oa_pdf/77/d8/krnb-14-05-1191735.PMC5449078.pdf
Eur J Biochem 2000; 267:5168-78; PMID:10931201; http://dx.doi.org.10.1046/j.1432- 1327.2000.01585.x 83.,OADS,/arxiv_data1/oa_pdf/77/d8/krnb-14-05-1191735.PMC5449078.pdf
Cell 2015; 161:1474-e1; PMID:26046445; http://dx.doi.org/10.1016/j.cell.2015.05.050 85.,OADS,/arxiv_data1/oa_pdf/77/d8/krnb-14-05-1191735.PMC5449078.pdf
Exp Cell Res 2004; 300:283-96; PMID:15474994; http://dx.doi.org/10.1016/j.yexcr.2004.07.029 86.,OADS,/arxiv_data1/oa_pdf/77/d8/krnb-14-05-1191735.PMC5449078.pdf
Invest Ophthalmol Visual Sci 2006; 47:3052-64;PMID:16799052; http://dx.doi.org/ 10.1167/iovs.05-1443 8 7 .,Non-OADS,/arxiv_data1/oa_pdf/77/d8/krnb-14-05-1191735.PMC5449078.pdf
Nucleic Acids Res 2014; 42:13897-910;PMID:25428373; http://dx.doi.org/10.1093/nar/gku1238.,OADS,/arxiv_data1/oa_pdf/77/d8/krnb-14-05-1191735.PMC5449078.pdf
Curr Opin Cell Biol 2012; 24:431-8;PMID:22464735; http://dx.doi.org/10.1016/j.ceb.2012.03.004.,OADS,/arxiv_data1/oa_pdf/77/d8/krnb-14-05-1191735.PMC5449078.pdf
Nucleic Acids Res 2014; 42:8008-23; PMID:24848011; http://dx.doi.org/10.1093/nar/gku431.,OADS,/arxiv_data1/oa_pdf/77/d8/krnb-14-05-1191735.PMC5449078.pdf
J MedGenetics 2014; 51:444-8; PMID:24737827; http://dx.doi.org/ 10.1136/jmedgenet-2014-102316.,Non-OADS,/arxiv_data1/oa_pdf/77/d8/krnb-14-05-1191735.PMC5449078.pdf
PLoS One 2011; 6:e15860; PMID:21283520;http://dx.doi.org/10.1371/journal.pone.0015860.,Non-OADS,/arxiv_data1/oa_pdf/77/d8/krnb-14-05-1191735.PMC5449078.pdf
PLoS Biol 2007; 5:e90; PMID:17388687; http://dx.doi.org/10.1371/journal.pbio.005009094.,Non-OADS,/arxiv_data1/oa_pdf/77/d8/krnb-14-05-1191735.PMC5449078.pdf
Cell 2012; 151:440-54;PMID:23063131; http://dx.doi.org/10.1016/j.cell.2012.09.012 95.,OADS,/arxiv_data1/oa_pdf/77/d8/krnb-14-05-1191735.PMC5449078.pdf
J Biol Chem 2008; 283:13302-9; PMID:18305110; http://dx.doi.org/10.1074/jbc.M800342200.,OADS,/arxiv_data1/oa_pdf/77/d8/krnb-14-05-1191735.PMC5449078.pdf
Cell 2015; 162:1066-77; PMID:26317470; http://dx.doi.org/10.1016/j.cell.2015.07.047.,OADS,/arxiv_data1/oa_pdf/77/d8/krnb-14-05-1191735.PMC5449078.pdf
Cell Death Dis 2016; 7:e2085; PMID:26844699;http://dx.doi.org/10.1038/cddis.2015.325.,Non-OADS,/arxiv_data1/oa_pdf/77/d8/krnb-14-05-1191735.PMC5449078.pdf
Hum Mol Genet2001; 10:1555-62; PMID:11468273; http://dx.doi.org/10.1093/hmg/10.15.1555 101.,OADS,/arxiv_data1/oa_pdf/77/d8/krnb-14-05-1191735.PMC5449078.pdf
J Medical Genetics 2005; 42:e47; PMID:15994872; http://dx.doi.org/10.1136/jmg.2005.031682 102.,Non-OADS,/arxiv_data1/oa_pdf/77/d8/krnb-14-05-1191735.PMC5449078.pdf
Invest Ophthalmol Visual Sci 2007; 48:1330-4;PMID:17325180; http://dx.doi.org/10.1167/iovs.06-0963 104.,Non-OADS,/arxiv_data1/oa_pdf/77/d8/krnb-14-05-1191735.PMC5449078.pdf
J MedicalGenetics 2008; 45:465-72; PMID:18310263; http://dx.doi.org/ 10.1136/jmg.2007.056416.,Non-OADS,/arxiv_data1/oa_pdf/77/d8/krnb-14-05-1191735.PMC5449078.pdf
Invest Ophthalmol Visual Sci 2010; 51:1036-43; PMID:19710410; http://dx.doi.org/10.1167/iovs.09-3725.552 /C20SR U/C14/C20ZI/C20CKOV /C19A AND D. STAN /C20EK,Non-OADS,/arxiv_data1/oa_pdf/77/d8/krnb-14-05-1191735.PMC5449078.pdf
"5, 553 –567 http://dx.doi.org/10.1080/15476286.2015.1137419",Non-OADS,/arxiv_data1/oa_pdf/cd/dc/krnb-14-05-1137419.PMC5449081.pdf
Mol Cell 2010; 40:228-37; PMID:20965418; http://dx.doi.org/10.1016/j.molcel.2010.09.028 3.,OADS,/arxiv_data1/oa_pdf/cd/dc/krnb-14-05-1137419.PMC5449081.pdf
Nat Rev Mol Cell Biol 2005; 6:318-27; PMID:15803138; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cd/dc/krnb-14-05-1137419.PMC5449081.pdf
Nat Rev Cancer 2010; 10:254-66; PMID:20332778; http://dx.doi.org/10.1038/nrc2824 5.,Non-OADS,/arxiv_data1/oa_pdf/cd/dc/krnb-14-05-1137419.PMC5449081.pdf
Cold Spring Harb Perspect Biol 2013; 1:5-2. pii: a012336; PMID: 22767671; http://dx.doi/ 0.1101/cshperspect.a012336.,Non-OADS,/arxiv_data1/oa_pdf/cd/dc/krnb-14-05-1137419.PMC5449081.pdf
Nature 1988; 334:320-5; PMID:2839775; http://dx.doi.org/10.1038/334320a0 7.,Non-OADS,/arxiv_data1/oa_pdf/cd/dc/krnb-14-05-1137419.PMC5449081.pdf
Nat Cell Biol 1999; 1:190-2; PMID:10559907; http://dx.doi.org/ 10.1038/11109 9.,OADS,/arxiv_data1/oa_pdf/cd/dc/krnb-14-05-1137419.PMC5449081.pdf
Nucleic Acids Res 2007; 35:4664-77; PMID:17591613; http://dx.doi.org/10.1093/nar/gkm483 10.,OADS,/arxiv_data1/oa_pdf/cd/dc/krnb-14-05-1137419.PMC5449081.pdf
Mol Cell Biol 2012; 32:1818-29; PMID:22431522;http://dx.doi.org/10.1128/MCB.06317-11 11.,Non-OADS,/arxiv_data1/oa_pdf/cd/dc/krnb-14-05-1137419.PMC5449081.pdf
Mol Cell Biol 2000; 20:4648-57; PMID:10848591; http://dx.doi.org/10.1128/MCB.20.13.4648-4657.2000 12.,Non-OADS,/arxiv_data1/oa_pdf/cd/dc/krnb-14-05-1137419.PMC5449081.pdf
Mol Cell Biol 2003; 23:280-8; PMID:12482981; http://dx.doi.org/10.1128/ MCB.23.1.280-288.2003 13.,Non-OADS,/arxiv_data1/oa_pdf/cd/dc/krnb-14-05-1137419.PMC5449081.pdf
Mol Biol Cell 2007; 18:1302-11; PMID:17287399; http://dx.doi.org/10.1091/mbc.E06-06-0515 14.,Non-OADS,/arxiv_data1/oa_pdf/cd/dc/krnb-14-05-1137419.PMC5449081.pdf
Nucleic Acids Res 2012; 40:541-52; PMID:21917851; http://dx.doi.org/10.1093/nar/gkr701 16.,Non-OADS,/arxiv_data1/oa_pdf/cd/dc/krnb-14-05-1137419.PMC5449081.pdf
104; PMID:17913620; http://dx.doi.org/10.1016/S0076-6879(07) 29005-6 17.,OADS,/arxiv_data1/oa_pdf/cd/dc/krnb-14-05-1137419.PMC5449081.pdf
Cell Death Differ 2010; 17:719-29; PMID:19893574; http://dx.doi.org/10.1038/cdd.2009.164 18.,Non-OADS,/arxiv_data1/oa_pdf/cd/dc/krnb-14-05-1137419.PMC5449081.pdf
Mol Cell Biol 2013; 33:307-18; PMID:23129811;http://dx.doi.org/10.1128/MCB.00546-12 19.,Non-OADS,/arxiv_data1/oa_pdf/cd/dc/krnb-14-05-1137419.PMC5449081.pdf
Nat Protoc 2006; 1:1610-6;PMID:17406453; http://dx.doi.org/10.1038/nprot.2006.249 20.,Non-OADS,/arxiv_data1/oa_pdf/cd/dc/krnb-14-05-1137419.PMC5449081.pdf
J Mol Biol 2002; 324:889- 902; PMID:12470947; http://dx.doi.org/10.1016/S0022-2836(02)01099-9 24.,OADS,/arxiv_data1/oa_pdf/cd/dc/krnb-14-05-1137419.PMC5449081.pdf
J Mol Biol 2009; 387:42-58; Epub 2009 Jan 1029;PMID:19361441; http://dx.doi.org/10.1016/j.jmb.2009.01.042 25.,OADS,/arxiv_data1/oa_pdf/cd/dc/krnb-14-05-1137419.PMC5449081.pdf
"Riley A, Jordan LE, Holcik M. Distinct 5 0UTRs regulate XIAP expres- sion under normal growth conditions and during cellular stress.Nucleic Acids Res 2010; 38:4665-74; PMID:20385593; http://dx.doi.org/10.1093/nar/gkq241 26.",OADS,/arxiv_data1/oa_pdf/cd/dc/krnb-14-05-1137419.PMC5449081.pdf
Nucleic Acids Res 2010; 38: e15; Epub 2009 Nov 1012; PMID:19910372; http://dx.doi.org/ 10.1093/nar/gkp1025 27.,OADS,/arxiv_data1/oa_pdf/cd/dc/krnb-14-05-1137419.PMC5449081.pdf
RNA 2005; 11:1605-9; PMID:16177136; http://dx.doi.org/10.1261/rna.2158605 28.,OADS,/arxiv_data1/oa_pdf/cd/dc/krnb-14-05-1137419.PMC5449081.pdf
Genes Dev 2001; 15:1593-612; PMID:11445534; http://dx.doi.org/10.1101/gad.891101 29.,Non-OADS,/arxiv_data1/oa_pdf/cd/dc/krnb-14-05-1137419.PMC5449081.pdf
Mol Cell 2004; 15:925-35; PMID:15383282; http://dx.doi.org/10.1016/j.molcel.2004.08.021 32.,OADS,/arxiv_data1/oa_pdf/cd/dc/krnb-14-05-1137419.PMC5449081.pdf
Nucleic Acids Res2008; 36:168-78; PMID:18003655; http://dx.doi.org/10.1093/nar/ gkm1007 34.,OADS,/arxiv_data1/oa_pdf/cd/dc/krnb-14-05-1137419.PMC5449081.pdf
Nat Cell Biol 2009; 11:903-8; PMID:19525934; http://dx.doi.org/10.1038/ncb1900 36.,OADS,/arxiv_data1/oa_pdf/cd/dc/krnb-14-05-1137419.PMC5449081.pdf
Mol Cell 2007; 28:501-12; PMID:17996713; http://dx.doi.org/10.1016/j.molcel.2007.10.019 37.,OADS,/arxiv_data1/oa_pdf/cd/dc/krnb-14-05-1137419.PMC5449081.pdf
EMBO J 2009; 28:58-68; Epub 2008 Dec 1011; PMID:19078965; http://dx.doi.org/10.1038/emboj.2008.259 38.,Non-OADS,/arxiv_data1/oa_pdf/cd/dc/krnb-14-05-1137419.PMC5449081.pdf
Nat Rev Mol Cell Biol 2001; 2:550-6; PMID:11433370; http://dx.doi.org/10.1038/ 35080103 39.,OADS,/arxiv_data1/oa_pdf/cd/dc/krnb-14-05-1137419.PMC5449081.pdf
Oncogene 2000; 19:4174-7; PMID:10962579; http://dx.doi.org/10.1038/sj.onc.1203765 40.,OADS,/arxiv_data1/oa_pdf/cd/dc/krnb-14-05-1137419.PMC5449081.pdf
Oncogene 2011; 30:1460-9; PMID:21102524; http://dx.doi.org/10.1038/onc.2010.527 41.,Non-OADS,/arxiv_data1/oa_pdf/cd/dc/krnb-14-05-1137419.PMC5449081.pdf
J Biol Chem 2010; 285:17098-111; PMID:20338999; http://dx.doi.org/10.1074/jbc.M110.109439 42.,OADS,/arxiv_data1/oa_pdf/cd/dc/krnb-14-05-1137419.PMC5449081.pdf
Science 2006; 312:902-6; PMID:16690864; http://dx.doi.org/10.1126/science.1123835 43.,OADS,/arxiv_data1/oa_pdf/cd/dc/krnb-14-05-1137419.PMC5449081.pdf
Can-cer Cell 2009; 15:363-75; PMID:19411066; http://dx.doi.org/10.1016/j.ccr.2009.03.002 44.,OADS,/arxiv_data1/oa_pdf/cd/dc/krnb-14-05-1137419.PMC5449081.pdf
Curr Opin Struct Biol 2009; 19:267-76; Epub 2009 Apr 1019;PMID:19362464; http://dx.doi.org/10.1016/j.sbi.2009.03.005 45.,OADS,/arxiv_data1/oa_pdf/cd/dc/krnb-14-05-1137419.PMC5449081.pdf
J Mol Biol 1999; 292:513-29; PMID:10497018; http://dx.doi.org/10.1006/jmbi.1999.3095 46.,Non-OADS,/arxiv_data1/oa_pdf/cd/dc/krnb-14-05-1137419.PMC5449081.pdf
J Biol Chem 2001; 276:41648-55;PMID:11498532; http://dx.doi.org/10.1074/jbc.M104128200 47.,OADS,/arxiv_data1/oa_pdf/cd/dc/krnb-14-05-1137419.PMC5449081.pdf
Cell 2003; 113:519-31; PMID:12757712; http://dx.doi.org/10.1016/ S0092-8674(03)00345-3 51.,OADS,/arxiv_data1/oa_pdf/cd/dc/krnb-14-05-1137419.PMC5449081.pdf
MolCell 2003; 11:757-71; PMID:12667457; http://dx.doi.org/10.1016/S1097-2765(03)00093-5 52.,OADS,/arxiv_data1/oa_pdf/cd/dc/krnb-14-05-1137419.PMC5449081.pdf
RNA 2004;10:287-98; PMID:14730027; http://dx.doi.org/10.1261/rna.5138804 53.,OADS,/arxiv_data1/oa_pdf/cd/dc/krnb-14-05-1137419.PMC5449081.pdf
J Biol Chem 2003;278:39330-6; Epub 32003 Jul 39311; PMID:12857733; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cd/dc/krnb-14-05-1137419.PMC5449081.pdf
Mol Cell Biol 2004; 24:7622-35; PMID:15314170;http://dx.doi.org/10.1128/MCB.24.17.7622-7635.2004 55.,Non-OADS,/arxiv_data1/oa_pdf/cd/dc/krnb-14-05-1137419.PMC5449081.pdf
J Mol Biol 2001; 310:111-26; PMID:11419940; http://dx.doi.org/10.1006/jmbi.2001.4745 56.,Non-OADS,/arxiv_data1/oa_pdf/cd/dc/krnb-14-05-1137419.PMC5449081.pdf
Mol Cell Biol 2004; 24:5595-605; PMID:15169918; http://dx.doi.org/10.1128/MCB.24.12.5595- 5605.2004 57.,Non-OADS,/arxiv_data1/oa_pdf/cd/dc/krnb-14-05-1137419.PMC5449081.pdf
J Virol 2011; 85:4452-61; Epub 02011 Feb 01116; PMID:21325406;http://dx.doi.org/10.1128/JVI.01107-10 58.,Non-OADS,/arxiv_data1/oa_pdf/cd/dc/krnb-14-05-1137419.PMC5449081.pdf
Biochim Biophys Acta 2009;1789:542-57; Epub 2009 Jul 1024; PMID:19632368; http://dx.doi.org/10.1016/j.bbagrm.2009.07.00560.,OADS,/arxiv_data1/oa_pdf/cd/dc/krnb-14-05-1137419.PMC5449081.pdf
RNA 2002; 8:1558-71; PMID:12515388 http://dx.doi.org/10-1017/S135583820202303 61.,OADS,/arxiv_data1/oa_pdf/cd/dc/krnb-14-05-1137419.PMC5449081.pdf
J Virol 2000; 74:10430-7; PMID: 11044087; http://dx.doi.org/10.1128/JVI.74.22.10430-10437.2000 62.,Non-OADS,/arxiv_data1/oa_pdf/cd/dc/krnb-14-05-1137419.PMC5449081.pdf
"Translation 2013; 1, e24400; http://dx.doi.org/10.4161/ trla.24400 63.",Non-OADS,/arxiv_data1/oa_pdf/cd/dc/krnb-14-05-1137419.PMC5449081.pdf
Nature 2014; 505:696-700; Epub 12013 Nov 12724; PMID:24270811; http://dx.doi.org/10.1038/nature12756 64.,Non-OADS,/arxiv_data1/oa_pdf/cd/dc/krnb-14-05-1137419.PMC5449081.pdf
Gene 2012; 502:75-86; PMID:22555019; http://dx.doi.org/10.1016/j.gene.2012.04.039 65.,OADS,/arxiv_data1/oa_pdf/cd/dc/krnb-14-05-1137419.PMC5449081.pdf
Cell Cycle 2011; 10:229-40; PMID:21220943; http://dx.doi.org/10.4161/cc.10.2.14472 66.,OADS,/arxiv_data1/oa_pdf/cd/dc/krnb-14-05-1137419.PMC5449081.pdf
Nature 2013; 503:539-43; Epub 12013 Nov 12653; PMID:24185006; http://dx.doi.org/10.1038/nature12658 67.,Non-OADS,/arxiv_data1/oa_pdf/cd/dc/krnb-14-05-1137419.PMC5449081.pdf
Cold Spring Harb Symp Quant Biol 2006; 71:537-43; PMID:17381337; http://dx.doi.org/10.1101/sqb.2006.71.061 69.,OADS,/arxiv_data1/oa_pdf/cd/dc/krnb-14-05-1137419.PMC5449081.pdf
Mol Cell Biol 2008; 28:6658-67;Epub 02008 Aug 00725; PMID:18725400; http://dx.doi.org/ 10.1128/MCB.00738-08 70.,Non-OADS,/arxiv_data1/oa_pdf/cd/dc/krnb-14-05-1137419.PMC5449081.pdf
Mol Cell Biol 2014; 34:1046-53; Epub02014 Jan 01076; PMID:24396066; http://dx.doi.org/10.1128/MCB.01079-13RNA BIOLOGY 567,Non-OADS,/arxiv_data1/oa_pdf/cd/dc/krnb-14-05-1137419.PMC5449081.pdf
"Published with license by Taylor & Francis Group, LLC © John R. Bracht, Xing Wang, Keerthi Shetty, Xiao Chen, Grace J. Uttarotai, Evan C. Callihan, Sier ra S. McCloud, Derek M. Clay, Jingmei Wang, Mariusz Nowacki, and Laura F. LandweberThis is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which permits unre- stricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5f/71/krnb-14-05-1195940.PMC5449082.pdf
"5, 620 –631 http://dx.doi.org/10.1080/15476286.2016.1195940",Non-OADS,/arxiv_data1/oa_pdf/5f/71/krnb-14-05-1195940.PMC5449082.pdf
"Availability of supporting data Small RNA sequences have been deposited in Gene Expression Omnibus (GEO: www.ncbi.nlm.nih.gov/geo/) under accessionnumber (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc D GSE78993), and germline DNA sequences have been deposited to GenBank (http://www.ncbi.nlm.nih.gov/genbank/) under accession number (ARYC00000000); data also available on theOxytricha trifallax genome database (oxy.ciliate.org).",OADS,/arxiv_data1/oa_pdf/5f/71/krnb-14-05-1195940.PMC5449082.pdf
The contig sequences used in this manuscript are given at http://trifallax.princeton.edu/cms/raw-data/genome/mic/chromosome_fusion_mic_loci.fa; the annotated MIC-MAC maps for thesesequences are available at: http://trifallax.princeton.edu/cms/raw-data/genome/mic/chromosome_fusion_mic_loci.gff.,Non-OADS,/arxiv_data1/oa_pdf/5f/71/krnb-14-05-1195940.PMC5449082.pdf
MAC chromosome data and annotations available at http://oxy.cili ate.org Disclosure of potential con ﬂicts of interest No potential con ﬂicts of interest were disclosed.,OADS,/arxiv_data1/oa_pdf/5f/71/krnb-14-05-1195940.PMC5449082.pdf
Cancer Genet 2011; 204:351-65; PMID:21872822; http://dx.doi.org/10.1016/j.cancergen.2011.07.008 2.,Non-OADS,/arxiv_data1/oa_pdf/5f/71/krnb-14-05-1195940.PMC5449082.pdf
Nat Rev Cancer 2007; 7:233-45;PMID:17361217; http://dx.doi.org/10.1038/nrc2091 3.,Non-OADS,/arxiv_data1/oa_pdf/5f/71/krnb-14-05-1195940.PMC5449082.pdf
Nature 1990; 344:251-3; PMID:2179728; http://dx.doi.org/10.1038/344251a0 4.,Non-OADS,/arxiv_data1/oa_pdf/5f/71/krnb-14-05-1195940.PMC5449082.pdf
Nature 1985; 318:533-8; PMID:3906410; http://dx.doi.org/10.1038/318533a0 5.,Non-OADS,/arxiv_data1/oa_pdf/5f/71/krnb-14-05-1195940.PMC5449082.pdf
Science 1990; 247:824-30; PMID:2406902; http://dx.doi.org/10.1126/science.2406902 6.,Non-OADS,/arxiv_data1/oa_pdf/5f/71/krnb-14-05-1195940.PMC5449082.pdf
2013; http://cgap.nci.,Non-OADS,/arxiv_data1/oa_pdf/5f/71/krnb-14-05-1195940.PMC5449082.pdf
Sci- ence 2008; 321:1302-4; PMID:18772424; http://dx.doi.org/10.1126/science.1163791 10.,OADS,/arxiv_data1/oa_pdf/5f/71/krnb-14-05-1195940.PMC5449082.pdf
Science 2008; 321:1357-61;PMID:18772439; http://dx.doi.org/10.1126/science.1156725 11.,Non-OADS,/arxiv_data1/oa_pdf/5f/71/krnb-14-05-1195940.PMC5449082.pdf
Nature Com-munications 2014; 5:3964; PMID:24888982; http://dx.doi.org/ 10.1038/ncomms4964 12.,Non-OADS,/arxiv_data1/oa_pdf/5f/71/krnb-14-05-1195940.PMC5449082.pdf
Nature 2014; 516:423-7; PMID:25337876; http://dx.doi.org/10.1038/nature13902 13.,Non-OADS,/arxiv_data1/oa_pdf/5f/71/krnb-14-05-1195940.PMC5449082.pdf
Cell 2012; 149:101-12; PMID:22445173; http://dx.doi.org/10.1016/j.cell.2012.03.002 14.,OADS,/arxiv_data1/oa_pdf/5f/71/krnb-14-05-1195940.PMC5449082.pdf
Nature2012; 488:231-5; PMID:22722852; http://dx.doi.org/10.1038/nature11179 15.,Non-OADS,/arxiv_data1/oa_pdf/5f/71/krnb-14-05-1195940.PMC5449082.pdf
Cancer Genetics Cytogenetics 1982; 5:81-94; PMID:6175392; http://dx.doi.org/ 10.1016/0165-4608(82)90043-7 17.,Non-OADS,/arxiv_data1/oa_pdf/5f/71/krnb-14-05-1195940.PMC5449082.pdf
Nature 2008; 451:153-8; PMID:18046331; http://dx.doi.org/10.1038/nature06452 19.,Non-OADS,/arxiv_data1/oa_pdf/5f/71/krnb-14-05-1195940.PMC5449082.pdf
PLoS ONE 2012; 7:e42371; PMID:22900016; http://dx.doi.org/10.1371/ journal.pone.0042371 21.,Non-OADS,/arxiv_data1/oa_pdf/5f/71/krnb-14-05-1195940.PMC5449082.pdf
Genes Dev 2008; 22:1501-12; PMID:18519642; http://dx.doi.org/10.1101/gad.473008 22.,Non-OADS,/arxiv_data1/oa_pdf/5f/71/krnb-14-05-1195940.PMC5449082.pdf
Nucleic Acids Res 2009; 37:903-15; PMID:19103667; http://dx.doi.org/10.1093/nar/gkn1018 23.,Non-OADS,/arxiv_data1/oa_pdf/5f/71/krnb-14-05-1195940.PMC5449082.pdf
Cell 2002; 110:689-99; PMID:12297043; http://dx.doi.org/ 10.1016/S0092-8674(02)00909-1 26.,OADS,/arxiv_data1/oa_pdf/5f/71/krnb-14-05-1195940.PMC5449082.pdf
PLoS Biol 2013; 11:e1001473; PMID:23382650; http://dx.doi.org/10.1371/journal.pbio.1001473 27.,Non-OADS,/arxiv_data1/oa_pdf/5f/71/krnb-14-05-1195940.PMC5449082.pdf
Cell 2014; 158:1187-98; PMID: 25171416; http://dx.doi.org/10.1016/j.cell.2014.07.034 28.,OADS,/arxiv_data1/oa_pdf/5f/71/krnb-14-05-1195940.PMC5449082.pdf
Annual Rev Genomics Hum Genetics 2011; 12:367-89; PMID:21801022; http://dx.doi.org/10.1146/annurev-genom-082410-101420 29.,OADS,/arxiv_data1/oa_pdf/5f/71/krnb-14-05-1195940.PMC5449082.pdf
Proc NatlAcad Sci U S A 2013; 110:7720-5; PMID:23610439; http://dx.doi.org/ 10.1073/pnas.1213431110 30.,OADS,/arxiv_data1/oa_pdf/5f/71/krnb-14-05-1195940.PMC5449082.pdf
PLoS ONE 2008; 3:e2330; PMID:18523559; http://dx.doi.org/10.1371/journal.pone.0002330 31.,Non-OADS,/arxiv_data1/oa_pdf/5f/71/krnb-14-05-1195940.PMC5449082.pdf
Chromosoma 1974; 45:401-29; PMID:4209692; http://dx.doi.org/ 10.1007/BF00283386 32.,Non-OADS,/arxiv_data1/oa_pdf/5f/71/krnb-14-05-1195940.PMC5449082.pdf
"Nature 1973; 242:576, 597 –600; PMID:4621095; http://dx.doi.org/ 10.1038/242576a0 34.",Non-OADS,/arxiv_data1/oa_pdf/5f/71/krnb-14-05-1195940.PMC5449082.pdf
Mol Cell 2008; 31:785-99; PMID:18922463; http://dx.doi.org/10.1016/j.molcel.2008.09.003 36.,OADS,/arxiv_data1/oa_pdf/5f/71/krnb-14-05-1195940.PMC5449082.pdf
Science 2011; 332:848-52; PMID:21566194; http://dx.doi.org/10.1126/science.1203919 37.,Non-OADS,/arxiv_data1/oa_pdf/5f/71/krnb-14-05-1195940.PMC5449082.pdf
Sci- ence 2004; 303:669-72; PMID:14752161; http://dx.doi.org/10.1126/ science.1092653 38.,OADS,/arxiv_data1/oa_pdf/5f/71/krnb-14-05-1195940.PMC5449082.pdf
Nature 2007; 450:304-8; PMID:17952056; http://dx.doi.org/10.1038/nature06263 39.,OADS,/arxiv_data1/oa_pdf/5f/71/krnb-14-05-1195940.PMC5449082.pdf
Genome Biol 2012; 13:R99; PMID:23075511; http://dx.doi.org/ 10.1186/gb-2012-13-10-r99 40.,OADS,/arxiv_data1/oa_pdf/5f/71/krnb-14-05-1195940.PMC5449082.pdf
Cell 2013; 152:406-16; PMID:23374338; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/5f/71/krnb-14-05-1195940.PMC5449082.pdf
Cell 1987; 48:779-88; PMID:3815524; http://dx.doi.org/ 10.1016/0092-8674(87)90075-4 42.,OADS,/arxiv_data1/oa_pdf/5f/71/krnb-14-05-1195940.PMC5449082.pdf
Nucleic Acids Res 1998; 26:4230-40; PMID:9722644; http://dx.doi.org/10.1093/nar/26.18.4230 43.,OADS,/arxiv_data1/oa_pdf/5f/71/krnb-14-05-1195940.PMC5449082.pdf
Protist2004; 155:311-22; PMID:15552058; http://dx.doi.org/10.1078/ 1434461041844196 44.,Non-OADS,/arxiv_data1/oa_pdf/5f/71/krnb-14-05-1195940.PMC5449082.pdf
BMC Genetics 2002; 3:16; PMID:12199911; http://dx.doi.org/10.1186/1471-2156-3-16 45.,Non-OADS,/arxiv_data1/oa_pdf/5f/71/krnb-14-05-1195940.PMC5449082.pdf
Genes Dev 2009; 23:2478-83; PMID:19884254; http://dx.doi.org/10.1101/gad.547309 46.,OADS,/arxiv_data1/oa_pdf/5f/71/krnb-14-05-1195940.PMC5449082.pdf
Mol Biol Cell 2010; 21:1753-62; PMID:20357003; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5f/71/krnb-14-05-1195940.PMC5449082.pdf
Science 2009; 324:935-8; PMID:19372392; http://dx.doi.org/10.1126/science.1170023 48.,Non-OADS,/arxiv_data1/oa_pdf/5f/71/krnb-14-05-1195940.PMC5449082.pdf
Annual Rev Biochem 2015; 84:405-33;PMID:25747396;http://dx.doi.org/10.1146/annurev-biochem-060614-034258 49.,Non-OADS,/arxiv_data1/oa_pdf/5f/71/krnb-14-05-1195940.PMC5449082.pdf
"Lee JH, Schutte D, Wulf G, Fuzesi L, Radzun HJ, Schweyer S, Engel W, Nayernia K. Stem-cell protein Piwil2 is widely expressed in tumorsand inhibits apoptosis through activation of Stat3/Bcl-XL pathway.Hum Mol Genet 2006; 15:201-11; PMID:16377660; http://dx.doi.org/ 10.1093/hmg/ddi430 50.",OADS,/arxiv_data1/oa_pdf/5f/71/krnb-14-05-1195940.PMC5449082.pdf
Oncogene 2002; 21:3988- 99; PMID:12037681; http://dx.doi.org/10.1038/sj.onc.1205505 51.,OADS,/arxiv_data1/oa_pdf/5f/71/krnb-14-05-1195940.PMC5449082.pdf
Front Genet 2012; 3:204; PMID:23087701; http://dx.doi.org/ 10.3389/fgene.2012.00204 53.,OADS,/arxiv_data1/oa_pdf/5f/71/krnb-14-05-1195940.PMC5449082.pdf
Clin Transl Oncol 2013; 15:563-8; PMID: 23229900; http://dx.doi.org/10.1007/s12094-012-0966-0 5 4 .,Non-OADS,/arxiv_data1/oa_pdf/5f/71/krnb-14-05-1195940.PMC5449082.pdf
Cancer Lett 2012; 315:12-7; PMID:22047710; http://dx.doi.org/10.1016/j.canlet.2011.10.004 55.,Non-OADS,/arxiv_data1/oa_pdf/5f/71/krnb-14-05-1195940.PMC5449082.pdf
Leukemia 2015; 29:196-206; PMID:24732595; http://dx.doi.org/10.1038/leu.2014.135 56.,Non-OADS,/arxiv_data1/oa_pdf/5f/71/krnb-14-05-1195940.PMC5449082.pdf
Bio Essays 2013; 35:84-7; PMID:23281134;http://dx.doi.org/10.1002/bies.201200140 57.,Non-OADS,/arxiv_data1/oa_pdf/5f/71/krnb-14-05-1195940.PMC5449082.pdf
Cell 2016; 165:289-302; PMID:27040497; http://dx.doi.org/10.1016/j.cell.2016.03.020 58.,OADS,/arxiv_data1/oa_pdf/5f/71/krnb-14-05-1195940.PMC5449082.pdf
Nat Rev Genetics 2010;11:204-20; PMID:20142834; http://dx.doi.org/10.1038/nrg2719 60.,OADS,/arxiv_data1/oa_pdf/5f/71/krnb-14-05-1195940.PMC5449082.pdf
Mol Cell 2015; 59:229-42; PMID:26095658; http://dx.doi.org/10.1016/j.molcel.2015.05.024 61.,OADS,/arxiv_data1/oa_pdf/5f/71/krnb-14-05-1195940.PMC5449082.pdf
Genes Dev 2012; 26:1729-42; PMID:22855833; http://dx.doi.org/10.1101/ gad.196493.112 6 2 .,OADS,/arxiv_data1/oa_pdf/5f/71/krnb-14-05-1195940.PMC5449082.pdf
PLoS Comput Biol 2009; 5:e1000386; http://dx.doi.org/10.1371/journal.,OADS,/arxiv_data1/oa_pdf/5f/71/krnb-14-05-1195940.PMC5449082.pdf
"5, 651 –668 http://dx.doi.org/10.1080/15476286.2016.1208323",Non-OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Curr Opin Genet Dev 2014; 26:47-52; PMID:25005745; http://dx.doi.org/ 10.1016/j.gde.2014.05.006 2.,OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Nat Rev Genet 2012; 13:246-59; PMID:22392217; http://dx.doi.org/10.1038/nrg3254 3.,OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
J Cell Biol 2016; 212:13-27; PMID:26728853;http://dx.doi.org/10.1083/jcb.201510032 4.,OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Nat Rev Genet 2007; 8:711-23; PMID:17680008; http://dx.doi.org/10.1038/nrg2142 5.,OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Cell Death Dis 2013; 4:e752; PMID:23907466; http://dx.doi.org/10.1038/cddis.2013.276 6.,Non-OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Annu Rev Pharmacol Toxicol 2010; 50:259-93; PMID:20055705;http://dx.doi.org/10.1146/annurev.pharmtox.010909.105654 7.,Non-OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Expert Opin Drug Metab Toxicol 2009; 5:381-91; PMID:19379126; http://dx.doi.org/10.1517/17425250902877680 9.,Non-OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
"Gene Therapy in Lung Disease CRC Press,2002; 383 –396; http://dx.doi.org/10.3109/9780203908822-18 11.",Non-OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Nat Med 2015; 21:492-7; PMID:25849132; http://dx.doi.org/10.1038/nm.3847 12.,Non-OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Nature 1998; 391:806-11; PMID:9486653; http://dx.doi.org/10.1038/35888 13.,Non-OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
J Biol Chem 2004; 279:17181-9; PMID:14960586; http://dx.doi.org/10.1074/jbc.M311683200 14.,OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Am J Ophthalmol 2002; 133:467-74; PMID:11931780; http://dx.doi.org/10.1016/S0002-9394(02)01327-2 15.,Non-OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Am J Ophthalmol 2002; 133:475-83; PMID:11931781; http://dx.doi.org/10.1016/S0002-9394(02)01326-0 16.,Non-OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Am J Oph-thalmol 2002; 133:484-98; PMID:11931782; http://dx.doi.org/ 10.1016/S0002-9394(02)01332-617.,OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
United European Gas-troenterol J 2016; 4:97-104; PMID:26966529; http://dx.doi.org/ 10.1177/2050640615593681 18.,Non-OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Invest Ophthalmol Vis Sci 2012; 53:1195-203; PMID:22323484; http://dx.doi.org/10.1167/iovs.11-9064 20.,Non-OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Aganirsen antisense oligonucleotide eye drops inhibit keratitis-induced corneal neovascu- larization and reduce need for transplantation: the I-CAN study.Ophthalmology 2014; 121:1683-92; PMID:24811963; http://dx.doi.org/10.1016/j.ophtha.2014.03.038 21.,Non-OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
( http://strong-nvg.com/the-study/ ).,Non-OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Antitumor activity of a novel antisense oligonucleotide against Akt1.J Cell Biochem 2009; 108:832-8; PMID:19693774; http://dx.doi.org/10.1002/jcb.22311 24.,Non-OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Nat Struct Mol Biol 1999; 6:535-9; PMID:10360355; http://dx.doi.org/10.1038/9304.,OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
The Lancet 2010; 375:998-1006; http://dx.doi.org/10.1016/S0140-6736(10)60284-X 30.,Non-OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Circulation 2012; 126:2283-92; PMID:23060426;http://dx.doi.org/10.1161/CIRCULATIONAHA.112.104125 31.,Non-OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Eur Heart J 2015; 36:566-75; PMID:24366918; http://dx.doi.org/10.1093/eurheartj/eht549 3 2 .,Non-OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Amyloid 2012; 19:43-4; PMID:22494066; http://dx.doi.org/10.3109/13506129.2012.673140 33.,Non-OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
( http://ir.isispharm.com/phoe nix.zhtml?c D222170&p Dirol-newsArticle&ID2105651 ).,Non-OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
( http://ir.oncogenex.com/releasedetail.,Non-OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
J Thorac Oncol 2012; 7:579-86;PMID:22198426; http://dx.doi.org/10.1097/JTO.0b013e31823f459c 40.,Non-OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
J Org Chem 2010; 75:1569-81; PMID:20136157; http://dx.doi.org/10.1021/jo902560f 42.,OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Sci Translat Med 2015; 7:314ra185-314ra185; http://dx.doi.org/10.1126/scitranslmed.aac5272 43.,OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
J Am Chem Soc 2014;136:16958-61; PMID:25434769; http://dx.doi.org/10.1021/ja505986a 49.,OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Nucleic Acids Res 2014;42:8796-807; PMID:24992960; http://dx.doi.org/10.1093/nar/gku531 50.,OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
( http://ir.isispharm.com/phoe nix.zhtml?c D222170&p Dirol-newsArticle&ID D2110180 ) 2015 51.,Non-OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Cell 1987; 51:919-28; PMID:3319190; http://dx.doi.org/10.1016/0092-8674(87)90579-4 53.,OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Lancet Neurol 2014; 13:987-96; PMID:25209738;http://dx.doi.org/10.1016/S1474-4422(14)70195-4 56.,Non-OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Ann Neurol 2013; 74:637-47; PMID:23907995; http://dx.doi.org/10.1002/ana.23982 59.,OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
( http://www.fda.gov/downloads/Advisory Committees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM473737.pdf ).,Non-OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Neuromuscular Disorders 2015; 25:S261-S2; http://dx.doi.org/ 10.1016/j.nmd.2015.06.276 62.,Non-OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
( https://www.nippon-shinyaku.co.,Non-OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Biol Pharm Bull 2004;27:453-6; PMID:15056846; http://dx.doi.org/10.1248/bpb.27.453 64.,Non-OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
( http://www.daiichisankyo.com/ media_investors/media_relations/press_releases/detail/006412/ 160225_635_E.pdf ).,Non-OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Cell 1995; 80:155-65; PMID:7813012; http://dx.doi.org/10.1016/ 0092-8674(95)90460-3 67.,OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Am J Hum Genet 2008; 82:834- 48; PMID:18371932; http://dx.doi.org/10.1016/j.ajhg.2008.01.014 69.,OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
( http://ir.ionispharma.com/phoenix.zhtml?,Non-OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Hum Gene Ther 2014; 25:587-98; PMID:24826963; http://dx.doi.org/10.1089/hum.2013.234 73.,OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Nat Rev Drug Discov 2010; 9:537-50; PMID:20592747; http://dx.doi.org/ 10.1038/nrd3141RNA BIOLOGY 663,OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Annu Rev Pharmacol Toxicol2010; 50:237-57; PMID:20055704; http://dx.doi.org/10.1146/annurev.pharmtox.010909.105547 75.,Non-OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
J Biol Chem 1998; 273:20556-67;PMID:9685413; http://dx.doi.org/10.1074/jbc.273.32.20556 76.,OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Nat Rev Drug Discov 2006; 5:123-32; PMID:16518379;http://dx.doi.org/10.1038/nrd1955 77.,OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Drug Discovery Today 2015; 20:147-55; PMID:25236655; http://dx.doi.org/10.1016/j.drudis.2014.09.004 85.,Non-OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
"J Am Chem Soc 1992; 114:9731-6; http://dx.doi.org/10.1021/ja00051a001 86. van Eijk LT, John AS, Schwoebel F, Summo L, Vaul /C19eon S, Z€ollner S, Laarakkers CM, Kox M, van der Hoeven JG, Swinkels DW, et al.",OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Blood 2014; 124:2643-6; PMID:25163699; http://dx.doi.org/10.1182/ blood-2014-03-559484 87.,Non-OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Cell Rep 2014; 9:118-28; PMID:25263552; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Nat Commun 2015; 6:6923; PMID:25901662; http://dx.doi.org/10.1038/ncomms792391.,OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Proc Natl Acad Sci US A 2008; 105:512-7; PMID:18178619; http://dx.doi.org/10.1073/ pnas.0710869105 94.,OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Nature 2001; 411:494-8; PMID:11373684; http://dx.doi.org/10.1038/35078107 96.,Non-OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Mech Dev 2002; 118:57-63; PMID:12351170; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Nat Med 2014; 20:109; PMID:24504395; http://dx.doi.org/10.1038/nm0214-109 99.,OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Trends Biotechnol 2015; 33:141-4; PMID:25595555; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Mol Ther 2011; 19:1001-2; PMID:21629254; http://dx.doi.org/10.1038/mt.2011.94 107.,OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
N Engl JMed 2013; 369:819-29; PMID:23984729; http://dx.doi.org/ 10.1056/NEJMoa1208760 108.,OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
"Lancet 2014; 383:60-8; PMID:24094767; http://dx.doi.org/10.1016/S0140- 6736(13)61914-5 109. van de Water FM, Boerman OC, Wouterse AC, Peters JG, Russel FG, Masereeuw R. Intravenously administered short interfering RNA accumulates in the kidney and selectively suppresses gene function664 P. REAUTSCHNIG ET AL.",OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Drug Metab Dispos 2006; 34:1393-7; PMID:16714375; http://dx.doi.org/10.1124/dmd.106.009555 110.,Non-OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
J Control Release 2015; 203:1-15; PMID:25660205; http://dx.doi.org/10.1016/j.jconrel.2015.02.003 112.,OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Adv Drug Deliv Rev 2016; 107:29-43; PMID:26494399; http://dx.doi.org/10.1016/j.addr.2015.10.008 113.,Non-OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Methods Mol Biol 2013; 942:87-109; PMID:23027047; http://dx.doi.org/10.1007/978-1-62703-119-6_5 114.,OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Annu Rev Pharmacol Toxicol 2016; 56:103-22; PMID:26738473; http://dx.doi.org/10.1146/annurev-pharmtox-010715-103633 124.,Non-OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Mol Ther Nucleic Acids 2015; 4:e252; PMID:26372022; http://dx.doi.org/10.1038/mtna.2015.23 125.,Non-OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
J Microbiol 2014; 52:445-51; PMID:24871972; http://dx.doi.org/10.1007/s12275-014-4267-x 127.,Non-OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Science 1990; 247:1465-8; PMID:1690918; http://dx.doi.org/10.1126/science.1690918 130.,Non-OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Science 1992; 255:996-8; PMID:1546298;http://dx.doi.org/10.1126/science.1546298 131.,OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Expert Rev Vaccines 2015; 14:265-81; PMID:25359562; http://dx.doi.org/10.1586/14760584.2015.973859 133.,Non-OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Nature 2001; 413:732-8; PMID:11607032; http://dx.doi.org/10.1038/35099560 134.,Non-OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
NucleicAcids Res 2010; 38:5884-92; PMID:20457754; http://dx.doi.org/ 10.1093/nar/gkq347 135.,OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Mol Ther 2008; 16:1833-40; PMID:18797453; http://dx.doi.org/10.1038/mt.2008.200 136.,Non-OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Immunity 2013; 38:855-69; PMID:23706667; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Immunity 2005; 23:165-75; PMID:16111635; http://dx.doi.org/10.1016/j.immuni.2005.06.008 138.,OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Nat Biotechnol 2011; 29:154-7; PMID:21217696; http://dx.doi.org/10.1038/nbt.1733 139.,Non-OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Nature 2011; 474:395-8; PMID:21677757; http://dx.doi.org/10.1038/nature10165 140.,Non-OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
J Vis Exp 2009; PMID:19865070;http://dx.doi.org/10.3791/1485 (2009) 141.,Non-OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Nucleic Acids Res 2011; 39:e142; PMID:21890902;http://dx.doi.org/10.1093/nar/gkr695 142.,OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
RNA 2007; 13:1745-55; PMID:17720878; http://dx.doi.org/10.1261/rna.,OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
PLoS one 2011; 6:e17596; PMID:21408612; http://dx.doi.org/10.1371/journal.pone.0017596 146.,Non-OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Mol Ther 2012; 20:954-9; PMID:22434136; http://dx.doi.org/10.1038/mt.2012.29 147.,Non-OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Mol Ther 2015; 23:1416-7; PMID:26321183; http://dx.doi.org/ 10.1038/mt.2015.138 148.,Non-OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Mol Cell Biol 1995; 15:2219-30; PMID:7891716; http://dx.doi.org/10.1128/MCB.15.4.2219RNA BIOLOGY 665,Non-OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Haematologica 2011; 96:905-13; PMID:21357703; http://dx.doi.org/10.3324/haematol.2010.039206 150.,Non-OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
J Cell Biochem 2011; 112:3085- 92; PMID:21769913; http://dx.doi.org/10.1002/jcb.23272 152.,Non-OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Genes Dev 1991; 5:2108-16; PMID:1682219; http://dx.doi.org/10.1101/gad.5.11.2108 153.,OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Methods Mol Biol2008; 419:215-30; PMID:18369986; http://dx.doi.org/10.1007/978-1- 59745-033-1_15 154.,Non-OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Biomaterials 2016; 87:131-46; PMID:26923361; http://dx.doi.org/10.1016/j.biomaterials.2016.02.018 155.,OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
J Control Release 2015; 218:22-8; PMID:26415855; http://dx.doi.org/10.1016/j.jconrel.2015.09.050 156.,OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
PloS one 2010; 5:e14397; PMID:21209933;http://dx.doi.org/10.1371/journal.pone.0014397 157.,Non-OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Cell Stem Cell 2010; 7:618-30; PMID:20888316; http://dx.doi.org/10.1016/j.stem.2010.08.012 158.,OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Nat Protoc 2013; 8:568-82; PMID:23429718; http://dx.doi.org/10.1038/nprot.2013.019 159.,OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Biochem Biophys Res Commun 2015; PMID:26449459; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
PloS One 2014; 9:e100134; PMID:24963715; http://dx.doi.org/10.1371/journal.pone.0100134 161.,OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Mol Ther 2012;20:948-53; PMID:22334017; http://dx.doi.org/10.1038/mt.2012.7 162.,OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
NatBiotechnol 2014; 32:551-3; PMID:24681508; http://dx.doi.org/10.1038/nbt.2884 163.,OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Sci Rep 2015; 5:13878; PMID:26354037; http://dx.doi.org/10.1038/srep13878 164.,OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
PloS one 2015; 10:e0142755;PMID:26556280; http://dx.doi.org/10.1371/journal.pone.0142755 165.,Non-OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Gene 2014; 543:28-33; PMID:24713411; http://dx.doi.org/10.1016/j.gene.2014.04.013 166.,OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
J Vis Exp 2013; 81; e50957; PMID:24301055; http://dx.doi.org/10.3791/50957167.,OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Stem Cells Transl Med 2014; 3:636-42; PMID:24682287; http://dx.doi.org/10.5966/sctm.2013-0206 169.,Non-OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Mol Ther 2008; 16:1609-16; PMID:18612271; http://dx.doi.org/10.1038/mt.2008.141 170.,Non-OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Blood 2011; 117:2791-9; PMID:21148083; http://dx.doi.org/10.1182/blood-2010- 09-309591 172.,Non-OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
BMC Genomics 2016;17:177; PMID:26941072; http://dx.doi.org/10.1186/s12864-016- 2479-7 174.,OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Nat Rev Immunol 2012; 12:479-91; PMID:22728526; http://dx.doi.org/10.1038/nri3247 175.,Non-OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Annu Rev Immunol2015; 33:257-90; PMID:25581309; http://dx.doi.org/10.1146/ annurev-immunol-032414-112240 176.,Non-OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
The role of dendritic cells in the innate immune system.Microbes Infect 2000; 2:257-72; PMID:10758402; http://dx.doi.org/ 10.1016/S1286-4579(00)00302-6 177.,Non-OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
J Acquir Immune De ﬁc Syndr 2016; 72:31-8; PMID:26751016; http://dx.doi.org/10.1097/QAI.0000000000000926 178.,OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Hum Vaccin Immunother 2014; 10:703-7;PMID:24280693; http://dx.doi.org/10.4161/hv.27183 179.,Non-OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Curr Opin Allergy ClinImmunol 2010; 10:567-74; PMID:20856111; http://dx.doi.org/10.1097/ACI.0b013e32833fd5b6 180.,Non-OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
J Immunother 2011; 34:1-15; PMID:21150709; http://dx.doi.org/10.1097/CJI.0b013e3181f7dbe8 181.,Non-OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Radiat Oncol 2014; 9:180; PMID:25127546; http://dx.doi.org/10.1186/1748-717X-9-180 182.,Non-OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Metabolo- mics 2013; 9:1134-56; PMID:24273472; http://dx.doi.org/10.1007/s11306-013-0556-3666 P. REAUTSCHNIG ET AL.,OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Nat Biotechnol 2012; 30:1210-6; PMID:23159882; http://dx.doi.org/ 10.1038/nbt.2436 184.,OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Nat Biotechnol 2012; 30:1202-4; PMID:23222788; http://dx.doi.org/10.1038/nbt.2439 187.,Non-OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Clin Exp Immunol 2003; 134:378-84; PMID:14632740; http://dx.doi.org/10.1046/j.1365-2249.2003.02286.x 189.,Non-OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Cancer Immunol Immunother 2013; 62:1499-509; PMID:23817721; http://dx.doi.org/10.1007/s00262-013-1453-3 190.,Non-OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
AIDS 2012; 26:F1-12;PMID:22156965; http://dx.doi.org/10.1097/QAD.0b013e32834f33e8 191.,Non-OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Clin Cancer Res 2012; 18:5460-70; PMID:22896657; http://dx.doi.org/10.1158/1078-0432.CCR-11-3368 192.,Non-OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Cancer Immunol Immunother 2011; 60:809-18; PMID:21365467; http://dx.doi.org/ 10.1007/s00262-011-0991-9 193.,Non-OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
JClin Oncol 2016; 34:1330-8; PMID:26926680; http://dx.doi.org/ 10.1200/JCO.2015.63.4121 198.,Non-OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Oncoimmunology 2015; 4:e1019197;PMID:26405571; http://dx.doi.org/10.1080/2162402X.2015.1019197 199.,Non-OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
J Immunother 2009; 32:498-507; PMID:19609242; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Emerg Microbes Infect 2013; 2:e52; PMID:26038486; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Int J Cancer 2015; 137:372-84; PMID:25530186; http://dx.doi.org/10.1002/ijc.29402 212.,Non-OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
( http://www.curevac.com/ ﬁleadmin/curevac.,Non-OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Biomater Sci 2015; 3:1519-33; PMID:26280625;http://dx.doi.org/10.1039/C5BM00198F 214.,OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Int J Nanomedicine 2014; 9:1833-43; PMID:24748793;http://dx.doi.org/10.2147/IJN.S39810 216.,OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Mol Pharm 2013; 10:3366-74;PMID:23924216; http://dx.doi.org/10.1021/mp400190z 217.,Non-OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Expert Rev Vaccines 2015; 14:153-6; PMID:25586101; http://dx.doi.org/10.1586/14760584.2015.1000871 218.,Non-OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Immunol Res 2015; 2015:797421; PMID:26557723; http://dx.doi.org/ 10.1155/2015/797421 219.,Non-OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
J Allergy Clin Immunol 1993; 92:229- 36; PMID:8349933; http://dx.doi.org/10.1016/0091-6749(93)90166-D 220.,Non-OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
J Allergy Clin Immunol 2009; 124:1070-7 e1-11;PMID:19665781; http://dx.doi.org/10.1016/j.jaci.2009.06.036 221.,Non-OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Eur JImmunol 1999; 29:2026-36; PMID:10382766; http://dx.doi.org/ 10.1002/(SICI)1521-4141(199906)29:06%3c2026::AID- IMMU2026%3e3.0.CO;2-2 222.,OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Clin ExpAllergy 1997; 27:68-74; PMID:9117883; http://dx.doi.org/10.1046/ j.1365-2222.1997.d01-416.x 223.,Non-OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Angewandte Chemie 2012; 51:11166-9;PMID:23038402; http://dx.doi.org/10.1002/anie.201206489 224.,Non-OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Nucleic Acids Res 2014; 42:e87; PMID:24744243;http://dx.doi.org/10.1093/nar/gku272 225.,OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Proc Natl Acad Sci U S A 2013; 110:18285-90; PMID:24108353; http://dx.doi.org/ 10.1073/pnas.1306243110 226.,OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Annu Rev Biochem 2002; 71:817-46; PMID:12045112; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Annu Rev Biochem 2010; 79:321-49; PMID:20192758;http://dx.doi.org/10.1146/annurev-biochem-060208-105251 228.,Non-OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
ChemMed- Chem 2014; 9:2021-5; PMID:24954543; http://dx.doi.org/10.1002/ cmdc.201402139 229.,OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Angewandte Chemie 2014; 53:6267-71; PMID:24890431; http://dx.doi.org/10.1002/anie.201402634 230.,Non-OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Nat Methods 2008; 5:95-100; PMID:18066073;http://dx.doi.org/10.1038/nmeth1142 232.,OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Nat Rev Drug Discov2012; 11:125-40; PMID:22262036; http://dx.doi.org/10.1038/nrd3625233.,Non-OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
J Biol Chem 2003; 278:1395-8; PMID:12446660;http://dx.doi.org/10.1074/jbc.R200024200 234.,OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Nat Struct Mol Biol 2016; 23:98-102; PMID:26840897; http://dx.doi.org/ 10.1038/nsmb.3162 235.,OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Nucleic Acids Res 2013; 41:D262-D7; PMID:23118484; http://dx.doi.org/10.1093/nar/gks1007 236.,OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Angewandte Chemie International Edition 2016; 55:1917-20;http://dx.doi.org/10.1002/anie.201507577 237.,Non-OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Nucleic Acids Res 2001; 29:1293-9; PMID:11238995; http://dx.doi.org/10.1093/nar/29.6.1293 238.,OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
Mechanism of transfer RNA maturation by CCA-adding enzyme without using an oligonucleotide template.Nature 2004; 430:640-5; PMID:15295590; http://dx.doi.org/10.1038/ nature02711 239.,OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
RNA 2006; 12:1494-504; PMID:16790842; http://dx.doi.org/ 10.1261/rna.87706 241.,OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
RNA 2007; 13:1834-49; PMID:17872511; http://dx.doi.org/10.1261/ rna.652807 242.,OADS,/arxiv_data1/oa_pdf/b0/bd/krnb-14-05-1208323.PMC5449091.pdf
"5, 460 –470 http://dx.doi.org/10.1080/15476286.2016.1189069",Non-OADS,/arxiv_data1/oa_pdf/aa/c8/krnb-14-05-1189069.PMC5449094.pdf
"Typical riboswitches are parts of the 5 0- UTRs of genes, where they can for instance act as transcription terminators or anti-terminators, or control the access of the small ribosomal subunit to the SD sequence.73The structure of these motifs is highly conserved across species, allowing theirrather accurate prediction throughout genomes and their anno-tation in databases like Rfam ( http://rfam.xfam.org ).",Non-OADS,/arxiv_data1/oa_pdf/aa/c8/krnb-14-05-1189069.PMC5449094.pdf
Int J FoodMicrobiol 2005; 100:179-86; PMID:15854703; http://dx.doi.org/ 10.1016/j.ijfoodmicro.2004.10.015 2.,OADS,/arxiv_data1/oa_pdf/aa/c8/krnb-14-05-1189069.PMC5449094.pdf
Proc Natl Acad Sci USA 2004; 101:12318-23; PMID:15302931; http://dx.doi.org/ 10.1073/pnas.0404924101 3.,OADS,/arxiv_data1/oa_pdf/aa/c8/krnb-14-05-1189069.PMC5449094.pdf
Mol Microbiol 1994; 13:395-402; PMID:7997157; http://dx.doi.org/10.1111/j.1365-2958.,Non-OADS,/arxiv_data1/oa_pdf/aa/c8/krnb-14-05-1189069.PMC5449094.pdf
Science 2001; 294:849-52; PMID: 11679669; http://dx.doi.org/10.1126/science.1063447 5.,OADS,/arxiv_data1/oa_pdf/aa/c8/krnb-14-05-1189069.PMC5449094.pdf
J Biol 2009; 8:107; PMID:20053304; http://dx.doi.org/10.1186/jbiol202 6.,OADS,/arxiv_data1/oa_pdf/aa/c8/krnb-14-05-1189069.PMC5449094.pdf
Foodborne Pathog Dis 2011; 8:843-52; PMID:21495855; http://dx.doi.org/10.1089/fpd.2010.0746 7.,Non-OADS,/arxiv_data1/oa_pdf/aa/c8/krnb-14-05-1189069.PMC5449094.pdf
"Front Microbiol 2015; 6:1199;PMID:26579105; http://dx.doi.org/10.3389/fmicb.2015.01199 9. las Heras de A, Cain RJ, Bielecka MK, V /C19azquez-Boland JA.",OADS,/arxiv_data1/oa_pdf/aa/c8/krnb-14-05-1189069.PMC5449094.pdf
Curr Opin Microbiol 2011; 14:118-27; PMID:21388862; http://dx.doi.org/10.1016/j.mib.2011.01.005 10.,OADS,/arxiv_data1/oa_pdf/aa/c8/krnb-14-05-1189069.PMC5449094.pdf
Mol Microbiol 2003; 47:1613-25; PMID:12622816; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/aa/c8/krnb-14-05-1189069.PMC5449094.pdf
RNA Biol 2012; 9:372-8; PMID:22336762; http://dx.doi.org/10.4161/rna.19235 13.,Non-OADS,/arxiv_data1/oa_pdf/aa/c8/krnb-14-05-1189069.PMC5449094.pdf
Mol Microbiol 1991; 5:2273-83; PMID:1662763;http://dx.doi.org/10.1111/j.1365-2958.1991.tb02158.x 16.,OADS,/arxiv_data1/oa_pdf/aa/c8/krnb-14-05-1189069.PMC5449094.pdf
FEMS MicrobiolRev 2003; 27:559-92; PMID:14638413; http://dx.doi.org/10.1016/S0168-6445(03)00066-4 17.,OADS,/arxiv_data1/oa_pdf/aa/c8/krnb-14-05-1189069.PMC5449094.pdf
Trends Microbiol 2012; 20:360-8; PMID:22652164; http://dx.doi.org/10.1016/j.tim.2012.04.006 18.,OADS,/arxiv_data1/oa_pdf/aa/c8/krnb-14-05-1189069.PMC5449094.pdf
Int J Med Microbiol 2001; 291:145-57; PMID:11437337; http://dx.doi.org/10.1078/1438-4221-00111 19.,OADS,/arxiv_data1/oa_pdf/aa/c8/krnb-14-05-1189069.PMC5449094.pdf
Mol Microbiol 1991; 5:361-6; PMID:1645838; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/aa/c8/krnb-14-05-1189069.PMC5449094.pdf
Cold Spring Harb Perspect Med 2012; 2:a010009-a010009; PMID:23125201; http://dx.doi.org/10.1101/cshperspect.a010009 24.,Non-OADS,/arxiv_data1/oa_pdf/aa/c8/krnb-14-05-1189069.PMC5449094.pdf
MolMicrobiol 2002; 45:1095-106; PMID:12180927; http://dx.doi.org/10.1046/j.1365-2958.2002.03080.x 25.,OADS,/arxiv_data1/oa_pdf/aa/c8/krnb-14-05-1189069.PMC5449094.pdf
Mol Microbiol 1999; 34:552-61; PMID:10564496; http://dx.doi.org/ 10.1046/j.1365-2958.1999.01621.x 27.,Non-OADS,/arxiv_data1/oa_pdf/aa/c8/krnb-14-05-1189069.PMC5449094.pdf
Nature 2015; 517:170-3; PMID:25567281; http://dx.doi.org/10.1038/nature14029 28.,Non-OADS,/arxiv_data1/oa_pdf/aa/c8/krnb-14-05-1189069.PMC5449094.pdf
PLoS Pathog 2009; 5:e1000449;PMID:19478867; http://dx.doi.org/10.1371/journal.ppat.1000449 29.,Non-OADS,/arxiv_data1/oa_pdf/aa/c8/krnb-14-05-1189069.PMC5449094.pdf
Nat Rev Microbiol 2009; 7:623-8;PMID:19648949; http://dx.doi.org/10.1038/nrmicro2171 30.,Non-OADS,/arxiv_data1/oa_pdf/aa/c8/krnb-14-05-1189069.PMC5449094.pdf
J Bacteriol 2008; 190:5412-30; PMID:18502850; http://dx.doi.org/10.1128/JB.00259-08 32.,Non-OADS,/arxiv_data1/oa_pdf/aa/c8/krnb-14-05-1189069.PMC5449094.pdf
J Bacteriol 2003; 185:5722-34; PMID:13129943; http://dx.doi.org/ 10.1128/JB.185.19.5722-5734.2003 34.,Non-OADS,/arxiv_data1/oa_pdf/aa/c8/krnb-14-05-1189069.PMC5449094.pdf
Nature 2009; 459:950-6; PMID:19448609; http://dx.doi.org/10.1038/nature08080 35.,Non-OADS,/arxiv_data1/oa_pdf/aa/c8/krnb-14-05-1189069.PMC5449094.pdf
BMC Genomics 2009; 10:641; PMID:20042087; http://dx.doi.org/10.1186/1471-2164-10- 641 36.,Non-OADS,/arxiv_data1/oa_pdf/aa/c8/krnb-14-05-1189069.PMC5449094.pdf
Infect Immun 2002; 70:3948-52; PMID:12065541; http://dx.doi.org/10.1128/ IAI.70.7.3948-3952.2002 37.,Non-OADS,/arxiv_data1/oa_pdf/aa/c8/krnb-14-05-1189069.PMC5449094.pdf
Infect Immun 2009; 77:2113-24; PMID:19255187; http://dx.doi.org/10.1128/IAI.01205-08 38.,Non-OADS,/arxiv_data1/oa_pdf/aa/c8/krnb-14-05-1189069.PMC5449094.pdf
Mol Microbiol 2005; 57:1367-80; PMID:16102006; http://dx.doi.org/10.1111/j.1365-2958.2005.04776.x 39.,Non-OADS,/arxiv_data1/oa_pdf/aa/c8/krnb-14-05-1189069.PMC5449094.pdf
ApplEnviron Microbiol 2015; 81:4553-62; PMID:25911485; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/aa/c8/krnb-14-05-1189069.PMC5449094.pdf
Mol Microbiol 2002; 43:1-14; PMID:11849532; http://dx.doi.org/10.1046/j.1365-2958.2002.02723.x 41.,Non-OADS,/arxiv_data1/oa_pdf/aa/c8/krnb-14-05-1189069.PMC5449094.pdf
Mol Microbiol 2006; 62:1325-39; PMID:17042784; http://dx.doi.org/10.1111/j.1365-2958.2006.05452.x 42.,Non-OADS,/arxiv_data1/oa_pdf/aa/c8/krnb-14-05-1189069.PMC5449094.pdf
Microb Drug Resist 1996; 2:219-23; PMID:9158763; http://dx.doi.org/10.1089/mdr.1996.2.219 43.,Non-OADS,/arxiv_data1/oa_pdf/aa/c8/krnb-14-05-1189069.PMC5449094.pdf
Antimicrob Agents Chemother 2010; 54:4416-23; PMID:20643901; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/aa/c8/krnb-14-05-1189069.PMC5449094.pdf
PLoS Pathog 2006; 2:e30; PMID:16617375; http://dx.doi.org/10.1371/journal.ppat.0020030 45.,Non-OADS,/arxiv_data1/oa_pdf/aa/c8/krnb-14-05-1189069.PMC5449094.pdf
Infect Immun 2006; 74:6675-81; PMID:16982842; http://dx.doi.org/10.1128/IAI.00886-06 46.,Non-OADS,/arxiv_data1/oa_pdf/aa/c8/krnb-14-05-1189069.PMC5449094.pdf
Mol Microbiol 2009; 74:421-35; PMID:19796338; http://dx.doi.org/10.1111/j.1365-2958.2009.06874.x 48.,Non-OADS,/arxiv_data1/oa_pdf/aa/c8/krnb-14-05-1189069.PMC5449094.pdf
FEMS Microbiol Lett 1998; 169:341-7; PMID :9868779; http://dx.doi.org/ 10.1111/j.1574-6968.1998.tb13338.x 50.,OADS,/arxiv_data1/oa_pdf/aa/c8/krnb-14-05-1189069.PMC5449094.pdf
Mol Microbiol 2003; 48:1537-51; PMID:12791137; http://dx.doi.org/10.1046/j.1365-2958.2003.03534.x 51.,Non-OADS,/arxiv_data1/oa_pdf/aa/c8/krnb-14-05-1189069.PMC5449094.pdf
Mol Microbiol 2007; 63:1453-67; PMID:17302820; http://dx.doi.org/10.1111/j.1365-2958.2007.05597.x 52.,Non-OADS,/arxiv_data1/oa_pdf/aa/c8/krnb-14-05-1189069.PMC5449094.pdf
PLoS Genet 2012; 8:e1002887; PMID:22969433; http://dx.doi.org/10.1371/journal.pgen.1002887 53.,Non-OADS,/arxiv_data1/oa_pdf/aa/c8/krnb-14-05-1189069.PMC5449094.pdf
PLoS Genet 2016; 12: e1005870; PMID:26895237; http://dx.doi.org/10.1371/journal.pgen.,OADS,/arxiv_data1/oa_pdf/aa/c8/krnb-14-05-1189069.PMC5449094.pdf
Mol Microbiol 2015; 95:624-44; PMID:25430920; http://dx.doi.org/10.1111/mmi.12890468 A. LEBRETON AND P. COSSART,Non-OADS,/arxiv_data1/oa_pdf/aa/c8/krnb-14-05-1189069.PMC5449094.pdf
Trends Microbiol 2006; 14:294-8; PMID:16730443; http://dx.doi.org/10.1016/j.tim.2006.05.001 56.,OADS,/arxiv_data1/oa_pdf/aa/c8/krnb-14-05-1189069.PMC5449094.pdf
Mol Micr obiol 2005; 57:1460-73; PMID:16102013; http://dx.doi.org/10.1111/j.1365-2958.2005.04780.x 57.,OADS,/arxiv_data1/oa_pdf/aa/c8/krnb-14-05-1189069.PMC5449094.pdf
Appl Environ Microbiol 2010; 76:3625-36; PMID:20363781; http://dx.doi.org/10.1128/ AEM.02612-09 58.,OADS,/arxiv_data1/oa_pdf/aa/c8/krnb-14-05-1189069.PMC5449094.pdf
J Bacteriol 2005; 187:2836-45; PMID:15805530; http://dx.doi.org/10.1128/JB.187.8.2836-2845.2005 59.,Non-OADS,/arxiv_data1/oa_pdf/aa/c8/krnb-14-05-1189069.PMC5449094.pdf
Mol Microbiol 1996; 20:633-43; PMID:8736542; http://dx.doi.org/ 10.1046/j.1365-2958.1996.5401046.x 60.,Non-OADS,/arxiv_data1/oa_pdf/aa/c8/krnb-14-05-1189069.PMC5449094.pdf
C ell Microbiol 2004; 6:155-66; PMID: 14706101; http://dx.doi.org/10.1046/j.1462-5822.2003.00348.x 62.,Non-OADS,/arxiv_data1/oa_pdf/aa/c8/krnb-14-05-1189069.PMC5449094.pdf
Nucleic Acids Res 2011; 39:4235-48;PMID:21278422; http://dx.doi.org/10.1093/nar/gkr033 63.,OADS,/arxiv_data1/oa_pdf/aa/c8/krnb-14-05-1189069.PMC5449094.pdf
Nucleic Acids Res 2012; 40:1818- 27; PMID:22053088; http://dx.doi.org/10.1093/nar/gkr850 64.,OADS,/arxiv_data1/oa_pdf/aa/c8/krnb-14-05-1189069.PMC5449094.pdf
Cell 2002; 110:551-61; PMID:12230973; http://dx.doi.org/10.1016/S0092-8674(02)00905-4 66.,OADS,/arxiv_data1/oa_pdf/aa/c8/krnb-14-05-1189069.PMC5449094.pdf
Biochim Bio-phys Acta 2013; 1829:866-77; PMID:23415794; http://dx.doi.org/10.1016/j.bbagrm.2013.01.012 67.,OADS,/arxiv_data1/oa_pdf/aa/c8/krnb-14-05-1189069.PMC5449094.pdf
Appl Environ Microbiol 2009; 75:1621-7;PMID:19151183; http://dx.doi.org/10.1128/AEM.02154-08 68.,Non-OADS,/arxiv_data1/oa_pdf/aa/c8/krnb-14-05-1189069.PMC5449094.pdf
Appl Environ Microbiol 2007; 73:6484-98; PMID:17720827; http://dx.doi.org/10.1128/AEM.00897-07 70.,OADS,/arxiv_data1/oa_pdf/aa/c8/krnb-14-05-1189069.PMC5449094.pdf
Environ Microbiol 2012; 14:2223-32; PMID:22564273; http://dx.doi.org/10.1111/j.1462-2920.2012.02761.x 71.,OADS,/arxiv_data1/oa_pdf/aa/c8/krnb-14-05-1189069.PMC5449094.pdf
J Bacteriol 2012; 194:4377-85; PMID:22707705; http://dx.doi.org/10.1128/JB.00348-12 72.,Non-OADS,/arxiv_data1/oa_pdf/aa/c8/krnb-14-05-1189069.PMC5449094.pdf
Infect Imm un 2015; 84(1):67-76; PMID:25939511; http://dx.doi.org/10.1128/IAI.00849-15 73.,Non-OADS,/arxiv_data1/oa_pdf/aa/c8/krnb-14-05-1189069.PMC5449094.pdf
Biochim Biophys Acta 2014; 1839:908-18; PMID: 24583553; http://dx.doi.org/10.1016/j.bbagrm.2014.02.012 74.,OADS,/arxiv_data1/oa_pdf/aa/c8/krnb-14-05-1189069.PMC5449094.pdf
Science 2014; 345:940-3; PMID:25146292; http://dx.doi.org/10.1126/science.1255083 76.,OADS,/arxiv_data1/oa_pdf/aa/c8/krnb-14-05-1189069.PMC5449094.pdf
Science 2014; 345:937-40; PMID:25146291; http://dx.doi.org/10.1126/science.1255091 77.,OADS,/arxiv_data1/oa_pdf/aa/c8/krnb-14-05-1189069.PMC5449094.pdf
J Bacteriol 2009; 191:7157-64; PMID:19783625;http://dx.doi.org/10.1128/JB.00838-09 78.,Non-OADS,/arxiv_data1/oa_pdf/aa/c8/krnb-14-05-1189069.PMC5449094.pdf
Science 2016; 352:aad9822-2; PMID:27120414;http://dx.doi.org/10.1126/science.aad9822 79.,Non-OADS,/arxiv_data1/oa_pdf/aa/c8/krnb-14-05-1189069.PMC5449094.pdf
Trends Genet 2015; 31:150-6; PMID:25708284; http://dx.doi.org/ 10.1016/j.tig.2015.01.005 80.,OADS,/arxiv_data1/oa_pdf/aa/c8/krnb-14-05-1189069.PMC5449094.pdf
Foodborne Pathog Dis 2008; 5:517-29; PMID:18673071; http://dx.doi.org/10.1089/fpd.2008.0112 81.,Non-OADS,/arxiv_data1/oa_pdf/aa/c8/krnb-14-05-1189069.PMC5449094.pdf
Mol Syst Biol 2012; 8:583; PMID:22617957; http://dx.doi.org/10.1038/msb.2012.11 82.,OADS,/arxiv_data1/oa_pdf/aa/c8/krnb-14-05-1189069.PMC5449094.pdf
Annu Rev Genet 2010; 44:167-88; PMID:20707673; http://dx.doi.org/10.1146/annurev-genet-102209-163523 83.,Non-OADS,/arxiv_data1/oa_pdf/aa/c8/krnb-14-05-1189069.PMC5449094.pdf
Nat Rev Microbiol 2013; 11:75-82; PMID:23268228; http://dx.doi.org/10.1038/nrmicro2934 84.,OADS,/arxiv_data1/oa_pdf/aa/c8/krnb-14-05-1189069.PMC5449094.pdf
FEMS Microbiol Rev 2015; 39:331-49;PMID:26009640; http://dx.doi.org/10.1093/femsre/fuv022 85.,Non-OADS,/arxiv_data1/oa_pdf/aa/c8/krnb-14-05-1189069.PMC5449094.pdf
Future Microbiol 2014; 9:1025-37; PMID:25340833; http://dx.doi.org/10.2217/fmb.14.79 86.,Non-OADS,/arxiv_data1/oa_pdf/aa/c8/krnb-14-05-1189069.PMC5449094.pdf
Cold Spring Harb Perspect Biol 2011; 3:a003798-8; PMID:20980440; http://dx.doi.org/10.1101/cshperspect.a003798 87.,OADS,/arxiv_data1/oa_pdf/aa/c8/krnb-14-05-1189069.PMC5449094.pdf
Nucleic Acids Res 2007; 35:962-74;PMID:17259222; http://dx.doi.org/10.1093/nar/gkl1096 88.,OADS,/arxiv_data1/oa_pdf/aa/c8/krnb-14-05-1189069.PMC5449094.pdf
J Bacteriol 2004; 186:3355-62; PMID:15150220; http://dx.doi.org/10.1128/JB.186.11.3355-3362.2004 89.,Non-OADS,/arxiv_data1/oa_pdf/aa/c8/krnb-14-05-1189069.PMC5449094.pdf
RNA 2006; 12:1383-96; PMID:16682563; http://dx.doi.org/10.1261/rna.49706 90.,OADS,/arxiv_data1/oa_pdf/aa/c8/krnb-14-05-1189069.PMC5449094.pdf
Nucleic Acids Res 2010; 38:907-19; PMID:19942685; http://dx.doi.org/10.1093/nar/gkp1081 91.,OADS,/arxiv_data1/oa_pdf/aa/c8/krnb-14-05-1189069.PMC5449094.pdf
PLoS One 2011; 6:e19019; PMID:21533114; http://dx.doi.org/ 10.1371/journal.pone.0019019 92.,Non-OADS,/arxiv_data1/oa_pdf/aa/c8/krnb-14-05-1189069.PMC5449094.pdf
Appl Environ Microbiol 2010; 76:7302-5; PMID:20817810; http://dx.doi.org/10.1128/AEM.01338-10 93.,OADS,/arxiv_data1/oa_pdf/aa/c8/krnb-14-05-1189069.PMC5449094.pdf
MBio 2016; 7:e00240-16; PMID:27048798; http://dx.doi.org/10.1128/mBio.00240-16 94.,OADS,/arxiv_data1/oa_pdf/aa/c8/krnb-14-05-1189069.PMC5449094.pdf
PLoS Genet 2014; 10:e1004765; PMID:25356775; http://dx.doi.org/10.1371/journal.pgen.1004765 95.,Non-OADS,/arxiv_data1/oa_pdf/aa/c8/krnb-14-05-1189069.PMC5449094.pdf
PLoS Genet 2014; 10: e1004065; PMID:24415952; http://dx.doi.org/10.1371/journal.pgen.,OADS,/arxiv_data1/oa_pdf/aa/c8/krnb-14-05-1189069.PMC5449094.pdf
PLoS One 2010; 5: e15138; PMID:21151923; http://dx.doi.org/10.1371/journal.pone.0015138 99.,Non-OADS,/arxiv_data1/oa_pdf/aa/c8/krnb-14-05-1189069.PMC5449094.pdf
Curr Opin Microbiol 2016; 30:50-7; PMID:26803287;http://dx.doi.org/10.1016/j.mib.2016.01.001 101.,OADS,/arxiv_data1/oa_pdf/aa/c8/krnb-14-05-1189069.PMC5449094.pdf
EMBO J 2012; 31(21):4153-4164; PMID:23064150; http://dx.doi.org/10.1038/ emboj.2012.274 102.,OADS,/arxiv_data1/oa_pdf/aa/c8/krnb-14-05-1189069.PMC5449094.pdf
FEBS Lett 2014; 588:2437-45; PMID:24911203; http://dx.doi.org/10.1016/j.febslet.,OADS,/arxiv_data1/oa_pdf/aa/c8/krnb-14-05-1189069.PMC5449094.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/5f/b7/prbm-10-147.PMC5449095.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/5f/b7/prbm-10-147.PMC5449095.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Psychology Research and Behavior Management 2017:10 147–153Psychology Research and Behavior Management Dovepress submit your manuscript | www.dovepress.com Dovepress 147 ORiginal ReseaRch open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PRBM.S136049 antecedents of positive self-disclosure online:  an empirical study of Us college students’  Facebook usage hongliang chen Department of communication,   T exas  a&M University, college  station,  TX, UsaAbstract: This study investigates the factors predicting positive self-disclosure on social  networking sites (SNSs).",Non-OADS,/arxiv_data1/oa_pdf/5f/b7/prbm-10-147.PMC5449095.pdf
"To address this literature gap, the current study investigates the fac-tors that may predict positive self-disclosure on SNSs, using data collected from the US Facebook users.correspondence: hongliang chen Department of communication, 4234 Texas a&M University, college station, TX 77843-4234, UsaTel +1 860 634 8677Fax +1 979 845 5500email hongliang.chen@tamu.eduJournal name: Psychology Research and Behavior Management Article Designation: Original ResearchY ear: 2017V olume: 10Running head verso: ChenRunning head recto: Predicting positive self-disclosureDOI: http://dx.doi.org/10.2147/PRBM.S136049",Non-OADS,/arxiv_data1/oa_pdf/5f/b7/prbm-10-147.PMC5449095.pdf
Available from: https://www.statista.com/statistics/264810/number-of-monthly-active-facebook-users-worldwide/.,OADS,/arxiv_data1/oa_pdf/5f/b7/prbm-10-147.PMC5449095.pdf
"Psychology Research and Behavior Management 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Psychology Research and Behavior Management Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/psychology-research-and-behavior-management-journalPsychology Research and Behavior Management is an international, peer- reviewed, open access journal focusing on the science of psychology and its  application in behavior management to develop improved outcomes in the  clinical, educational, sports and business arenas.",Non-OADS,/arxiv_data1/oa_pdf/5f/b7/prbm-10-147.PMC5449095.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/7d/f6/ott-10-2721.PMC5449096.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 2721–2728OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2721Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S13891 2 leucine-rich glioma inactivated 3: integrative  analyses support its prognostic role in glioma nyoun soo Kwon Dong-seok Kim hye-Y oung Yun Department of Biochemistry, chung- ang University, college of Medicine,   seoul, republic of KoreaBackground:  Leucine-rich glioma inactivated 3 (LGI3) is a secreted protein member of LGI  family.",Non-OADS,/arxiv_data1/oa_pdf/7d/f6/ott-10-2721.PMC5449096.pdf
"Keywords:  LGI3, glioma, cytokine, cancer, prognosis Introduction Leucine-rich glioma inactivated 3 (LGI3) is a secreted protein member of LGI  family that is abundantly expressed in brain in a developmentally regulated fashion.1  Expression of LGI3 in brain was shown to be transcriptionally regulated by activating  enhancer-binding protein 2 and neuronal restrictive silencer.1 We reported that LGI3  regulated neuronal exocytosis and neurite outgrowth.2,3 LGI3 is also expressed in skin  and adipose tissues.4,5 We showed that LGI3 secretion was induced by ultraviolet B  (UVB) and promoted keratinocyte survival.5 We demonstrated that LGI3 promoted  the migration of keratinocytes and melanogenesis.6,7 We reported that the expression of LGI3 was decreased during adipocyte differentia - tion and increased in obese adipose tissues.4,8 We further showed that LGI3 suppressed  adipogenesis through a disintegrin and metalloproteinase domain-containing protein 23  (ADAM23) which is one of the LGI3 receptors (ADAM22 and ADAM23) and that  LGI3 upregulated inflammatory genes including tumor necrosis factor- α (TNF-α) correspondence: hye-Young Yun Department of Biochemistry, chung- ang University, college of Medicine,  84 heukseok-ro, Dongjak-gu, seoul  06974, republic of Korea Tel +82 2 820 5684 email hyyunoffice@gmail.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2017 Volume: 10 Running head verso: Kwon et al Running head recto: LGI3 in glioma prognosis DOI: http://dx.doi.org/10.2147/OTT.S138912",Non-OADS,/arxiv_data1/oa_pdf/7d/f6/ott-10-2721.PMC5449096.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/7d/f6/ott-10-2721.PMC5449096.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/7d/f6/ott-10-2721.PMC5449096.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/7d/8c/opth-11-959.PMC5449097.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2017:11 959–962Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  959Letteropen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/OPTH.S13676 1 Psychological morbidity in Leber’s hereditary  optic neuropathy depends on phenotypic, social,  economic, and genetic factors Josef Finsterer1 Sinda Zarrouk-Mahjoub2 1Krankenanstalt rudolfstiftung, Vienna,   Austria; 2University of tunis el Manar,   Genomics Platform, Pasteur Institute  of tunis, tunis, tunisiaDear editor We have read with interest the article by Garcia et al1 about the effect of visual  impairment on psychological well-being with regard to mood, interpersonal interac - tions, and career-related goals.1 Among the 103 Leber’s hereditary optic neuropathy  (LHON) patients, half became depressed with negative impacts on interpersonal  relations and career goals.",Non-OADS,/arxiv_data1/oa_pdf/7d/8c/opth-11-959.PMC5449097.pdf
Available from: http://www.orpha.net/consor/cgi-bin/OC_Exp.php?,Non-OADS,/arxiv_data1/oa_pdf/7d/8c/opth-11-959.PMC5449097.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/7d/8c/opth-11-959.PMC5449097.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/7d/8c/opth-11-959.PMC5449097.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/af/2d/opth-11-931.PMC5449098.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2017:11 931–938Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  931CliniC al Trial repO rTopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S13350 2 intravitreal use of bone marrow mononuclear  fraction containing CD34+ stem cells in patients  with atrophic age-related macular degeneration Carina Costa Cotrim luiza T oscano andré Messias rodrigo Jorge rubens Camargo Siqueira Department of Ophthalmology,   Otorhinolaryngology and Head and  neck Surgery, ribeirao preto School  of Medicine, University of Sao paulo,   Sao paulo, BrazilPurpose:  To evaluate the therapeutic potential and safety of intravitreal injections of bone  marrow mononuclear fraction (BMMF) containing CD34+ cells in patients with atrophic age- related macular degeneration (AMD).",Non-OADS,/arxiv_data1/oa_pdf/af/2d/opth-11-931.PMC5449098.pdf
"Keywords:  AMD, stem cells, hematopoietic cells Introduction Age-related macular degeneration (AMD) is a degenerative and disabling ocular disease  that requires effective preventive and curative treatment.1 Its main manifestation is  progressive and irreversible loss of central vision in over 50-year-old individuals.2–4  Worldwide, it affects 8.7% of the elderly;5 the prevalence is estimated at 196 million  in 2020 and 288 million in 2040.6 It is the leading cause of blindness in over 50-year- old patients in developed countries.7 In developing countries, such as Brazil, it is in  the third place, but, due to alterations in the epidemiological profile and aging of the  population, this is expected to change.8Correspondence: rubens Camargo  Siqueira rua Saldanha Marinho 2815  Sala 42, Centro, São José do rio  preto 15010-080, Sp, Brazil Tel +55 17 3234 5858 Fax +55 17 3214 0896 email rubenssiqueira@terra.com.b r Journal name: Clinical Ophthalmology Article Designation: Clinical Trial Report Y ear: 2017 Volume: 11 Running head verso: Cotrim et al Running head recto: Intravitreal injection of BMMF containing CD34+ for AMD DOI: http://dx.doi.org/10.2147/OPTH.S133502",Non-OADS,/arxiv_data1/oa_pdf/af/2d/opth-11-931.PMC5449098.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/af/2d/opth-11-931.PMC5449098.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/af/2d/opth-11-931.PMC5449098.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/6a/4d/jpr-10-1255.PMC5449099.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/6a/4d/jpr-10-1255.PMC5449099.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2017:10 1255–1263Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  1255 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S132595Use of immediate-release opioids as supplemental  analgesia during management of moderate- to-severe chronic pain with buprenorphine  transdermal system Sanford Silverman1,2 Robert B Raffa3,4 Marc J Cataldo5 Monica Kwarcinski5 Steven R Ripa5 1Comprehensive Pain Medicine,   Pompano Beach, 2Department of  Integrated Medical Sciences, Charles E  Schmidt College of Medicine, Florida Atlantic University, Boca Raton,  FL,  3Department of Pharmaceutical  Sciences, School of Pharmacy,  T emple University, Philadelphia, PA,   4Department of Pharmacology and  T oxicology, College of Pharmacy,  University of Arizona, T ucson, AZ,   5Purdue Pharma LP , Stamford, CT, USBackground: The buprenorphine transdermal system (BTDS) is approved in the US for the  management of chronic pain.",Non-OADS,/arxiv_data1/oa_pdf/6a/4d/jpr-10-1255.PMC5449099.pdf
"Usually, IR opioids are short-acting, intended for use every 3–6 hours, and are more appropriate for transient pain types, Correspondence: Marc J Cataldo Purdue Pharma LP, One Stamford Forum, 201 Tresser Boulevard, Stamford, CT 06901-3431, USTel +1 203 588 8000Email marc.cataldo@pharma.comJournal name: Journal of Pain Research  Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Silverman et alRunning head recto: Immediate-release opioids with transdermal buprenorphineDOI: http://dx.doi.org/10.2147/JPR.S132595",Non-OADS,/arxiv_data1/oa_pdf/6a/4d/jpr-10-1255.PMC5449099.pdf
Available from: https://www.fda.gov/downloads/Drugs/Guidances/UCM334743.pdf.,Non-OADS,/arxiv_data1/oa_pdf/6a/4d/jpr-10-1255.PMC5449099.pdf
"Journal of Pain Research  2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/6a/4d/jpr-10-1255.PMC5449099.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 1263 Immediate-release opioids with transdermal buprenorphine  31.,Non-OADS,/arxiv_data1/oa_pdf/6a/4d/jpr-10-1255.PMC5449099.pdf
Available from: http://www.medicines.org.uk/emc/medicine/8864.,Non-OADS,/arxiv_data1/oa_pdf/6a/4d/jpr-10-1255.PMC5449099.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/25/b0/ott-10-2655.PMC5449100.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 2655–2664OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2655Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S13564 1 The prognostic value of neutrophil–lymphocyte  ratio is superior to derived neutrophil– lymphocyte ratio in advanced gastric cancer  treated with preoperative chemotherapy and  sequential r0 resection: a 5-year follow-up hailong Jin Jianyi sun Kankai Zhu Xiaosun liu Qing Zhang Qianyun shen Yuan gao Jiren Yu Department of gastrointestinal  surgery, the First affiliated hospital,   Medical college, Zhejiang University,   hangzhou, People’s republic of chinaAim:  The role of neutrophil–lymphocyte ratio (NLR) and derived neutrophil–lymphocyte ratio  (d-NLR) in outcome prediction is assessed in patients with advanced gastric cancer receiving  preoperative chemotherapy in a 5-year follow-up cohort.",Non-OADS,/arxiv_data1/oa_pdf/25/b0/ott-10-2655.PMC5449100.pdf
"Keywords:  advanced gastric cancer, preoperative chemotherapy, neutrophil, lymphocyte,  prognosiscorrespondence: Jiren Yu Department of gastrointestinal  Surgery, the First Affiliated Hospital,  Medical college, Zhejiang University,  no 79, Qingchun road, 310003  hangzhou, Zhejiang Province, People’s  republic of china Tel +86 571 8723 6147 Fax +86 571 8707 2577 email yujr0909@zju.edu.c n Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2017 Volume: 10 Running head verso: Jin et al Running head recto: NLR and d-NLR in advanced gastric cancer with preoperative chemotherapy DOI: http://dx.doi.org/10.2147/OTT.S135641",Non-OADS,/arxiv_data1/oa_pdf/25/b0/ott-10-2655.PMC5449100.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/25/b0/ott-10-2655.PMC5449100.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/25/b0/ott-10-2655.PMC5449100.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/81/c0/opth-11-1015.PMC5449101.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2017:11 1015–1020Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1015PersPeCtivesopen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/OPTH.S11626 5 Automated retinal imaging and trend analysis –  a tool for health monitoring Karin roesch tristan swedish ramesh raskar Mit Media Lab, Massachusetts  institute of technology, Cambridge,   MA, UsAAbstract:  Most current diagnostic devices are expensive, require trained specialists to operate and  gather static images with sparse data points.",Non-OADS,/arxiv_data1/oa_pdf/81/c0/opth-11-1015.PMC5449101.pdf
"In addition, retinal vessel patterns can Correspondence: ramesh raskar Massachusetts institute of technology,  Media Lab, e14-274K, 75 Amherst street,  Cambridge, MA 02139, UsA tel +1 617 253 0329 Fax +1 617 258 6264 email raskar@media.mit.ed u Journal name: Clinical Ophthalmology Article Designation: Perspectives Y ear: 2017 Volume: 11 Running head verso: Roesch et al Running head recto: Retinal imaging and predictive analysis DOI: http://dx.doi.org/10.2147/OPTH.S116265",Non-OADS,/arxiv_data1/oa_pdf/81/c0/opth-11-1015.PMC5449101.pdf
Available  from: https://www.kaggle.com/c/diabetic-retinopathy-detectio n.  Accessed 16 August 2016.,Non-OADS,/arxiv_data1/oa_pdf/81/c0/opth-11-1015.PMC5449101.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/81/c0/opth-11-1015.PMC5449101.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/81/c0/opth-11-1015.PMC5449101.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c8/c1/ijn-12-3927.PMC5449102.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 3927–3940International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3927OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S13645 3 Iron oxide nanoparticles induce cytokine  secretion in a complement-dependent manner  in a human whole blood model susann Wolf-grosse1 anne Mari rokstad1–3 syed ali4 John D lambris5 T om e Mollnes2,6–9 asbjørn M Nilsen1,* Jørgen stenvik1,2,* 1Department of cancer research  and Molecular Medicine, 2centre of  Molecular Inflammation research  (ceMIr), Faculty of Medicine  and health sciences, Norwegian  University of science and T echnology,   Trondheim, 3central Norway regional  health authority, stjørdal, Norway;   4Division of Neurotoxicology, U s  FDa/National center for T oxicological  research, Jefferson, ar, 5Department  of Pathology and laboratory  Medicine, University of Pennsylvania,   Philadelphia, P a, Usa; 6Department of  Immunology, Oslo University hospital,   rikshospitalet, Oslo, 7research  laboratory, Nordland hospital,   Bodø, 8K.g.",Non-OADS,/arxiv_data1/oa_pdf/c8/c1/ijn-12-3927.PMC5449102.pdf
"It has long been known that the plasma cascade systems not only  interact with each other, but also exhibit extensive crosstalk with the cellular elements  in the blood.3 The complement system, which consists of over 40 plasma and membrane- bound proteins (receptors and regulators),4 destroys and removes foreign sub - stances, either directly or by activating leukocytes and initiating pro-inflammatory correspondence: susann Wolf-grosse Department of cancer research  and Molecular Medicine, Norwegian  University of science and Technology,  Prinsesse Kristinasgt 1, N-7491  Trondheim, Norway Tel +47 40332006 email susann.grosse@ntnu.n o Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Wolf-Grosse et al Running head recto: Complement-dependent cytokine secretion by IONPs DOI: http://dx.doi.org/10.2147/IJN.S136453",Non-OADS,/arxiv_data1/oa_pdf/c8/c1/ijn-12-3927.PMC5449102.pdf
Available from:  http://www.readcube.com/articles/10.1038/nnano.2017.47.,Non-OADS,/arxiv_data1/oa_pdf/c8/c1/ijn-12-3927.PMC5449102.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/c8/c1/ijn-12-3927.PMC5449102.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c8/c1/ijn-12-3927.PMC5449102.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/17/b8/ppa-11-975.PMC5449103.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2017:11 975–984Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  975OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S13162 5 Understanding deprescribing of preventive  cardiovascular medication: a Q-methodology  study in patients clare h luymes1 nelleke J Boelhouwer1 rosalinde K e Poortvliet1 Wouter de ruijter1 ria reis1–3 Mattijs e numans1 1Department of Public health and  Primary care, leiden University  Medical center, leiden, 2Amsterdam  institute for social science research,   University of Amsterdam, Amsterdam,   the netherlands; 3The children’s  institute, University of cape T own,   cape T own, south AfricaBackground:  Patients with low cardiovascular disease (CVD) risk potentially use preventive  cardiovascular medication unnecessarily.",Non-OADS,/arxiv_data1/oa_pdf/17/b8/ppa-11-975.PMC5449103.pdf
"Keywords:  general practice, preventive medicine, cardiovascular diseases, antihypertensive  agents, anticholesteremic agents, inappropriate prescribing Introduction According to the guidelines of many countries, patients with predicted low cardiovas - cular disease (CVD) risk do not require medication to prevent CVD.1–6 Nonetheless,  preventive cardiovascular medication is often prescribed and used by patients with  lower levels of predicted CVD risk than the actual guideline thresholds, because correspondence: clare h luymes Department of Public health and Primary  care (V-0-P), leiden University Medical  center, PO Box 9600, 2300 rc leiden,  the netherlands Tel +31 71 526 8444 Fax +31 71 526 8259 email c.h.luymes@lumc.n l Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Luymes et al Running head recto: Understanding deprescribing of preventive cardiovascular medication DOI: http://dx.doi.org/10.2147/PPA.S131625",Non-OADS,/arxiv_data1/oa_pdf/17/b8/ppa-11-975.PMC5449103.pdf
"Available from: http://heartfoundation.org.au/images/ uploads/publications/HypertensionGuidelines2008to2010Update.pd f.  Accessed April 15, 2017.",Non-OADS,/arxiv_data1/oa_pdf/17/b8/ppa-11-975.PMC5449103.pdf
Available from: http://www.ehs-egypt.net/pdf/WhatsnewNICE2011.,Non-OADS,/arxiv_data1/oa_pdf/17/b8/ppa-11-975.PMC5449103.pdf
"Available  from: http://leitlinien.dgk.org/files/2007_Pocket-Leitlinien_Risikoad - justierte_Praevention.pd f. Accessed April 15, 2017.",Non-OADS,/arxiv_data1/oa_pdf/17/b8/ppa-11-975.PMC5449103.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/17/b8/ppa-11-975.PMC5449103.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/0f/2b/hp-5-061.PMC5449104.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/0f/2b/hp-5-061.PMC5449104.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Hypoxia 2017:5 61–66Hypoxia Dovepress submit your manuscript | www.dovepress.com Dovepress 61 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/HP .S127560Targeted metabolomics in colorectal cancer: a  strategic approach using standardized laboratory  tests of the blood and urine Katarzyna J Jerzak1,2 Marissa Laureano3 Radwa Elsharawi4 Peter Kavsak5 Kelvin KW Chan2,6 Sukhbinder K Dhesy-Thind7 Kevin Zbuk7 1Department of Medicine, University  of T oronto, T oronto, Ontario,   2Sunnybrook Odette Cancer Centre,   University of T oronto, T oronto,   3Department of Medicine, McMaster  University, Hamilton, Ontario,   4Department of Health Research  Methods, Evidence and Impact,   McMaster University, Hamilton,  Ontario,  5Department of Pathology  and Molecular Medicine, McMaster University, Hamilton, Ontario,   6Division of Biostatistics, Dalla Lana  School of Public Health, University of T oronto, T oronto,  7Department  of Oncology, McMaster University,  Hamilton, Ontario, CanadaBackground: Glycolytic markers have been detected in colorectal cancer (CRC) using advanced  analytical methods.",Non-OADS,/arxiv_data1/oa_pdf/0f/2b/hp-5-061.PMC5449104.pdf
"4 Furthermore, glycolytic intermediates are used to produce fatty acids and  nonessential amino acids, which support their high proliferation rate.5 This unique  dependence on macromolecule synthesis and glucose/pyruvate flux, rather than Correspondence:  Katarzyna J Jerzak Sunnybrook Odette Cancer Centre,  University of Toronto, 2075 Bayview Ave, Toronto, ON, Canada M4N 3M5Email katarzyna.jerzak@sunnybrook.caJournal name: Hypoxia Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 5Running head verso: Jerzak et alRunning head recto: Metabolic dysfunction in colorectal cancerDOI: http://dx.doi.org/10.2147/HP .S127560",Non-OADS,/arxiv_data1/oa_pdf/0f/2b/hp-5-061.PMC5449104.pdf
"Hypoxia 2017:5submit your manuscript | www.dovepress.com Dovepress Dovepress Hypoxia Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/hypoxia-journalHypoxia is an international, peer-reviewed, open access journal that aims  to improve understanding of the biological response to hypoxia.",Non-OADS,/arxiv_data1/oa_pdf/0f/2b/hp-5-061.PMC5449104.pdf
"Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 66 Jerzak et al Conclusion In our small prospective study, venous pCO2 levels were  statistically higher among patients with metastatic CRC when  compared to those with local disease.",Non-OADS,/arxiv_data1/oa_pdf/0f/2b/hp-5-061.PMC5449104.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/cf/9e/opth-11-973.PMC5449105.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2017:11 973–981Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  973Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S13517 0 Functional characterization of rs2229094 (T .C)  polymorphism in the tumor necrosis factor locus  and lymphotoxin alpha expression in human  retina: the retina 4 project salvador Pastor-idoate1,2 irene rodríguez- hernández2,3 Jimena rojas1 lucia gonzalez-Buendia1 santiago Delgado-Tirado1,4 Jose Carlos lópez1 rogelio gonzález- sarmiento2,3 Jose C Pastor1,4 1iOBa eye institute, University of  Valladolid, Valladolid, 2Molecular  Medicine Unit, Department of  Medicine, 3Molecular and Cellular  Cancer Biology institute, high  Council of scientific research,   Biomedical research institute of  salamanca, University of salamanca,   salamanca, 4Department of  Ophthalmology, hospital Clínico  Universitario, Valladolid, spainPurpose:  The objective of this study is to determine the expression and localization of  lymphotoxin alpha (LTA) in human retinas and the functionality of one of its polymorphisms  rs2229094 (C13R) (T .C), previously associated with proliferative vitreoretinopathy (PVR)  development.",Non-OADS,/arxiv_data1/oa_pdf/cf/9e/opth-11-973.PMC5449105.pdf
"Keywords:  proliferative vitreoretinopathy, lymphotoxin alpha, tumor necrosis factor alpha,  inflammation, cytokines, polymorphism Introduction Proliferative vitreoretinopathy (PVR) is the major cause of failure in retinal detach - ment (RD) surgery,1 affecting 5%–10% of RD and accounting for ~75% of all pri - mary failures after RD surgery.1–3 PVR is a multifactorial disease4–9 considered as an  abnormal wound-healing process induced by a retinal break, whereupon the levels of  certain inflammatory cytokines (eg, tumor necrosis factor-alpha [TNF α]) and growth  factors (eg, transforming growth factor beta [TGF β], connective tissue growth factor  or platelet-derived growth factor) are increased and may play an important role in its  pathogenesis.2,4,5,10–13Correspondence: rogelio gonzález- sarmiento Unidad de Medicina Molecular,  Departamento de Medicina, Universidad  de salamanca, 58-182 Paseo de san  Vicente, 37007 salamanca, spain Tel +34 9 2329 4553 Fax +34 9 2329 4593 email gonzalez@usal.e s Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Pastor-Idoate et al Running head recto: The Retina 4 project DOI: http://dx.doi.org/10.2147/OPTH.S135170",Non-OADS,/arxiv_data1/oa_pdf/cf/9e/opth-11-973.PMC5449105.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/cf/9e/opth-11-973.PMC5449105.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/cf/9e/opth-11-973.PMC5449105.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/dc/da/jmdh-10-217.PMC5449106.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/dc/da/jmdh-10-217.PMC5449106.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Multidisciplinary Healthcare 2017:10 217–225Journal of Multidisciplinary Healthcare Dovepress submit your manuscript | www.dovepress.com Dovepress 217 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JMDH.S131382Future challenges for occupational health services  can be prevented by proactive collaboration with  the companies using the services: a participatory  and reflection project Marie Lydell1 Cathrine Hildingh1 Arne Söderbom2 Kristina Ziegert1 1Center of Research on Welfare,   Health and Sport (CVHI), School of  Social and Health Sciences, 2Center  for Innovation, Entrepreneurship and Learning Research (CIEL), School of Economics, T echnology and Science,  Halmstad University, Halmstad,  SwedenBackground: There is clearly a need for research in the field of occupational health service  (OHS) for applying new perspectives.",Non-OADS,/arxiv_data1/oa_pdf/dc/da/jmdh-10-217.PMC5449106.pdf
"1 The modern OHS is supposed to be  multiprofessional and customer-oriented but seems foremost to be driven by a tra-ditional pathogenic biomedical agenda, 1 with a primary focus on preventing disease Correspondence: Marie Lydell School of Social and Health Sciences, Halmstad University, PO Box 823, S-301 18 Halmstad, SwedenTel +46 35 16 7742Email marie.lydell@hh.seJournal name: Journal of Multidisciplinary Healthcare Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Lydell et alRunning head recto: Collaboration with companies for preventing health service challengesDOI: http://dx.doi.org/10.2147/JMDH.S131382",Non-OADS,/arxiv_data1/oa_pdf/dc/da/jmdh-10-217.PMC5449106.pdf
"Journal of Multidisciplinary Healthcare 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/journal-of-multidisciplinary-healthcare-journalThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/dc/da/jmdh-10-217.PMC5449106.pdf
Visit http://www.dovepress.com/   testimonials.php to read real quotes from published authors.Dovepress 225 Collaboration with companies for preventing health service challenges  8.,Non-OADS,/arxiv_data1/oa_pdf/dc/da/jmdh-10-217.PMC5449106.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/b7/a0/ott-10-2689.PMC5449107.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 2689–2700OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2689Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S12733 5 effects of chemopreventive agents on the  incidence of recurrent colorectal adenomas:  a systematic review with network meta-analysis  of randomized controlled trials sajesh K Veettil,1 nattawat  T eerawattanapong,2 siew  Mooi ching,3,4 Kean ghee  lim,5 surasak saokaew,6–9  Pochamana Phisalprapa,10  nathorn chaiyakunapruk7,8,11,12 1school of Pharmacy/ school of  Postgraduate studies, international  Medical University, Kuala lumpur, Malaysia;   2Division of Pharmacy Practice, Faculty of  Pharmaceutical sciences, Ubon ratchathani  University, Ubon ratchathani, Thailand;   3Department of Family Medicine, Faculty of  Medicine and health sciences, 4Malaysian  research institute on ageing, Universiti  Putra Malaysia, serdang, 5clinical school,   Department of  surgery, international  Medical University, seremban, negeri  sembilan, 6center of health Outcomes  research and Therapeutic safety  (cohorts), school of Pharmaceutical  sciences, University of Phayao, Phayao,   7school of Pharmacy, Monash University  Malaysia, selangor, Malaysia; 8centre of  Pharmaceutical Outcomes research,   Department of Pharmacy Practice, Faculty  of Pharmaceutical sciences, naresuan  University, Phitsanulok, Thailand; 9Unit of  excellence on herbal Medicine, school  of Pharmaceutical sciences, University of  Phayao, Thailand; 10Division of ambulatory  Medicine, Department of Medicine, Faculty  of Medicine siriraj hospital, Mahidol  University, Bangkok, 11school of Pharmacy,   University of Wisconsin, Madison, Usa;   12health and Well-being cluster, global  asia Platform in the 21st century ( ga21)  Platform, Monash University Malaysia,   selangor, MalaysiaBackground:  Protective effects of several chemopreventive agents (CPAs) against colorectal  adenomas have been well documented in randomized controlled trials (RCTs); however, there  is uncertainty regarding which agents are the most effective.",Non-OADS,/arxiv_data1/oa_pdf/b7/a0/ott-10-2689.PMC5449107.pdf
"Keywords:  colorectal adenomas, chemoprevention, systematic review, meta-analysis, network  meta-analysis, randomized controlled trials Introduction Colorectal cancer (CRC) is among the most common forms of cancer in the world,  with ~1.36 million new cases in 20121; it is the fourth leading cause of cancer death  worldwide.1 The burden of CRC in terms of mortality, morbidity and costs is enormous  for the community.2,3 Moreover, CRC-related mortality is increasing owing to the correspondence: nathorn chaiyakunapruk school of Pharmacy, Monash University  Malaysia, Jalan lagoon selatan, Bandar sunway  47500, selangor, Malaysia Tel +60 3 551 4413 email nathorn.chaiyakunapruk@monash.ed u Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2017 Volume: 10 Running head verso: Veettil et al Running head recto: Chemopreventive agents on the incidence of recurrent colorectal adenomas DOI: http://dx.doi.org/10.2147/OTT.S127335",Non-OADS,/arxiv_data1/oa_pdf/b7/a0/ott-10-2689.PMC5449107.pdf
"Available from: http://www.cdc.gov/media/releases/2013/p1105- colorectal-cancer-screening.htm l. Accessed December 15, 2016.",Non-OADS,/arxiv_data1/oa_pdf/b7/a0/ott-10-2689.PMC5449107.pdf
Avail - able from: http://www.crd.york.ac.uk/PROSPERO/display_record.,Non-OADS,/arxiv_data1/oa_pdf/b7/a0/ott-10-2689.PMC5449107.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/b7/a0/ott-10-2689.PMC5449107.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/b7/a0/ott-10-2689.PMC5449107.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/e5/dc/ott-10-2665.PMC5449108.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 2665–2673OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2665Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S13268 0 expression of urinary mirnas targeting nlrs  inflammasomes in bladder cancer ettore Mearini1,* giulia Poli2,* giovanni cochetti1 andrea Boni1 Maria giulia egidi1 stefano Brancorsini2 1Department of surgical and  Biomedical sciences, institute of  Urological, andrological surgery  and Minimally invasive T echniques,   2Department of experimental  Medicine – section of T erni, University  of Perugia, T erni, italy *These authors contributed equally  to this workAim of the study:  Inflammasome, a large complex of NOD-like receptors (NLRs), drives  tumor growth and progression.",Non-OADS,/arxiv_data1/oa_pdf/e5/dc/ott-10-2665.PMC5449108.pdf
"Keywords:  miRNA, bladder cancer, inflammasome, NOD-like receptors, urine sediment,  inflammation Introduction Bladder cancer (BC) is the second most frequent urological malignancy and it is  the fourth and ninth most common cancer in men and women, respectively, in the  Western world.1 About 75% of newly diagnosed BC cases are non-muscle invasive (NMI): of  these, ~70% are confined to the mucosa (stage Ta), 20% involves submucosa (stage  T1) and 10% are carcinoma in situ (CIS) lesions.2 Regarding prognosis, 30%–80% of  NMIBC will recur and 1%–45% of cases will progress to muscle invasive form within  5 years.3 The risk of recurrence and progression increases with the stage, the grade  of malignancy, the size and number of lesions and the presence of the CIS.4 Cancer  mortality is significantly affected by progression rates of high-risk (HR) NMIBC and correspondence: giovanni cochetti Department of surgical and Biomedical  sciences, institute of Urological,  andrological surgery and Minimally  invasive Techniques, University of  Perugia, Piazza lucio severi 1,  06132 Perugia, Terni, italy Tel +39 075 578 2533 Fax +39 075 578 2533 email giovannicochetti@libero.i t Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2017 Volume: 10 Running head verso: Mearini et al Running head recto: Urinary miRNAs targeting NLRs inflammasomes DOI: http://dx.doi.org/10.2147/OTT.S132680",Non-OADS,/arxiv_data1/oa_pdf/e5/dc/ott-10-2665.PMC5449108.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/e5/dc/ott-10-2665.PMC5449108.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e5/dc/ott-10-2665.PMC5449108.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ba/97/ott-10-2711.PMC5449109.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 2711–2720OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2711Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S13556 3 mir-124 suppresses proliferation and invasion of  nasopharyngeal carcinoma cells through the Wnt/ β-catenin signaling pathway by targeting capn4 haili hu1,* guanghui Wang1,* congying li2 1Department of Otorhinolaryngology,   huaihe hospital of henan  University, 2Department of  Otorhinolaryngology, school of  Medicine, Kaifeng University, Kaifeng,   People’s republic of china *These authors contributed equally  to this workBackground:  Recent studies have demonstrated that microRNA 124 (miR-124) acts as a tumor  suppressor in nasopharyngeal carcinoma (NPC); however, the exact molecular mechanism by  which miR-124 exerts tumor suppression has not been well elucidated.",Non-OADS,/arxiv_data1/oa_pdf/ba/97/ott-10-2711.PMC5449109.pdf
"MicroRNAs (miRNAs) are endogenous small non-coding RNA molecules with  about 20 nucleotides in length that regulate the expression of their target genes through correspondence: haili hu Department of Otorhinolaryngology,  huaihe hospital of henan University,  115 Ximen street, Kaifeng 475200,  People’s republic of china Tel +86 371 2390 6591 email huhaili12@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2017 Volume: 10 Running head verso: Hu et al Running head recto: Suppression of proliferation and invasion of NPC cells by miR-124 DOI: http://dx.doi.org/10.2147/OTT.S135563",Non-OADS,/arxiv_data1/oa_pdf/ba/97/ott-10-2711.PMC5449109.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/ba/97/ott-10-2711.PMC5449109.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ba/97/ott-10-2711.PMC5449109.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/9e/b9/ndt-13-1373.PMC5449110.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2017:13 1373–1384Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1373OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S12273 9 Developmental and behavioral outcomes of  uncomplicated monochorionic diamniotic   twins born in the third trimester amy sierakowski1 Valsamma eapen2,3 Rudi Črnčec2,3 John smoleniec4,5 1University of New south Wales,   2school of Psychiatry, University  of New south Wales, 3academic  Unit of infant, child and adolescent  Psychiatry, ingham institute, liverpool  hospital, south Western sydney  local health District, 4Division of  Women’s and children’s health,   University of New south Wales,   sydney, 5Department of Maternal- Fetal Medicine, liverpool hospital,   liverpool, N sW, australiaBackground:  Relatively little is known about the neurodevelopmental and behavioral outcomes  of monochorionic diamniotic (MCDA) twin pregnancies where there are no antenatal complica - tions peculiar to monochorionicity or prematurity.",Non-OADS,/arxiv_data1/oa_pdf/9e/b9/ndt-13-1373.PMC5449110.pdf
"In addition, severe discordant congenital anomalies occur more frequently  in MCDA pregnancies and are associated with an increased risk of morbidity and  mortality.10 In the case of spontaneous intrauterine demise of one fetus, its co-twin  may subsequently die (15%) or suffer from severe cerebral injury (34%) due to acute correspondence: Valsamma eapen academic Unit of infant, child and  adolescent Psychiatry, ingham institute,  liverpool hospital, south Western  sydney local health District, Mental  health centre (level 1: icaMhs),  locked Bag 7103, liverpool Bc,  NsW 1871, australia email v.eapen@unsw.edu.a u Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2017 Volume: 13 Running head verso: Sierakowski et al Running head recto: Development and behavior of MCDA twins born in third trimester DOI: http://dx.doi.org/10.2147/NDT.S122739",Non-OADS,/arxiv_data1/oa_pdf/9e/b9/ndt-13-1373.PMC5449110.pdf
Available from: http://www.swslhd.nsw.gov.au/planning /.,Non-OADS,/arxiv_data1/oa_pdf/9e/b9/ndt-13-1373.PMC5449110.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/9e/b9/ndt-13-1373.PMC5449110.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/9e/b9/ndt-13-1373.PMC5449110.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/f8/7b/opth-11-963.PMC5449112.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2017:11 963–972Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  963Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S13233 8 Prevalence of and risk factors for age-related  macular degeneration in nepal: the Bhaktapur  retina study raba Thapa1 sanyam Bajimaya1 govinda Paudyal1 shankar Khanal2 stevie Tan3 suman s Thapa1 ger van rens3 1Vitreo-retina service, Tilganga  institute of Ophthalmology,   Kathmandu, 2Central Departments  of statistics, Tribhuvan University,   Kirtipur, nepal; 3Department of  Ophthalmology, Vrije University  Medical Center, amsterdam,   the netherlandsAim:  This study aimed to explore the prevalence of and risk factors for age-related macular  degeneration (AMD) in an elderly population in Nepal.",Non-OADS,/arxiv_data1/oa_pdf/f8/7b/opth-11-963.PMC5449112.pdf
"Keywords:  age-related macular degeneration, prevalence, risk factors, Nepal Introduction Age-related macular degeneration (AMD) is an emerging public health problem in  the developing world due to rapid increases in the aging population.1–3 AMD is the  most common cause of irreversible blindness in the developed world among elderly  people,4–9 and it is the third leading cause of global blindness, contributing to 8.7% of  the total blindness in the world.1 Population-based studies in developed countries have  shown a prevalence of AMD between 9.1% and 20.9%.4,5,7–9 In developing countries,  its prevalence is between 3.1% and 10.6%.10–15 AMD was among the leading causes of  blindness in Nepal, contributing to 8.7% of the total blindness in a population-based  study.16 Retinal disease was the second most common cause of blindness, and among  the retinal diseases, AMD was the most prevalent form of retinal disease.17,18 Although  the wet variety of AMD constitutes only 10% of total AMD, it is the main cause of  irreversible blindness.19 Besides non-modifiable risk factors such as age and genetic  predisposition,5,6,13,20–24 there are several studies that have reported modifiable risk Correspondence: raba Thapa Vitreo-retina service, Tilganga institute  of Ophthalmology, PO Box 561,   gaushala, Kathmandu, nepal Tel +977 1 449 3775 Fax +977 1 447 4937 email rabathapa@live.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Thapa et al Running head recto: Age-related macular degeneration in Nepal DOI: http://dx.doi.org/10.2147/OPTH.S132338",Non-OADS,/arxiv_data1/oa_pdf/f8/7b/opth-11-963.PMC5449112.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/f8/7b/opth-11-963.PMC5449112.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f8/7b/opth-11-963.PMC5449112.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/94/64/tcrm-13-669.PMC5449113.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2017:13 669–674Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  669ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S13301 1 Color M-mode echocardiography-derived  propagation velocity of descending aorta  decreases with aging Mehmet Yaman1,2 Ug ˘ur Arslan1 Adil Bayramog ˘lu2 Osman Bektaş2 Ahmet Karataş3 1Cardiology Department, samsun  Training and Research hospital,   health sciences University, samsun,   2Cardiology Department, 3nephrology  Department, education and  Research hospital, Ordu University,   Ordu, T urkeyBackground:  Arterial stiffness (AS) can be determined by some noninvasive tests such as  pulse wave velocity (PWV).",Non-OADS,/arxiv_data1/oa_pdf/94/64/tcrm-13-669.PMC5449113.pdf
"The carotid artery intima–media thickness (CIMT) is strongly correlated  with the presence and extent of CVD13,14 and associated with cardiovascular and Correspondence: Mehmet Yaman Cardiology Department, education  and Research hospital, Ordu University,  1 nefsi Bucak street, 52100 Ordu, Turkey Tel +90 53 3477 4146 Fax +90 45 2245 4144 email dr.yaman@windowslive.co m Journal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2017 Volume: 13 Running head verso: Y aman et al Running head recto: AVP decreases with aging as an indicator of aortic stiffness DOI: http://dx.doi.org/10.2147/TCRM.S133011",Non-OADS,/arxiv_data1/oa_pdf/94/64/tcrm-13-669.PMC5449113.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/94/64/tcrm-13-669.PMC5449113.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/94/64/tcrm-13-669.PMC5449113.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/93/52/ott-10-2729.PMC5449114.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 2729–2736OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2729Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S13206 2 The prognostic value of nodal skip metastasis  in resectable thoracic esophageal squamous cell  carcinoma ge song1,2,* Wang Jing3,* song Xue1,2 hongbo guo4 Jinming Yu1,2 1Department of radiation Oncology,   school of Medicine and life sciences,   University of Jinan- shandong academy  of Medical sciences; 2Department of  radiation Oncology, shandong cancer  hospital affiliated with shandong  University, Jinan, 3Department  of radiation Oncology, the First  affiliated hospital of Zhengzhou  University, Zhengzhou, 4Department  of Thoracic surgery, shandong cancer  hospital affiliated with shandong  University, Jinan, china *These authors contributed equally  to the workPurpose:  This study aimed to investigate the incidence of nodal skip metastasis (NSM) to  identify the risk factors that influence NSM and to assess the prognostic value of NSM in  patients with thoracic esophageal squamous cell carcinoma (ESCC).",Non-OADS,/arxiv_data1/oa_pdf/93/52/ott-10-2729.PMC5449114.pdf
"This is a common pathway for metastatic spread in up to 73.6% correspondence: Jinming Yu Department of radiation Oncology,  Shandong Cancer Hospital Affiliated with  shandong University, Jiyan road 440,  Jinan 250117, shandong Province, china Tel +86 531 6762 6971 Fax +86 531 8798 4079 email sdyujinming@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2017 Volume: 10 Running head verso: Song et al Running head recto: Prognostic value of nodal skip metastasis DOI: http://dx.doi.org/10.2147/OTT.S132062",Non-OADS,/arxiv_data1/oa_pdf/93/52/ott-10-2729.PMC5449114.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/93/52/ott-10-2729.PMC5449114.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/93/52/ott-10-2729.PMC5449114.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/48/19/opth-11-993.PMC5449115.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2017:11 993–998Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  993Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/OPTH.S13264 4 refractive predictability in eyes with intraocular  gas tamponade – results of a prospective  controlled clinical trial lars Wagenfeld1 Kristin hermsdorf1 Birthe stemplewitz1 Vasyl Druchkiv1 andreas Frings2 1Department of Ophthalmology,   University Medical Centre hamburg- eppendorf (UK e), hamburg,   2Department of Ophthalmology,   University hospital Düsseldorf,   heinrich-heine University,   Düsseldorf, germanyPurpose:  To determine the postoperative refractive error in eyes with intraocular gas tamponade  in combined phacovitrectomy using a Z-haptic intraocular lens (IOL).",Non-OADS,/arxiv_data1/oa_pdf/48/19/opth-11-993.PMC5449115.pdf
"In a meta-analysis of cataract surgery results by Norrby published  in 2008, preoperative estimation of postoperative  IOL position, postoperative refraction Correspondence: andreas Frings Department of Ophthalmology,  University hospital Düsseldorf, heinrich- heine University, Moorenstraße 5, 40225  Düsseldorf, germany Tel +49 211 81 17 333 Fax +49 211 81 17 340 email andi.frings@gmail.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Wagenfeld et al Running head recto: Refractive predictability in eyes with gas tamponade DOI: http://dx.doi.org/10.2147/OPTH.S132644",Non-OADS,/arxiv_data1/oa_pdf/48/19/opth-11-993.PMC5449115.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/48/19/opth-11-993.PMC5449115.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/48/19/opth-11-993.PMC5449115.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/fb/aa/imcrj-10-177.PMC5449116.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/fb/aa/imcrj-10-177.PMC5449116.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).International Medical Case Reports Journal 2017:10 177–179International Medical Case Reports Journal Dovepress submit your manuscript | www.dovepress.com Dovepress 177 CASE REPORT open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IMCRJ.S136255Solitary neurofibroma of eyelid masquerading as  chalazion Nancy Chen1 Yung-Hsiang Hsu2 Yuan-Chieh Lee1,3 1Department of Ophthalmology,   Buddhist Tzu Chi General Hospital,   Hualien, Taiwan; 2Department  of Pathology, Buddhist Tzu Chi General Hospital, Hualien, Taiwan;   3Department of Ophthalmology and  Visual Science, Tzu Chi University,  Hualien, TaiwanAbstract:  Neurofibroma, a benign peripheral nerve sheath tumor, usually appears together  with café-au-lait spots, iris nodules, and other tumors within the scope of neurofibromatosis  von Recklinghausen type 1 tumors.",Non-OADS,/arxiv_data1/oa_pdf/fb/aa/imcrj-10-177.PMC5449116.pdf
"Correspondence: Yuan-Chieh Lee  Department of Ophthalmology, Hualien Tzu Chi Hospital, 707 Sec 3, Chung Yung Road, Hualien 970, TaiwanTel +886 3 856 1825 Ext 12169Email yuanchieh.lee@gmail.com Journal name: International Medical Case Reports Journal Article Designation: CASE REPORTY ear: 2017V olume: 10Running head verso: Chen et alRunning head recto: Neurofibroma mimicking chalazionDOI: http://dx.doi.org/10.2147/IMCRJ.S136255",Non-OADS,/arxiv_data1/oa_pdf/fb/aa/imcrj-10-177.PMC5449116.pdf
"International Medical Case Reports Journal 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/international-medical-case-reports-journal-journalThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/fb/aa/imcrj-10-177.PMC5449116.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 179 Neurofibroma mimicking chalazion like to emphasize that a histopathological evaluation is rec- ommended for persistent or atypical chalazions of the eyelid.,Non-OADS,/arxiv_data1/oa_pdf/fb/aa/imcrj-10-177.PMC5449116.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/37/48/jpr-10-1265.PMC5449117.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/37/48/jpr-10-1265.PMC5449117.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2017:10 1265–1271Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  1265ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S132185T umor necrosis factor α modulates sodium- activated potassium channel SLICK in rat dorsal  horn neurons via p38 MAPK activation pathway Kun Wang1 Feng Wang1 Jun-Ping Bao2 Zhi-Yang Xie1 Lu Chen1 Bao-Yi Zhou1 Xin-Hui Xie2 Xiao-Tao Wu1,2 1Medical School of Southeast  University, 2Department of  Orthopaedics, Zhongda Hospital,   Southeast University, Nanjing, People’s Republic of ChinaAbstract:  The dorsal horn (DH) of the spinal cord is the integrative center that processes and  transmits pain sensation.",Non-OADS,/arxiv_data1/oa_pdf/37/48/jpr-10-1265.PMC5449117.pdf
"8–10 As previously reported,  acute TNF-α stimulation at the dorsal root ganglion rapidly enhances TTX-R cur - rents via the p38-dependent pathway,11 and TNF-α-induced p38 MAPK activation  regulates TRPA1 and TRPV4 activity in odontoblast-like cells.12 Although TNF-α has Correspondence: Xiao-Tao Wu Department of Orthopaedics, Zhongda Hospital, Southeast University, 87 Dingjia Bridge, Nanjing Shi, Jiangsu Sheng 210009, People’s Republic of ChinaEmail wuxiaotao@medmail.com.cnJournal name: Journal of Pain Research  Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Wang et alRunning head recto: TNF-α modulates SLICK channelDOI: http://dx.doi.org/10.2147/JPR.S132185",Non-OADS,/arxiv_data1/oa_pdf/37/48/jpr-10-1265.PMC5449117.pdf
"Journal of Pain Research  2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/37/48/jpr-10-1265.PMC5449117.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 1271 TNF-α modulates SLICK channel10.,Non-OADS,/arxiv_data1/oa_pdf/37/48/jpr-10-1265.PMC5449117.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/af/99/tcrm-13-663.PMC5449118.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2017:13 663–668Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  663ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S13526 2 Comparison of the clinical features and outcomes  of infective endocarditis between hemodialysis  and non-hemodialysis patients Ching-Chung hsiao1,* Cheng-hao Weng1,2,* Yi-Jung li1 hsin-hsu Wu1,2 Yung-Chang Chen1 Yu-Ming Chen1 hsiang-hao hsu1 Ya-Chung Tian1 1Kidney Research Center and  Department of nephrology, Chang  gung Memorial hospital, Taipei,   2graduate institute of Clinical Medical  sciences, Chang gung University,   Taoyuan, Taiwan *These authors contributed equally  to this workAbstract:  Hemodialysis (HD) patients are more susceptible to infective endocarditis (IE) due  to the increased risk of bacterial invasion through intravascular access.",Non-OADS,/arxiv_data1/oa_pdf/af/99/tcrm-13-663.PMC5449118.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/af/99/tcrm-13-663.PMC5449118.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/af/99/tcrm-13-663.PMC5449118.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/46/ab/ndt-13-1385.PMC5449119.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2017:13 1385–1388Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1385Case repor Topen access to scientific and medical research open access Full T ext article http: //dx.doi.org/10.2147/NDT .S13831 5 Hirayama disease (monomelic amyotrophy)  clinically confused for carpal tunnel syndrome Halil ay Neurology Department of  Medical Faculty, Harran University,   sanliurfa, T urkeyAbstract:  Hirayama disease (HD) is a rare motor neuron disorder that involves a single upper  extremity.",Non-OADS,/arxiv_data1/oa_pdf/46/ab/ndt-13-1385.PMC5449119.pdf
"Case report A 19-year-old woman who presented to the orthopedics outpatient clinic with  weakness and atrophy in her right hand was diagnosed with advanced stage carpal Correspondence: Halil ay Neurology Department of Medical  Faculty, Harran University, sanliurfa- Mardin Highway 18th km, 63050,  sanliurfa, Turkey Tel +90 530 693 4206 email ayhalil27@hotmail.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Case report Y ear: 2017 Volume: 13 Running head verso: Ay Running head recto: Hirayama disease DOI: http://dx.doi.org/10.2147/NDT.S138315",Non-OADS,/arxiv_data1/oa_pdf/46/ab/ndt-13-1385.PMC5449119.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/46/ab/ndt-13-1385.PMC5449119.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/46/ab/ndt-13-1385.PMC5449119.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/2f/d0/ott-10-2685.PMC5449122.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 2685–2687OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2685EdiTO rialopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S13877 7 Ezh2, a novel target in detection and therapy  of breast cancer Sarah Pourakbar1,2 Timothy J Pluard3 anthony d accurso1 Faris Farassati1,3 1Midwest Biomedical research  Foundation, Kansas City Veterans  affairs Medical Center, 2University  of Missouri–Kansas City School  of Medicine, 3Saint luke’s Cancer  institute, Kansas City, MO, USaIn 2013, 232,340 new cases of invasive breast cancer and 39,620 breast cancer deaths  were estimated among US women.1 Currently, one in eight women in the US will  develop breast cancer in her lifetime, and breast cancer is the second leading cause of  cancer death among women.1 Despite many therapeutic advances over the last 20  years,  metastatic disease remains a major cause of death for breast cancer patients, elucidating  a crucial problem in the overall management of patients.2 The 5-year survival rate for  metastatic breast cancer is currently estimated as ,25%.3,4 The primary molecular subtypes of breast cancer have been identified by molecular  markers: luminal tumors that are estrogen receptor and progesterone receptor positive,  HER-2 positive tumors, and triple-negative breast cancer (TNBC) in which all markers  are negative.5 As expected, these different cancer phenotypes have varying behaviors  and prognoses, with the luminal type being well differentiated and the HER-2 and  TNBC types being poorly differentiated.",Non-OADS,/arxiv_data1/oa_pdf/2f/d0/ott-10-2685.PMC5449122.pdf
"Furthermore, overexpression of Ezh2 has been associated with poorly differentiated Correspondence: Faris Farassati Midwest Biomedical research  Foundation, Kansas City Veterans  affairs Medical Center, 4801 E linwood  Boulevard, Kansas City, MO 64128, USa Tel +1 816 922 2858 Fax +1 816 922 4712 Email ffarassati@gmail.co m Journal name: OncoTargets and Therapy Article Designation: Editorial Y ear: 2017 Volume: 10 Running head verso: Pourakbar et al Running head recto: Ezh2 and breast cancer DOI: http://dx.doi.org/10.2147/OTT.S138777",Non-OADS,/arxiv_data1/oa_pdf/2f/d0/ott-10-2685.PMC5449122.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/2f/d0/ott-10-2685.PMC5449122.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/2f/d0/ott-10-2685.PMC5449122.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/81/49/jpr-10-1201.PMC5449124.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/81/49/jpr-10-1201.PMC5449124.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2017:10 1201–1206Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  1201 Case RePo Rt open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S132951Healing of achilles tendon partial tear following   focused shockwave: a case report and  literature review Yu-Chun Hsu1,* Wei-ting Wu2,* Ke-Vin Chang2–4 Der-sheng Han2–4 Li-Wei Chou5–7 1Department of Physical Medicine  and Rehabilitation, taipei Veterans  General Hospital, 2Department of  Physical Medicine and Rehabilitation  and Community and Geriatric Research Center, National taiwan  University Hospital, Bei-Hu Branch,   3National taiwan University College  of Medicine, 4Community and  Geriatric Research Center, National taiwan University Hospital, Bei-Hu  Branch, taipei,  5Department of  Physical Medicine and Rehabilitation,  China Medical University Hospital,   6Graduate Institute of acupuncture  science, College of Chinese Medicine, China Medical University,   7Department of Rehabilitation, asia  University Hospital, taichung, taiwan *these authors contributed equally to this workAbstract:  Achilles tendinopathy is a common cause of posterior heel pain and can progress  to partial tendon tear without adequate treatment.",Non-OADS,/arxiv_data1/oa_pdf/81/49/jpr-10-1201.PMC5449124.pdf
"7 Due to ESWT has been used for the  treatment of Achilles tendinopathy,7 with specific improvement in reports by Vulpiani  et al8 but no article focused on more severe problems like tear, we try using focused  shockwave on a case with left side partial tear of the Achilles tendon.Correspondence: Li-Wei Chou Department of Physical Medicine and Rehabilitation, China Medical University Hospital, No 2 Yuh-Der Road, taichung 40447, taiwantel +886 4 2205 2121 (extension 2381)Fax +886 4 2202 6041email chouliwe@gmail.comJournal name: Journal of Pain Research  Article Designation: Case ReportY ear: 2017V olume: 10Running head verso: Hsu et alRunning head recto: Focused shockwave for Achilles tendon partial tearDOI: http://dx.doi.org/10.2147/JPR.S132951",Non-OADS,/arxiv_data1/oa_pdf/81/49/jpr-10-1201.PMC5449124.pdf
"Journal of Pain Research  2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/81/49/jpr-10-1201.PMC5449124.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 1206 Hsu et al  10.,Non-OADS,/arxiv_data1/oa_pdf/81/49/jpr-10-1201.PMC5449124.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c9/7e/ndt-13-1409.PMC5449125.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2017:13 1409–1417Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1409OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S13425 8 Primary angle-closure glaucomas disturb regional  spontaneous brain activity in the visual pathway:  an fMri study Wei chen li Zhang Y ong-gen Xu Kai Zhu Man luo Department of Ophthalmology,   shaoxing People’s hospital, shaoxing,   Zhejiang, People’s republic of chinaObjective:  To explore the underlying regional brain activity deficits in the visual cortex in  patients with primary angle-closure glaucoma (PACG) relative to normal controls (NCs) using  regional homogeneity (ReHo) method, and its relationship with behavioral performances.",Non-OADS,/arxiv_data1/oa_pdf/c9/7e/ndt-13-1409.PMC5449125.pdf
"Previous studies found that primary open-angle glaucoma (POAG) showed altered  diffusion tensor imaging parameters of fractional anisotropy, mean diffusivity, and radial  diffusivity in the chiasm, optic nerve, and optic radiations.2–5 Voxel-based morphometry correspondence: Man luo Department of Ophthalmology, shaoxing  People’s hospital, 568 Zhongxing North  road, shaoxing 312000, Zhejiang,  People’s republic of china Tel +86 575 8822 9632 email idhamne@sina.co mJournal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2017 Volume: 13 Running head verso: Chen et al Running head recto: Primary angle-closure glaucomas disturb regional brain activity DOI: http://dx.doi.org/10.2147/NDT.S134258",Non-OADS,/arxiv_data1/oa_pdf/c9/7e/ndt-13-1409.PMC5449125.pdf
"Data analysis Data preprocessing was conducted using DPABI software  (http://rfmri.org/dpab i) which is based on MATLAB2010a  (MathWorks, Natick, MA, USA).",OADS,/arxiv_data1/oa_pdf/c9/7e/ndt-13-1409.PMC5449125.pdf
"Pearson correlation and receiver  operating characteristic (r Oc) curve The ReHo differences in brain regions were saved as regions  of interest, and the mean signal values (beta value) of these  brain regions were extracted by averaging ReHo values over all  voxels using REST software ( http://www.resting-fmri.Source - forge.ne t).",OADS,/arxiv_data1/oa_pdf/c9/7e/ndt-13-1409.PMC5449125.pdf
The final MRI results were presented by Xjview  toolbox ( http://www.alivelearn.net/xjview /) and REST.,OADS,/arxiv_data1/oa_pdf/c9/7e/ndt-13-1409.PMC5449125.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/c9/7e/ndt-13-1409.PMC5449125.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c9/7e/ndt-13-1409.PMC5449125.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/6e/9f/jpr-10-1241.PMC5449126.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/6e/9f/jpr-10-1241.PMC5449126.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2017:10 1241–1253Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  1241 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S132485Quantitative sensory testing measures   individual pain responses in emergency  department patients Kevin J Duffy Katharyn L Flickinger Jeffrey T Kristan Melissa J RepineAlexandro GianforcaroRebecca B Hasley Saad Feroz Jessica M RuppJumana Al-BaghliMaria L Pacella Brian P Suffoletto Clifton W Callaway Department of Emergency Medicine,   School of Medicine, University of Pittsburgh, Pittsburgh, PA, USABackground: Refining and individualizing treatment of acute pain in the emergency department  (ED) is a high priority, given that painful complaints are the most common reasons for ED visits.",Non-OADS,/arxiv_data1/oa_pdf/6e/9f/jpr-10-1241.PMC5449126.pdf
"1–3 This situation potentially con- tributes to opioid overuse.4,5 Competing efforts focus on reducing inappropriate ED  opioid prescribing6,7 as well as on reducing ED barriers and inequities in the effective  treatment of pain.8–10 Despite this attention to ED pain treatment, few studies examine  individualized pain treatment for emergency patients.11Correspondence: Clifton W Callaway Department of Emergency Medicine, School of Medicine, University of Pittsburgh, 400A Iroquois, 3600 Forbes Avenue, Pittsburgh, PA 15260, USATel +1 412 647 9047Fax +1 412 647 6999Email callawaycw@upmc.eduJournal name: Journal of Pain Research  Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Duffy et alRunning head recto: QST in emergency departmentDOI: http://dx.doi.org/10.2147/JPR.S132485",Non-OADS,/arxiv_data1/oa_pdf/6e/9f/jpr-10-1241.PMC5449126.pdf
"Journal of Pain Research  2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/6e/9f/jpr-10-1241.PMC5449126.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 1253 QST in emergency department,Non-OADS,/arxiv_data1/oa_pdf/6e/9f/jpr-10-1241.PMC5449126.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/85/91/ndt-13-1367.PMC5449127.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2017:13 1367–1371Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1367Case repor Topen access to scientific and medical research open access Full T ext article http: //dx.doi.org/ 10.2147/NDT .S13662 8 effect of aripiprazole on non-24-hour sleep–wake  rhythm disorder comorbid with major depressive  disorder: a case report Kentaro Matsui1,2 Y oshikazu Takaesu2,3 Takeshi Inoue3 Ken Inada1 Katsuji Nishimura1 1Department of psychiatry, Tokyo  Women’s Medical University, 2Japan  somnology Center, Neuropsychiatric  research Institute, 3Department of  psychiatry, T okyo Medical University,   T okyo, JapanBackground:  Patients with non-24-hour sleep–wake rhythm disorder (N24SWD) exhibit  a sleep pattern that is asynchronous with the external light–dark cycle, typically involving a  cycling, relapsing–remitting pattern of sleep disturbances, including nighttime insomnia and  daytime sleepiness.",Non-OADS,/arxiv_data1/oa_pdf/85/91/ndt-13-1367.PMC5449127.pdf
"Regarding the efficacy of aripiprazole for CRSWD Correspondence: Kentaro Matsui Department of psychiatry, Tokyo  Women’s Medical University, 8-1,  Kawadacho, shinjuku-ku,  Tokyo 162-8666, Japan Tel +81 3 3374 8111 Fax +81 3 3351 8979 email matsui.kentaro@twmu.ac.j p Journal name: Neuropsychiatric Disease and Treatment Article Designation: Case report Y ear: 2017 Volume: 13 Running head verso: Matsui et al Running head recto: Effect of aripiprazole on non-24-hour sleep–wake rhythm disorder DOI: http://dx.doi.org/10.2147/NDT.S136628",Non-OADS,/arxiv_data1/oa_pdf/85/91/ndt-13-1367.PMC5449127.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/85/91/ndt-13-1367.PMC5449127.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/85/91/ndt-13-1367.PMC5449127.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/62/c1/ott-10-2675.PMC5449128.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 2675–2683OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2675Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S13065 3 Bisdemethoxycurcumin in combination with  α-PD-l1 antibody boosts immune response  against bladder cancer Yiqun shao1 Wenjing Zhu2 Jun Da1 Mingxi Xu1 Yiwei Wang1 Juan Zhou1 Zhong Wang1 1Department of Urology, shanghai  ninth People’s hospital, shanghai  JiaoTong University school of  Medicine, shanghai, People’s republic  of china; 2Department of Urology,   Yueyang hospital of integrated  Traditional chinese and Western  Medicine, shanghai University of  Traditional chinese Medicine,   shanghai, People’s republic of chinaAbstract:  Curcumin was recently discovered to strengthen immune response through multiple  mechanisms.",Non-OADS,/arxiv_data1/oa_pdf/62/c1/ott-10-2675.PMC5449128.pdf
"In addition, tumors  can develop an immunosuppressive microenvironment via different pathways, correspondence: Zhong Wang Department of Urology, shanghai  ninth People’s hospital, 639 Zhizaoju  road, shanghai 200011, People’s  republic of china Tel +86 21 2327 1699 5116 Fax +86 21 6313 6856 email wangzhongshjy@gmail.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2017 Volume: 10 Running head verso: Shao et al Running head recto: BDMC and anti-PD-L1 against bladder cancer DOI: http://dx.doi.org/10.2147/OTT.S130653",Non-OADS,/arxiv_data1/oa_pdf/62/c1/ott-10-2675.PMC5449128.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/62/c1/ott-10-2675.PMC5449128.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/62/c1/ott-10-2675.PMC5449128.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/8c/ee/jpr-10-1207.PMC5449129.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/8c/ee/jpr-10-1207.PMC5449129.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2017:10 1207–1215Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  1207 ORiginal ReseaRch open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S132853Outcomes and prognostic variables of  radiofrequency zygapophyseal joint neurotomy   in Utah workers’ compensation patients Tyler J christensen M scott DeBerard anthony J Wheeler Department of Psychology, Utah state  University, logan, UT, UsaPurpose: The prevalence of radiofrequency zygapophyseal joint neurotomy (RFN) has increased  substantially across the past decade.",Non-OADS,/arxiv_data1/oa_pdf/8c/ee/jpr-10-1207.PMC5449129.pdf
"5,6 Degenerative changes in the zygapophyseal joints correspondence: M scott DeBerard Department of Psychology, Utah state University, logan, UT 84322-2810, Usa Tel +1 435 797 1462Fax +1 435 797 1448email scott.deberard@usu.eduJournal name: Journal of Pain Research  Article Designation: Original ResearchY ear: 2017V olume: 10Running head verso: Christensen et alRunning head recto: Outcomes and prognostic variables of radio-frequency neurotomyDOI: http://dx.doi.org/10.2147/JPR.S132853",Non-OADS,/arxiv_data1/oa_pdf/8c/ee/jpr-10-1207.PMC5449129.pdf
"Journal of Pain Research  2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/8c/ee/jpr-10-1207.PMC5449129.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 1215 Outcomes and prognostic variables of radio-frequency neurotomy  8.,Non-OADS,/arxiv_data1/oa_pdf/8c/ee/jpr-10-1207.PMC5449129.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/2c/24/nss-9-151.PMC5449130.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/2c/24/nss-9-151.PMC5449130.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Nature and Science of Sleep Nature and Science of Sleep 2017:9 151–161Dovepress submit your manuscript | www.dovepress.com Dovepress  151REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NSS.S134864Short- and long-term health consequences of  sleep disruption Goran Medic1,2 Micheline Wille1 Michiel EH Hemels1 1Market Access, Horizon  Pharma B.V., Utrecht, 2Unit  of Pharmacoepidemiology &  Pharmacoeconomics, Department of Pharmacy, University of Groningen,  Groningen, The NetherlandsAbstract:  Sleep plays a vital role in brain function and systemic physiology across many body  systems.",Non-OADS,/arxiv_data1/oa_pdf/2c/24/nss-9-151.PMC5449130.pdf
"3 Despite the  importance of sleep, up to 70 million people in the US and ~ 45 million people in Europe  have a chronic sleep disorder that impacts daily functioning and health.2,4 For example,  ~20% of the serious injuries that result from car accidents can be associated with driver  sleepiness, independent of the effects of alcohol.2 Lifestyle and  environmental factors, Correspondence: Michiel EH Hemels Market Access, Horizon Pharma B.V., Graadt van Roggenweg 340, Building D, Fifth Floor, 3531 AH Utrecht, The NetherlandsTel +31 6 2970 0411Email mhemels@horizonpharma.comJournal name: Nature and Science of Sleep Article Designation: REVIEWY ear: 2017V olume: 9Running head verso: Medic et alRunning head recto: Consequences of sleep disruptionDOI: http://dx.doi.org/10.2147/NSS.S134864",Non-OADS,/arxiv_data1/oa_pdf/2c/24/nss-9-151.PMC5449130.pdf
"Nature and Science of Sleep 2017:9submit your manuscript | www.dovepress.com Dovepress Dovepress Nature and Science of Sleep Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/nature-and-science-of-sleep-journalNature and Science of Sleep is an international, peer-reviewed, open  access journal covering all aspects of sleep science and sleep medicine, including the neurophysiology and functions of sleep, the genetics of sleep, sleep and society, biological rhythms, dreaming, sleep disorders and therapy, and strategies to optimize healthy sleep.",Non-OADS,/arxiv_data1/oa_pdf/2c/24/nss-9-151.PMC5449130.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/b5/a8/ppa-11-965.PMC5449131.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2017:11 965–973Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  965OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S13555 1 A randomized trial of individual versus group- format exercise and self-management in individuals  with Parkinson’s disease and comorbid depression Martha sajatovic1,2 Angela l ridgel3 ellen M Walter1,4 curtis M Tatsuoka1,2 Kari colón-Zimmermann2 riane K ramsey2 elisabeth Welter2 steven A gunzler1,4 christina M Whitney1,4 Benjamin l Walter1,4 1Department of neurology, case  Western reserve University  school of Medicine, 2neurological  and Behavioral Outcomes center,   University hospitals cleveland  Medical center, cleveland,   3Department of exercise Physiology,   Kent state University, Kent,   4Movement Disorders center,   University hospitals cleveland  Medical center, cleveland, Oh, UsABackground:  Depression is common in people with Parkinson’s disease (PD), and exercise is  known to improve depression and PD.",Non-OADS,/arxiv_data1/oa_pdf/b5/a8/ppa-11-965.PMC5449131.pdf
"Serotonin reuptake inhibitors can worsen PD symptoms,13 while tricyclic  antidepressants can cause orthostatic hypotension, sedation, cardiac arrhythmias, correspondence: Angela l ridgel Department of exercise Physiology,  Kent state University, 350 Midway  Drive, Kent, Oh 44242, UsA Tel +1 330 672 7495 Fax +1 330 672 2250 email aridgel@kent.ed u Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Sajatovic et al Running head recto: Self-management for PD and depression DOI: http://dx.doi.org/10.2147/PPA.S135551",Non-OADS,/arxiv_data1/oa_pdf/b5/a8/ppa-11-965.PMC5449131.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/b5/a8/ppa-11-965.PMC5449131.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/cc/62/opth-11-951.PMC5449132.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2017:11 951–957Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  951Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/OPTH.S11718 8 Lifitegrast ophthalmic solution in the treatment  of signs and symptoms of dry eye disease: design,  development, and place in therapy Morgan R Godin Preeya K Gupta Department of Ophthalmology,   Division of Cornea and Refractive  Surgery, Duke University eye Center,   Durham, NC, USAAbstract:  A new topical ophthalmic medication, lifitegrast 5%, was recently approved by the  US Food and Drug Administration for use in dry eye patients.",Non-OADS,/arxiv_data1/oa_pdf/cc/62/opth-11-951.PMC5449132.pdf
"Therefore, therapies  targeting pro-inflammatory T cells are key in the treatment of DED.4 Intercellular  adhesion molecule-1 (ICAM-1) has been previously shown to be upregulated in the Correspondence: Preeya K Gupta Department of Ophthalmology, Division  of Cornea and Refractive Surgery,  Duke University eye Center, 4709  Creekstone Drive, Suite 100, Durham,  NC 27703, USA Tel +1 919 660 5234 Fax +1 919 660 5070 email preeya.gupta@duke.ed u Journal name: Clinical Ophthalmology Article Designation: Review Y ear: 2017 Volume: 11 Running head verso: Godin and Gupta Running head recto: Lifitegrast ophthalmic solution in the treatment of dry eye disease DOI: http://dx.doi.org/10.2147/OPTH.S117188",Non-OADS,/arxiv_data1/oa_pdf/cc/62/opth-11-951.PMC5449132.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/cc/62/opth-11-951.PMC5449132.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/cc/62/opth-11-951.PMC5449132.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/e7/e5/jpr-10-1217.PMC5449133.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/e7/e5/jpr-10-1217.PMC5449133.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2017:10 1217–1224Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  1217 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S132814Cannabis and intractable chronic pain: an  explorative retrospective analysis of Italian  cohort of 614 patients Guido Fanelli1,2 Giuliano De Carolis3 Claudio Leonardi4 Adele Longobardi5,6 Ennio Sarli7,8  Massimo Allegri1,2 Michael E Schatman9 1Anesthesia, Critical Care and  Pain Medicine Unit, Division of  Surgical Sciences, Department of Medicine and Surgery, University of Parma,  2Anesthesia, Intensive  Care and Pain Therapy Service,  Azienda Ospedaliero Universitaria Parma, Parma,  3Pain Therapy Service,   Azienda Ospedaliero Universitaria Pisana, Pisa,  4Department of Drug  Addiction Diseases, Local Public Health of Rome, Rome,  5Department  of Neurosciences, Reproductive and Odontostomatological Sciences,  University of Naples “Federico II”,  Naples,  6Y oung Against the Pain (YAP)  Group, Parma, 7Progetti Live Surgery,   8PinHub Group, Florence, Italy;   9Department of Public Health and  Community Medicine, T ufts University School of Medicine, Boston, MA, USABackground: Despite growing interest in the therapeutic use of cannabis to manage chronic  pain, only limited data that address these issues are available.",Non-OADS,/arxiv_data1/oa_pdf/e7/e5/jpr-10-1217.PMC5449133.pdf
"5,6 The current definition of cannabinoids includes all endogenous  and exogenous compounds that act on cannabinoid receptors.7Correspondence: Guido Fanelli Department of Medicine and Surgery, University of Parma, Via Gramsci, 43126 Parma, ItalyTel +39 05 2170 3965Email guido.fanelli@unipr.itJournal name: Journal of Pain Research  Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Fanelli et alRunning head recto: Cannabis for the treatment of chronic painDOI: http://dx.doi.org/10.2147/JPR.S132814",Non-OADS,/arxiv_data1/oa_pdf/e7/e5/jpr-10-1217.PMC5449133.pdf
"Journal of Pain Research  2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/e7/e5/jpr-10-1217.PMC5449133.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 1224 Fanelli et al 11.,Non-OADS,/arxiv_data1/oa_pdf/e7/e5/jpr-10-1217.PMC5449133.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/a1/da/opth-11-999.PMC5449134.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2017:11 999–1007Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  999Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S13606 1 Treatment of moderate-to-high hyperopia with  the Wavelight allegretto 400 and eX500 excimer  laser systems Manoj Motwani1 ronald Pei1,2 1Motwani lasiK institute, san Diego,   2Precision Outcome Consultants,   Fresno, C a, UsaPurpose:  To evaluate the efficacy of treating patients with +3.00 diopters (D) to +6.00 D of  hyperopia via laser-assisted in situ keratomileusis (LASIK) with the WaveLight Allegretto  400 and EX500 excimer laser systems.",Non-OADS,/arxiv_data1/oa_pdf/a1/da/opth-11-999.PMC5449134.pdf
"Essentially, although the technology improved,  the recommendation from senior and trusted refractive surgeons was that corrections Correspondence: Manoj Motwani Motwani lasiK institute, 4520 executive  Dr, suite 230, san Diego, Ca 92121, Usa Tel +1 858 554 0008 email drmmlj@gmail.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Motwani and Pei Running head recto: Treatment of moderate-to-high hyperopia DOI: http://dx.doi.org/10.2147/OPTH.S136061",Non-OADS,/arxiv_data1/oa_pdf/a1/da/opth-11-999.PMC5449134.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/a1/da/opth-11-999.PMC5449134.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a1/da/opth-11-999.PMC5449134.pdf
Available from: http://www.eyeworld.org/printarticle.php?id=134 8.,Non-OADS,/arxiv_data1/oa_pdf/a1/da/opth-11-999.PMC5449134.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/45/96/ndt-13-1389.PMC5449135.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2017:13 1389–1394Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1389OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S13475 1 Dexmedetomidine for the management of  postictal agitation after electroconvulsive therapy  with s-ketamine anesthesia suna su aksay1 Jan Malte Bumb2 Dmitry remennik3 Manfred Thiel3 laura Kranaster1 alexander sartorius1 christoph Janke3 1Department of Psychiatry and  Psychotherapy, central institute  of Mental health ( ciMh), Medical  Faculty Mannheim, University  of heidelberg, 2Department of  addictive Behavior and addiction  Medicine, central institute of Mental  health ( ciMh), Medical Faculty  Mannheim, University of heidelberg,   3Department of anesthesiology and  critical care Medicine, Medical  Faculty Mannheim, heidelberg  University, germanyObjectives:  Postictal agitation (PIA) represents one of the most common complications during  a modified electroconvulsive therapy (ECT) course.",Non-OADS,/arxiv_data1/oa_pdf/45/96/ndt-13-1389.PMC5449135.pdf
"Fairly typical short-term side effects include headache, muscle aches correspondence: alexander sartorius Department of Psychiatry and  Psychotherapy, central institute of  Mental health, Medical Faculty Mannheim,  University of heidelberg, square J 5,  Mannheim D-68159, germany Tel +49 621 1703 2913 Fax +49 621 1703 3165 e-mail alexander.sartorius@ zi-mannheim.d e Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2017 Volume: 13 Running head verso: Aksay et al Running head recto: Dexmedetomidine for the management of PIA after ECT DOI: http://dx.doi.org/10.2147/NDT.S134751",Non-OADS,/arxiv_data1/oa_pdf/45/96/ndt-13-1389.PMC5449135.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/45/96/ndt-13-1389.PMC5449135.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/45/96/ndt-13-1389.PMC5449135.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/9b/2c/jpr-10-1273.PMC5449136.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/9b/2c/jpr-10-1273.PMC5449136.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research 2017:10 1273–1278Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  1273 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S123772Durapain in symptomatic treatment of severe  acute pain: a post-marketing, prospective,  multicenter, observational study – PRIME study Kshitij Shah1 Omvijay B Chaudhari2 Palash Gupta3 R Hom Chaudhuri4 Ranjan Kamilya5 Shreedhar S Kulkarni6 S Subbaiah7 Zubair H Sorathia8 Gauri Billa9 1MS Orthopedic, Prime Hospital,   Andheri (West), 2Vatsalya Nursing  Home, Kalyan (West), Mumbai,   3Dr.",Non-OADS,/arxiv_data1/oa_pdf/9b/2c/jpr-10-1273.PMC5449136.pdf
"Ltd., 1st Floor, D-Mart Building, Mulund – Goregaon Link Road, Mulund (West), Mumbai 400080, IndiaTel +91 22 3953 7006Email gauri.billa@abbott.comJournal name: Journal of Pain Research  Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Shah et alRunning head recto: Durapain: a post-marketing observational studyDOI: http://dx.doi.org/10.2147/JPR.S123772",Non-OADS,/arxiv_data1/oa_pdf/9b/2c/jpr-10-1273.PMC5449136.pdf
"Journal of Pain Research 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/9b/2c/jpr-10-1273.PMC5449136.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 1278 Shah et al 11.,Non-OADS,/arxiv_data1/oa_pdf/9b/2c/jpr-10-1273.PMC5449136.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/e5/b9/ndt-13-1399.PMC5449137.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2017:13 1399–1408Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1399OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S12948 0 The impact of comorbid psychiatric disorders on  methadone maintenance treatment in opioid use  disorder: a prospective cohort study T ea rosic1 leen Naji2 Monica Bawor3 Brittany B Dennis3 carolyn Plater4 David c Marsh5 lehana Thabane6–8 Zainab samaan6–11 1st Joseph’s healthcare, 2Michael  g Degroote school of Medicine,   McMaster University, hamilton, ON,   canada; 3st george’s University  of london, london, UK; 4canadian  addiction Treatment centre,   richmond hill, 5Northern Ontario  school of Medicine, sudbury,   6Biostatistics Unit, research institute,   st Joseph’s healthcare, 7Department  of clinical epidemiology and  Biostatistics, McMaster University,   8Peter Boris centre for addictions  research, 9Mood Disorders research  Unit, st Joseph’s healthcare,   10Population genomics Program,   chanchlani research centre,   11Department of Psychiatry and  Behavioural Neurosciences, McMaster  University, hamilton, ON, canadaObjective:  There is a significant interindividual variability in treatment outcomes in methadone  maintenance treatment (MMT) for opioid use disorder (OUD).",Non-OADS,/arxiv_data1/oa_pdf/e5/b9/ndt-13-1399.PMC5449137.pdf
"Keywords:  opioid use disorder, methadone, substance abuse, comorbidity, psychiatric disorder Introduction Opioid use disorder (OUD) is the largest contributor to disability-adjusted life years  caused by drug use worldwide.1 Efforts to maximize treatment efficacy and reduce  opioid abuse are timely as the prevalence of OUD is on the rise,2,3 with its global  burden increasing by 74% between 1990 and 2010.4 Methadone maintenance treatment (MMT) is a widely implemented and effective  treatment for OUD,5 yet there is significant interindividual variability in treatment  effectiveness and outcomes.6–8 To improve treatment, research groups are actively  investigating the factors that influence MMT outcomes.9–15 Well-documented predictors  of treatment outcome include length of time in treatment,11–13 methadone dose,14 and  injecting behavior.15 The impact of comorbid psychiatric disorders on MMT outcome,  however, remains unclear.correspondence: Zainab samaan Mood Disorders Program, st Joseph’s  healthcare hamilton, 100 West 5th  street, hamilton, ON l8N 3K7, canada Tel +1 905 522 1155 ext 35448 Fax +1 905 381 5629 email samaanz@mcmaster.c a Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2017 Volume: 13 Running head verso: Rosic et al Running head recto: The impact of comorbid psychiatric disorders on MMT in OUD DOI: http://dx.doi.org/10.2147/NDT.S129480",Non-OADS,/arxiv_data1/oa_pdf/e5/b9/ndt-13-1399.PMC5449137.pdf
Or use: http://youtu.be/e61g6OlKJQ YVideo abstract,Non-OADS,/arxiv_data1/oa_pdf/e5/b9/ndt-13-1399.PMC5449137.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/e5/b9/ndt-13-1399.PMC5449137.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e5/b9/ndt-13-1399.PMC5449137.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/9d/2d/rmhp-10-087.PMC5449138.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/9d/2d/rmhp-10-087.PMC5449138.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Risk Management and Healthcare Policy 2017:10 87–93Risk Management and Healthcare Policy Dovepress submit your manuscript | www.dovepress.com Dovepress 87 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/RMHP .S129652 Handover checklist: testing a standardization  process in an Italian hospital Davide Ferorelli1  T eresa Giandola2 Mariangela Laterza2 Biagio Solarino2 Angela Pezzolla3 Fiorenza Zotti2 Alessandro Dell’Erba1 1Interdisciplinary Department of  Medicine, 2Section of Legal Medicine,   3Department of Emergency and Organ  Transplantation, University of Bari,   Bari, ItalyObjectives: This study aimed to standardize and rationalize the handover, a critical and  essential moment in common health care practices, through the realization of an efficient and  standardized checklist, which could be used daily to ensure complete, thorough and effective  handover.",Non-OADS,/arxiv_data1/oa_pdf/9d/2d/rmhp-10-087.PMC5449138.pdf
"This is a global patient safety initiative to facilitate the  development, Correspondence: Davide Ferorelli Istituto di Medicina Legale, Policlinico di Bari, Piazza Giulio Cesare 11, 70124 Bari, ItalyTel +39 8 0547 8290Email davideferorelli@gmail.comJournal name: Risk Management and Healthcare Policy Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 10Running head verso: Ferorelli et alRunning head recto: Handover checklistDOI: http://dx.doi.org/10.2147/RMHP .S129652",Non-OADS,/arxiv_data1/oa_pdf/9d/2d/rmhp-10-087.PMC5449138.pdf
"Risk Management and Healthcare Policy 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Risk Management and Healthcare Policy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/risk-management-and-healthcare-policy-journalRisk Management and Healthcare Policy is an international, peer-reviewed,  open access journal focusing on all aspects of public health, policy, and preventative measures to promote good health and improve morbidity and mortality in the population.",Non-OADS,/arxiv_data1/oa_pdf/9d/2d/rmhp-10-087.PMC5449138.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 93 Handover checklist Table S3  Questionnaire distributed before and after the induction of the new handover checklist 1.,Non-OADS,/arxiv_data1/oa_pdf/9d/2d/rmhp-10-087.PMC5449138.pdf
Two months after publication it is available to  the public under an Attribution–Noncommercial–Share Alike 3.0 Unported Creative  Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/81/a4/1401.PMC5449139.pdf
Available at https://loop.nigms   .nih.gov/2016/04/p01-outcomes-analysis/  (accessed 21 March 2017).,OADS,/arxiv_data1/oa_pdf/81/a4/1401.PMC5449139.pdf
Available at https://nexus.od.nih   .gov/all/2016/09/08/nih-rcr/  (accessed 21 March 2017).,OADS,/arxiv_data1/oa_pdf/81/a4/1401.PMC5449139.pdf
Available at https://nexus.od.nih.gov/all/2016/10/21/   applying-the-relative-citation-ratio-as-a-measure-of-grant-productivity/   (accessed 21 March 2017).,Non-OADS,/arxiv_data1/oa_pdf/81/a4/1401.PMC5449139.pdf
Available at https://replicationindex.wordpress.com/2014/12/01/ quantifying-statistical-research-integrity-r-index/  (accessed 21 March 2017).,Non-OADS,/arxiv_data1/oa_pdf/81/a4/1401.PMC5449139.pdf
Two months after publication it is  available to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/by   -nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/67/4c/1409.PMC5449140.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/b5/21/1412.PMC5449141.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/47/6d/1418.PMC5449142.pdf
Two months after publication it  is available to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/by   -nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/e1/8e/1426.PMC5449143.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported Cre - ative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/5a/08/1435.PMC5449144.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/23/4b/1444.PMC5449145.pdf
Two months after publication it is available to  the public under an Attribution–Noncommercial–Share Alike 3.0 Unported Creative  Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/23/91/1457.PMC5449146.pdf
A second picture of  the beads was taken afterward that was later aligned via the ImageJ  (http://rsb.info.nih.gov/ij) registration plug-in StackReg.,OADS,/arxiv_data1/oa_pdf/6c/31/1467.PMC5449147.pdf
The PIV and FTTC microscopy  software for ImageJ was kindly made available by Qingzong Tseng  (https://sites.google.com/site/qingzongtseng/tfm).,Non-OADS,/arxiv_data1/oa_pdf/6c/31/1467.PMC5449147.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/62/ed/1489.PMC5449148.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/8b/83/1507.PMC5449149.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/71/93/1519.PMC5449150.pdf
The  source code for analyzing denticle positions in vivo and for in silico  statistical modeling can be found at https://github.com/ZallenLab/ denticleorganization.,Non-OADS,/arxiv_data1/oa_pdf/71/93/1519.PMC5449150.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/9d/7d/1530.PMC5449151.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported Cre - ative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/56/9c/1539.PMC5449152.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/6e/70/1551.PMC5449153.pdf
"In wild-type cells, these proteins accumulate observation derived from genome-wide expression data ( Tetrahy - mena  Functional Genomics Database [TFGD]; http://tfgd.ihb.ac.cn;  Xiong et al.",OADS,/arxiv_data1/oa_pdf/6e/70/1551.PMC5449153.pdf
"Volume 28 June 1, 2017 Syntaxin and AP-3 in ciliate secretion  | 1555  PSI-BLAST and reciprocal BLAST searches,  as well as a SNARE classification website  (http://bioinformatics.mpibpc.mpg.de/ snare/index.jsp), to identify two T. ther - mophila  SNAREs that fall into the Qa.III.b  subclass (Supplemental Figure S4A).",OADS,/arxiv_data1/oa_pdf/6e/70/1551.PMC5449153.pdf
"Based on  data in the TFGD (http://tfgd.ihb.ac.cn),  TTHERM_00420770, but not the other  Qa.III.b-SNARE, has an expression profile  similar to those of known mucocyst-associ - ated genes, including APM3  (Figure 5).",Non-OADS,/arxiv_data1/oa_pdf/6e/70/1551.PMC5449153.pdf
Each optical midsection was analyzed by using the ImageJ tool Ana - lyze Particles (http://imagej.nih.gov/ij/).,OADS,/arxiv_data1/oa_pdf/6e/70/1551.PMC5449153.pdf
The top  two T. thermophila  hits were both confirmed as Qa.III.b-SNAREs in  the online SNARE-typing database (http://bioinformatics.mpibpc   .mpg.de/snare/index.jsp).,OADS,/arxiv_data1/oa_pdf/6e/70/1551.PMC5449153.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/83/34/1565.PMC5449154.pdf
Two months after publication it is  available to the public under an Attribution–Noncommercial–Share Alike 3.0 Un - ported Creative Commons License (http://creativecommons.org/licenses/by-nc   -sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/ba/68/1580.PMC5449155.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/62/4e/ott-10-2701.PMC5449156.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 2701–2709OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2701Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S11431 8 Microrna-216a promotes the metastasis and  epithelial–mesenchymal transition of ovarian  cancer by suppressing the PTen/aKT pathway haizhi liu Ying Pan Xiaoxue han Jia liu ruiman li Department of Obstetrics and  gynecology, The First affiliated  hospital of Jin an University,   guangzhou, People’s republic  of chinaAbstract:  MicroRNAs, a group of posttranscriptional regulators of numerous genes, are active  participators during the development and progression of ovarian cancer (OC).",Non-OADS,/arxiv_data1/oa_pdf/62/4e/ott-10-2701.PMC5449156.pdf
"MicroRNAs (miRNAs), a group of small noncoding RNAs with 20–22 nucleotides  in length,6 can regulate the expression of target genes posttranscriptionally and play  fundamental roles in regulating tissue-specific protein expression.7 Accumulating  studies have confirmed that miRNAs play important roles in the development and  progression of various human cancers,8–13 including OS, and miRNAs have been  regarded as promising biomarkers and therapeutic targets of OC.9,14  MiR-216a, a novel cancer-related miRNA, has been found to be downregulated in  non-small cell lung cancer,15 pancreatic cancer,16 and oral squamous cell carcinoma,17 correspondence: ruiman li Department of Obstetrics and  Gynecology, The First Affiliated Hospital  of Jinan University, no 613 huangpu  road, guangzhou, People’s republic  of china email manruili@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2017 Volume: 10 Running head verso: Liu et al Running head recto: MiR-216a in ovarian cancer DOI: http://dx.doi.org/10.2147/OTT.S114318",Non-OADS,/arxiv_data1/oa_pdf/62/4e/ott-10-2701.PMC5449156.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/62/4e/ott-10-2701.PMC5449156.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/62/4e/ott-10-2701.PMC5449156.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/17/0b/jpr-10-1225.PMC5449157.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/17/0b/jpr-10-1225.PMC5449157.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2017:10 1225–1239Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  1225 Review open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S138698Opioid analgesics-related pharmacokinetic drug  interactions: from the perspectives of evidence  based on randomized controlled trials and clinical  risk management Xiu-qin Feng1 Ling-ling Zhu2 Quan Zhou3 1Nursing Administration Office,   Division of Nursing, 2viP Care ward,   Division of Nursing, 3Department  of Pharmacy, The Second Affiliated  Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang,  People’s Republic of ChinaBackground: Multimorbidity results in complex polypharmacy which may bear a risk of drug  interactions.",Non-OADS,/arxiv_data1/oa_pdf/17/0b/jpr-10-1225.PMC5449157.pdf
"Keywords: adverse drug reaction, clinical efficacy, combination therapy, drug-drug interac- tions, drug metabolism, drug transporter, pain management, pharmacokinetics, polypharmacyCorrespondence: Ling-ling Zhu viP Care ward, Division of Nursing, The Second Affiliated Hospital, School of Medicine, Zhejiang University, 88 Jiefang Road, Shangcheng, Hangzhou 310009, Zhejiang, People’s Republic of ChinaTel +86 571 8778 3690Fax +86 571 8702 2776email zhouquan142602@aliyun.com Quan Zhou Department of Pharmacy, The Second Affiliated Hospital, School of Medicine, Zhejiang University, 88 Jiefang Road, Shangcheng, Hangzhou 310009, Zhejiang, People’s Republic of Chinaemail zhouquan142602@zju.edu.cnJournal name: Journal of Pain Research  Article Designation: ReviewY ear: 2017V olume: 10Running head verso: Feng et alRunning head recto: Opioid analgesics-related pharmacokinetic drug interactionsDOI: http://dx.doi.org/10.2147/JPR.S138698",Non-OADS,/arxiv_data1/oa_pdf/17/0b/jpr-10-1225.PMC5449157.pdf
"Journal of Pain Research  2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/17/0b/jpr-10-1225.PMC5449157.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 1239 Opioid analgesics-related pharmacokinetic drug interactions  43.,Non-OADS,/arxiv_data1/oa_pdf/17/0b/jpr-10-1225.PMC5449157.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c9/7a/ijn-12-3941.PMC5449158.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 3941–3965International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3941RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJN.S13452 6 Antibacterial properties and toxicity from metallic  nanomaterials Gina v vimbela1,* Sang M Ngo2,* Carolyn Fraze3 Lei Yang4,5 David A Stout5–7 1Department of Chemical engineering,   2Department of electrical engineering,   California State University, Long  Beach, CA, 3Brigham Y oung University  Idaho, Rexburg, ID, USA; 4Department  of Orthopaedics, Orthopaedic  Institute, The First Affiliated Hospital,   5International Research Center for  Translational Orthopaedics (IRCTO),   Soochow University, Suzhou,   Jiangsu, People’s Republic of China;   6Department of Mechanical and  Aerospace engineering, 7Department  of Biomedical engineering, California  State University, Long Beach, CA, USA *These authors contributed equally  to this workAbstract:  The era of antibiotic resistance is a cause of increasing concern as bacteria continue  to develop adaptive countermeasures against current antibiotics at an alarming rate.",Non-OADS,/arxiv_data1/oa_pdf/c9/7a/ijn-12-3941.PMC5449158.pdf
"The discovery of the role of bacteria  as infectious agents propelled the scientific community toward the development of  synthetic antibacterial agents.Correspondence: David A Stout Department of Mechanical and  Aerospace Engineering, 1250 Bellflower  Blvd, eCS-632 Long Beach, CA 90840,  USA Tel +1 562 985 1502 email david.stout@csulb.ed u Lei Yang Orthopaedic Institute of Soochow  University, 313 Buidling #1, 708 Renmin  Road, Suzhou, Jiangsu 215006, People’s  Republic of China Tel +86 512 6778 1540 email leiy@suda.edu.c nJournal name: International Journal of Nanomedicine Article Designation: Review Y ear: 2017 Volume: 12 Running head verso: Vimbela et al Running head recto: Antibacterial properties and toxicity from metallic nanomaterials DOI: http://dx.doi.org/10.2147/IJN.S134526",Non-OADS,/arxiv_data1/oa_pdf/c9/7a/ijn-12-3941.PMC5449158.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/c9/7a/ijn-12-3941.PMC5449158.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c9/7a/ijn-12-3941.PMC5449158.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/22/83/tcrm-13-655.PMC5449159.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2017:13 655–661Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  655Case Repo RTopen access to scientific and medical research open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S12982 0 a retrograde y-stenting of the trachea for  treatment of mediastinal fistula in an unusual  situation Wolfgang Hohenforst- schmidt1 paul Zarogoulidis2 Michael steinheimer1 Thomas schneider1 Naim Benhassen1 Holger Rupprecht3 Lutz Freitag4 1Medical Clinic I, “Fuerth” Hospital,   University of erlangen, Fuerth,   Germany; 2pulmonary Department- oncology Unit, “G papanikolaou”  General Hospital, aristotle University  of Thessaloniki, Thessaloniki, Greece;   3Department of General, Vascular  and Thoracical surgery, “Fuerth”  Hospital, University of erlangen,   Fuerth, 4Department of Interventional  pneumology, Ruhrlandklinik,   University Hospital essen, University  of essen-Duisburg, essen, GermanyIntroduction:  Stents have been used for quite some time for the treatment of benign and  malignant airway stenosis.",Non-OADS,/arxiv_data1/oa_pdf/22/83/tcrm-13-655.PMC5449159.pdf
"Furthermore, stents can be introduced using a variety of techniques  under general or mild anesthesia, the choice based on the treating physicians’ experi - ence, medical underlying disease, and the centers’ available equipment.7,8 Regarding  patients with malignancy, some prognostic factors such as stridor and postprocedure  chemotherapy have been identified as independent prognostic factors.6,9 It is essentially Correspondence: paul Zarogoulidis pulmonary Department-oncology Unit,  “G papanikolaou” General Hospital,  aristotle University of Thessaloniki,  exohi 1100, Thessaloniki, Greece Tel +30 6977271974 Fax +30 231 099 2424 email pzarog@hotmail.co m Journal name: Therapeutics and Clinical Risk Management Article Designation: Case report Y ear: 2017 Volume: 13 Running head verso: Hohenforst-Schmidt et al Running head recto: A retrograde y-stenting of the trachea DOI: http://dx.doi.org/10.2147/TCRM.S129820",Non-OADS,/arxiv_data1/oa_pdf/22/83/tcrm-13-655.PMC5449159.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/22/83/tcrm-13-655.PMC5449159.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/22/83/tcrm-13-655.PMC5449159.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/82/93/ndt-13-1395.PMC5449160.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2017:13 1395–1397Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1395Case repor Topen access to scientific and medical research open access Full T ext article http: //dx.doi.org/10.2147/NDT .S13566 6 T opiramate add-on treatment associated with  normalization of prolactin levels in a patient with  schizophrenia Yinglin Huang1,2 Huan Ma1 Yuan Wang2 Miao peng2 Gang Zhu1 1Department of p sychiatry, The First  affiliated Hospital of China Medical  University, 2Department of psychiatry,   shengjing Hospital of China Medical  University, shenyang, ChinaAbstract:  Topiramate has been used increasingly in the management of psychiatric conditions.",Non-OADS,/arxiv_data1/oa_pdf/82/93/ndt-13-1395.PMC5449160.pdf
"Prolactin was measured by using electrochemiluminescence  immunoassay, with commercial kits recommended by the manufacturer (Siemens Correspondence: Gang Zhu Department of psychiatry, The First  Affiliated Hospital of China Medical  University, shenyang 110001, China Tel +86 24 8328 2184 email gzhu@mail.cmu.edu.c n Journal name: Neuropsychiatric Disease and Treatment Article Designation: Case report Y ear: 2017 Volume: 13 Running head verso: Huang et al Running head recto: Normalization of prolactin levels by topiramate in schizophrenia DOI: http://dx.doi.org/10.2147/NDT.S135666",Non-OADS,/arxiv_data1/oa_pdf/82/93/ndt-13-1395.PMC5449160.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/82/93/ndt-13-1395.PMC5449160.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/82/93/ndt-13-1395.PMC5449160.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/a4/21/jbm-8-055.PMC5449161.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/a4/21/jbm-8-055.PMC5449161.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Blood Medicine 2017:8 55–60Journal of Blood Medicine Dovepress submit your manuscript | www.dovepress.com Dovepress  55 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JBM.S135191Analysis of blood donor pre-donation deferral   in Dubai: characteristics and reasons Laila Al Shaer1 Ranjita Sharma2 Mahera AbdulRahman2 1College of Medicine, Mohammed Bin  Rashid University of Medicine and  Health Sciences, Dubai, UAE; 2Dubai  Health Authority, Dubai, UAEBackground: To ensure an adequate and safe blood supply, it is crucial to select suitable donors  according to stringent eligibility criteria.",Non-OADS,/arxiv_data1/oa_pdf/a4/21/jbm-8-055.PMC5449161.pdf
"Box: 505055, Dubai, UAE Tel +971 4 383 8708 Email laila.alsuwaidi@mbru.ac.aeJournal name: Journal of Blood Medicine Article Designation: ORIGINAL RESEARCHY ear: 2017V olume: 8Running head verso: Al Shaer et alRunning head recto: Donor deferral in DubaiDOI: http://dx.doi.org/10.2147/JBM.S135191",Non-OADS,/arxiv_data1/oa_pdf/a4/21/jbm-8-055.PMC5449161.pdf
Available at: https://www.dsc.gov.ae/Publication/%D9%86%D8%B4%D8%B1%D8%A9%20%D8%A7%D9%84%D8%B3%D9%83%D8%A7%D9%86%202013%20En.pdf.,Non-OADS,/arxiv_data1/oa_pdf/a4/21/jbm-8-055.PMC5449161.pdf
"Journal of Blood Medicine 2017:8submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Blood Medicine Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/journal-of-blood-medicine-journalThe Journal of Blood Medicine is an international, peer-reviewed, open  access, online journal publishing laboratory, experimental and clinical aspects   of all aspect pertaining to blood based medicine including but not limited to:   Transfusion Medicine; Blood collection, Donor issues, Transmittable diseases,   and Blood banking logistics; Immunohematology; Artificial and alternative blood based therapeutics; Hematology; Biotechnology/nanotechnology of blood related medicine; Legal aspects of blood medicine; Historical perspec-tives.",Non-OADS,/arxiv_data1/oa_pdf/a4/21/jbm-8-055.PMC5449161.pdf
Visit http://www.dovepress.com/ testimonials.php to read real quotes from published authors.Dovepress 60 Al Shaer et al  12.,Non-OADS,/arxiv_data1/oa_pdf/a4/21/jbm-8-055.PMC5449161.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/b4/6a/ott-10-2645.PMC5449162.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2017:10 2645–2654OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2645Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S13320 3 association between clinicopathological features  and survival in patients with primary and paired  metastatic colorectal cancer and KRAS mutation Xue-lian Pang* Qiao-Xin li* Zhi-Ping Ma Yi shi Yu-Qing Ma Xin-Xia li Wen-li cui Wei Zhang Department of Pathology, The First  affiliated hospital of Xinjiang Medical  University, Urumqi, People’s republic  of china *These authors contributed equally   to this workAbstract:  The KRAS  gene mutation is involved in several types of tumors.",Non-OADS,/arxiv_data1/oa_pdf/b4/6a/ott-10-2645.PMC5449162.pdf
"A previous study has showed that  the survival rate of patients with the wild-type KRAS  gene receiving EGFR  antibody correspondence: Wen-li cui;   Wei Zhang Department of Pathology, The First  Affiliated Hospital of Xinjiang Medical  University, 137 liyushan south road,  Urumqi 830054, Xinjiang, People’s  republic of china Tel +86 991 436 2806 email cwl860@163.co m;   zwyhr100@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2017 Volume: 10 Running head verso: Pang et al Running head recto: Clinicopathological features and survival of patients with KRAS -mutant CRC DOI: http://dx.doi.org/10.2147/OTT.S133203",Non-OADS,/arxiv_data1/oa_pdf/b4/6a/ott-10-2645.PMC5449162.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/b4/6a/ott-10-2645.PMC5449162.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/b4/6a/ott-10-2645.PMC5449162.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/f3/0f/opth-11-939.PMC5449164.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2017:11 939–944Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  939Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S13512 8 novel positioning sensor with real-time feedback  for improved postoperative positioning: pilot  study in control subjects Frank l Brodie1 David a ramirez2,* sundar Pandian3,* Kelly Woo3 ashwin Balakrishna3 eugene De Juan1 hyuck Choo3 robert h grubbs3 1Department of Ophthalmology,   University of California san Francisco,   san Francisco, C a, Usa; 2school of  Medicine, University of California san  Francisco, san Francisco, C a, Usa;   3Department of Medical engineering,   California institute of T echnology,   Pasadena, C a, Usa  *These authors contributed equally  to this workIntroduction:  Repair of retinal detachment frequently requires use of intraocular gas.",Non-OADS,/arxiv_data1/oa_pdf/f3/0f/opth-11-939.PMC5449164.pdf
"There has been some debate in the literature as to the need  to position, especially after macular hole surgery,1 but a recent Preferences and  Trends survey from the American Society of Retinal Surgeons found that over  90% of retinal surgeons instruct their patients to position themselves postopera - tively.2 In addition to increasing the likelihood of a successful surgical outcome,  correct positioning can reduce the incidence of postoperative complications, such  as glaucoma and cataract.3 Correspondence: Frank l Brodie University of California san Francisco,  10 Koret Way, san Francisco,  Ca 94143, Usa Tel +1 415 710 2410 Fax +1 415 476 0336  email frank.brodie@ucsf.ed u Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Brodie et al Running head recto: Novel positioning sensor for improved postoperative positioning DOI: http://dx.doi.org/10.2147/OPTH.S135128",Non-OADS,/arxiv_data1/oa_pdf/f3/0f/opth-11-939.PMC5449164.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/f3/0f/opth-11-939.PMC5449164.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f3/0f/opth-11-939.PMC5449164.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/f7/f2/opth-11-983.PMC5449165.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2017:11 983–992Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  983Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/OPTH.S12576 8 Comprehensive review of visual defects reported  with topiramate Lisa Ford1 Jeffrey L Goldberg2 Fred Selan1 Howard e Greenberg1 Yingqi Shi1 1Janssen Research & Development,   LLC, Titusville, NJ, 2Byers eye  institute, Stanford University,   Palo Alto, CA, USAObjective:  The objective of this study was to analyze clinical patterns of visual field defects  (VFDs) reported with topiramate treatment and assess possible mechanism of action (MOA)  for antiepileptic drug (AED) associated VFDs.",Non-OADS,/arxiv_data1/oa_pdf/f7/f2/opth-11-983.PMC5449165.pdf
"Results from electrophysiological and biochemical studies on cultured neurons  have suggested three properties that may contribute to the antiepileptic efficacy  of topiramate: sodium channel blocking action, potentiation of the inhibitory Correspondence: Lisa Ford Neurosciences, Janssen Research &  Development, LLC, 1125 Trenton- Harbourton Road, Titusville,  NJ 08560, USA Tel +1 609 730 2909 Fax +1 609 730 4583 email lford1@its.jnj.co m Journal name: Clinical Ophthalmology Article Designation: Review Y ear: 2017 Volume: 11 Running head verso: Ford et al Running head recto: Visual defects reported with topiramate DOI: http://dx.doi.org/10.2147/OPTH.S125768",Non-OADS,/arxiv_data1/oa_pdf/f7/f2/opth-11-983.PMC5449165.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/f7/f2/opth-11-983.PMC5449165.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f7/f2/opth-11-983.PMC5449165.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/a0/96/ijn-12-3977.PMC5449166.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 3977–3991International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3977OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S13332 6 Investigating the use of curcumin-loaded  electrospun filaments for soft tissue repair  applications Pierre-alexis Mouthuy1,2 Maja somogyi Škoc3 Ana Čipak Gašparović1 Lidija Milković1 andrew J carr2 Neven Žarković1 1laboratory for Oxidative stress,   rudjer Boskovic Institute, Zagreb,   croatia; 2Botnar research centre,   Nuffield Department of Orthopaedics,   rheumatology and Musculoskeletal  sciences, Medical science Division,   University of Oxford, Oxford, UK;   3Department of Materials, Fibres and  T extile T esting, University of Zagreb,   Zagreb, croatiaAbstract:  Electrospun filaments represent a new generation of medical textiles with promising  applications in soft tissue repair.",Non-OADS,/arxiv_data1/oa_pdf/a0/96/ijn-12-3977.PMC5449166.pdf
ox.ac.u k Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Mouthuy et al Running head recto: Curcumin-loaded electrospun filaments for soft tissue repair applications DOI: http://dx.doi.org/10.2147/IJN.S133326,Non-OADS,/arxiv_data1/oa_pdf/a0/96/ijn-12-3977.PMC5449166.pdf
Available  from: http://www.grandviewresearch.com/industry-analysis/medical- textiles-market.,Non-OADS,/arxiv_data1/oa_pdf/a0/96/ijn-12-3977.PMC5449166.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/a0/96/ijn-12-3977.PMC5449166.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a0/96/ijn-12-3977.PMC5449166.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/e3/7a/opth-11-1009.PMC5449167.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2017:11 1009–1014Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1009Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/OPTH.S13745 1 Comparison of visual acuity, refractive outcomes,  and satisfaction between lasiK performed with  a microkeratome and a femto laser sharif hashmani1 nauman hashmani1  hina rajani2 Priyanka ramesh2  Junaid ahmed soomro2 syed rashid hussain shah2 Jaish Kumar2 sayed Mustafa Mahmood  shah2 1Department of Ophthalmology,   hashmanis hospital, Karachi, Pakistan;   2Dow Medical College, Karachi,   PakistanPurpose:  To compare refractive outcomes, visual acuities, and satisfaction of patients between  those treated with laser-assisted in situ keratomileusis (LASIK) using a Hansatome microker - atome (HM) and femto-assisted laser (FAL).",Non-OADS,/arxiv_data1/oa_pdf/e3/7a/opth-11-1009.PMC5449167.pdf
"Some show superior outcomes with the  former,7–10 others favor the use of a microkeratome,11 and a few show no significant  differences in either of the treatment modalities.12,13Correspondence: nauman hashmani Department of Ophthalmology,  hashmanis hospital, 68/B Khayaban-e- shahbaz, Dha Phase 7, Karachi, Pakistan Tel +92 321 282 8062 email naumanhashmani@gmail.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Hashmani et al Running head recto: Comparison of laser-assisted in situ keratomileusis DOI: http://dx.doi.org/10.2147/OPTH.S137451",Non-OADS,/arxiv_data1/oa_pdf/e3/7a/opth-11-1009.PMC5449167.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/e3/7a/opth-11-1009.PMC5449167.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e3/7a/opth-11-1009.PMC5449167.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/b0/fe/ijn-12-3967.PMC5449168.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2017:12 3967–3975International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3967OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S12580 8 aggregation is a critical cause of poor transfer  into the brain tissue of intravenously administered  cationic P aMaM dendrimer nanoparticles Y oshika Kurokawa1 hideko sone1 Tin-Tin Win-shwe1 Yang Zeng1 hiroyuki Kimura2 Y osuke Koyama1 Yusuke Yagi2 Yasuto Matsui3 Masashi Yamazaki4 seishiro hirano1 1center for health and environmental  risk research, National Institute  for environmental studies, Tsukuba,   Ibaraki, 2Department of analytical  and Bioinorganic chemistry,   Kyoto Pharmaceutical University,   3Department of environmental  engineering, Kyoto University  graduate school of engineering,   Kyoto, 4TIa center Office, National  Institute of advanced Industrial  science and T echnology, Tsukuba,   Ibaraki, JapanAbstract:  Dendrimers have been expected as excellent nanodevices for brain medication.",Non-OADS,/arxiv_data1/oa_pdf/b0/fe/ijn-12-3967.PMC5449168.pdf
"In general, in relation to nanodevice-implemented  delivery of biomaterials, a number of technical difficulties need to be overcome, such  as how the materials can escape the clearance systems of the living body, how they can  be guided to the target organs, how they can be internalized and utilized in the target  cells, and how adverse effects associated with their use can be avoided.2 The second  of the above items, namely, targeting, is a special problem when the target organ is  the brain because of the existence of the blood–brain barrier (BBB).3 Dendrimers are nanoparticles with unique features: they are usually spherical in  shape, show wide variances of size and surface radicals, and contain an inner pocket.4  They are built of a series of branches from core element and are utilized as binders correspondence: Yoshika Kurokawa center for health and environmental  risk research, National Institute for  environmental studies, Onogawa 16-2,  Tsukuba, Ibaraki 305-8506, Japan Tel +81 029 850 2437 email kurokawa@nies.go.j p Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2017 Volume: 12 Running head verso: Kurokawa et al Running head recto: Aggregation prevent brain transfer of PAMAM dendrimer DOI: http://dx.doi.org/10.2147/IJN.S125808",Non-OADS,/arxiv_data1/oa_pdf/b0/fe/ijn-12-3967.PMC5449168.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/b0/fe/ijn-12-3967.PMC5449168.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b0/fe/ijn-12-3967.PMC5449168.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/8d/e4/imcrj-10-173.PMC5449169.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/8d/e4/imcrj-10-173.PMC5449169.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).International Medical Case Reports Journal 2017:10 173–175International Medical Case Reports Journal Dovepress submit your manuscript | www.dovepress.com Dovepress 173 CASE REPORT   open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IMCRJ.S134944Extraordinary and prolonged erlotinib-induced  clinical response in a patient with EGFR wild-type  squamous lung cancer in third-line therapy: a case  report Elisabetta Gambale1  Consiglia Carella1  Paolo Amerio2  Fiamma Buttitta3  Rosa Lucia Patea4  Clara Natoli1  Michele De T ursi1 1Medical Oncology Unit, Department  of Medical, Oral and Biotechnological  Sciences, 2Department of  Dermatology and Venereology,  University G. d’Annunzio, Chieti,   3Department of Medicine and Aging  Sciences, University of Chieti-Pescara,  Chieti,  4Department of Radiologic  Sciences, University of Chieti-Pescara,  Chieti, ItalyAbstract:  Several small molecules, epidermal growth factor receptor (EGFR)-tyrosine kinase  inhibitors (TKIs), such as gefitinib, erlotinib and afatinib, have been demonstrated to significantly  improve clinical outcomes in patients with advanced EGFR-mutated non-small cell lung cancer  (NSCLC), but erlotinib activity in EGFR wild-type squamous carcinoma is still highly debated.",Non-OADS,/arxiv_data1/oa_pdf/8d/e4/imcrj-10-173.PMC5449169.pdf
"A whole-body computed tomography (CT) scan showed an area of parenchymal consolidation in the anterior segment of the right upper lobe Correspondence: Michele De Tursi Medical Oncology Unit, Department of Medical, Oral and Biotechnological Sciences, University G. D’Annunzio, PO SS Annunziata, UOC Clinical Oncology, Via Dei Vestini 5, 66100 Chieti, Italy Tel +39 0871 35 8243   Fax +39 0871 35 8365   Email detursi@unich.itJournal name: International Medical Case Reports Journal Article Designation: CASE REPORT Y ear: 2017V olume: 10Running head verso: Gambale et alRunning head recto: Extraordinary erlotinib response in squamous NSCLCDOI: http://dx.doi.org/10.2147/IMCRJ.S134944",Non-OADS,/arxiv_data1/oa_pdf/8d/e4/imcrj-10-173.PMC5449169.pdf
"International Medical Case Reports Journal 2017:10submit your manuscript | www.dovepress.com Dovepress Dovepress International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/international-medical-case-reports-journal-journalThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/8d/e4/imcrj-10-173.PMC5449169.pdf
"Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 175 Extraordinary erlotinib response in squamous NSCLC In patients with progressive EGFR wild-type sqNSCLC  after failure of standard chemotherapy, comorbidities and  a low probability of a response to a chemotherapy, EGFR-TKIs are a valid treatment option over placebo or best supportive care.",Non-OADS,/arxiv_data1/oa_pdf/8d/e4/imcrj-10-173.PMC5449169.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/dc/2a/ppa-11-985.PMC5449171.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2017:11 985–994Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  985OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S12786 2 Barriers and facilitators associated with  colonoscopy completion in individuals with  multiple chronic conditions: a qualitative study shahnaz sultan1–4 Melissa r Partin1,2 Phalgoon shah5 Jennifer lelaurin4 ivette Magaly Freytes4 chandylen l nightingale6 susan F Fesperman4 Barbara A curbow7 rebecca J Beyth3,4,8 1center for chronic Disease  Outcomes research, Minneapolis  Veterans Affairs health care system,   2Department of Medicine, University  of Minnesota, Minneapolis, M n,   3Department of Medicine, University  of Florida college of Medicine,   gainesville, Fl, 4center of innovation  on Disability and rehabilitation  research, north Florida/ south  georgia Veterans health system,   gainesville, Fl, 5Department of  Medicine, Tripler Army Medical  center, honolulu, hi, 6Department  of social sciences and health Policy,   Wake Forest school of Medicine,   Winston-salem nc, 7Department of  community and Behavioral health,   University of Maryland, college Park,   MD, 8geriatric research, education  and clinical center, north Florida/ south georgia Veterans health  system, gainesville, Fl, UsABackground:  A recommendation to undergo a colonoscopy, an invasive procedure that requires  commitment and motivation, planning (scheduling and finding a driver) and preparation (diet  restriction and laxative consumption), may be uniquely challenging for individuals with multiple  chronic conditions (MCCs).",Non-OADS,/arxiv_data1/oa_pdf/dc/2a/ppa-11-985.PMC5449171.pdf
"Keywords:  adherence, colonoscopy barriers, multiple chronic conditions, Veterans Introduction Over the past decade, efforts to promote patient-centered care for individuals with  chronic conditions have included moving away from disease-specific approaches to  strategies that consider patients’ personal goals, their social context, and their ability to  self-manage.1,2 Chronic conditions are defined as conditions lasting 12  months or more  that limit self-care and independent living and require ongoing medical intervention.3–5  According to recent estimates, approximately half of adults in the US have at least  one chronic condition and more than one in four Americans have multiple chronic  conditions (MCCs).5–7 Individuals with MCCs have high rates of health care utilization correspondence: shahnaz sultan center for chronic Disease Outcomes  research, Minneapolis Veterans Affairs  health care system, One Veteran Drive,  Minneapolis, Mn 55417, UsA Tel +1 612 467 4364 Fax +1 612 717 5699 email shahnaz.sultan@va.go v Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Sultan et al Running head recto: Barriers to colonoscopy in individuals with chronic conditions DOI: http://dx.doi.org/10.2147/PPA.S127862",Non-OADS,/arxiv_data1/oa_pdf/dc/2a/ppa-11-985.PMC5449171.pdf
"Available from: http://www.rwjf.org/content/rwjf/en/research- publications/find-rwjf-research/2010/01/chronic-care.htm l. Accessed  September 1, 2016.",Non-OADS,/arxiv_data1/oa_pdf/dc/2a/ppa-11-985.PMC5449171.pdf
Available from: http://www.hhs.gov/ash/initiatives/mcc /.,Non-OADS,/arxiv_data1/oa_pdf/dc/2a/ppa-11-985.PMC5449171.pdf
"Available from: http://sru.soc.surrey.ac.uk/SRU22.htm l. Accessed  September 1, 2016.",Non-OADS,/arxiv_data1/oa_pdf/dc/2a/ppa-11-985.PMC5449171.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/dc/2a/ppa-11-985.PMC5449171.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/34/75/opth-11-945.PMC5449174.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2017:11 945–950Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  945Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/OPTH.S13506 8 randomized comparison of in vivo performance  of two point-of-care tear film osmometers Jerry nolfi Barbara Caffery T oronto eye Care Optometric Clinic,   T oronto, On , CanadaPurpose:  To compare the in vivo precision of two commercially available point-of-care  osmometers among normal subjects with no dry eye disease.",Non-OADS,/arxiv_data1/oa_pdf/34/75/opth-11-945.PMC5449174.pdf
"This cascade of events includes  inflammation, ocular surface damage, and symptoms of discomfort.1–6 Tear osmolarity  is maintained through homeostatic, compensatory mechanisms in healthy subjects.7,8  In dry eye disease, this homeostasis is lost, resulting in increased osmolarity and  tear instability.9–12Correspondence: Jerry Nolfi Toronto eye Care Optometric  Clinic, 55 Bloor street W, Toronto,  On M4W 1a5, Canada Tel +1 416 966 1955 email jnolfi@torontoeyecare.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2017 Volume: 11 Running head verso: Nolfi and Caffery Running head recto: Comparison of osmometers in a clinic setting DOI: http://dx.doi.org/10.2147/OPTH.S135068",Non-OADS,/arxiv_data1/oa_pdf/34/75/opth-11-945.PMC5449174.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/34/75/opth-11-945.PMC5449174.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/34/75/opth-11-945.PMC5449174.pdf
Available from  https://health-products.canada.ca/mdall-limh/dispatch-repartition.,Non-OADS,/arxiv_data1/oa_pdf/34/75/opth-11-945.PMC5449174.pdf
"Available from https://www.tearlab.com/ pdfs/technical/TearLab_TC_IFU_ML_Small.pd f. Accessed May 12,  2017.",Non-OADS,/arxiv_data1/oa_pdf/34/75/opth-11-945.PMC5449174.pdf
"Table 1 shows the distribution of these p articipants according to self- reported ethnicity (see also Supplementary Methods, available on theArthritis & Rheumatology web site at http://onlinelibrary.wiley.",Non-OADS,/arxiv_data1/oa_pdf/13/56/ART-69-1294.PMC5449251.pdf
Additional cross-study quality control per formance is described in Supplemen- tary Methods (available on the Arthritis & Rheumatology web site at http://onlinelibrary.wiley.com/do i/10.1002/art.40040/ abstract).,Non-OADS,/arxiv_data1/oa_pdf/13/56/ART-69-1294.PMC5449251.pdf
"Principal components analysis (PCA) using EigenStrat (16) was used for ancestryestimation (see Supplementa ry Methods, available on the Arthri- tis & Rheumatology web site at http://onlinelibrary.wiley.com/doi/ 10.1002/art.40040/abstract).",OADS,/arxiv_data1/oa_pdf/13/56/ART-69-1294.PMC5449251.pdf
"Due to the multiethnic and multiplatform nature of our study, we perform ed multiple phases of analysis using logistic regression for e ach SNP as a predictor of case– control status: 1) analysis of al l SICCA participants and external controls (AREDS and COGEND) genotyped on the Omni2.5M platform (1,444,854 SNPs), adju sting for 9 PCs, sex, and smoking status (see Supplementary Methods, available on the Arthritis & Rheumatology web site at http://onlinelibrary.wiley.com/doi/10.",Non-OADS,/arxiv_data1/oa_pdf/13/56/ART-69-1294.PMC5449251.pdf
Regulatory evidence for sites of i nterest was collected from RegulomeDB (17) and ANNOVAR (18) data; evidence for associ- ation with related phenotypes was c ollected from National Center for Biotechnology Informatio n Phenotype–Genotype Integrator (http://www.ncbi.nlm.nih.gov/gap/phegeni).,OADS,/arxiv_data1/oa_pdf/13/56/ART-69-1294.PMC5449251.pdf
Supplementary Figure 4 (available on the Arthritis & Rheumatology web site at http://onlinelibrary.wiley.com/ doi/10.1002/art.40040/abstract) shows associations of geno- typed and imputed SNPs in the KLRG1 region for Euro- pean and Asian participants separately.,Non-OADS,/arxiv_data1/oa_pdf/13/56/ART-69-1294.PMC5449251.pdf
Sup- plementary Table 2 (available on the Arthritis & Rheumatol- ogyweb site at http://onlinelibrary.wiley.com/doi/10.1002/art.,Non-OADS,/arxiv_data1/oa_pdf/13/56/ART-69-1294.PMC5449251.pdf
"40040/abstract) contains details of the SNP/proxy selection, and Supplementary Table 5 (available on the Arthritis & Rheumatology web site at http://onlinelibrary.wiley.com/ doi/10.1002/art.40040/abstract) contains results from the 3 GWAS.",OADS,/arxiv_data1/oa_pdf/13/56/ART-69-1294.PMC5449251.pdf
"The results of this analysis are shown in Supplemen-tary Table 6, available on the Arthritis & Rheumatology web site at http://onlinelibrary.wiley.com/doi/10.1002/art.40040/abstract.",OADS,/arxiv_data1/oa_pdf/13/56/ART-69-1294.PMC5449251.pdf
"As shown in Supplementary Figure 5 (available on the Arthritis &R h e u m a t o l o g y web site at http://onlinelibrary.wiley.com/ doi/10.1002/art.40040/abstract), we plotted the heterogeneityPvalue from the Q statistic for the 24 representative SNPs between the European and Asian analyses versus the differ-ence in MAF between controls in the 2 population groups.Although most of these SNPs had highly significant allelefrequency differences, there was also substantial heteroge-neity of association; i.e., the frequency differences did notfully explain these differences in association.",OADS,/arxiv_data1/oa_pdf/13/56/ART-69-1294.PMC5449251.pdf
"Because it is possible that the relationship between ancestry and subphenotype was confounded by the geo-graphic recruitment site, we adjusted for site via meta- analysis and provide site-specific statistics for PC1 (see Supplementary Table 7, available on the Arthritis & Rheu- matology web site at http://onlinelibrary.wiley.com/doi/10.",OADS,/arxiv_data1/oa_pdf/13/56/ART-69-1294.PMC5449251.pdf
"Our results for the top SNPs werevery similar if the subjects po sitive for only 1 criterion are omitted or if the newer 2016 ACR/European LeagueAgainst Rheumatism criteria (32) were used (see Supple- mentary Table 8, available on the Arthritis & Rheumatology web site at http://onlinelibrary.wiley.com/doi/10.1002/art.40040/abstract).",Non-OADS,/arxiv_data1/oa_pdf/13/56/ART-69-1294.PMC5449251.pdf
"Overall, changes were made to blood pressure management and lipid and glycemic medication, including insulin.Enhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/6517 F06067C51742 .",Non-OADS,/arxiv_data1/oa_pdf/20/ce/40123_2016_Article_69.PMC5449289.pdf
"This article is distributed under the terms of the Creative CommonsAttribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/20/ce/40123_2016_Article_69.PMC5449289.pdf
2015. https://www.nice.org.uk/guidance/ ng28 .,Non-OADS,/arxiv_data1/oa_pdf/20/ce/40123_2016_Article_69.PMC5449289.pdf
2014. https://www.nice.org.uk/ Guidance/cg181 .,Non-OADS,/arxiv_data1/oa_pdf/20/ce/40123_2016_Article_69.PMC5449289.pdf
2012. https://www.rcophth.ac.uk/wp- content/uploads/2014/12/2013-SCI-301-FINAL-DR-GUIDELINES-DEC-2012-updated-July-2013.pdf .,Non-OADS,/arxiv_data1/oa_pdf/20/ce/40123_2016_Article_69.PMC5449289.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/34/e9/40123_2016_Article_71.PMC5449290.pdf
"High rates of undetected diabetic retinopathy were found in low-income and minority areas.Enhanced content To view enhanced content for this article, go to http://www.medengine.com/Redeem/B32 7F06060F24265 .",Non-OADS,/arxiv_data1/oa_pdf/d3/6b/40123_2016_Article_72.PMC5449291.pdf
"This article is distributed under the terms of the Creative CommonsAttribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit tothe original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/d3/6b/40123_2016_Article_72.PMC5449291.pdf
https://www.medicaid.gov/medicaid- chip-program-informati on/by-state/illinois.html .,Non-OADS,/arxiv_data1/oa_pdf/d3/6b/40123_2016_Article_72.PMC5449291.pdf
http://www.census.gov/ quickfacts/table/HEA775214/17031 .,OADS,/arxiv_data1/oa_pdf/d3/6b/40123_2016_Article_72.PMC5449291.pdf
https://nei.nih.gov/health/diabetic/retinopathy .,Non-OADS,/arxiv_data1/oa_pdf/d3/6b/40123_2016_Article_72.PMC5449291.pdf
http://www.esri.com/data/streetmap .,Non-OADS,/arxiv_data1/oa_pdf/d3/6b/40123_2016_Article_72.PMC5449291.pdf
http://bphc.hrsa.gov/about/what- is-a-health-center/index.html .,Non-OADS,/arxiv_data1/oa_pdf/d3/6b/40123_2016_Article_72.PMC5449291.pdf
http://www.nearnorthhealth.,Non-OADS,/arxiv_data1/oa_pdf/d3/6b/40123_2016_Article_72.PMC5449291.pdf
http://ilpriorauth.com/Default.aspx .,Non-OADS,/arxiv_data1/oa_pdf/d3/6b/40123_2016_Article_72.PMC5449291.pdf
https://www.healthypeople.,Non-OADS,/arxiv_data1/oa_pdf/d3/6b/40123_2016_Article_72.PMC5449291.pdf
2012.https://nei.nih.gov/sites/default/ﬁles/nei-pdfs/VisionResearch2012.pdf .,Non-OADS,/arxiv_data1/oa_pdf/d3/6b/40123_2016_Article_72.PMC5449291.pdf
http://www.ncbi.nlm.nih.gov/ books/NBK207133/ .,Non-OADS,/arxiv_data1/oa_pdf/d3/6b/40123_2016_Article_72.PMC5449291.pdf
"In fact, visual acuity as a soleEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/8527 F0602EBCC959 .",Non-OADS,/arxiv_data1/oa_pdf/a4/42/40123_2016_Article_73.PMC5449292.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any non- commercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source,provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/a4/42/40123_2016_Article_73.PMC5449292.pdf
"Laboratory of Experimental Ophthalmology of Aristotle University, Thessaloniki, Greece 2000.http://www.rand.org/health/surveys_tools/vfq.html .",Non-OADS,/arxiv_data1/oa_pdf/a4/42/40123_2016_Article_73.PMC5449292.pdf
"However, the response was incomplete and they still had inﬂammatory corneoconjunctival ﬂares despite continuousEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ 3137F0606E0C4AA6 .",Non-OADS,/arxiv_data1/oa_pdf/c7/e3/40123_2016_Article_74.PMC5449293.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, providea link to the Creative Commons license, and indicate if changes were made.204 Ophthalmol Ther (2017) 6:195–206",Non-OADS,/arxiv_data1/oa_pdf/c7/e3/40123_2016_Article_74.PMC5449293.pdf
Keywords: Central serous retinopathy; Mineralocorticoid antagonists; Neovascular AMD; Subretinal ﬂuid; Wet AMD INTRODUCTION Overactivation of mineralocorticoid receptor pathways in choroidal vessels have been noted in experimental models of central serous chorioretinopathy (CSCR) [ 1].Enhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/5137 F0603E01499A .,Non-OADS,/arxiv_data1/oa_pdf/1f/40/40123_2016_Article_75.PMC5449294.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any non- commercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source,provide a link to the Creative Commons license, and indicate if changes were made.Ophthalmol Ther (2017) 6:141–146 145",Non-OADS,/arxiv_data1/oa_pdf/1f/40/40123_2016_Article_75.PMC5449294.pdf
"Keywords: Keratoconus; Iontophoretic collagen cross-linking; Standard cross-linking; Riboﬂavin INTRODUCTION Keratoconus (KC) is a degenerative eye disorder that progressively damages the internal struc- ture of the cornea, which becomes cone-shaped and gets thinner, gradually causing visualEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ 4D77F0605700577F .",Non-OADS,/arxiv_data1/oa_pdf/d9/c7/40123_2017_Article_76.PMC5449295.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in any medium, provided you give appropriate creditto the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/d9/c7/40123_2017_Article_76.PMC5449295.pdf
This article is based on previously conducted studies and does not involve any new studies of human or animal subjects performed by any of the authors.Enhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ E487F06069F3094F .,Non-OADS,/arxiv_data1/oa_pdf/88/eb/40123_2017_Article_77.PMC5449296.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, andindicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/88/eb/40123_2017_Article_77.PMC5449296.pdf
"In light of the above, the purpose of this study was to investigate the clinical efﬁcacy of a gas tamponade in cases of retinectomy for PVR.Enhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ F487F0606138D6CA .",Non-OADS,/arxiv_data1/oa_pdf/71/57/40123_2017_Article_78.PMC5449297.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, andindicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/71/57/40123_2017_Article_78.PMC5449297.pdf
Keywords: Botulinum toxin; Dry eye; Lacrimal plugs; LASIKEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/B58 7F0603FC2D5E3 .,Non-OADS,/arxiv_data1/oa_pdf/70/56/40123_2017_Article_79.PMC5449298.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in any medium, provided you give appropriate creditto the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.Ophthalmol Ther (2017) 6:167–174 173",Non-OADS,/arxiv_data1/oa_pdf/70/56/40123_2017_Article_79.PMC5449298.pdf
"New methods in medicine often face intense and, arguably, not always fair scrutiny—even the most beneﬁcial inventions like smallpoxEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/F887 F0600575E4B2 .",Non-OADS,/arxiv_data1/oa_pdf/3d/cb/40123_2017_Article_80.PMC5449299.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, andindicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/3d/cb/40123_2017_Article_80.PMC5449299.pdf
His visual acuity wasEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ EA87F060643674FD .,Non-OADS,/arxiv_data1/oa_pdf/34/c0/40123_2017_Article_81.PMC5449300.pdf
"This article is distributed under the terms of the Creative CommonsAttribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, providea link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/34/c0/40123_2017_Article_81.PMC5449300.pdf
"Although the effect of SLT wanes over time, repeating the procedure may lead to clinical success comparable to that achieved with the initial treatment [ 3–5].Enhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ B097F0605AB49042 .",Non-OADS,/arxiv_data1/oa_pdf/74/6e/40123_2017_Article_82.PMC5449301.pdf
"This article is distributed under the terms of the Creative CommonsAttribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, providea link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/74/6e/40123_2017_Article_82.PMC5449301.pdf
"Improved access to care and newly developed drugs are reducing the prevalence of DR within diabetic populations, but because the incidenceEnhanced content To view enhanced content for this article, go to http://www.medengine.com/Redeem/ 84F7F0603F049DFA .",Non-OADS,/arxiv_data1/oa_pdf/58/7b/40123_2017_Article_83.PMC5449302.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, andindicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/58/7b/40123_2017_Article_83.PMC5449302.pdf
"With all of these developments, it is crucial for modern ophthalmic surgery sys- tems to provide the best solutions for both anterior and posterior segment surgery.Enhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ 19F7F0606B42CE1D .",Non-OADS,/arxiv_data1/oa_pdf/3d/cb/40123_2017_Article_84.PMC5449303.pdf
"August 29,2016. http://ois.net/bausch-and-lomb-shares- developments-in-vitrectomy/ .",Non-OADS,/arxiv_data1/oa_pdf/3d/cb/40123_2017_Article_84.PMC5449303.pdf
"This relaxed zonular state allows the lens to obtain a more spherical shape, which leads to an overallEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ 4B08F060344E8FDA .",Non-OADS,/arxiv_data1/oa_pdf/98/c6/40123_2017_Article_85.PMC5449304.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in any medium, provided you give appropriate creditto the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/98/c6/40123_2017_Article_85.PMC5449304.pdf
http://lo.um.es/paper/optical-modeling- of-a-corneal-inlay-in-real-eyes-to-increase-depth-of-focus-optimum-centration-and-residual-defocus-2/ .,Non-OADS,/arxiv_data1/oa_pdf/98/c6/40123_2017_Article_85.PMC5449304.pdf
Although the exact pathophysio- logical mechanisms behind the disease are notEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ 8B08F060682C7A0C .,Non-OADS,/arxiv_data1/oa_pdf/b0/31/40123_2017_Article_86.PMC5449305.pdf
"To identify the publications concerning geographic atrophy, a systematic literaturesearch of the MEDLINE/PubMed database (http://www.ncbi.nlm.nih.gov/pubmed ) was performed in February 2017, using the follow-ing search strategy: ‘‘geographic atrophy’’ or ‘‘age related macular degeneration’’ in combi- nation with management, outcome, quality oflife, diagnosis and treatment.",Non-OADS,/arxiv_data1/oa_pdf/b0/31/40123_2017_Article_86.PMC5449305.pdf
An additional system-atic literature search of the Clinical Trials(https://clinicaltrials.gov ) was performed using ‘‘geographic atrophy’’ as keyword.,Non-OADS,/arxiv_data1/oa_pdf/b0/31/40123_2017_Article_86.PMC5449305.pdf
"This article is distributed under the terms of the Creative CommonsAttribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, providea link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/b0/31/40123_2017_Article_86.PMC5449305.pdf
The above led to the design of the prospec- tive ProNTO (Prospective Optical Coherence Tomography Imaging of Patients With Neovas- cular AMD Treated With IntraocularEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ 6D08F06045CB4DE0 .,Non-OADS,/arxiv_data1/oa_pdf/cb/2a/40123_2017_Article_87.PMC5449306.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, andindicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/cb/2a/40123_2017_Article_87.PMC5449306.pdf
Keywords: Corneal inlay; KAMRA; Presbyopia; Small aperture inlayEnhanced Content To view enhanced content for this article go to http://www.medengine.com/Redeem/ 3818F06066AEAC90 .,Non-OADS,/arxiv_data1/oa_pdf/97/dc/40123_2017_Article_88.PMC5449307.pdf
"This article is distributed under the terms of the Creative CommonsAttribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any non- commercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source,provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/97/dc/40123_2017_Article_88.PMC5449307.pdf
"Finally, posterior segment OCT for imaging of the macular region and optic nerve should be conducted on an annual basis.Enhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/9B18 F0605FE630F9 .",Non-OADS,/arxiv_data1/oa_pdf/7b/ef/40123_2017_Article_89.PMC5449308.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, andindicate if changes were made.102 Ophthalmol Ther (2017) 6:93–104",Non-OADS,/arxiv_data1/oa_pdf/7b/ef/40123_2017_Article_89.PMC5449308.pdf
2017. http://ec.europa.eu/health/documents/ community-register/html/h1049.htm .,Non-OADS,/arxiv_data1/oa_pdf/7b/ef/40123_2017_Article_89.PMC5449308.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any non- commercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/b4/8e/40123_2017_Article_90.PMC5449309.pdf
"Mean change from baseline (date of ﬁrst injection) in visual acuity and central sub- ﬁeld retinal thickness to 12 months was ?7.6 Early Treatment Diabetic Retinopathy Study letters [95% conﬁdence interval (CI) 2.8, 12.4; p=0.003; n=27] and -67.7lm (95% CIEnhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/8C18 F0603703D331 .",Non-OADS,/arxiv_data1/oa_pdf/7b/31/40123_2017_Article_91.PMC5449310.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in any medium, provided you give appropriate creditto the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/7b/31/40123_2017_Article_91.PMC5449310.pdf
2014. http://www.ema.,Non-OADS,/arxiv_data1/oa_pdf/7b/31/40123_2017_Article_91.PMC5449310.pdf
Conclusion : A comprehensive diabetic retinopathy screening programme is much needed in Samoa given the high prevalence of diabetic eye disease.Enhanced content To view enhanced content for this article go to http://www.medengine.com/Redeem/ 1028F06022C1308B .,Non-OADS,/arxiv_data1/oa_pdf/cb/c6/40123_2017_Article_92.PMC5449311.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any non- commercial use, distribution, and reproductionin any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license,and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/cb/c6/40123_2017_Article_92.PMC5449311.pdf
"Ann Hepatobiliary Pancreat Surg 2017;21:101-105 https://doi.org/10.14701 /ahbps.2017.21.2.101 Case Report Surgery for intractable pain in a patient with chronic pancreatitis  complicated with biliary obstr uction, portal vein stenosis and  mesenteric venous collaterals Cuneyt Kayaalp, Murat Sait  Dogan, and Veysel Ersan Department of Surgery, Inonu University, Malatya, Turkey Pancreatic head resection for chronic pancreatitis is a c hallenging procedure, in the presence of venous collaterals,  cavernous transformation, extensive fibros is or porto-mesenteric stenosis or thro mbosis.",Non-OADS,/arxiv_data1/oa_pdf/01/97/ahbps-21-101.PMC5449365.pdf
"Ann Hepatobiliary Pancreat Surg 2017;21:67-75 https://doi.org/10.14 701/ahbps.2017.21.2.67 Original Article Mirizzi syndrome: a new insight pr ovided by a novel classification Carmen Payá-Llorente, Antonio Vázquez-Tarragón, Antonio Alberola-Soler, Aleix Martínez-Pérez,  Elías Martínez-López, Sandra Santarrufina-Martínez, In maculada Ortiz-Tarín, and Ernesto Armañanzas-Villena Department of Surgery, Hospital Doctor Peset, Valencia, Spain Backgrounds/Aims:  Mirizzi syndrome (MS) is an uncommon complication  of cholelithiasis.",Non-OADS,/arxiv_data1/oa_pdf/4a/1c/ahbps-21-67.PMC5449366.pdf
Ann Hepatobiliary Pancreat Surg 2017;21:76-79 https://doi.org/10.14 701/ahbps.2017.21.2.76 Original Article Central pancreatectomy - an oncolog ically safe opt ion to treat  metastases of other ne oplasms of the mid-po rtion of t he pancreas?,Non-OADS,/arxiv_data1/oa_pdf/c8/ed/ahbps-21-76.PMC5449367.pdf
"Ann Hepatobiliary Pancreat Surg 2017;21:80-83 https://doi.org/10.14 701/ahbps.2017.21.2.80 Case Report Robotic-assisted right hepatectomy via anterior  approach for intrahepatic cholangiocarcinoma Sanjay Goja, Manoj K Singh, Rohan Ja gat Chaudhary, and Arvinder S Soin Medanta Institute of Liver Diseases and Tr ansplantation, Medanta-The Medicity, India Major hepatic resection, especially right  hepatectomy, has been successfully performed by specialized hepatobiliary  centers using the robotic platform with lo w morbidity, conversion rates and outcomes comparable to laparoscopic and  open surgery.",Non-OADS,/arxiv_data1/oa_pdf/39/41/ahbps-21-80.PMC5449368.pdf
"Ann Hepatobiliary Pancreat Surg 2017;21:84-87 https://doi.org/10.14 701/ahbps.2017.21.2.84 Case Report Laparoscopic cholecystectomy in a ca se of situs inversus totalis:  a review of technical challenges and adaptations Azhar Alam, and Abhijit Santra Department of Surgery, B.R.",Non-OADS,/arxiv_data1/oa_pdf/27/f9/ahbps-21-84.PMC5449369.pdf
"Ann Hepatobiliary Pancreat Surg 2017;21:88-92 https://doi.org/10.14 701/ahbps.2017.21.2.88 Case Report Hemobilia due to arteriobiliary fistula complicating ERCP for  residual bile duct stone in a case of Mirizzi syndrome Surendrakumar Mathur1, Vinaykumar Thapar2, and Vasudev Chowda3 Departments of 1HBP and Liver Transplant, 2General and Laparoscopic Surgery, and 3Gastroenterology,  SevenHills Hospital and Health City, Mumbai, India Hemobilia is a rare cause of upper gastrointestinal tract bleeding.",Non-OADS,/arxiv_data1/oa_pdf/c9/3c/ahbps-21-88.PMC5449370.pdf
"Ann Hepatobiliary Pancreat Surg 2017;21:93-95 https://doi.org/10.14 701/ahbps.2017.21.2.93 Case Report Distal pancreatectomy with splenorenal shunt to preserve spleen  in a cirrhotic patient Giuseppe Maria Ettorre, Giovanni Battista Levi Sandri, Marco Colasanti,  Edoardo de Werra, and Pasquale Lepiane Division of General Surgery and Liver Transp lantation, San Camillo Hospital, Rome, Italy At pancreatic ductal adenocarcinoma is an aggressive malig nancy with a high recurrence rate.",Non-OADS,/arxiv_data1/oa_pdf/ad/6f/ahbps-21-93.PMC5449371.pdf
"Ann Hepatobiliary Pancreat Surg 2017;21:96-100 https://doi.org/10.14 701/ahbps.2017.21.2.96 Case Report Laparoscopic total pancreatectomy fo r multiple meta stasis of renal cell carcinoma of the pancreas: a case report and literature revie w Yun Jong Choi1, Jin Ho Lee2, Cho Rok Lee1,3,5,  Woong Kyu Han1,6, Chang Moo Kang1,4,5,7, and Woo Jung Lee1,4,5,7 1Yonsei University College of Medicine, Seoul, 2Department of Surgery, National Health Insurance Service Ilsan Hospital,  Goyang, 3Division of Thyroid and Endocrine Surgery, 4Division of Hepatobiliary and Pancreatic Surgery, Departments of  5Surgery and 6Urology, 7Pancreaticobiliary Cancer Clinic, Yonsei Cancer Center, Severance Hospital, Seoul, Korea Advances in surgical techniques and laparoscopic instruments have resulted in the development of laparoscopic pan- creatic surgery.",Non-OADS,/arxiv_data1/oa_pdf/15/b1/ahbps-21-96.PMC5449372.pdf
"Nutrition Research and Practice 2017;11(3):173-179 ⓒ2017 The Korean Nutrition Society and the Korean Society of Community Nutrition http://e-nrp.org   Inhibitory effect of  Gastrodia elata Blume extract on  alpha-melanocyte stimulating hormone-induced melanogenesis in murine B16F10 melanoma Eugene Shim1, Eunju Song2, Kyoung Sook Choi3, Hyuk-Joon Choi3, and Jinah Hwang2§ 1Department of Food and Nutrition, Soongeui Women’s College, Seoul 04628, Korea 2Department of Food and Nutrition, Colleg e of Natural Sciences, Myongji University, 116 Myongji-ro, Cheoin-gu, Yongin, Gyeonggi 17058, Korea 3BK Bio Co. Ltd., Seongnam, Gyeonggi 13229, Korea BACKGROUND/OBJECTIVES:  Gastrodia elata  Blume (GEB), a traditional herbal medicine, has been used to treat a wide range  of neurological disorders ( e.g., paralysis and stroke) and skin problems ( e.g., atopic dermatitis and eczema) in oriental medicine.",Non-OADS,/arxiv_data1/oa_pdf/6a/d1/nrp-11-173.PMC5449373.pdf
"Nutrition Research and Practice 2017;11(3):173-179; https://doi.org/10.4162/nrp.2017.11.3.173; pISSN 1976-1457 eISSN 2005-6168 Keywords : Gastrodia elata , melanogenesis, tyrosinase INTRODUCTION 1) Human skin color is affected by genetics and many factors,  mainly by amounts and types of melanin.",Non-OADS,/arxiv_data1/oa_pdf/6a/d1/nrp-11-173.PMC5449373.pdf
"Nutrition Research and Practice 2017;11(3):180-189 ⓒ2017 The Korean Nutrition Society and the Korean Society of Community Nutrition http://e-nrp.org   Increased glucose metabolism and alpha-glucosidase inhibition in  Cordyceps militaris  water extract-treated HepG2 cells Dae Jung Kim1, Yun Hwan Kang2, Kyoung Kon Kim3, Tae Woo Kim1, Jae Bong Park4 and Myeon Choe1,3§ 1Well-being Bioproducts RIC, Kangwon National University, Gangwon 25209, Korea 2National Development Institute of Korean Medicine, Gyeongbuk 38540, Korea 3Department of Bio-Health Technology, Kangwon National University, 1 Gangwondaehak-gil, Chuncheon, Gangwon 24341, Korea 4Department of Biochemistry, Hallym University  College of Medicine, Gangwon 24252, Korea BACKGROUND/OBJECTIVES: Recent living condition improvements, changes in dietary habits, and reductions in physical activity  are contributing to an increase in metabolic syndrome symptoms including diabetes and obesity.",Non-OADS,/arxiv_data1/oa_pdf/37/7d/nrp-11-180.PMC5449374.pdf
"Nutrition Research and Practice 2017;11(3):180-189; https://doi.org/10.4162/nrp.2017.11.3.180; pISSN 1976-1457 eISSN 2005-6168 Keywords : Cordyceps militaris , antidiabetics, glucose transporter, glucokinase, glycogen INTRODUCTION 2) Diabetes is a chronic metabolic disease with a high global  prevalence.",Non-OADS,/arxiv_data1/oa_pdf/37/7d/nrp-11-180.PMC5449374.pdf
"Nutrition Research and Practice 2017;11(3):190-197 ⓒ2017 The Korean Nutrition Society and the Korean Society of Community Nutrition http://e-nrp.org   Melanin extract from Gallus gallus domesticus  promotes  proliferation and differentiation of osteoblastic MG-63 cells via  bone morphogenetic protein-2 signaling Han-Seok Yoo1, Kang-Hyun Chung1, Kwon-Jai Lee2, Dong-Hee Kim3 and Jeung Hee An4§ 1Department of Food Science and Technology, Seoul National  University of Science & Te chnology, Seoul 01811, Korea 2Department of Advanced Materials Engineering, Daejeon University, Daejeon 34520, Korea 3Department of Oriental Medicine, Daejeon University, Daejeon 34520, Korea 4Division of Food Bioscience, Konkuk University, 268, Chungwon-daero, Chunju, Chungbuk 27478, Korea BACKGROUND/OBJECTIVES: Gallus gallus domesticus  (GD)  is a natural mutant breed of chicken in Korea with an atypical characterization  of melanin in its tissue.",Non-OADS,/arxiv_data1/oa_pdf/ae/8d/nrp-11-190.PMC5449375.pdf
"Nutrition Research and Practice 2017;11(3):190-197; https://doi.org/10.4162/nrp.2017.11.3.190; pISSN 1976-1457 eISSN 2005-6168 Keywords : Melanin, alkaline phosphatase, osteoblast, cell differentiation INTRODUCTION 3) Osteoporosis, which is a metabolic condition characterized  by decreased bone mass and increased risk of fracture, occurs  frequently in women following menopause [1].",Non-OADS,/arxiv_data1/oa_pdf/ae/8d/nrp-11-190.PMC5449375.pdf
"Nutrition Research and Practice 2017;11(3):198-205 ⓒ2017 The Korean Nutrition Society and the Korean Society of Community Nutrition http://e-nrp.org   Pear pomace ethanol extract improves insulin resistance through  enhancement of insulin signaling pathway without lipid accumulation Mi-Kyoung You, Hwa-Jin Kim, Jin Rhyu and Hyeon-A Kim§ Department of Food and Nutrition / Research Institute of Human Ecology, Mokpo National University, 1666, Yeongsan-ro, Cheonggye -myeon, Muan-gun, Jeonam  58554, Korea BACKGROUND/OBJECTIVES: The anti-diabetic activity of pear through inhibition of α-glucosidase has been demonstrated.",Non-OADS,/arxiv_data1/oa_pdf/f1/ca/nrp-11-198.PMC5449376.pdf
"Nutrition Research and Practice 2017;11(3):198-205; https://doi.org/10.4162/nrp.2017.11.3.198; pISSN 1976-1457 eISSN 2005-6168 Keywords : Insulin sensitivity, glucose transporter, lipid metabolism, adipose tissue, pyrus INTRODUCTION 4) Obesity is associated with insulin resistance [1,2], which is  defined as a reduction in the ability of insulin to activate its  signaling pathway in the main target organs [3,4].",Non-OADS,/arxiv_data1/oa_pdf/f1/ca/nrp-11-198.PMC5449376.pdf
"Nutrition Research and Practice 2017;11(3):206-213 ⓒ2017 The Korean Nutrition Society and the Korean Society of Community Nutrition http://e-nrp.org   Antioxidant mechanism of black garlic extract involving nuclear  factor erythroid 2-like factor 2 pathway Ae Wha Ha and Woo Kyoung Kim§ Department of Food Science and Nutrition, 119, Dandae-ro, Dongnam-gu, Cheonan-si, Chungnam 31116, Korea BACKGROUN/OBJECTIVES: Although studies have revealed  that black garlic is a potent antioxidant, its antioxidant mechanism  remains unclear.",Non-OADS,/arxiv_data1/oa_pdf/fc/b6/nrp-11-206.PMC5449377.pdf
"Nutrition Research and Practice 2017;11(3):206-213; https://doi.org/10.4162/nrp.2017.11.3.206; pISSN 1976-1457 eISSN 2005-6168 Keywords : Garlic, antioxidant, oxidative stress, glucose, insulin INTRODUCTION 5) Reactive oxygen species (ROS) are free radicals that accelerate  prooxidant processes and produce toxicity in the body.",Non-OADS,/arxiv_data1/oa_pdf/fc/b6/nrp-11-206.PMC5449377.pdf
"Nutrition Research and Practice 2017;11(3):214-222 ⓒ2017 The Korean Nutrition Society and the Korean Society of Community Nutrition http://e-nrp.org   Lymphocyte DNA damage and plasma antioxidant status in  Korean subclinical hypertensive patients by glutathione  S-transferase polymorphism Jeong-Hwa Han1, Hye-Jin Lee2, Hee Jeong Choi3, Kyung Eun Yun4, Myung-Hee Kang2§ 1Nutrition Safety Policy Division, Food Nutrit ion and Dietary Safety Bureau, Ministry of Food and Drug Safety, Heungdeok-gu, Che ongju-si, Chungbuk 28159, Korea 2Department of Food Science and Nutrition, Daedeok Valley Campus, Hannam University, 461-6 Jeonmin-dong, Yuseong-gu, Daejeon 340 54, Korea 3Department of Family Medicine, Eulji University School of Medicine, Daejeon 35233, Korea 4Center for Cohort Studies, Total Healthcare Center, Kangbuk Sams ung Hospital, Sungkyunkwan University School of Medicine, Seoul  03181, Korea BACKGROUND/OBJECTIVES: Glutathione S-transferase (GST) forms a multigene family of phase II detoxification enzymes which  are involved in the detoxification of xenobiotics by conjugating substances with glutathione.",Non-OADS,/arxiv_data1/oa_pdf/b0/59/nrp-11-214.PMC5449378.pdf
"Nutrition Research and Practice 2017;11(3):214-222; https://doi.org/10.4162/nrp.2017.11.3.214; pISSN 1976-1457 eISSN 2005-6168 Keywords : Glutathione S-transferase, hypertension, DNA damage, oxidative stress, antioxidants INTRODUCTION 6) Essential hypertension is a complex, multifactorial, polygenic  disease whose genetic influences (i.e.",Non-OADS,/arxiv_data1/oa_pdf/b0/59/nrp-11-214.PMC5449378.pdf
"Nutrition Research and Practice 2017;11(3):223-231 ⓒ2017 The Korean Nutrition Society and the Korean Society of Community Nutrition http://e-nrp.org   Effect of soy isoflavones supplement on climacteric symptoms, bone  biomarkers, and quality of life in Korean postmenopausal women:  a randomized clinical trial Hansongyi Lee1, Ryowon Choue1,2 and Hyunjung Lim1,2§ 1Department of Medical Nutrition, Graduate School of East-West Medical Science, Kyung Hee University, 1732 Deogyeong-daero, Gihe ung-gu, Yongin 17104, Korea 2Research Institute of Medical Nutrition, Kyung Hee University, Seoul 02447, Korea BACKGROUND/OBJECTIVES:  Soy isoflavones are expected to improve menopausal symptoms and osteoporosis in women.",Non-OADS,/arxiv_data1/oa_pdf/07/ba/nrp-11-223.PMC5449379.pdf
"Nutrition Research and Practice 2017;11(3):223-231; https://doi.org/10.4162/nrp.2017.11.3.223; pISSN 1976-1457 eISSN 2005-6168 Keywords : Isoflavones, postmenopause, climacteric, bone, quality of life INTRODUCTION 7) Soy and soy products have been studied in menopausal  women for decades.",Non-OADS,/arxiv_data1/oa_pdf/07/ba/nrp-11-223.PMC5449379.pdf
Available from: https://cris.nih.,Non-OADS,/arxiv_data1/oa_pdf/07/ba/nrp-11-223.PMC5449379.pdf
Available  from: http://www.fsc.go.jp/sonota/daizu_isoflavone.html.,Non-OADS,/arxiv_data1/oa_pdf/07/ba/nrp-11-223.PMC5449379.pdf
Available from: https://www.ars.usda.gov/ARSUserFiles/80400525/  Data/isoflav/Isoflav_R2.pdf.,Non-OADS,/arxiv_data1/oa_pdf/07/ba/nrp-11-223.PMC5449379.pdf
Available from:  http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm071643.pdf.,Non-OADS,/arxiv_data1/oa_pdf/07/ba/nrp-11-223.PMC5449379.pdf
"Nutrition Research and Practice 2017;11(3):232-239 ⓒ2017 The Korean Nutrition Society and the Korean Society of Community Nutrition http://e-nrp.org   Instant noodle consumption is associated with cardiometabolic risk  factors among college students in Seoul In Sil Huh1*, Hyesook Kim2*, Hee Kyung Jo3, Chun Soo Lim3, Jong Seung Kim3, Soo Jin Kim4, Oran Kwon2, Bumjo Oh5§ and  Namsoo Chang2§  1Seoul National University Medical Research Center, Seoul 03080, Korea 2Department of Nutritional Science and Food Management, Ewha Womans University, 52, Ewhayeodae-gil, Seodaemun-gu, Seoul 03760, K orea 3Seoul National University Health Service Center, Seoul 08826, Korea 4Health Promotion Center, Chung-Ang University Hospital, Seoul 06973, Korea 5Department of Family Medicine, SMG - SNU Boramae Medical Ce nter, 20, Boramae-ro 5-gil, Dongjak-gu, Seoul 07061, Korea BACKGROUND/OBJECTIVES:  Increased consumption of instant noodles has recently been reported to be positively associated  with obesity and cardiometabolic syndrome in South Korea, which has the highest per capita instant noodle consumption worldwide.",Non-OADS,/arxiv_data1/oa_pdf/be/f1/nrp-11-232.PMC5449380.pdf
"Nutrition Research and Practice 2017;11(3):232-239; https://doi.org/10.4162/nrp.2017.11.3.232; pISSN 1976-1457 eISSN 2005-6168 Keywords : Overweight, blood pressure, hypertriglyceridemia, metabolic factors INTRODUCTION 8) Overconsumption of instant noodles has recently received  special attention, owing to its association with obesity and cardiometabolic syndrome among adults in South Korea [1].",Non-OADS,/arxiv_data1/oa_pdf/be/f1/nrp-11-232.PMC5449380.pdf
Available from: http://koreabizwire.com/south- korea-ranked-no-1-in-instant-noodle-consumption/19034.,Non-OADS,/arxiv_data1/oa_pdf/be/f1/nrp-11-232.PMC5449380.pdf
Available from: http://www.gallup.co.kr/gallupdb/reportDownload.,Non-OADS,/arxiv_data1/oa_pdf/be/f1/nrp-11-232.PMC5449380.pdf
Available from: http://instantnoodles.org/en/  noodles/report.html.,Non-OADS,/arxiv_data1/oa_pdf/be/f1/nrp-11-232.PMC5449380.pdf
"Nutrition Research and Practice 2017;11(3):240-246 ⓒ2017 The Korean Nutrition Society and the Korean Society of Community Nutrition http://e-nrp.org   Preconceptional use of folic acid and knowledge about folic acid  among low-income pregnant women in Korea Jihyun Kim1, Miyong Yon2, Cho-il Kim2§, Yoonna Lee3, Gui-Im Moon4, Jinhwan Hong4 and Taisun Hyun1§ 1Department of Food and Nutrition, Chungbuk National University, 1, Chungdae-ro, Seowon-gu, Cheongju-si, Chungbuk 28644, Korea 2Nutrition Management Service and Policy Team , Korea Health Industry Development Institut e, Osongsaengmyeong2-ro 187, Chungbuk 2 8159, Korea 3D e p a r t m e n t  o f  F o o d  a n d  N u t r i t i o n ,  S h i n g u  C o l l e g e ,  G y e o n g g i  1 3 1 7 4 ,  K o r e a 4Food Safety Evaluation Department, Ministry of Food and Drug Safety, Chungbuk 28159, Korea BACKGROUND/OBJECTIVES:  Folic acid supplementation before pregnancy is known to significantly reduce the risk of having  a baby with neural tube defects (NTDs).",Non-OADS,/arxiv_data1/oa_pdf/17/f4/nrp-11-240.PMC5449381.pdf
"Nutrition Research and Practice 2017;11(3):240-246; https://doi.org/10.4162/nrp.2017.11.3.240; pISSN 1976-1457 eISSN 2005-6168 Keywords : Folic acid, dietary supplements, awareness, knowledge, pregnancy INTRODUCTION 9) The neural tube is an embryonic structure that develops into  the brain and spinal cord.",Non-OADS,/arxiv_data1/oa_pdf/17/f4/nrp-11-240.PMC5449381.pdf
Available from: http://www.icbdsr.org/.,Non-OADS,/arxiv_data1/oa_pdf/17/f4/nrp-11-240.PMC5449381.pdf
Available from: http://www.eurocat-ne twork.eu/accessprevalencedata/prevalencetables.,OADS,/arxiv_data1/oa_pdf/17/f4/nrp-11-240.PMC5449381.pdf
Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/000 19479.htm.,OADS,/arxiv_data1/oa_pdf/17/f4/nrp-11-240.PMC5449381.pdf
Available from: http://www.who.int/elena/titles/folate_periconceptional/en/.,Non-OADS,/arxiv_data1/oa_pdf/17/f4/nrp-11-240.PMC5449381.pdf
Available from: https://www.khidi.or.kr/board /view?pageNum=2&rowCnt=10&no1=78&linkId=100750&menuId= MENU00085&maxIndex=00001786749998&minIndex=00001000799998&schType=1&schText=&boardStyl e=&categoryId=09&continent= &country=.,Non-OADS,/arxiv_data1/oa_pdf/17/f4/nrp-11-240.PMC5449381.pdf
Available from: http://www.mohw.go.kr/  front_new/jb/sjb0406ls.jsp?PAR_MENU_ID=03&MENU_ID=030406.,Non-OADS,/arxiv_data1/oa_pdf/17/f4/nrp-11-240.PMC5449381.pdf
"Nutrition Research and Practice 2017;11(3):247-256 ⓒ2017 The Korean Nutrition Society and the Korean Society of Community Nutrition http://e-nrp.org   Development of tailored nutrition information messages based on  the transtheoretical model for smartphone application of an obesity  prevention and management program for elementary-school students Ji Eun Lee1*, Da Eun Lee1*, Kirang Kim2, Jae Eun Shim3, Eunju Sung4, Jae-Heon Kang5 and Ji-Yun Hwang1§ 1Department of Foodservice Management and Nutrition, Sangmyung University, 20 Hongjimun 2-gil, Jongno-gu, Seoul 03016, Korea  2Department of Food Science and Nutrition, Dankook University, Chungnam 31116, Korea 3Department of Food and Nutrition, Da ejeon University, Daejeon 34520, Korea 4Department of Family Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul 03181, Korea 5Department of Family Medicine, Seoul Paik Hospital, In je University College of Medicine, Seoul 04551, Korea BACKGROUND/OBJECTIVES:  Easy access to intervention and support for certain behaviors is important for obesity prevention  and management.",Non-OADS,/arxiv_data1/oa_pdf/4f/2c/nrp-11-247.PMC5449382.pdf
"Nutrition Research and Practice 2017;11(3):247-256; https://doi.org/10.4162/nrp.2017.11.3.247; pISSN 1976-1457 eISSN 2005-6168 Keywords : Pediatric obesity, preventive health services, nutritional status, health behavior, mobile applications INTRODUCTION 10) The economic burden attributable to obesity and its related  diseases was estimated at approximately 1,363 billion Korean  Won [1].",Non-OADS,/arxiv_data1/oa_pdf/4f/2c/nrp-11-247.PMC5449382.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Alberto Grassi, MD, PhD,  Internal  Medicine and Hepatology Division, Infermi Hospital, Viale  Settembrini 2, 47921 Rimini, Italy.",Non-OADS,/arxiv_data1/oa_pdf/57/30/WJG-23-3569.PMC5449413.pdf
"European Association for the Study of the Liver  Recommendations on Treatment of Hepatitis C 2016  confirm that HCV treatment for IDUs should be  considered on an individualized basis and delivered  within a multidisciplinary team setting; a history of  intravenous drug use and recent drug use at treatment  initiation are not associated with reduced sustained EDITORIALSubmit a Manuscript: http://www.f6publishing.com DOI: 10.3748/wjg.v23.i20.3569 3569 May 28, 2017 |Volume 23 |Issue 20 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 May 28; 23(20): 3569-3571  ISSN 1007-9327 (print)  ISSN 2219-2840 (online)",Non-OADS,/arxiv_data1/oa_pdf/57/30/WJG-23-3569.PMC5449413.pdf
World J Gastroenterol  2017; 23(20): 3569-3571   Available from: URL: http://www.wjgnet.com/1007-9327/full/ v23/i20/3569.htm   DOI: http://dx.doi.org/10.3748/wjg.v23.,Non-OADS,/arxiv_data1/oa_pdf/57/30/WJG-23-3569.PMC5449413.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 452  0",Non-OADS,/arxiv_data1/oa_pdf/57/30/WJG-23-3569.PMC5449413.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to : Lisardo Boscá, Ph �,  Lisardo Boscá, Ph �, Department of  Metabolism and Cell Signaling, Institute of Biomedical Research  Alberto Sols, Arturo Duperier 4, Madrid 28029,  Spain.",Non-OADS,/arxiv_data1/oa_pdf/79/9c/WJG-23-3572.PMC5449414.pdf
"Since potent and  selective inhibitors of COX-2 exist, but also stable PGE 2  analogues to be used in therapy, unraveling the precise  contribution of this enzyme and its products to the  prevention of the progress of liver dysfunctions appears  to be a useful approach for managing liver diseases.EDITORIALSubmit a Manuscript: http://www.f6publishing.com DOI: 10.3748/wjg.v23.i20.3572 3572 May 28, 2017 |Volume 23 |Issue 20 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 May 28; 23(20): 3572-3580  ISSN 1007-9327 (print)  ISSN 2219-2840 (online)",Non-OADS,/arxiv_data1/oa_pdf/79/9c/WJG-23-3572.PMC5449414.pdf
"������ ��������  ��  Gast��ente���  2017; 23(20): 3572-3580  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v23/i20/3572.htm   DOI:  http://dx.doi.org/10.3748/wjg.v23.i20.3572 INTRODUCTION Prostaglandins and thromboxanes are bioactive lipids  that regulate many physiological responses but in  some cases are recognized as players in inflammatory  and tumor diseases, including colorectal and hepatic  cancer[1,2].",Non-OADS,/arxiv_data1/oa_pdf/79/9c/WJG-23-3572.PMC5449414.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 452  0",Non-OADS,/arxiv_data1/oa_pdf/79/9c/WJG-23-3572.PMC5449414.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Zenichi Morise, MD, PhD, FACS, AGAF,   Department of Surgery, Fujita Health University School of  Medicine, 1-98 Kutsukakecho, Toyoake, Aichi 470-1192,  Japan.",Non-OADS,/arxiv_data1/oa_pdf/11/25/WJG-23-3581.PMC5449415.pdf
"During  this period, two international consensus conferences REVIEWSubmit a Manuscript: http://www.f6publishing.com DOI: 10.3748/wjg.v23.i20.3581 3581 May 28, 2017 |Volume 23 |Issue 20 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 May 28; 23(20): 3581-3588  ISSN 1007-9327 (print)  ISSN 2219-2840 (online)",Non-OADS,/arxiv_data1/oa_pdf/11/25/WJG-23-3581.PMC5449415.pdf
World J Gastroenterol  2017; 23(20): 3581-3588   Available from: URL: http://www.wjgnet.com/1007-9327/full/ v23/i20/3581.htm   DOI: http://dx.doi.org/10.3748/wjg.v23.,Non-OADS,/arxiv_data1/oa_pdf/11/25/WJG-23-3581.PMC5449415.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 452  0",Non-OADS,/arxiv_data1/oa_pdf/11/25/WJG-23-3581.PMC5449415.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Chien-Ching Hung, MD, PhD, Clinical  Professor,  Department of Internal Medicine, National Taiwan  University Hospital, 7 Chung-Shan South Road, Taipei 10002,  Taiwan.",Non-OADS,/arxiv_data1/oa_pdf/18/53/WJG-23-3589.PMC5449416.pdf
"The REVIEWSubmit a Manuscript: http://www.f6publishing.com DOI: 10.3748/wjg.v23.i20.3589 3589 May 28, 2017 |Volume 23 |Issue 20 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 May 28; 23(20): 3589-3606  ISSN 1007-9327 (print)  ISSN 2219-2840 (online)",Non-OADS,/arxiv_data1/oa_pdf/18/53/WJG-23-3589.PMC5449416.pdf
World J Gastroenterol  2017; 23(20): 3589-3606   Available from: URL: http://www.wjgnet.com/1007-9327/full/ v23/i20/3589.htm   DOI: http://dx.doi.org/10.3748/wjg.v23.,Non-OADS,/arxiv_data1/oa_pdf/18/53/WJG-23-3589.PMC5449416.pdf
Available from: URL:  https://www.cdc.gov/mmwr/preview/mmwrhtml/rr5507a1.htm 114 World Health Organization .,Non-OADS,/arxiv_data1/oa_pdf/18/53/WJG-23-3589.PMC5449416.pdf
"Available from:  URL: http://www.who.int/ith/vaccines/hepatitisA/en/ 115 Tseng YT , Chang SY, Liu WC, Sun HY, Wu CH, Wu PY,  Lu CL, Hung CC, Chang SC.",Non-OADS,/arxiv_data1/oa_pdf/18/53/WJG-23-3589.PMC5449416.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 452  0",Non-OADS,/arxiv_data1/oa_pdf/18/53/WJG-23-3589.PMC5449416.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to: Mao- Sheng Xu, MD, PhD, Chief,  Department of Radiology, The First Affiliated Hospital of  Zhejiang Chinese Medical University, 54 Youdian Road,  Shangcheng District, Hangzhou 310006, Zhejiang Province,  China.",Non-OADS,/arxiv_data1/oa_pdf/cf/0e/WJG-23-3607.PMC5449417.pdf
"Overall, this REVIEWSubmit a Manuscript: http://www.f6publishing.com DOI: 10.3748/wjg.v23.i20.3607 3607 May 28, 2017 |Volume 23 |Issue 20 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 May 28; 23(20): 3607-3614  ISSN 1007-9327 (print)  ISSN 2219-2840 (online)",Non-OADS,/arxiv_data1/oa_pdf/cf/0e/WJG-23-3607.PMC5449417.pdf
World J Gastroenterol  2017;  23(20): 3607-3614  Available from: URL: http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/cf/0e/WJG-23-3607.PMC5449417.pdf
com/1007-9327/full/v23/i20/3607.htm   DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/cf/0e/WJG-23-3607.PMC5449417.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 452  0",Non-OADS,/arxiv_data1/oa_pdf/cf/0e/WJG-23-3607.PMC5449417.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Zong-Fang Li, MD, PhD,  National  Local Joint Engineering Research Center of Biodiagnostics and  Biotherapy, Department of General Surgery, the Second Affiliated  Hospital of Xi’an Jiaotong University College of Medicine, 157  West 5th Road, Xi’an 710004, Shaanxi Province,  China.",Non-OADS,/arxiv_data1/oa_pdf/5a/00/WJG-23-3615.PMC5449418.pdf
"Traditional Chinese REVIEWSubmit a Manuscript: http://www.f6publishing.com DOI: 10.3748/wjg.v23.i20.3615 3615 May 28, 2017 |Volume 23 |Issue 20 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 May 28; 23(20): 3615-3623  ISSN 1007-9327 (print)  ISSN 2219-2840 (online)",Non-OADS,/arxiv_data1/oa_pdf/5a/00/WJG-23-3615.PMC5449418.pdf
"World J Gastroenterol  2017; 23(20): 3615-3623  Available from:  URL: http://www.wjgnet.com/1007-9327/full/v23/i20/3615.htm    DOI: http://dx.doi.org/10.3748/wjg.v23.i20.3615 INTRODUCTION Acute pancreatitis (AP) is characterized by the  activation of trypsinogen and the establishment of a  local inflammatory response in the pancreas, with the  risk of developing into severe acute pancreatitis (SAP),  characterized by systemic inflammatory response  syndrome (SIRS) and multiple organ dysfunction  syndrome (MODS)[1-3].",Non-OADS,/arxiv_data1/oa_pdf/5a/00/WJG-23-3615.PMC5449418.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 452  0",Non-OADS,/arxiv_data1/oa_pdf/5a/00/WJG-23-3615.PMC5449418.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Anita Afzali, MD, MPH,  Division of  Gastroenterology, University of Washington, Harborview Medical  Center, 325 Ninth Avenue, Box 359773 , Seattle, Washington, WA  98104, United States.",Non-OADS,/arxiv_data1/oa_pdf/50/0c/WJG-23-3624.PMC5449419.pdf
"MINIREVIEWSSubmit a Manuscript: http://www.f6publishing.com DOI: 10.3748/wjg.v23.i20.3624 3624 May 28, 2017 |Volume 23 |Issue 20 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 May 28; 23(20): 3624-3631  ISSN 1007-9327 (print)  ISSN 2219-2840 (online)",Non-OADS,/arxiv_data1/oa_pdf/50/0c/WJG-23-3624.PMC5449419.pdf
World J  Gastroenterol  2017; 23(20): 3624-3631  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v23/i20/3624.htm   DOI:  http://dx.doi.org/10.3748/wjg.v23.i20.3624 INTRODUCTION Inflammatory bowel disease (IBD) is a heterogeneous  group of diseases that includes both ulcerative colitis  (UC) and Crohn’s disease (CD).,Non-OADS,/arxiv_data1/oa_pdf/50/0c/WJG-23-3624.PMC5449419.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 452  0",Non-OADS,/arxiv_data1/oa_pdf/50/0c/WJG-23-3624.PMC5449419.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Angel Lanas, MD, DSc, AGAF, FACG,  Professor, Chairman,  Service of Digestive Diseases, University  Clinic Hospital Lozano Blesa, Avenida San Juan Bosco, Zaragoza  50009, Spain.",Non-OADS,/arxiv_data1/oa_pdf/47/40/WJG-23-3632.PMC5449420.pdf
"Published by Baishideng Publishing  Group Inc. All rights reserved.MINIREVIEWSSubmit a Manuscript: http://www.f6publishing.com DOI: 10.3748/wjg.v23.i20.3632 3632 May 28, 2017 |Volume 23 |Issue 20 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 May 28; 23(20): 3632-3642  ISSN 1007-9327 (print)  ISSN 2219-2840 (online)",Non-OADS,/arxiv_data1/oa_pdf/47/40/WJG-23-3632.PMC5449420.pdf
World J Gastroenterol  2017; 23(20): 3632-3642  Available from:  URL: http://www.wjgnet.com/1007-9327/full/v23/i20/3632.htm    DOI: http://dx.doi.org/10.3748/wjg.v23.i20.3632 INTRODUCTION Colorectal cancer (CRC) is one the most commonly  diagnosed cancers worldwide.,Non-OADS,/arxiv_data1/oa_pdf/47/40/WJG-23-3632.PMC5449420.pdf
"Available from: URL: http://www.cancer.gov 21 Atkin WS , Edwards R, Kralj-Hans I, Wooldrage K, Hart AR,  Northover JM, Parkin DM, Wardle J, Duffy SW, Cuzick J. Once- only flexible sigmoidoscopy screening in prevention of colorectal  cancer: a multicentre randomised controlled trial.",Non-OADS,/arxiv_data1/oa_pdf/47/40/WJG-23-3632.PMC5449420.pdf
"Available from: URL:  http://www.cribadocancer.com 35 Heijnen ML , Landsdorp-Vogelaar I. CRC Screening in the  Netherlands.",Non-OADS,/arxiv_data1/oa_pdf/47/40/WJG-23-3632.PMC5449420.pdf
"Available  from: URL: http://www.rivm.nl/en/Topics/B/Bowel_cancer_screen ing_programme 36 McNamara D , Qasim A, Lee N, Condon C, O’Morain C. Round  one of the Adelaide and Meath Hospital/Trinity College Colorectal  Cancer Screening Programme: programme report and analysis  based on established international key performance indices.",Non-OADS,/arxiv_data1/oa_pdf/47/40/WJG-23-3632.PMC5449420.pdf
"Available from: URL: http://www.ncc.go.jp/ en/cis/index.html 52 Suh M , Song S, Cho HN, Park B, Jun JK, Choi E, Kim Y,  Choi KS.",OADS,/arxiv_data1/oa_pdf/47/40/WJG-23-3632.PMC5449420.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 452  0",Non-OADS,/arxiv_data1/oa_pdf/47/40/WJG-23-3632.PMC5449420.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: François-Pierre Martin, PhD,  Nestle  Institute of Health Sciences, 1015 Lausanne,  Switzerland.",Non-OADS,/arxiv_data1/oa_pdf/0b/a5/WJG-23-3643.PMC5449421.pdf
"In particular, levels of pyroglutamic acid, glutamic Submit a Manuscript: http://www.f6publishing.com DOI: 10.3748/wjg.v23.i20.3643 3643 May 28, 2017 |Volume 23 |Issue 20 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 May 28; 23(20): 3643-3654  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) ORIGINAL ARTICLE Urinary metabolic insights into host-gut microbial interactions  in healthy and IBD childrenBasic Study Francois-Pierre Martin, Ming-Ming Su, Guo-Xiang Xie, Seu Ping Guiraud, Martin Kussmann, Jean-Philippe Godin,  Wei Jia, Andreas Nydegger",Non-OADS,/arxiv_data1/oa_pdf/0b/a5/WJG-23-3643.PMC5449421.pdf
"World J  Gastroenterol  2017; 23(20): 3643-3654  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v23/i20/3643.htm   DOI:  http://dx.doi.org/10.3748/wjg.v23.i20.3643 INTRODUCTION The use of systems biology-oriented technologies  (e.g., metabonomics, proteomics, genomics and  microbiomics) redefines disease understanding and  phenotyping of clinical characteristics in medical  disorders such as in gastrointestinal deregulations[1,2].",Non-OADS,/arxiv_data1/oa_pdf/0b/a5/WJG-23-3643.PMC5449421.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 452  0",Non-OADS,/arxiv_data1/oa_pdf/0b/a5/WJG-23-3643.PMC5449421.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to: Jian-Sheng Li, Professor,  Department  of Gastroenterology, First Affiliated Hospital of Zhengzhou  University, No.",Non-OADS,/arxiv_data1/oa_pdf/a8/e9/WJG-23-3655.PMC5449422.pdf
"The Submit a Manuscript: http://www.f6publishing.com DOI: 10.3748/wjg.v23.i20.3655 3655 May 28, 2017 |Volume 23 |Issue 20 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 May 28; 23(20): 3655-3663  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) ORIGINAL ARTICLE M2-like Kupffer cells in fibrotic liver may protect against  acute insultBasic Study Qing-Fen Zheng, Li Bai, Zhong-Ping Duan, Yuan-Ping Han, Su-Jun Zheng, Yu Chen, Jian-Sheng Li",Non-OADS,/arxiv_data1/oa_pdf/a8/e9/WJG-23-3655.PMC5449422.pdf
World J Gastroenterol  2017; 23(20): 3655-3663  Available  from: URL: http://www.wjgnet.com/1007-9327/full/v23/ i20/3655.htm   DOI: http://dx.doi.org/10.3748/wjg.v23.i20.3655 INTRODUCTION Liver fibrosis is the most clinically relevant consequence of chronic liver diseases.,Non-OADS,/arxiv_data1/oa_pdf/a8/e9/WJG-23-3655.PMC5449422.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 452  0",Non-OADS,/arxiv_data1/oa_pdf/a8/e9/WJG-23-3655.PMC5449422.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to: Ma Mu Ti Jiang A Ba Bai Ke Re, MD,  PhD, Chief Physician, Professor,  Department of Anorectal  Surgery, First Affiliated Hospital, Xinjiang Medical University,  No.",Non-OADS,/arxiv_data1/oa_pdf/46/83/WJG-23-3664.PMC5449423.pdf
"The  concordance of ultrasonographic results with pathology Submit a Manuscript: http://www.f6publishing.com DOI: 10.3748/wjg.v23.i20.3664 3664 May 28, 2017 |Volume 23 |Issue 20 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 May 28; 23(20): 3664-3674  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) ORIGINAL ARTICLE Sonographic appearance of anal cushions of hemorrhoidsBasic Study Adilijiang Aimaiti, Ma Mu Ti Jiang A Ba Bai Ke Re, Irshat Ibrahim, Hui Chen, Maimaitituerxun Tuerdi, Mayinuer",Non-OADS,/arxiv_data1/oa_pdf/46/83/WJG-23-3664.PMC5449423.pdf
World J Gastroenterol  2017; 23(20): 3664-3674   Available from: U rL: http://www.wjgnet.com/1007-9327/full/ v23/i20/3664.htm   DOI: http://dx.doi.org/10.3748/wjg.v23.,Non-OADS,/arxiv_data1/oa_pdf/46/83/WJG-23-3664.PMC5449423.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 452  0",Non-OADS,/arxiv_data1/oa_pdf/46/83/WJG-23-3664.PMC5449423.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to: Zhao-Lian Bian, PhD,  Nantong Institute  of Liver Diseases, Nantong Third People’s Hospital, Nantong University, No.",Non-OADS,/arxiv_data1/oa_pdf/32/53/WJG-23-3675.PMC5449424.pdf
"Submit a Manuscript: http://www.f6publishing.com DOI: 10.3748/wjg.v23.i20.3675 3675 May 28, 2017 |Volume 23 |Issue 20 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 May 28; 23(20): 3675-3683  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) ORIGINAL ARTICLE Effect of NDC80 in human hepatocellular carcinomaBasic Study Lin-Ling Ju, Lin Chen, Jun-Hong Li, Yi-Fan Wang, Ru-Jian Lu, Zhao-Lian Bian, Jian-Guo Shao",Non-OADS,/arxiv_data1/oa_pdf/32/53/WJG-23-3675.PMC5449424.pdf
"World J  Gastroenterol  2017; 23(20): 3675-3683  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v23/i20/3675.htm   DOI:  http://dx.doi.org/10.3748/wjg.v23.i20.3675 INTRODUCTION Hepatocellular carcinoma (HCC) is one of the most  common cancers worldwide, and the third most  frequent cause of cancer mortality, following lung  and stomach cancers[1,2].",Non-OADS,/arxiv_data1/oa_pdf/32/53/WJG-23-3675.PMC5449424.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 452  0",Non-OADS,/arxiv_data1/oa_pdf/32/53/WJG-23-3675.PMC5449424.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to: Dan-Yang Liu, PhD,  Department of  Endocrinology, Affiliated Dalian Municipal Friendship Hospital  of Dalian Medical University, 8 Sanba Square, Zhongshan  District, Dalian 116001, Liaoning Province,  China.",Non-OADS,/arxiv_data1/oa_pdf/a0/67/WJG-23-3684.PMC5449425.pdf
"For satisfactory Submit a Manuscript: http://www.f6publishing.com DOI: 10.3748/wjg.v23.i20.3684 3684 May 28, 2017 |Volume 23 |Issue 20 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 May 28; 23(20): 3684-3689  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) ORIGINAL ARTICLE Animal experimental studies using small intestine  endoscopeBasic Study Jin-Hua Liu, Dan-Yang Liu, Li Wang, Li-Ping Han, Zhe-Yu Qi, Hai-Jun Ren, Yan Feng, Feng-Ming Luan,  Liang-Tian Mi, Shu-Mei Shan",Non-OADS,/arxiv_data1/oa_pdf/a0/67/WJG-23-3684.PMC5449425.pdf
World J Gastroenterol  2017;  23(20): 3684-3689  Available from: URL: http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/a0/67/WJG-23-3684.PMC5449425.pdf
com/1007-9327/full/v23/i20/3684.htm   DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a0/67/WJG-23-3684.PMC5449425.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 452  0",Non-OADS,/arxiv_data1/oa_pdf/a0/67/WJG-23-3684.PMC5449425.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Daniele Nicolini, MD, PhD,  Division  of Hepatobiliary and Transplant Surgery, Department of  Experimental and Clinical Medicine, Polytechnic University of  Marche, via Tronto n°10/a, 60126 Ancona,  Italy.",Non-OADS,/arxiv_data1/oa_pdf/9d/b5/WJG-23-3690.PMC5449426.pdf
"daniele.nicolini@ospedaliriuniti.marche.it Telephone:  +39-71-5965051 Fax:  +39-71-5965100  Received:  January 18, 2017 Peer-review started:  January 19, 2017 First decision:  February 9, 2017 Revised:  March 7, 2017 Accepted:  May 4, 2017 Article in press:  May 4, 2017 Published online: May 28, 2017 Abstract AIM To investigate the prognostic value of the radiologi - cal response after transarterial chemoembolization  3690 May 28, 2017 |Volume 23 |Issue 20 | WJG|www.wjgnet.comORIGINAL ARTICLE Radiological response and inflammation scores predict  tumour recurrence in patients treated with transarterial  chemoembolization before liver transplantationRetrospective Cohort Study Daniele Nicolini, Andrea Agostini, Roberto Montalti, Federico Mocchegiani, Cinzia Mincarelli,  Alessandra Mandolesi, Nicola L Robertson, Roberto Candelari, Andrea Giovagnoni, Marco VivarelliSubmit a Manuscript: http://www.f6publishing.com DOI: 10.3748/wjg.v23.i20.3690World J Gastroenterol   2017 May 28; 23(20): 3690-3701  ISSN 1007-9327 (print)  ISSN 2219-2840 (online)",Non-OADS,/arxiv_data1/oa_pdf/9d/b5/WJG-23-3690.PMC5449426.pdf
"World J  Gastroenterol  2017; 23(20): 3690-3701  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v23/i20/3690.htm   DOI:  http://dx.doi.org/10.3748/wjg.v23.i20.3690 INTRODUCTION Liver transplantation (LT) is the best chance of a cure  for patients with hepatocellular carcinoma (HCC)[1],  removing both the tumour and underlying cirrhosis,  known to be a premalignant condition.",Non-OADS,/arxiv_data1/oa_pdf/9d/b5/WJG-23-3690.PMC5449426.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 452  0",Non-OADS,/arxiv_data1/oa_pdf/9d/b5/WJG-23-3690.PMC5449426.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/Manuscript source:  Unsolicited manuscript Correspondence to: Hong Wu, MD, phD, Department of  Liver Surgery and Liver Transplantation Centre, West China  Hospital, Sichuan University, Chengdu 610041, Sichuan  Province, China.",Non-OADS,/arxiv_data1/oa_pdf/62/07/WJG-23-3702.PMC5449427.pdf
"RESULTS IVC replacement was carried out in 37 (68.5%) patients Submit a Manuscript: http://www.f6publishing.com DOI: 10.3748/wjg.v23.i20.3702 3702 May 28, 2017 |Volume 23 |Issue 20 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 May 28; 23(20): 3702-3712  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) ORIGINAL ARTICLE Surgical management of liver diseases invading the  hepatocaval confluence based on IH classification: The  surgical guideline in our centerRetrospective Study Wei Li, Jun Han, Zhao-ping Wu, Hong Wu",Non-OADS,/arxiv_data1/oa_pdf/62/07/WJG-23-3702.PMC5449427.pdf
"World J  Gastroenterol  2017; 23(20): 3702-3712  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v23/i20/3702.htm   DOI:  http://dx.doi.org/10.3748/wjg.v23.i20.3702 INTRODUCTION Liver malignancies including hepatocellular carcinoma  (HCC), intrahepatic cholangiocarcinoma (ICC) and  colorectal liver metastases, combined with liver  parasitic diseases like alveolar echinococcosis (AE),  often show an infiltrative growth pattern.",Non-OADS,/arxiv_data1/oa_pdf/62/07/WJG-23-3702.PMC5449427.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 452  0",Non-OADS,/arxiv_data1/oa_pdf/62/07/WJG-23-3702.PMC5449427.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to: Xiu-Yan Wang, Chief Physician, Department of Ultrasound, Tongji Hospital, Medical School  of Tongji University, No 389 Xincun Road, Shanghai 200065,  China.",Non-OADS,/arxiv_data1/oa_pdf/d5/7d/WJG-23-3713.PMC5449428.pdf
"RESULTS A total of 35 su bjects had abnormal serum miR-106b  3713 May 28, 2017 |Volume 23 |Issue 20 | WJG|www.wjgnet.comORIGINAL ARTICLE Study on the value of serum miR-106b for the early  diagnosis of hepatocellular carcinomaObservational Study Bao-Min Shi, Wen Lu, Kun Ji, Yu-Feng Wang, Shuai Xiao, Xiu-Yan WangSubmit a Manuscript: http://www.f6publishing.com DOI: 10.3748/wjg.v23.i20.3713World J Gastroenterol   2017 May 28; 23(20): 3713-3720  ISSN 1007-9327 (print)  ISSN 2219-2840 (online)",Non-OADS,/arxiv_data1/oa_pdf/d5/7d/WJG-23-3713.PMC5449428.pdf
World J Gastroenterol  2017; 23(20): 3713-3720   Available from: URL: http://www.wjgnet.com/1007-9327/full/ v23/i20/3713.htm   DOI: http://dx.doi.org/10.3748/wjg.v23.,Non-OADS,/arxiv_data1/oa_pdf/d5/7d/WJG-23-3713.PMC5449428.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 452  0",Non-OADS,/arxiv_data1/oa_pdf/d5/7d/WJG-23-3713.PMC5449428.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ manuscript source:  Unsolicited manuscript Correspondence to: Hong- lang li, mD, Chief physician,  Department of Gastrointestinal Surgery, The Second Affiliated  Hospital of Nanchang University, No.",Non-OADS,/arxiv_data1/oa_pdf/e5/49/WJG-23-3721.PMC5449429.pdf
"furthermore, prognosis-related factors,  as well as the expression of pCNA and E-cadherin, were  analyzed in patie nts with gastric cancer to determine Submit a Manuscript: http://www.f6publishing.com DOI: 10.3748/wjg.v23.i20.3721 3721 May 28, 2017 |Volume 23 |Issue 20 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 May 28; 23(20): 3721-3729  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) ORIGINAL ARTICLE Clinical significance of expression of proliferating cell  nuclear antigen and E-cadherin in gastric carcinomaProspective Study lin Hu, Hong-lang li, Wei-feng li, Jun-min Chen, Jian-tao Yang, Jun-Jing Gu, lin Xin",Non-OADS,/arxiv_data1/oa_pdf/e5/49/WJG-23-3721.PMC5449429.pdf
World J Gastroenterol  2017;  23(20): 3721-3729  Available from: UR l: http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/e5/49/WJG-23-3721.PMC5449429.pdf
com/1007-9327/full/v23/i20/3721.htm   DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e5/49/WJG-23-3721.PMC5449429.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 452  0",Non-OADS,/arxiv_data1/oa_pdf/e5/49/WJG-23-3721.PMC5449429.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to : Gen-Shu Wang, MD, �hD,�rofessor,  Gen-Shu Wang, MD, �hD, �rofessor,  Department of Hepatic Surgery and Liver Transplantation Center  of the Third Affiliated Hospital, Organ Transplantation Institute,  Sun Yat-Sen University, Guangzhou 510630, Guangdong Province,  China.",Non-OADS,/arxiv_data1/oa_pdf/70/ba/WJG-23-3730.PMC5449430.pdf
"Intraoperative and postoperative  outcomes (operative time, estimated blood loss,  postoperative li ver function, length of hospital stay,  analgesia use, complications, and survival rate) were META-ANALYSISSubmit a Manuscript: http://www.f6publishing.com DOI: 10.3748/wjg.v23.i20.3730 3730 May 28, 2017 |Volume 23 |Issue 20 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 May 28; 23(20): 3730-3743  ISSN 1007-9327 (print)  ISSN 2219-2840 (online)",Non-OADS,/arxiv_data1/oa_pdf/70/ba/WJG-23-3730.PMC5449430.pdf
wjgnet.com/1007-9327/full/v23/i20/3730.htm   DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/70/ba/WJG-23-3730.PMC5449430.pdf
"Available from: URL: http://onlinelibrary.wiley.com/o/cochrane/ clcmr/articles/CMR-7606/frame.html 28 Manterola C , Asenjo-Lobos C, Otzen T. [Hierarchy of evidence:  levels of evidence and grades of recommendation from current  use].",OADS,/arxiv_data1/oa_pdf/70/ba/WJG-23-3730.PMC5449430.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 452  0",Non-OADS,/arxiv_data1/oa_pdf/70/ba/WJG-23-3730.PMC5449430.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to: Wei-Lin Wang, MD, PhD,  Division  of Hepatobiliary and Pancreatic Surgery, Department of  Surgery, First Affiliated Hospital, School of Medicine, Zhejiang  University, 79 Qingchun Road, Hangzhou 310003, Zhejiang  Province, China.",Non-OADS,/arxiv_data1/oa_pdf/1b/b3/WJG-23-3744.PMC5449431.pdf
"wam@zju.edu.c n  Telephone:  +86-571-87236466 Fax:  +86-571-87236466  Received:  January 17, 2017 Peer-review started:  January 19, 2017 First decision:  February 10, 2016 Revised:  February 26, 2016 Accepted:  March 21, 2017    Article in press:  March 21, 2017 Published online: May 28, 2017CASE REPORTSubmit a Manuscript: http://www.f6publishing.com DOI: 10.3748/wjg.v23.i20.3744 3744 May 28, 2017 |Volume 23 |Issue 20 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 May 28; 23(20): 3744-3751  ISSN 1007-9327 (print)  ISSN 2219-2840 (online)",Non-OADS,/arxiv_data1/oa_pdf/1b/b3/WJG-23-3744.PMC5449431.pdf
World J Gastroenterol  2017;  23(20): 3744-3751  Available from: URL: http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/1b/b3/WJG-23-3744.PMC5449431.pdf
com/1007-9327/full/v23/i20/3744.htm   DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1b/b3/WJG-23-3744.PMC5449431.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 452  0",Non-OADS,/arxiv_data1/oa_pdf/1b/b3/WJG-23-3744.PMC5449431.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to : Kunihiko Kaneda, M �,�h�,  Kunihiko Kaneda, M �, �h�, Department  of Surgery, Kakogawa Central City Hospital, 439, Honmachi,  Kakogawa-cho, Kakogawa 675-8611, Japan.",Non-OADS,/arxiv_data1/oa_pdf/e2/d1/WJG-23-3752.PMC5449432.pdf
"Key words:  Laparoscopic surgery; India ink marking;  Small bowel hemangioma; Obscure gastrointestinal  bleeding; Minimally invasiveCASE REPORTSubmit a Manuscript: http://www.f6publishing.com DOI: 10.3748/wjg.v23.i20.3752 3752 May 28, 2017 |Volume 23 |Issue 20 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 May 28; 23(20): 3752-3757  ISSN 1007-9327 (print)  ISSN 2219-2840 (online)",Non-OADS,/arxiv_data1/oa_pdf/e2/d1/WJG-23-3752.PMC5449432.pdf
World J Gastroenterol  2017;  23(20): 3752-3757  Available from: URL: http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/e2/d1/WJG-23-3752.PMC5449432.pdf
com/1007-9327/full/v23/i20/3752.htm   DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e2/d1/WJG-23-3752.PMC5449432.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 452  0",Non-OADS,/arxiv_data1/oa_pdf/e2/d1/WJG-23-3752.PMC5449432.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to: Guillaume Léonard, PT, PhD,  Researcher,  Research Centre on Aging, Université de Sherbrooke,  1036 rue Belvédère Sud, Québec J1H 4C4, Canada.",Non-OADS,/arxiv_data1/oa_pdf/db/17/WJG-23-3758.PMC5449433.pdf
"Key words:  Transcranial direct current stimulation;  Transcutaneous electrical nerve stimulation; Pelvic  pain; Abdominal pain; Chronic painLETTERS TO THE EDITORSubmit a Manuscript: http://www.f6publishing.com DOI: 10.3748/wjg.v23.i20.3758 3758 May 28, 2017 |Volume 23 |Issue 20 | WJG|www.wjgnet.comWorld J Gastroenterol   2017 May 28; 23(20): 3758-3760  ISSN 1007-9327 (print)  ISSN 2219-2840 (online)",Non-OADS,/arxiv_data1/oa_pdf/db/17/WJG-23-3758.PMC5449433.pdf
World J Gastroenterol  2017;  23(20): 3758-3760  Available from: URL: http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/db/17/WJG-23-3758.PMC5449433.pdf
com/1007-9327/full/v23/i20/3758.htm   DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/db/17/WJG-23-3758.PMC5449433.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.f6publishing.com/helpdesk http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 452  0",Non-OADS,/arxiv_data1/oa_pdf/db/17/WJG-23-3758.PMC5449433.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Review Article https://doi.org/10.4070/kcj.2016.0017Print ISSN 1738-5520 • On-line ISSN 1738-5555",Non-OADS,/arxiv_data1/oa_pdf/d8/84/kcj-47-291.PMC5449520.pdf
Genetic Testing in Idiopathic DCM https://doi.org/10.4070/kcj.2016.0017 www.e-kcj.org292 arrhythmia (http://helpline.nih.go.kr).,Non-OADS,/arxiv_data1/oa_pdf/d8/84/kcj-47-291.PMC5449520.pdf
"Hyun-Young Park https://doi.org/10.4070/kcj.2016.0017 www.e-kcj.org293 adulthood, and the penetrance rate was estimated as 100% after  60 years of age.8) Conduction system diseases precede heart  failure development, which may cause sudden cardiac death with fetal ventricular arrhythmia.",Non-OADS,/arxiv_data1/oa_pdf/d8/84/kcj-47-291.PMC5449520.pdf
Genetic Testing in Idiopathic DCM https://doi.org/10.4070/kcj.2016.0017 www.e-kcj.org294 clinical Barth syndrome features.,Non-OADS,/arxiv_data1/oa_pdf/d8/84/kcj-47-291.PMC5449520.pdf
Hyun-Young Park https://doi.org/10.4070/kcj.2016.0017 www.e-kcj.org295 Table 2.,OADS,/arxiv_data1/oa_pdf/d8/84/kcj-47-291.PMC5449520.pdf
Genetic Testing in Idiopathic DCM https://doi.org/10.4070/kcj.2016.0017 www.e-kcj.org296 genetic testing recommendations.,Non-OADS,/arxiv_data1/oa_pdf/d8/84/kcj-47-291.PMC5449520.pdf
Hyun-Young Park https://doi.org/10.4070/kcj.2016.0017 www.e-kcj.org297 re-evaluated in sporadic cases due to technical advances in  genetics.,OADS,/arxiv_data1/oa_pdf/d8/84/kcj-47-291.PMC5449520.pdf
Genetic Testing in Idiopathic DCM https://doi.org/10.4070/kcj.2016.0017 www.e-kcj.org298 14.,Non-OADS,/arxiv_data1/oa_pdf/d8/84/kcj-47-291.PMC5449520.pdf
299 Copyright © 2017 The Korean Society of CardiologyKorean Circulation Journal Review Article https://doi.org/10.4070/kcj.2016.0303 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Idiopathic Polymorphic Ventricular Tachycardia:  a “Benign Disease”                                with a Touch of Bad Luck?,Non-OADS,/arxiv_data1/oa_pdf/ac/6a/kcj-47-299.PMC5449521.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ac/6a/kcj-47-299.PMC5449521.pdf
300 Idiopathic Polymorphic RVOT-VT https://doi.org/10.4070/kcj.2016.0303 www.e-kcj.orgpolymorphic VT invariably began with outflow tract ventricular  extrasystole with QRS morphology that was indistinguishable from numerous extrasystoles recorded over the years.,Non-OADS,/arxiv_data1/oa_pdf/ac/6a/kcj-47-299.PMC5449521.pdf
301 Sami Viskin https://doi.org/10.4070/kcj.2016.0303 www.e-kcj.org Definition The term “idiopathic polymorphic RVOT VT” should be reserved  for patients with frequent and otherwise typical outflow tract  ventricular ectopy (see “clinical characteristics” below) who develop rapid polymorphic VT as their only sustained arrhythmia or (not infrequently) in addition to well-tolerated sustained monomorphic VT (Fig.,Non-OADS,/arxiv_data1/oa_pdf/ac/6a/kcj-47-299.PMC5449521.pdf
"302  Idiopathic Polymorphic RVOT-VT https://doi.org/10.4070/kcj.2016.0303 www.e-kcj.org RVOT VT are not different from patients with the more common  and benign form of monomorphic RVOT VT. Not surprisingly, a history of syncope is reported more frequently among patients with polymorphic VT (Table 1).",Non-OADS,/arxiv_data1/oa_pdf/ac/6a/kcj-47-299.PMC5449521.pdf
303 Sami Viskin https://doi.org/10.4070/kcj.2016.0303 www.e-kcj.org coupling interval of extrasystoles initiating monomorphic VT and is  not different from the coupling intervals of extrasystoles that do not trigger arrhythmias (Table 2) (Fig.,Non-OADS,/arxiv_data1/oa_pdf/ac/6a/kcj-47-299.PMC5449521.pdf
"304  Idiopathic Polymorphic RVOT-VT https://doi.org/10.4070/kcj.2016.0303 www.e-kcj.org mapping of the RVOT has located these extrasystoles with positive  QRS in lead I to the posterior aspect of the RVOT.28) Mechanism In general, idiopathic RVOT arrhythmias are believed to be  due to triggered activity.29)30) As discussed in detail elsewhere,31)  initiation of polymorphic VT/VF, which is triggered  by an ectopic beat with a short coupling interval, could well represent the “normal” response to a timed electrical stimuli falling on the “vulnerable phase” of the ventricle at a point when the dispersion of ventricular refractoriness is greatest.",Non-OADS,/arxiv_data1/oa_pdf/ac/6a/kcj-47-299.PMC5449521.pdf
"305 Sami Viskin https://doi.org/10.4070/kcj.2016.0303 www.e-kcj.org second (moderator band) extrasystole is the real trigger of the  polymorphic VT (F. E. Marchlinski, personal communication).",Non-OADS,/arxiv_data1/oa_pdf/ac/6a/kcj-47-299.PMC5449521.pdf
306  Idiopathic Polymorphic RVOT-VT https://doi.org/10.4070/kcj.2016.0303 www.e-kcj.org Electrophysiol 2005;16:912-6.,Non-OADS,/arxiv_data1/oa_pdf/ac/6a/kcj-47-299.PMC5449521.pdf
307 Copyright © 2017 The Korean Society of CardiologyKorean Circulation Journal Review Article https://doi.org/10.4070/kcj.2016.0444  Print ISSN 1738-5520 • On-line ISSN 1738-5555 Data Sharing: a New Editorial Initiative from the International Committee of Medical Journal Editors.,Non-OADS,/arxiv_data1/oa_pdf/f9/c5/kcj-47-307.PMC5449522.pdf
308  Data Sharing https://doi.org/10.4070/kcj.2016.0444 www.e-kcj.org scientific community.,OADS,/arxiv_data1/oa_pdf/f9/c5/kcj-47-307.PMC5449522.pdf
https://doi.org/10.4070/kcj.2016.0444 www.e-kcj.orgidentifier of the data set.,OADS,/arxiv_data1/oa_pdf/f9/c5/kcj-47-307.PMC5449522.pdf
"310  Data Sharing https://doi.org/10.4070/kcj.2016.0444 www.e-kcj.org of clinical trial results and, subsequently, encouraged sharing  of research datasets whenever appropriate.21-23) More recently,  the WHO developed global norms for sharing data and results during public health emergencies, with special focus on clinical, epidemiologic, and genetic features of new infectious diseases and experimental therapeutics and vaccines.",Non-OADS,/arxiv_data1/oa_pdf/f9/c5/kcj-47-307.PMC5449522.pdf
https://doi.org/10.4070/kcj.2016.0444 www.e-kcj.orgprograming language is necessary.,Non-OADS,/arxiv_data1/oa_pdf/f9/c5/kcj-47-307.PMC5449522.pdf
312  Data Sharing https://doi.org/10.4070/kcj.2016.0444 www.e-kcj.org Cardiovascular Journals.,Non-OADS,/arxiv_data1/oa_pdf/f9/c5/kcj-47-307.PMC5449522.pdf
(Updated 2012) Available: http://www.CouncilScienceEditors.org.,Non-OADS,/arxiv_data1/oa_pdf/f9/c5/kcj-47-307.PMC5449522.pdf
Available: http://www.wame.org.,Non-OADS,/arxiv_data1/oa_pdf/f9/c5/kcj-47-307.PMC5449522.pdf
https://doi.org/10.4070/kcj.2016.0444 www.e-kcj.org35.,Non-OADS,/arxiv_data1/oa_pdf/f9/c5/kcj-47-307.PMC5449522.pdf
"314 Copyright © 2017 The Korean Society of CardiologyKorean Circulation Journal Editorial https://doi.org/10.4070/kcj.2017.0076 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Refer to the page 383-391 There is robust evidence that C-reactive protein (CRP) is a marker for  cardiovascular disease (CVD) and mortality in patients at risk, as well  as in patients with established CVD.1) AHA/ACC Guidelines recommend  CRP for CV risk assessment in asymptomatic intermediate-risk men 50 years of age or younger or women 60 years of age or younger with a IIb recommendation class.",Non-OADS,/arxiv_data1/oa_pdf/79/06/kcj-47-314.PMC5449523.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/79/06/kcj-47-314.PMC5449523.pdf
"315 Chul Soo Park https://doi.org/10.4070/kcj.2017.0076 www.e-kcj.orgimprove cardiovascular outcomes, and even posed a cardiovascular  risk.7) The COX-2 selective inhibitors may change the balance  between thromboxane A2 and prostacyclin production toward thromboxane A2 production which causes platelet aggregation, thrombus formation and vasoconstriction.",Non-OADS,/arxiv_data1/oa_pdf/79/06/kcj-47-314.PMC5449523.pdf
"316 Copyright © 2017 The Korean Society of CardiologyKorean Circulation Journal Editorial https://doi.org/10.4070/kcj.2017.0075 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Refer to the page 341-353 Heart failure (HF) is an important cardiovascular disease because  of its increasing prevalence, significant morbidity, high mortality,  and rapidly expanding health care costs.1) Acute heart failure (AHF)  refers to rapid onset or worsening of symptoms and/or signs of HF.",Non-OADS,/arxiv_data1/oa_pdf/ca/9a/kcj-47-316.PMC5449524.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ca/9a/kcj-47-316.PMC5449524.pdf
"https://doi.org/10.4070/kcj.2017.0075 www.e-kcj.orgTo prevent increasing HF burdens, it is essential to set up long- term effective prevention strategies for better control of ischemic  heart disease, hypertension, and diabetes, which might be risk factors for the development of HF.",Non-OADS,/arxiv_data1/oa_pdf/ca/9a/kcj-47-316.PMC5449524.pdf
318 Copyright © 2017 The Korean Society of CardiologyKorean Circulation Journal Editorial https://doi.org/10.4070/kcj.2017.0066 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Refer to the page 354-360 Chronic kidney disease (CKD) is a strong risk factor for  cardiovascular morbidity and mortality.,Non-OADS,/arxiv_data1/oa_pdf/07/4f/kcj-47-318.PMC5449525.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/07/4f/kcj-47-318.PMC5449525.pdf
"https://doi.org/10.4070/kcj.2017.0066 www.e-kcj.orgJong Shin Woostroke in a propensity matched study.6) As in this  study, PCI was  associated with a similar  risk of death, lower risk of stroke, and  higher risk of repeated revascularization in the long term.",Non-OADS,/arxiv_data1/oa_pdf/07/4f/kcj-47-318.PMC5449525.pdf
"The CathPCI registry was a founding member of the National Original Article https://doi.org/10.4070/kcj.2017.0070 Print ISSN 1738-5520 • On-line ISSN 1738-5555 The Practice Pattern of Percutaneous Coronary Intervention in Korea –Based on Year 2014 Cohort of Korean Percutaneous Coronary  Intervention (K-PCI) Registry– Hyeon-Cheol Gwon, MD1, Dong Woon Jeon, MD2, Hyun-Jae Kang, MD3, Jae-Sik Jang, MD4, Duk-Woo Park, MD5,  Dong-Ho Shin, MD6, Keon-Woong Moon, MD7, Jung-Sun Kim, MD6, Juhan Kim, MD8, Jang-Whan Bae, MD9,      Seung-Ho Hur, MD10, Byung Ok Kim, MD11, Donghoon Choi, MD6, Kyoo-Rok Han, MD12, and Hyo-Soo Kim, MD3  1Heart Vascular and Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, 2Division of Cardiology, National Health Insurance  Service Ilsan Hospital, Goyang, 3Department of Internal Medicine, Seoul National University Hospital, Seoul, 4Division of Cardiology, Busan Paik Hospital, University of Inje  College of Medicine, Busan, 5Division of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, 6Division of Cardiology, Severance Cardiovascular  Hospital, Yonsei University College of Medicine, Seoul, 7Division of Cardiology, St. Vincent’s Hospital, College of Medicine, The Catholic University of Korea, Suwon,  8Division of Cardiology, Heart Center of Chonnam National University Hospital, Gwangju, 9Department of Internal Medicine, Chungbuk National University College of  Medicine, Cheongju, 10Division of Cardiology, Keimyung University Dongsan Medical Center, Daegu, 11Division of Cardiology, Sanggye-Paik Hospital, University of Inje  College of Medicine, Seoul, 12Department of Internal Medicine, Kangdong Sacred Heart Hospital, Hallym University Medical Center, Seoul, Korea Background and Objectives: Appropriate use criteria (AUC) was developed to improve the quality of percutaneous coronary intervention (PCI).",Non-OADS,/arxiv_data1/oa_pdf/7d/df/kcj-47-320.PMC5449526.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7d/df/kcj-47-320.PMC5449526.pdf
"https://doi.org/10.4070/kcj.2017.0070 www.e-kcj.orgCardiovascular Data Registry (NCDR), which represents one of the  most important efforts to monitor the quality of PCI practice since 1997.",Non-OADS,/arxiv_data1/oa_pdf/7d/df/kcj-47-320.PMC5449526.pdf
322  Korean PCI Practice Pattern  https://doi.org/10.4070/kcj.2017.0070 www.e-kcj.org patients were enrolled from 92 high volume coronary intervention  centers out of a total 150 intervention centers currently operating in Korea.,Non-OADS,/arxiv_data1/oa_pdf/7d/df/kcj-47-320.PMC5449526.pdf
https://doi.org/10.4070/kcj.2017.0070 www.e-kcj.orgTable 1.,Non-OADS,/arxiv_data1/oa_pdf/7d/df/kcj-47-320.PMC5449526.pdf
"324  Korean PCI Practice Pattern  https://doi.org/10.4070/kcj.2017.0070 www.e-kcj.org PCI was performed electively in 66.7% of patients, and was otherwise  performed as an urgent or emergent procedure.",Non-OADS,/arxiv_data1/oa_pdf/7d/df/kcj-47-320.PMC5449526.pdf
"https://doi.org/10.4070/kcj.2017.0070 www.e-kcj.orgon clinical, angiographic, and procedural characteristics.",OADS,/arxiv_data1/oa_pdf/7d/df/kcj-47-320.PMC5449526.pdf
"326  Korean PCI Practice Pattern  https://doi.org/10.4070/kcj.2017.0070 www.e-kcj.org registry has been developed as a nationwide registry by the American  College of Cardiology in the United States as previously described.7)  Sweden and other European countries have also developed nationwide registries of PCI, established either by academic societies or the government.",Non-OADS,/arxiv_data1/oa_pdf/7d/df/kcj-47-320.PMC5449526.pdf
https://doi.org/10.4070/kcj.2017.0070 www.e-kcj.orgCommittee who modified the AUC used in the United States through  expert consensus.,Non-OADS,/arxiv_data1/oa_pdf/7d/df/kcj-47-320.PMC5449526.pdf
Supplementary Materials The online-only Data Supplements are available with article athttps://doi.org/10.4070/kcj.2017.0070.,Non-OADS,/arxiv_data1/oa_pdf/7d/df/kcj-47-320.PMC5449526.pdf
"2-5) Specifically, performance Original Article https://doi.org/10.4070/kcj.2017.0071 Print ISSN 1738-5520 • On-line ISSN 1738-5555 The Current Status of Percutaneous Coronary Intervention in Korea  –Based on Year 2014 Cohort of Korean Percutaneous Coronary Intervention (K-PCI) Registry– Jae-Sik Jang, MD1, Kyoo-Rok Han, MD2, Keon-Woong Moon, MD3,  Dong Woon Jeon, MD4, Dong-Ho Shin, MD5,  Jung-Sun Kim, MD5, Duk-Woo Park, MD6, Hyun-Jae Kang, MD7, Juhan Kim, MD8, Jang-Whan Bae, MD9,   Seung-Ho Hur, MD10, Byung Ok Kim, MD11, Donghoon Choi, MD5, Hyeon-Cheol Gwon, MD12, and Hyo-Soo Kim, MD7 1Division of Cardiology, Busan Paik Hospital, University of Inje College of Medicine, Busan, 2Department of Internal Medicine, Kangdong Sacred Heart Hospital, Hallym  University Medical Center, Seoul, 3Division of Cardiology, St. Vincent’s Hospital, The Catholic University of Korea, Suwon, 4Division of Cardiology, National Health Insurance  Service Ilsan Hospital, Goyang, 5Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, 6Division of Cardiology, Asan  Medical Center, University of Ulsan College of Medicine, Seoul, 7Department of Internal Medicine, Seoul National University Hospital, Seoul, 8Division of Cardiology, Heart  Center of Chonnam National University Hospital, Gwangju, 9Department of Internal Medicine, Chungbuk National University College of Medicine, Cheongju, 10Division of  Cardiology, Keimyung University Dongsan Medical Center, Daegu, 11Division of Cardiology, Sanggye-Paik Hospital, University of Inje College of Medicine, Seoul, 12Heart  Vascular and Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea Background and Objectives:  Although several multicenter registries have evaluated percutaneous coronary intervention (PCI) procedures in  Korea, those databases have been limited by non-standardized data collection and lack of uniform reporting methods.",Non-OADS,/arxiv_data1/oa_pdf/15/94/kcj-47-328.PMC5449527.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/15/94/kcj-47-328.PMC5449527.pdf
https://doi.org/10.4070/kcj.2017.0071 www.e-kcj.orgmeasures for PCI and ST-elevation myocardial infarction (STEMI)/ non-ST-elevation myocardial infarction (NSTEMI) were established to guide physicians with approaches for these interventions.,Non-OADS,/arxiv_data1/oa_pdf/15/94/kcj-47-328.PMC5449527.pdf
"330  2014 Korean PCI Registry https://doi.org/10.4070/kcj.2017.0071 www.e-kcj.org Statistical analysis Discrete data for demographic, clinical, procedural and outcome  variables were presented as numbers and percentages and compared  using Chi-square tests.",OADS,/arxiv_data1/oa_pdf/15/94/kcj-47-328.PMC5449527.pdf
https://doi.org/10.4070/kcj.2017.0071 www.e-kcj.orgyears and the proportion of male patients was 70.3% (Fig.,OADS,/arxiv_data1/oa_pdf/15/94/kcj-47-328.PMC5449527.pdf
